References | The Antimicrobial Index Knowledgebase

Search All
Search by Antimicrobial
Search by Microorganism

Home › Reference

References

1Waitz, J. A., F. Sabatelli, F. Menzel, and E. L. Moss, Jr. 1974. Antibiotic G-418, a New Micromonospora-produced aminoglycoside with activity against protozoa and helminths: biological activity. Antimicrob. Agents Chemother. 6:579-582
2Harwick, H. J., G. Kalmanson, and L. B. Guze. 1973. In vitro activity of ampicillin or vancomycin combined with gentamicin or streptomycin against enterococci. Antimicrob. Agents Chemother. 4:383-387
3Nilius, A. M., L. L. Shen, D. Hensey-Rudloff, L. S. Almer, J. M. Beyer, D. J. Balli, Y. Cai, and R. K. Flamm. 2003. In vitro antibacterial potency and spectrum of ABT-492, a new fluoroquinolone. Antimicrob. Agents Chemother. 47:3260-3269
4Sorlozano A, Gutierrez J, Romero JM, de Dios LJ, Damas M, Piedrola G.. 2007. Activity in vitro of twelve antibiotics against clinical isolates of extended-spectrum beta-lactamase producing Escherichia coli. J Basic Microbiol 47:413-416
5Roblin, P. M. , and M. R. Hammerschlag. 1998. In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae. Antimicrob. Agents Chemother. 42:1515–1516
6Biedenbach, D. J., M. L. Beach, and R. N. Jones.. 2001. In vitro antimicrobial activity of GAR-936 tested against antibiotic resistant gram-positive blood stream infection isolates and strains producing extended-spectrum betalactamases. Diagn. Microbiol. Infect. Dis. 40:173–177
7Rybak, M. J., E. Hershberger, T. Moldovan, and R. G. Grucz. 2000. In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against staphylococci and enterococci, including vancomycin-intermediate and -resistant strains. Antimicrob. Agents Chemother. 44:1062–1066
8Strigl, S., P. M. Roblin, T. Reznik, and M. R. Hammerschlag. 2000. In vitro activity of ABT 773, a new ketolide antibiotic, against Chlamydia pneumoniae. Antimicrob. Agents Chemother. 44:1112–1113
9Li, Ren-Kai, Ciblak, M. A. , Nordoff, N., Pasarell, L. , Warnock, D. W. and McGinnis. M. R. 2000. In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum. Antimicrob. Agents Chemother. 44:1734–1736
10Espinel-Ingroff, A.. 1998. Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J. Clin. Microbiol. 36:2950–2956
11Rybak, M. J., Cappelletty, D. M. , Moldovan, T., Aeschlimann, J. R.and Kaatz. G. W. 1998. Comparative in vitro activity and postantibiotic effects of the oxazolidinone compounds eperezolid (PNU-100592) and linezolid (PNU-100766) versus vancomycin against Staphylococcus aureus, coagulase-negativestaphylococci, Enterococcus faecalis, and Enterococcus faecium. Antimicrob.Agents Chemother. 42:721–724
12Milatovic, D., Schmitz, F. J. , Brisse, S. , Verhoef, J. and Fluit, A. C. 2000. In vitro activities of sitafloxacin (DU-6859a) and six other fluoroquinolones against 8,796 clinical bacterial isolates. Antimicrob. Agents Chemother. 44: 1102–1107
13Snydman, D. R., Jacobus, N. V. , McDermott, L. A. , Lonks, J. R. and Boyce, J. M. 2000. Comparative in vitro activities of daptomycin and vancomycin against resistant gram-positive pathogens. Antimicrob. Agents Chemother. 44:3447–3450
14Ge, Y., D. L. MacDonald, K. J. Holroyd, C. Thornsberry, H. Wexler, and M. Zasloff. 1999. In vitro antibacterial properties of pexiganan, an analog of magainin. Antimicrob. Agents Chemother. 43:782–788
15Nilius, A. M., M. H. Bui, L. Almer, D. Hensey-Rudloff, J. Beyer, Z. Ma, Y. S. Or, and R. K. Flamm. 2001. Comparative in vitro activity of ABT-773, a novel antibacterial ketolide. Antimicrob. Agents Chemother. 45:2163–2168
16Petersen, P., P. Bradford, W. Weiss, T. Murphy, P. Sum, and S. Projan. 2002. In vitro and in vivo activities of tigecycline (GAR-936), daptomycin, and comparative antimicrobial agents against glycopeptide-intermediate Staphylococcus aureus and other resistant gram-positive pathogens. Antimicrob. Agents Chemother. 46:2595-2601
17Takahata, M., J. Mitsuyama, Y. Yamashiro, M. Yonezawa, H. Araki, Y. Todo, S. Minami, Y. Watanabe, and H. Narita. 1999. In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone. Antimicrob. Agents Chemother. 43:1077–1084
18Barry, A. L., P. C. Fuchs, and S. D. Brown. 1998. In vitro activities of the ketolide HMR 3647 against recent gram-positive clinical isolates and Haemophilus influenzae. Antimicrob. Agents Chemother. 42:2138–2140
19Souli, M., C. B. Wennersten, and G. M. Eliopoulos. 1998. In vitro activity of BAY 12-8039, a new fluoroquinolone, against species representative of respiratory tract pathogens. Int. J. Antimicrob. Agents 10:23–30
20Brickner, S. J., D. K. Hutchinson, M. R. Barbachyn, P. R. Manninen, D. A. Ulanowicz, S. A. Garmon, K. C. Grega, S. K. Hendges, D. S. Toops, G. E. Zurenko, and C. W. Ford. 1996. Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections. J. Med. Chem. 39:673–679
21Jones, M. E., M. R. Visser, M. Klootwijk, P. Heisig, J. Verhoef, and F.-J. Schmitz. 1999. Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, oflaxacin, sparfloxacin, and trovafloxacin and nonquinolones linozelid quinupristin-dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxacin-resistant and –susceptible Staphylococcus aureus strains. Antimicrob. Agents Chemother. 43:421–423
22Aeschlimann, J. R., L. D. Dresser, G. W. Kaatz, and M. J. Rybak. 1999. Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus. Antimicrob. Agents Chemother. 43:335–340
23W. E. WICK, D. A. PRESTON, W. A. WHITE, AND R. S. GORDEE 1973. Compound 64716, a New Synthetic Antibacterial Agent ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 415-420
24Patel, R., M. S. Rouse, K. E. Piper, and J. M. Steckelberg. 2000. In vitro activity of GAR-936 against vancomycin-resistant enterococci, methicillinresistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae. Diagn. Microbiol. Infect. Dis. 38:177–179
25Pachon-Ibanez, M. E., M. E. Jimenez-Mejias, C. Pichardo, A. C. Llanos, and J. Pachon. 2004. Activity of tigecycline (GAR-936) against Acinetobacter baumannii strains, including those resistant to imipenem. Antimicrob. Agents Chemother. 48:4479–4481
26Ji, B., N. Lounis, C. Maslo, C. Truffot-Pernot, P. Bonnafous, and J. Grosset. 1998. In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 42:2066–2069
27 S. N. Pandeya, D. Sriram, G. Nath and E. De Clercq 1999. Synthesis, antibacterial antifungal and anti-HIV activities of Schiff and Mannich bases derivatives from isatin derivatives and N-4-(4´-chlorophenyl) thiazol-2-ylthiosemicarbazides, Eur. J. Pharm. Sci. 9:25–31
28Schulin, T., C. B. Wennersten, M. J. Ferraro, R. C. Moellering, and G. M. Eliopoulous. 1998. Susceptibilities of Legionella spp. to newer antimicrobials in vitro. Antimicrob. Agents Chemother. 42:1520–1523
29Goldstein, E. J. C., D. M. Citron, C. V. Merriam, U. Warren, K. Tyrell, and H. T. Fernandez. 2003. In vitro activities of dalbavancin and nine comparator agents against anaerobic gram-positive species and corynebacteria. Antimicrob. Agents Chemother. 47:1968-1971
30Lister, P. D., and C. C. Sanders. 1999. Pharmacodynamics of trovafloxacin, ofloxacin, and ciprofloxacin against Streptococcus pneumoniae in an in-vitro pharmacokinetic model. Antimicrob. Agents Chemother. 43:1118–1123
31Be´be´ar, C. M., H. Renaudin, A. Bryskier, and C. Be´be´ar. 2000. Comparative activities of telithromycin (HMR 3647), levofloxacin, and other antimicrobial agents against human mycoplasmas. Antimicrob. Agents Chemother. 44: 1980–1982
32Edelstein, P. H., and M. A. C. Edelstein. 1999. In vitro activity of the ketolide HMR 3647 (RU 6647) for Legionella spp., its pharmacokinetics in guinea pigs, and use of the drug to treat guinea pigs with Legionella pneumophila pneumonia. Antimicrob. Agents Chemother. 43:90–95
33Musicki, B., A. M. Periers, P. Laurin, D. Ferroud, Y. Benedetti, S. Lachaud, F. Chatreaux, J. L. Haesslein, A. Iltis, C. Pierre, J. Khider, N. Tessot, M. Airault, J. Demassey, C. Dupuis-Hamelin, P. Lassaigne, A. Bonnefoy, P. Vicat, and M. Klich. 2000. Improved antibacterial activities of coumarin antibiotics bearing 5_,5_-dialkylnoviose: biological activity of RU79115. Bioorg. Med. Chem. Lett. 10:1695–1699
34van Ogtrop, M. L., D. Andes, T. J. Stamstad, B. Conklin, W. J. Weiss, W. A. Craig, and O. Vesga. 2000. In vivo pharmacodynamic activities of two glycylcyclines (GAR-936 and WAY 152,288) against various gram-positive and gram-negative bacteria. Antimicrob. Agents Chemother. 44:943–949
35Betriu, C., M. Redondo, M. L. Palau, A. Sanchez, M. Gomez, E. Culebras, A. Boloix, and J. J. Picazo. 2000. Comparative in vitro activities of linezolid, quinupristin-dalfopristin, moxifloxacin, and trovafloxacin against erythromycin- susceptible and -resistant streptococci. Antimicrob. Agents Chemother. 44:1838–1841
36Hoban, D. J., S. K. Bouchillon, B. M. Johnson, J. L. Johnson, and M. J. Dowzicky. 2005. In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST program, 2004). Diagn. Microbiol. Infect. Dis. 52:215–227
37Labthavikul, P., P. J. Petersen, and P. A. Bradford. 2003. In vitro activity of tigecycline against Staphylococcus epidermidis growing in an adherent cell biofilm model. Antimicrob. Agents Chemother. 47:3967–3969
38Foroumadi A., Mansouri S., Kiani Z., Rahmani A. 2003. Synthesis and in vitro antibacterial evaluation of N-[5-(5-nitro-2-thienyl)-1, 3, 4-thiadiazole-2-yl] piperazinyl quinolones . Eur. J. Med. Chem. 38:851—854
39Fritsche, T. R., J. T. Kirby, and R. N. Jones. 2004. In vitro activity of tigecycline (GAR-936) tested against 11,859 recent clinical isolates associated with community-acquired respiratory tract and gram-positive cutaneous infections. Diagn. Microbiol. Infect. Dis. 49:201–209
40Hikida, M., K. Itahashi, A. Igarashi, T. Shiba, and M. Kitamura. 1999. In vitro antibacterial activity of LJC11,036, an active metabolite of L-084, a new oral carbapenem antibiotic with potent antipneumococcal activity. Antimicrob. Agents Chemother. 43:2010–2016
41Mabe, K., M. Yamada, I. Oguni, and T. Takahashi. 1999. In vitro and in vivo activities of tea catechins against Helicobacter pylori. Antimicrob. Agents Chemother. 43:1788–1791
42Bouchillon, S. K., D. J. Hoban, B. M. Johnson, J. L. Johnson, A. Hsiung, and M. J. Dowzicky. 2005. In vitro activity of tigecycline against 3989 gram-negative and gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004). Diagn. Microbiol. Infect. Dis. 52:173-179
43Garcia-Garrote, F., E. Cercenado, L. Alcala, and E. Bouza. 1998. In vitro activity of the new glycopeptide LY333328 against multiply resistant gram-positive clinical isolates. Antimicrob. Agents Chemother. 42:2452–2455
44K. Ingólfsdóttir, G. A. C. Chung, V. G. Skúlason, S. R. Gissurarson and M. Vilhelmsdóttir 1998. Antimycobacterial activity of lichen metabolites in vitro. Eur. J. Pharm. Sci. 6:141-144
45Brueggemann, A. B., G. V. Doern, H. K. Huynh, E. M. Wingret, and P. R. Rhomberg. 2000. In vitro activity of ABT-773, a new ketolide, against recent clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Antimicrob. Agents Chemother. 44:447–449
46Hoellman, D. B., G. A. Pankuch, M. R. Jacobs, and P. C. Appelbaum. 2000. Antipneumococcal activities of GAR-936 (a new glycylcycline) compared to those of nine other agents against penicillin-susceptible and -resistant pneumococci. Antimicrob. Agents Chemother. 44:1085–1088
47Projan, S. J. 2000. Preclinical pharmacology of GAR-936, a novel glycylcyline antibacterial agent. Pharmacotherapy 20:219S–223S
48Mushtaq, S., Y. Ge, and D. M. Livermore. 2004. Doripenem versus Pseudomonas aeruginosa in vitro: activity against characterized isolates, mutants, and transconjugants and resistance selection potential. Antimicrob. Agents Chemother. 48:3086-3092
49Farrell, D. J., I. Morrissey, S. Bakker, S. Buckridge, and D. Felmingham. 2004. In vitro activities of telithromycin, linezolid, and quinupristin-dalfopristin against Streptococcus pneumoniae with macrolide resistance due to ribosomal mutations. Antimicrob. Agents Chemother. 48:3169–3171
50Callegan MC, Ramirez R, Kane ST, Cochran DC, Jensen H.; 2003. Antibacterial activity of the fourth-generation fluoroquinolones gatifloxacin and moxifloxacin against ocular pathogens. Adv Ther. 20(5):246–252
51Nicas, T. I., D. L. Mullen, J. E. Flokowitsch, D. A. Preston, N. J. Snyder, R. E. Stratford, and R. D. Cooper. 1995. Activities of the semisynthetic glycopeptide LY191145 against vancomycin-resistant enterococci and other gram-positive bacteria. Antimicrob. Agents Chemother 39:2585–2587
52Bemer-Melchior, P., M. E. Juvin, S. Tassin, A. Bryskier, G. C. Schito, and H. B. Drugeon. 2000. In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes: influence of resistance mechanisms and methodological factors. Antimicrob. Agents Chemother. 44:2999–3002
53Wexler, H. M., A. E. Engel, D. Glass, and C. Li. 2005. In vitro activities of doripenem and comparator agents against 364 anaerobic clinical isolates. Antimicrob. Agents Chemother. 49:4413–4417
54Oluwatuyi M, Kaatz GW, Gibbons S. 2004. Antibacterial and resistance modifying activity of Rosmarinus officinalis. Phytochemistry 65: 3249–54
55Bouchillon, S. K., D. J. Hoban, B. M. Johnson, T. M. Stevens, M. J. Dowzicky, D. H. Wu, and P. A. Bradford. 2005. In vitro evaluation of tigecycline and comparative agents in 3,049 clinical isolates: 2001 to 2002. Diagn. Microbiol. Infect. Dis 51:291–295
56Miyazaki, S., T. Hosoyama, N. Furuya, Y. Ishii, T. Matsumoto, A. Ohno, K. Tateda, and K. Yamaguchi. 2001. In vitro and in vivo antibacterial activities of L-084, a novel oral carbapenem, against causative organisms of respiratory tract infections. Antimicrob. Agents Chemother. 45:203–207
57Cha, R., W. J. Brown, and M. J. Rybak. 2003. Bactericidal activities of daptomycin, quinupristin-dalfopristin, and linezolid against vancomycin-resistant Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations. Antimicrob. Agents Chemother. 47:3960–3963
58Denis, A., C. Agouridas, J. M. Auger, Y. Benedetti, A. Bonnefoy, F. Bretin, J. F. Chantot, A. Dussarat, C. Fromentin, S. G. D’Ambrieres, S. Lachaud, P. Laurin, O. Le Martret, V. Loyau, N. Tessot, J. M. Pejac, and S. Perron. 1999. Synthesis and antibacterial activity of HMR 3647 a new ketolide highly potent against erythromycin-resistant and susceptible pathogens. Bioorg. Med. Chem. Lett. 9:3075–3080
59Piddock, L. J. V., M. Johnson, V. Ricci, and S. L. Hill. 1998. Activities of new fluoroquinolones against fluoroquinolone-resistant pathogens of the lower respiratory tract. Antimicrob. Agents Chemother. 42:2956–2960
60Iauk L, Lo Bue AM, Milazzo I, Rapisarda A, Blandino G. 2003. Antibacterial activity of medicinal plant extracts against periodontopathic bacteria. Phytother Res 17: 599-604
61Rastogi, N., K. S. Goh, M. Berchel, and A. Bryskier. 2000. In vitro activities of the ketolides telithromycin (HMR 3647) and HMR 3004 compared to those of clarithromycin against slowly growing mycobacteria at pHs 6.8 and 7.4. Antimicrob. Agents Chemother. 44:2848–2852
62Sierra JM, Ruiz J, Navia MM, Vargas M, Gascon J, Vila J. 2001. In vitro activity of rifaximin against enteropathogens producing traveler’s diarrhea. Antimicrob Agents Chemother. 45:643–644
63McFarland, J. W.; Berger, C. M.; Froshauer, S. A.; Hayashi, S. F.; Hecker, S. J.; Jaynes, B. H.; Jefson, M. R.; Kamicker, B. J.; Lipinski, C. A.; Lundy, K. M.; Reese, C. P.; Vu, C. B. 1997. Quantitative structureactivity relationships among macrolide antibacterial agents: In vitro and in vivo potency against Pasteurella multocida. J. Med. Chem. 40:1340–1346
64Tegos, G., F. R. Stermitz, O. Lomovskaya, and K. Lewis. 2002. Multidrug pump inhibitors uncover remarkable activity of plant antimicrobials. Antimicrob. Agents Chemother. 46:3133–3141
65Fuchs PC, Barry AL, Brown SD. 1998. In vitro antimicrobial activity of MSI-78, a magainin analog. Antimicrob Agents Chemother. 42(5):1213-1216.
66Kowalski RP, Dhaliwal DK, Karenchak LM, Romanowski EG, Mah FS,Ritterband DC, Gordon YJ. 2003. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. Am J Ophthalmol. 136:500-505
67Fuchs, P. C., A. L. Barry, and S. D. Brown. 2000. Daptomycin susceptibility tests: interpretive criteria, quality control, and effect of calcium on in vitro tests Diagn. Microbiol. Infect. Dis. 38:51–58
68Kone WM, Atindehou KK, Terreaux C, Hostettmann K, Traore D, Dosso M 2004. Traditional medicine in north Cote-d'Ivoire: screening of 50 medicinal plants for antibacterial activity. Journal of ethnopharmacology 93:43-49
69Gibbons, S., and E. E. Udo. 2000. The effect of reserpine, a modulator of multidrug efflux pumps, on the in vitro activity of tetracycline against clinical isolates of methicillin resistant Staphylococcus aureus (MRSA) possessing the tet(K) determinant. Phytother. Res. 14:139–140
70Trujillano-Martin, I., E. Garcia-Sanchez, I. M. Martinez, M. J. Fresnadillo, J. E. Garcia-Sanchez, and J. A. Garcia-Rodriguez. 1999. In vitro activities of six new fluoroquinolones against Brucella melitensis. Antimicrob. Agents Chemother. 43:194–195
71Pfaller, M. A., D. J. Diekema, R. N. Jones, H. S. Sader, A. C. Fluit, R. J. Hollis, S. A. Messer, et al. 2001. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY Antimicrobial Surveillance Program. J. Clin. Microbiol. 39:3254–3259
72Lin, G., K. Credito, L. M. Ednie, and P. C. Appelbaum. 2005. Antistaphylococcal activity of dalbavancin, an experimental glycopeptide. Antimicrob. Agents Chemother. 49:770–772
73Jansen, W. T., A. Verel, J. Verhoef, and D. Milatovic. 2007. In vitro activity of telavancin against gram-positive clinical isolates recently obtained in Europe. Antimicrob. Agents Chemother. 51:3420–3424
74Rhomberg PR, Jones RN. 2002. In vitro activity of 11 antimicrobial agents, including gatifloxacin and GAR936, tested against clinical isolates of Mycobacterium marinum. Diagn Microbiol Infect Dis 42: 145–147
75Brown-Elliott B. A., R. J. Wallace, Jr., C. J. Crist, L. Mann, and R. W. Wilson. 2002. Comparison of in vitro activities of gatifloxacin and ciprofloxacin against four taxa of rapidly growing mycobacteria. Antimicrob. Agents Chemother. 46:3283–3285
76Alovero, F. L., X.-S. Pan, J. E. Morris, R. H. Manzo, and L. M. Fisher. 2000. Engineering the specificity of antibacterial fluoroquinolones: benzenesulfonamide modifications at C-7 of ciprofloxacin change its primary target in Streptococcus pneumoniae from topoisomerase IV to gyrase. Antimicrob. Agents Chemother. 44:320–325
77Tsuchiya, H., M. Sato, T. Miyazaki, S. Fujiwara, S. Tanigaki, M. Ohyama, T. Tanaka, and M. Iinuma. 1996. Comparative study on the antibacterial activity of phytochemical flavanones against methicillin-resistant Staphylococcus aureus. J. Ethnopharmacol. 50:27–34.
78Hong CY, Kim YK, Chang JH, Kim SH, Choit H, Nam DH, Kim YZ, Kwak JH. 1997. Novel fluoroquinolone antibacterial agents containing oxime-substituted(aminomethyl) pyrrolidines: synthesis and antibacterial activity of 7- (4- (aminomethyl)-3- (methoxyimino)pyrrolidin-1 -yl) - 1 -cyclopropyl-6- fluoro-4-oxo- 1,4-dihydro [ 1,8 ]naphthyridine-3-carboxylic acid (LB20304). J Med Chem 40 (22) : 3584-3593.
79Kawakami Y, Akahane T, Yamaguchi M, Oana K, Takahashi Y, Okimura Y, Okabe T, Gotoh A,Katsuyama T. 2000. In vitro activities of rabeprazole, a novel proton pump inhibitor, and its thioether derivative alone and in combination with other antimicrobials against recent clinical isolates of Helicobacter pylori. Antimicrob Agents Chemother 44: 458-461
80Santos FA, Bastos EMA, Uzeda B, Carvalho MAR, Farias ESA, Braga FC. 2002. Antibacterial activity of Brazilian propolis and fractions against oral anaerobic bacteria. J Ethnopharmacol 80: 1-7.
81Yamaguchi, T., Y. Hirakata, K. Izumikawa, Y. Miyazaki, S. Miyasaki, K. Tomono, Y. Yamada, S. Kamihira, and S. Kohno. 2000. In vitro activity of telithromycin (HMR 3647), a new ketolide, against clinical isolates of Mycoplasma pneumoniae in Japan. Antimicrob. Agents Chemother 44:1381– 1382
82Akins, R. L., and M. J. Rybak. 2001. Bactericidal activities of two daptomycin regimens against clinical strains of glycopeptide intermediate-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and methicillin- resistant Staphylococcus aureus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations. Antimicrob. Agents Chemother 45:454–459
83Wise, R., J. M. Andrews, and J. Ashby 2002. In vitro activities of peptide deformylase inhibitors against gram-positive pathogens. Antimicrob. Agents Chemother. 46:1117–1118.
84Jones, R. N., D. J. Biedenbach, M. A. T. Croco, and M. S. Barrett. 1998. In vitro evaluation of a novel orally administered cephalosporin (cefditoren) tested against 1249 recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae. Diagn. Microbiol. Infect. Dis. 31:573–578.
85Jones, R. N., D. J. Biedenbach, M. E. Erwin, M. L. Beach, and M. A. Pfaller. 1999. Activity of gatifloxacin against Haemophilus influenzae and Moraxella catarrhalis, including susceptibility test development, E-test comparisons, and quality control guidelines for H. influenzae. J. Clin. Microbiol. 37:1999–2002.
86Saez-Nieto, J. A. & Vazquez, J. A. 1999. In vitro activities of ketolides HMR 3647 and HMR 3004, levofloxacin, and other quinolones and macrolides against Neisseria spp. and Moraxella catarrhalis.. Antimicrobial Agents and Chemotherapy 43:983–984
87Barbachyn, M. R., D. K. Hutchinson, S. J. Brickner, M. H. Cynamon, O. J. Kilburn, S. P. Klemens, S. E. Glickman, K. C. Grega, S. K. Hendges, D. S. Toops, C. W. Ford, and G. E. Zurenko.. 1996. Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity. J. Med. Chem 39:680–685
88Hackbarth, D. J., D. Z. Chen, J. G. Lewis, K. Clark, J. B. Mangold, J. A. Cramer, P. S. Margolis, W. Wang, J. Koehn, C. Wu, S. Lopez, G. Withers, H. Gu, E. Dunn, R. Kulathila, S. H. Pan, W. L. Porter, J. Jacobs, J. Trias, D. V. Patel, B. Weidmann, R. J. White, and Z. Yuan. 2002. N-Alkyl urea hydroxamic acids as a new class of peptide deformylase inhibitors with antibacterial activity Antimicrob. Agents Chemother 46:2752–2764.
89Singh, M. P., P. J. Petersen, W. J. Weiss, J. E. Janso, S. W. Luckman, E. B. Lenoy, P. A. Bradford, R. T. Testa, and M. Greenstein. 2003. Mannopeptimycins, new cyclic glycopeptide antibiotics produced by Streptomyces hygroscopicus LL-AC98: antibacterial and mechanistic activities. Antimicrob. Agents Chemother. 47:62–69.
90Ruiz-Serrano, M. J., L. Alcala, L. Martinez, M. Diaz, M. Marin, M. J. Gonzalez-Abad, and E. Bouza. 2000. In vitro activities of six fluoroquinolones against 250 clinical isolates of Mycobacterium tuberculosis susceptible or resistant to first-line antituberculosis drugs. Antimicrob. Agents Chemother. 44:2567-2568
91Chohan ZH, Supuran CT. 2005. In-vitro antibacterial and cytotoxic activity of cobalt (II), copper (II), nickel (II) and zinc (II) complexes of the antibiotic drug cephalothin (keflin). Journal of Enzyme Inhibition and Medicinal Chemistry. 20(5):463–468
92LaPlante, K. L., and M. J. Rybak. 2004. Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model. Antimicrob. Agents Chemother. 48:4665-4672
93Morosini, M. I., M. Garcia-Castillo, T. M. Coque, A. Valverde, A. Novais, E. Loza, F. Baquero, and R. Canton. 2006. Antibiotic coresistance in extendedspectrum- beta-lactamase-producing Enterobacteriaceae and in vitro activity of tigecycline. Antimicrob. Agents Chemother. 50:2695–2699
94Martinez-Martinez, L., A. Pascual, S. Hernandez-Alles, D. Alvarez-Diaz, A. I. Suarez, J. Tran, V. J. Benedi, and G. A. Jacoby. 1999. Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae. Antimicrob. Agents Chemother. 43:1669–1673
95Malay, S., P. M. Roblin, T. Reznik, A. Kutin, and M. R. Hammerschlag 2002. In vitro activities of BMS-284756 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae. Antimicrob. Agents Chemother. 46:517–518.
96Friedrich, C. L., D. Moyles, T. J. Beveridge, and R. E. Hancock. 2000. Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria. Antimicrob. Agents Chemother. 44:2086–2092
97Chen, Y., E. Garber, Q. Zhao, Y. Ge, M. A. Wikler, K. Kaniga, and L. Saiman. 2005. In vitro activity of doripenem (S-4661) against multidrugresistant gram-negative bacilli isolated from patients with cystic fibrosis. Antimicrob. Agents Chemother. 49:2510–2511.
98Betriu, C., E. Culebras, I. Rodriguez-Avial, M. Gomez, B. A. Sanchez, and J. J. Picazo. 2000. In vitro activities of tigecycline against erythromycinresistant Streptococcus pyogenes and Streptococcus agalactiae: mechanisms of macrolide and tetracycline resistance. Antimicrob. Agents Chemother. 48: 323–325
99Fuchs, P. C., A. L. Barry, and S. D. Brown. 2000. Bactericidal activity of quinupristin-dalfopristin against Staphylococcus aureus: clindamycin susceptibility as a surrogate indicator. Antimicrob. Agents Chemother 44:2880– 2882.
100Katsura, H., R. Tsukiyama, A. Suzuki, and M. Kobayashi.. 2001. In vitro antimicrobial activity of bakuchiol against oral microorganisms. Antimicrob. Agents Chemother 45:3009–3013.
101Jarvest, J. R., J. M. Berge, V. Berry, H. F. Boyd, M. J. Brown, J. S. Elder, A. K. Forrest, A. P. Fosberry, D. R. Gentry, M. J. Hibbs, D. D. Jaworski, P. J. O’Hanlon, A. J. Pope, S. Rittenhouse, R. J. Sheppard, C. Slater-Radosti, and A. Worby.. 2002. Nanomolar inhibitors of Staphylococcus aureus methionyl tRNA synthetase with potent antibacterial activity against gram-positive pathogens. J. Med. Chem. 45:1952–1962
102Bassetti, M., L. M. Dembry, P. A. Farrel, D. A. Callan, and V. T. Andriole. 2002. Antimicrobial activities of BMS-284756 compared with those of fluoroquinolones and beta-lactams against gram-positive clinical isolates. Antimicrob. Agents Chemother. 46:234–238.
103Priebe, S., and S. Schwarz. 2003. In vitro activities of florfenicol against bovine and porcine respiratory tract pathogens. Antimicrob. Agents Chemother. 47:2703–2705.
104Qi LF, Xu ZR, Jiang X, Hu CH, Zou XF. 2004. Preparation and antibacterial activity of chitosan nanoparticles. Carbohyd Res 339: 2693-2700
105Kanamaru, T., Y. Nakano, Y. Toyoda, K. I. Miyagawa, M. Tada, T. Kaisho, and M. Nakao 2001. In vitro and in vivo antibacterial activities of TAK-083, an agent for treatment of Helicobacter pylori infection Antimicrob. Agents Chemother. 45:2455–2459
106Wang, J., S. Kodali, S. H. Lee, A. Galgoci, R. Painter, K. Dorso, F. Racine, M. Motyl, L. Hernandez, E. Tinney, S. L Colletti, K Herath, R Cummings, O Salazar,I Gonzalez, A Basilio, F Vicente, O Genilloud, F Pelaez,H Jayasuriya, K Young, DF Cully and S.B Singh 2007. Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties. Proc. Natl. Acad. Sci. USA 104:7612–7616
107Jones, M. E., D. F. Sahm, N. Martin, S. Scheuring, P. Heisig, C. Thornsberry, K. Ko¨hrer, and F.-J. Schmitz. 2000. Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from worldwide surveillance studies during the 1997-1998 respiratory season. Antimicrob. Agents Chemother 44:462–466
108Draghi, D. C., D. J. Sheehan, P. Hogan, and D. F. Sahm. 2005. In vitro activity of linezolid against key gram-positive organisms isolated in the United States: results of the LEADER 2004 surveillance program. Antimicrob. Agents Chemother. 49:5024–5032
109Kurazono, M., T. Ida, K. Yamada, Y. Hirai, T. Maruyama, E. Shitara, and M. Yonezawa.. 2004. In vitro activities of ME1036 (CP5609), a novel parenteral carbapenem, against methicillin-resistant staphylococci. Antimicrob. Agents Chemother 48:2831–2837
110Sader, H. S., T. R. Fritsche, and R. N. Jones. 2008. Antimicrobial activities of ceftaroline and ME1036 tested against clinical strains of communityacquired methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 52:1153–1155.
111X Huang, A Zhang, D Chen, Z Jia, X Li 2010. 4-Substituted 4-(1H-1, 2, 3-triazol-1-yl) piperidine: Novel C7 moieties of fluoroquinolones as antibacterial agents. Bioorganic & Medicinal Chemistry. 20:2859-2863
112Ge, Y., D. MacDonald, M. M. Henry, H. I. Hait, K. A. Nelson, B. A. Lipsky, M. A. Zasloff, and K. J. Holroyd. 1999. In vitro susceptibility to pexiganan of bacteria isolated from infected diabetic foot ulcers. Diagn. Microbiol. Infect. Dis 35:45–53.
113Kessler, R. E., and J. Fung-Tome. 1996. Susceptibility of bacterial isolates to b-lactam antibiotics from US clinical trials over a 5-year period. Am. J. Med. 100(Suppl. 6A):13–19.
114Jones, R. N., D. J. Biedenbach, M. A. T. Croco, and M. S. Barrett. 1998. In vitro evaluation of a novel orally administered cephalosporin (cefditoren) tested against 1249 recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae. Diagn. Microbiol. Infect. Dis. 31:573–578
115Ueda, Y., K. Kanazawa, K. Eguchi, K. Takemoto, Y. Eriguchi, and M. Sunagawa. 2005. In vitro and in vivo antibacterial activities of SM-216601, a new broad-spectrum parenteral carbapenem. Antimicrob. Agents Chemother 49:4185–4196
116Foroumadi, A.; Emami, S.; Hassanzadeh, A.; Rajaee, M.; Sokhanvar, K.; Moshafi, M.H.; Shafiee 2005. A. Synthesis and antibacterial activity of N-(5-benzylthio-1,3,4-thiadiazol-2-yl) and N- (5-benzylsulfonyl-1,3,4-thiadiazol-2-yl)piperazinyl quinolone derivatives. Bioorg. Med. Chem. Lett. 15:4488-4492.
117Eliopoulos, G. M., C. B. Wennersten, and R. C. Moellering, Jr. 1996. Comparative in vitro activity of levofloxacin and ofloxacin against gram-positive bacteria. Diagn. Microbiol. Infect. Dis. 25:35–41
118Takei, M., H. Fukuda, R. Kishii, and M. Hosaka. 2001. Target preference of 15 quinolones against Staphylococcus aureus, based on antibacterial activities and target inhibition. Antimicrob. Agents Chemother. 45:3544–3547
119Johnson, D. M., D. J. Biedenbach, M. L. Beach, M. A. Pfaller, and R. N. Jones. 2000. Antimicrobial activity and in vitro susceptibility test development for cefditoren against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus species. Diagn. Microbiol. Infect. Dis. 37:99–105
120Rittenhouse, S., S. Biswas, J. Broskey, L. McCloskey, T. Moore, S. Vasey, J. West, M. Zalacain, R. Zonis, and D. Payne. 2006. Selection of retapamulin, a novel pleuromutilin for topical use. Antimicrob. Agents Chemother. 50:3882– 3885
121Kobayashi, R., M. Konomi, K. Hasegawa, M. Morozumi, K. Sunakawa, and K. Ubukata.. 2005. In vitro activity of tebipenem, a new oral carbapenem antibiotic, against penicillin-nonsusceptible Streptococcus pneumoniae. Antimicrob. Agents Chemother 49:889–894
122Roblin, P. M., and M. R. Hammerschlag. 2003. In vitro activity of a new antibiotic, NVP-PDF386 (VRC4887), against Chlamydia pneumoniae. Antimicrob. Agents Chemother. 47:1447–1448.
123Jones, R. N., M. L. Beach, M. A. Pfaller, and G. V. Doern. 1998. Antimicrobial activity of gatifloxacin tested against 1676 strains of ciprofloxacin-resistant gram-positive cocci isolated from patient infections in North and South America. Diagn. Microbiol. Infect. Dis. 32:247–252.
124Pereyre, S., H. Renaudin, C. Bebear, and C. M. Bebear. 2004. In vitro activities of the newer quinolones garenoxacin, gatifloxacin, and gemifloxacin against human mycoplasmas. Antimicrob. Agents Chemother 48:3165–3168
125Biedenbach, D. J., M. S. Barrett, and R. N. Jones. 1998. Comparative antimicrobial activity and kill-curve investigations of novel ketolide antimicrobial agents (HMR 3004 and HMR 3647) tested against Haemophilus influenzae and Moraxella catarrhalis strains. Diagn. Microbiol. Infect. Dis. 31:349-353
126Diekema, D. J., Coffman, S. L., Marshall, S. A. Beach M.L, Rolston K.V.I, Jones R.N. 1999. Comparison of activities of broad-spectrum b-lactam compounds against 1,128 Gram-positive cocci recently isolated in cancer treatment centers. Antimicrobial Agents and Chemotherapy 43:940–943
127Safdar, N., D. Andes, and W. A. Craig. 2004. In vivo pharmacodynamics activity of daptomycin. Antimicrob. Agents Chemother 48:63–68
128Göker, H.; Ozden, S.; Yıldız, S.; Boykin, D. W. 2005. Synthesis and Potent Antibacterial Activity against MRSA of Some Novel 1,2-Disubstituted-1H-Benzimidazole-N-alkylated-5- carboxamidines. Eur. J. Med. Chem. 40: 1062-1069
129Fuchs, P. C., A. L. Barry, and S. D. Brown. 1999. In vitro activities of SCH27899 alone and in combination with 17 other antimicrobial agents.. Antimicrob. Agents Chemother 43:2996–2997
130Otani, T., M. Tanaka, E. Ito, Y. Kurosaka, Y. Murakami, K. Onodera, T. Akasaka, and K. Sato. 2003. In vitro and in vivo antibacterial activities of DK-507k, a novel fluoroquinolone. Antimicrob. Agents Chemother. 47: 3750–3759.
131Higgins, D. L., R. Chang, D. V. Debabov, J. Leung, T. Wu, K. M. Krause, E. Sandvik, J. M. Hubbard, K. Kaniga, D. E. Schmidt, Jr., Q. Gao, R. T. Cass, D. E. Karr, B. M. Benton, and P. P. Humphrey. 2005. Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 49:1127–1134.
132Barrett, J. F., R. M. Goldschmidt, L. E. Lawrence, B. Foleno, R. Chen, J. P. Demers, S. Johnson, R. Kanojia, J. Fernandez, J. Bernstein, L. Licata, A. Donetz, S. Huang, D. J. Hlasta, M. J. Macielag, K. Ohemeng, R. Frechette, M. B. Frosco, D. H. Klaubert, J. M. Whiteley, L. Wang, and J. A. Hoch. 1998. Antibacterial agents that inhibit two-component signal transduction systems. Proc. Natl. Acad. Sci. USA 95:5317–5322
133Yuan, Z., J. Trias, and R. J. White. 2001. Deformylase as a novel antibacterial target. Drug Discovery Today 6:954–961
134Pankuch, G. A., D. B. Hoellman, G. Lin, S. Bajaksouzian, M. R. Jacobs, and P. C. Appelbaum. 1998. Activity of HMR 3647 compared to those of five agents against Haemophilus influenzae and Moraxella catarrhalis by MIC determination and time-kill assay. Antimicrob. Agents Chemother 42:3032– 3034
135Fukuda, H., S. Hori, and K. Hiramatsu. 1998. Antibacterial activity of gatifloxacin (AM-1155, CG5501, BMS-206584), a newly developed fluoroquinolone, against sequentially acquired quinolone-resistant mutants and the norA transformant of Staphylococus aureus. Antimicrob. Agents Chemother. 42:1917–1922
136Seefeld, M. A., W. H. Miller, K. A. Newlander, W. J. Burgess, D. J. Payne, S. F. Rittenhouse, T. D. Moore, W. E. DeWolf, Jr., P. M. Keller, X. Qiu, C. A. Janson, K. Vaidya, A. P. Fosberry, M. G. Smyth, D. D. Jaworski, C. Slater- Radosti, and W. F. Huffman. 2001. Inhibitors of bacterial enoyl acyl carrier protein reductase (FabI): 2,9-disubstituted 1,2,3,4-tetrahydropyrido[3,4-b] indoles as potential antibacterial agents. Bioorg. Med. Chem. Lett. 11:2241– 2244
137Sharma, P.; Rane, N.; Gurram V. K. 2004. Synthesis and QSAR studies of pyrimido [4, 5-d] pyrimidine-2, 5-dione derivatives as potential antimicrobial agents. Med. Chem. Lett. 14:4185 - 4190
138Sato Y., Suzaki S., Nishikawa T., Kihara M., Shibata H. and Higuti T. 2000. Phytochemical flavones isolated from Scutellaria barbata and antibacterial activity against methicillin-resistant Staphylococcus aureus. J. Ethnopharmacol. 72:483 - 488
139Waites, K. B., D. M. Crabb, and L. B. Duffy. 2003. In vitro activities of ABT-773 and other antimicrobials against human mycoplasmas. Antimicrob. Agents Chemother. 47:39–42
140Bonacorsi, S., F. Fitoussi, S. Lhopital, and E. Bingen. 1999. Comparative in vitro activities of meropenem, imipenem, temocillin, piperacillin, and ceftazidime in combination with tobramycin, rifampin, or ciprofloxacin against Burkholderia cepacia isolates from patients with cystic fibrosis. Antimicrob. Agents Chemother. 43:213–217
141Robin, P.m.,Renzik, T,. Kutlin, A. and Hammerschlag,M.R. 1999. In vitro activities of gemifloxacin (SB 265805, LB20304) against recent clinical isolates of Chlamydia pneumonia. Antimicrob Antimicrob. Agents Chemother. p:2806-2807
142 Lister, P. D., V. M. Gardner, and C. C. Sanders.. 1999. Clavulanate induces expression of the Pseudomonas aeruginosa AmpC cephalosporinase at physiologically relevant concentrations and antagonizes the antibacterial activity of ticarcillin Antimicrob. Agents Chemother 43:882–889
143Martini, N.D., Katerere, D.R.P., Eloff,J.N. 2004. Biological activity of five antibacterial flavonoids from Combretum erythrophyllum (Combretaceae) J. Ethnopharmacol. 93:207-212
144Cercenado, E., Cercenado, S. and Bouza, E. 2003. In vitro activities of tigecycline (GAR-936) and 12 other antimicrobial agents against 90 Eikenella corrodens clinical isolates. Antimicrob. Agents Chemother. p:2644-2645.
145Murphy, T. M., J. M. Deitz, P. J. Petersen, S. M. Mickels, and W. J. Weiss. 2000. Therapeutic efficacy of GAR-936, a novel glycylcycline, in a rat model of experimental endocarditis. Antimicrob. Agents Chemother. 44: 3022–3027
146Foroumadi, A., Ghodsi, S., Emami, S., Najjari, S., Samadi, N., Faramarzi, M.A., Beikmohammadi, L., Shirazi, F.H. and Shafiee, A. 2006. Synthesis and antibacterial activity of new fluoroquinolones containing a substituted N-(phenethyl) piperazine moiety. Bioorg. Med. Chem. Lett. 16:3499-3503.
147Giacometti, A., O. Cirioni, F. Barchiesi, M. S. Del Prete, and G. Scalise. 1999. Antimicrobial activity of polycationic peptides. Peptides 20:1265–1273
148Moulari, B., Pellequer, Y., Lboutounne, H.,Girard, C.,Chaumont, J,-P., Millet, J., Muyard, F. 2006. Isolation and in vitro antibacterial activity of astilbin, the bioactive flavanone from the leaves of Harungana madagascariensis Lam. ex Poir. (Hypericaceae) J. Ethnopharmacol. 106:272-278
149Candan, F., Unlu, M.,Tepe, B., Daferera, D., Polissiou, M., Sokmen, A., Akpulat, H.A. 2003. Antioxidant and antimicrobial activity of the essential oil and methanol extracts of Achillea millefolium subsp. millefolium Afan. (Asteraceae). J. Ethnopharmacol. 87: 215-220
150Sharififar F, Moshafi H, Mansouri SH, Khodashenas M, Khoshnoodi M 2007. In vitro evaluation of antibacterial and antioxidant activities of the essential oil and methanol extract of endemic Zataria multiflora Boiss. Food Control 18: 800-805
151Brisse, S., D. Milatovic, A. C. Fluit, J. Verhoef, N. Martin, S. Scheuring, K. Kohrer, and F. J. Schmitz. 1999. Comparative in vitro activities of ciprofloxacin, clinafloxacin, gatifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, and Enterobacter aerogenes clinical isolates with alterations in GyrA and ParC proteins. Antimicrob. Agents Chemother 43:2051–2055.
152Denis A, Bretin F, Fromentin C, et al. 2000. Beta-keto-ester chemistry and ketolides. Synthesis and antibacterial activity of 2-halogeno, 2-methyl and 2,3 enol-ether ketolides. Bioorg Med Chem Lett. 10:2019-2022
153Shawar, R. M., D. L. MacLeod, R. L. Garber, J. L. Burns, J. R. Stapp, C. R. Clausen, and S. K. Tanaka. 1999. Activities of tobramycin and six other antibiotics against Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob. Agents Chemother 43:2877–2880
154Y. L. Chen, K. C. Fang, J. Y. Sheu, S. L. Hsu and C. C. Tzeng 2001. Synthesis and Antibacterial Evaluation of Certain Quinolone Derivatives J. Med. Chem. 44:2374-2377
155Nguyen, K. T., D. Ritz, J. Q. Gu, D. Alexander, M. Chu, V. Miao, P. Brian, and R. H. Baltz 2006. Combinatorial biosynthesis of novel antibiotics related to daptomycin. Proc. Natl. Acad. Sci. USA 103:17462–17467
156Mossa, J. S., F. S. El-Feraly, and I. Muhammad.. 2004. Antimycobacterial constitutents from Juniperus procera, Ferula communis and Plumbago zeylanica and their in vitro synergistic activity with isonicotinic acid hydrazide. Phytother. Res 18:934–937
157H. Tanaka, M. Sato, S. Fujiwara, M. Hirata, H. Etoh and H. Takeuchi 2002. Antibacterial activity of isoflavonoids isolated from Erythrina variegata against methicillin-resistant Staphylococcus aureus. Appl. Microbiol. Lett 35: 494–498
158Fritsche, T.R., Strabala, P.A., Sader, H.S., Dowzicky, M.J., Jones, R.N. 2005. Activity of tigecycline tested against a global collection of Enterobacteriaceae, including tetracycline-resistant isolates. Diagn Microbiol Infect Dis 52:209–13
159Nilsen IW, Øverbø K, Sandsdalen E, Sandaker E, Slettent K, Myrnes, B. 1999. Protein purification and gene isolation of chlamysin, a cold-active lysozyme-like enzyme with antibacterial activity. FEBS Letters 464: 153–158
160Vera-Cabrera, L., E. Gonzalez, A. Rendon, J. Ocampo-Candiani, O. Welsh, V. M. Velazquez-Moreno, S. H. Choi, and C. Molina-Torres 2006. In vitro activities of DA-7157 and DA-7218 against Mycobacterium tuberculosis and Nocardia brasiliensis. Antimicrob. Agents Chemother 50:3170–3172
161Streit, J. M., H. S. Sader, T. R. Fritsche, and R. N. Jones 2005. Dalbavancin activity against selected populations of antimicrobial-resistant gram-positive pathogens. Diagn. Microbiol. Infect. Dis 53:307–310
162Appelbaum, P. C., and M. R. Jacobs 2005. Recently approved and investigational antibiotics for treatment of severe infections caused by gram-positive bacteria. Curr. Opin. Microbiol 8:510–517
163Miller D, Flynn PM, Scott IU, Alfonso EC, Flynn HW, Jr. 2006. In vitro Fluoroquinolone resistance in staphylococcal endophthalmitis isolates. Arch Ophthalmol 124: 479-483
164Basile A, Ferrara L, Del Pozzo M, Mele G, Sorbo S, Bassi P, Montesano D. 2005. Antibacterial and antioxidant activities of ethanol extract from Paullinia cupana Mart. J Ethnopharmacol 102: 32-36
165Wexler, H. M., E. Molitoris, D. Molitoris, and S. M. Finegold 1998. In vitro activity of levofloxacin against a selected group of anaerobic bacteria isolated from skin and soft tissue infections. Antimicrob. Agents Chemother 42:984–986
166Mahady GB, Pendland SL, Stoia A, Chadwick LR. 2003. In vitro susceptibility of Helicobacter pylori to isoquinoline alkaloids from Sanguinaria canadensis and Hydrastis canadensis. Phytother Res 17:217-21
167Saleh-Mghir, A., A. Lefort, Y. Petegnief, S. Dautrey, J. Vallois, D. Le Guludec, C. Carbon, and B. Fantin. 1999. Activity and diffusion of LY333328 in experimental endocarditis due to vancomycin-resistant Enterococcus faecalis. Antimicrob. Agents Chemother. 43:115–120
168Cocco, M.T.; Congiu, C.; Onnis, V.; Pusceddo, M.C.; Schivo, M.L.; De Logu, A. 1999. Synthesis and antimycobacterial activity of some isonicotinoylhydrazones. Eur. J. Med. Chem. 34, 1071-1076.
169Karlowsky J. A., N. M. Laing, T. Baudry, N. Kaplan, D. Vaughan, D. J. Hoban, and G. G. Zhanel. 2007. In vitro activity of API-1252, a novel FabI inhibitor, against clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob. Agents Chemother. 51:1580-1581
170Roblin, P. M., T. Reznik, A. Kutlin, and M. R. Hammerschlag. 2003. In vitro activities of rifamycin derivatives ABI-1648 (rifalazil, KRM-1648), ABI- 1657, and ABI-1131 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae. Antimicrob. Agents Chemother. 47:1135– 1136
171Jones, R. N., and M. A. Pfaller 1998. Bacterial resistance: a worldwide problem. Diagn. Microbiol. Infect. Dis 31:379–388
172Portaels F, Traore H, De Ridder K, Meyers WM. 1998. In vitro susceptibility of Mycobacterium ulcerans to clarithromycin. Antimicrob Agents Chemother. 42(8):2070-2073.
173Genin, M. J., D. A. Allwine, D. J. Anderson, M. R. Barbachyn, D. E. Emmert,S. A. Garmon, D. R. Graber, K. C. Grega, J. B. Hester, D. K. Hutchinson, J.Morris, R. J. Reischer, C. W. Ford, G. E. Zurenko, J. C. Hamel, R. D.Schaadt, D. Stapert, and B. H. Yagi. 2000. Substituent effects on the antibacterial activity of nitrogen-carbon-linked (azolylphenyl)oxazolidinones with expanded activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella catarrhalis J. Med. Chem. 43:953–970
174Ruzin, A., M. A. Visalli, D. Keeney, and P. A. Bradford. 2005. Influence of transcriptional activator RamA on expression of multidrug efflux pump AcrAB and tigecycline susceptibility in Klebsiella pneumoniae. Antimicrob. Agents Chemother 49:1017–1022.
175Petersen, P. J., T. Z. Wang, R. G. Dushin, and P. A. Bradford. 2004. Comparative in vitro activities of AC98-6446, a novel semisynthetic glycopeptide derivative of the natural product mannopeptimycin α, and other antimicrobial agents against gram-positive clinical isolates. Antimicrob. Agents Chemother. 48:739–746
176Sökmen M, Serkedjieva J, Daferera D, Gulluce M, Polissiou M, Tepe B, Akpulat A, Sahin F, Sökmen A. 2004. In vitro antioxidant, antimicrobial, and antiviral activities of the essential oil and various extracts from herbal parts and callus cultures of Origanum acutidens. J Agric Food Chem 52: 3309-3311
177Savage, P. B., C. Li, U. Taotafa, B. Ding, and Q. Guan. 2002. Antibacterial properties of cationic steroid antibiotics: a minireview. FEMS Microbiol. Lett. 217:1–7
178Johnson, A. P., M. Warner, M. Carter, and D. M. Livermore. 2002. In vitro activity of cephalosporin RWJ-54428 (MC-02479) against multidrug-resistant gram-positive cocci. Antimicrob. Agents Chemother. 46:321–326
179S. Tehranchian, T. Akbarzadeh, M. R. Fazeli, H. Jamalifar, A. Shafiee 2005. Synthesis and antibacterial activity of 1-[1,2,4-triazol-3-yl] and 1-[1,3,4-thiadiazol-2-yl]-3-methylthio-6,7-dihydrobenzo[c]thiophen-4(5H)ones. Bioorg Med. Chem. Lett. 15：1023–1025
180Khan IA, Mirza ZM, Kumar A, Verma V, Qazi GN. 2006. Piperine, a phytochemical potentiator of ciprofloxacin against Staphylococcus aureus. Antimicrob Agents Chemother. 50(2):810-812.
181Jia, X., A. Patrzykat, R. H. Devlin, P. A. Ackerman, G. K. Iwama, and R. E. W. Hancock 2000. Antimicrobial peptides protect coho salmon from Vibrio anguillarum infections. Appl. Environ. Microbiol. 66:1928–1932
182Waites, K. B., D. M. Crabb, X. Bing, and L. B. Duffy. 2003. In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmas. Antimicrob. Agents Chemother 47:161–165
183Adeniyi, B. A., Fong, H. H. S., Pezzuto, J. M., Luyengi L.andOdelola1, H. A. 2000. Antibacterial Activity of Diospyrin, Isodiospyrin and Bisisodiospyrin from the Root of Diospyros piscatoria (Gurke) (Ebenaceae). Phytother. Res 14: 112–117
184Tsukiyama, R.-I., H. Katsura, N. Tokuriki, and M. Kobayashi 2002. Antibacterial activity of licochalcone A against spore-forming bacteria. Antimicrob. Agents Chemother 46:1226–1230
185Martinez-Martinez, L., A. Pascual, A. I. Suarez, and E. J. Perea. 1998. In vitro activities of ketolide HMR 3647, macrolides, and clindamycin against coryneform bacteria. Antimicrob. Agents Chemother. 42:3290–3292
186Li, Q., J. Y. Lee, R. Castillo, M. S. Hixon, C. Pujol, V. R. Doppalapudi, H. M. Shepard, G. M. Wahl, T. J. Lobl, and M. F. Chan. 2002. NB2001, a novel antibacterial agent with broad-spectrum activity and enhanced potency against beta-lactamase-producing strains. Antimicrob. Agents Chemother 46:1262–1268
187 Jamieson, C. E., P. A. Lambert, and I. N. Simpson. 2003. In vitro activities of novel oxapenems, alone and in combination with ceftazidime, against gram-positive and gram-negative organisms. Antimicrob. Agents Chemother 47:2615–2618
188Verweij, P. E., D. T. A. Te Dorsthorst, A. J. M. M. Rijs, H. G. De Vries- Hospers, and J. F. G. M. Meis.. 2002. Nationwide survey of in vitro activities of itraconazole and voriconazole against clinical Aspergillus fumigatus isolates cultured between 1945 and 1998. J. Clin. Microbiol. 40:2648–2650
189Foleno, B. D., D. Abbanat, R. M. Goldschmidt, R. K. Flamm, S. D. Paget, G. C. Webb, E. Wira, M. J. Macielag, and K. Bush. 2007. In vitro antibacterial activity of the pyrrolopyrazolyl-substituted oxazolidinone RWJ-416457. Antimicrob. Agents Chemother. 51:361–365
190Popova M, Silici S, Kaftanoglu O, Bankova V. 2005. Antibacterial activity of Turkish propolis and its qualitative and quatitative chemical composition. Phytomedicine 12:221-228
191Payne, D. J., W. H. Miller, V. Berry, J. Brosky, W. J. Burgess, E. Chen, W. E. DeWolf, Jr., A. P. Fosberry, R. Greenwood, M. S. Head, D. A. Heerding, C. A. Janson, D. D. Jaworski, P. M. Keller, P. J. Manley, T. D. Moore, K. A. Newlander, S. Pearson, B. J. Polizzi, X. Qiu, S. F. Rittenhouse, C. Slater- Radosti, K. L. Salyers, M. A. Seefeld, M. G. Smyth, D. T. Takata, I. N. Uzinskas, K. Vaidya, N. G. Wallis, S. B. Winram, C. C. Yuan, and W. F. Huffman. 2002. Discovery of a novel and potent class of FabI-directed antibacterial agents. Antimicrob. Agents Chemother. 46:3118–3124.
192Shaw, K. J., S. Poppe, R. Schaadt, V. Brown-Driver, J. Finn, C. M. Pillar, D. Shinabarger, and G. Zurenko. 2008. In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains. Antimicrob. Agents Chemother. 52:4442–4447
193Phillips, O. A., Udo, E. E., Ali, A. A. M. and Al-Hassawia, N. 2003. Synthesis and Antibacterial Activity of 5-Substituted Oxazolidinones. Bioorg. Med. Chem 11:35-41
194Zarrouk V, Bozdogan B, Leclercq R, Garry L, Feger C, Carbon C, Fantin B. 2001. Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics. Antimicrob Agents Chemother. 45(4):1244-1248.
195Biedenbach, D. J. , Barrett, M.S., Croco, M.A. T.and Jones, R. N. 1998. BAY 12-8039, A Novel Fluoroquinolone Activity Against Important Respiratory Tract Pathogens. Diagh Microbial Infect dis 31:45–50
196Kovala-Demertzi, D., Demertzis, M. A. , Miller, J.R., Papadopoulou, C. , Dodorou , C.,and Filousis G. 2001. Platinum(II) complexes with 2-acetyl pyridine thiosemicarbazone Synthesis, crystal structure, spectral properties, antimicrobial and antitumour activity. Journal of Inorganic Biochemistry 86: 555–563
197Dupont, S, Caffin, N, Bhandari, B and Dykes, GA 2006. In vitro antibacterial activity of Australian native herb extracts against food related bacteria Food Control 17:929-932
198Valdezate, S., A. Vindel, F. Baquero, and R. Canton 1999. Comparative in vitro activity of quinolones against Stenotrophomonas maltophilia. Eur. J. Clin. Microbiol. Infect. Dis 18:908–911
199Lefort, A., M. Lafaurie, L. Massias, Y. Petegnief, A. Saleh-Mghir, C. Muller- Serieys, D. Le Guludec, and B. Fantin 2003. Activity and diffusion of tigecycline (GAR-936) in experimental enterococcal endocarditis Antimicrob. Agents Chemother. 47:216–222
200Pandey, A., A. Kapil, S. Sood, V. Goel, B. Das, and P. Seth. 1998. In vitro activities of ampicillin-sulbactam and amoxicillin-clavulanic acid against Acinetobacter baumannii. J. Clin. Microbiol 36:3415–3416
201Doern, G. V., M. A. Pfaller, M. E. Erwin, A. B. Brueggemann, and R. N. Jones. 1998. The prevalence of fluoroquinolone resistance among clinically significant respiratory tract isolates of Streptococcus pneumoniae in the United States and Canada—1997 results from the SENTRY antimicrobial surveillance program. Diagn. Microbiol. Infect. Dis 32:313–316
202Cukurovali, A., Yilmaz, İ., Gur, S. and Kazaz, C 2006. Synthesis, antibacterial and antifungal activity of some new thiazolylhydrazone derivatives containing 3-substituted cyclobutane ring. J. Med Chem 41:201–207
203Biedenbach, D.J., Beach, M. L. and Jones, R.N. 1998. Antimicrobial Activity of Gatifloxacin Tested Against Neisseria gonorrhoeae Using Three Methods and a Collection of Fluoroquinolone- Resistant Strains. Diagh Microbiol Infect dis 32:307-311
204Kwok, A. K., M. Hui, C. P. Pang, R. C. Chan, S. W. Cheung, C. M. Yip, D. S. Lam, and A. F. Cheng. 2002. An in vitro study of ceftazidime and vancomycin concentrations in various fluid media: implications for use in treating endophthalmitis. Investig. Ophthalmol. Vis. Sci. 43:1182–1188
205Goldstein, E. J. C., D. M. Citron, C. V. Merriam, Y. A. Warren, K. L. Tyrrell, and H. T. Fernandez. 2006. Comparative in vitro activities of retapamulin (SB-275833) against 141 clinical isolates of Propionibacterium spp., including 117 P. acnes isolates. Antimicrob. Agents Chemother. 50:379–381
206Takeda, S., T. Nakai, Y. Wakai, F. Ikeda, and K. Hatano 2007. In vitro and In vivo activities of a new cephalosporin, FR264205, against Pseudomonas aeruginosa. Antimicrob. Agents Chemother 51: 826-30
207Credito, K., G. Lin, L. M. Ednie, and P. C. Appelbaum 2004. Antistaphylococcal activity of LBM415, a new peptide deformylase inhibitor, compared with those of other agents. Antimicrob. Agents Chemother 48:4033–4036
208Ramalingan C., Balasubramanian S., Kabilan S., Vasudevan M. 2004. Synthesis and study of antibacterial and antifungal activities of novel 1-[2-(benzoxazol-2-yl)ethoxy]- 2,6-diarylpiperidin-4-ones. Eur. J. Med. Chem 39:527—533
209Singh, M. P., P. J. Petersen, W. J. Weiss, F. Kong, and M. Greenstein. 2000. Saccharomicins, novel heptadecaglycoside antibiotics produced by Saccharothrix espanaensis: antibacterial and mechanistic activities. Antimicrob. Agents Chemother. 44:2154–2159
210Lefort, A., A. Saleh-Jghir, L. Garry, C. Carbon, and B. Fantin. 2000. Activity of LY333328 combined with gentamicin in vitro and in rabbit experimental endocarditis due to vancomycin-susceptible or -resistant Enterococcus faecalis. Antimicrob. Agents Chemother 44:3017–3021
211Akada, J. K., M. Shirai, K. Fujii, K. Okita, and T. Nakazawa. 1999. In vitro anti-Helicobacter pylori activities of new rifamycin derivatives, KRM-1648 and KRM-1657. Antimicrob. Agents Chemother. 43:1072–1076.
212Karou, D, Dicko, MH, Simpore, J & Traore, AS. 2005. Antioxidant and antibacterial activities of polyphenols from ethnomedicinal plants of Burkina Faso Afr J Biotechnol 4: 823–828
213Camporese, A., M. J. Balick, R. Arvigo, R. G. Esposito, N. Morsellino, F. D. Simone, and A. Tubaro. 2003. Screening of anti-bacterial activity of medicinal plants from Belize (Central America). J. Ethnopharmacol. 87:103–107
214Sacchidanand, S., R. L. Penn, J. M. Embil, M. E. Campos, D. Curcio, E. Ellis-Grosse, E. Loh, and G. Rose 2005. Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: results from a phase 3, randomized double-blind trial. Int. J. Infect. Dis. 9:251–261
215Murray, R. W., R. D. Schaadt, G. E. Zurenko, and K. R. Marotti. 1998. Ribosomes from an oxazolidinone-resistant mutant confer resistance to eperezolid in a Staphylococcus aureus cell-free transcription-translation assay. Antimicrob. Agents Chemother 42:947–950
216Sakya, S. M., M. Suarez-Contreras, J. P. Dirlam, T. N. O’Connell, S. F. Hayashi, S. L. Santoro, B. J. Kamicker, D. M. George, and C. B. Ziegler. 2001. Synthesis and structure-activity relationships of thiotetronic acid analogues of thiolactomycin Bioorg. Med. Chem. Lett 11:2751–2754
217Song, W., H. J. Woo, J. S. Kim, and K. M. Lee 2003. In vitro activity of beta-lactams in combination with other antimicrobial agents against resistant strains of Pseudomonas aeruginosa Int. J. Antimicrob. Agents 21:8–12
218Benincasa, M., B. Skerlavaj, R. Gennaro, A. Pellegrini, and M. Zanetti. 2003. In vitro and in vivo antimicrobial activity of two alpha-helical cathelicidin peptides and of their synthetic analogs. Peptides 24:1723–1731
219Baltch, A., R. P. Smith, and L. H. Bopp 1998. Comparison of inhibitory and bactericidal activities and postantibiotic effects of LY333328 and ampicillin used singly and in combination against vancomycin-resistant Enterococcus faecium Antimicrob. Agents Chemother 42:2564–2568
220Djipa CD, Delmée M, Quetin-Leclercq J. 2000. Antimicrobial activity of bark extracts of Syzygium jambos (L.) Alston (Myrtaceae). J Ethnopharmacol 71: 307-313
221Nishida, K., C. Kunugita, T. Uji, F. Higashitani, A. Hyodo, N. Unemi, S. N. Maiti, O. A. Phillips, P. Spevak, K. P. Atchison, S. M. Salama, H. Atwal, and R. G. Micetich. 1999. In vitro and in vivo activities of Syn2190, a novelβ-lactamase inhibitor. Antimicrob. Agents Chemother 43:1895–1900
222Pfaller, M. A., D. J. Diekema, J. H. Rex, D. Andes, V. Chaturvedi, A. Espinel-Ingroff, M. A. Ghannoum, E. M. Johnson, F. C. Odds, M. G. Rinaldi, D. J. Sheehan, L. Steele-Moore, P. Troke, T. J. Walsh, and D. J. Warnock. 2006. Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints. J. Clin. Microbiol 44:819–826.
223Funatogawa, K., Hayashi, S., Shimomura, H., Yoshida, T., Hatano, T., Ito, H., and Hirai, Y.. 2004. Antibacterial activity of hydrolyzable tannins derived from medicinal plants against Helicobacter pylori. Microbiol. Immunol. 48, 251-261
224Lee, J. S, Cho, Y. S., Chang, M. H., Koh, H. Y., Chungb, B.Y. and Pae, A. N. 2003. Synthesis and In Vitro Activity of Novel Isoxazolyl Tetrahydropyridinyl Oxazolidinone Antibacterial Agents 13:4117–4120.
225Huband, M. D., M. A. Cohen, M. Zurack, D. L. Hanna, L. A. Skerlos, M. C. Sulavik, G. W. Gibson, J. W. Gage, E. Ellsworth, M. A. Stier, and S. J. Gracheck. 2007. In vitro and in vivo activities of PD 0305970 and PD 0326448, new bacterial gyrase/topoisomerase inhibitors with potent antibacterial activities versus multidrug-resistant Gram-positive and fastidious organism groups. Antimicrob. Agents Chemother. 51:1191–1201
226D. Lechner, M. Stavri, M. Oluwatuyi, R. Pereda-Miranda and S. Gibbons, Phytochemistry 2004. The anti-staphylococcal activity of Angelica dahurica (Bai Zhi) Phytochemistry 65: 331-335.
227Kumarasamy Y. , Cox P.J. , Jaspars M. and Sarker S.D. 2002. Screening seeds of Scottish plants for antibacterial activity J Ethnopharmacol 83:73 – 77.
228 Bowersock, T. L., S. A. Salmon, E. S. Portis, J. F. Prescott, D. A. Robison, C. W. Ford, and J. L. Watts. 2000. MICs of oxazolidinones for Rhodococcus equi strains isolated from humans and animals. Antimicrob. Agents Chemother. 44:1367–1369
229Allen, G., G. Kaatz, and M. Rybak. 2003. Activities of mutant prevention concentration-targeted moxifloxacin and levofloxacin against Streptococcus pneumoniae in an in vitro pharmacodynamic model. Antimicrob. Agents Chemother. 47:2606–2614.
230de Paiva, S. R., M. R. Figueiredo, T. V. Aragao, and M. A. Kaplan. 2003. Antimicrobial activity in vitro of plumbagin isolated from Plumbago species. Mem. Inst. Oswaldo Cruz 98:959–961
231Grohs, P., M. D. Kitzis, and L. Gutmann. 2003. In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus. Antimicrob. Agents Chemother 47:418-420
232Montero, A., J. Ariza, X. Corbella, A. Domenech, C. Cabellos, J. Ayats, F. Tubau, C. Ardanuy, and F. Gudiol. 2002. Efficacy of colistin versus β-lactams, aminoglycosides, and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii. Antimicrob. Agents Chemother 46:1946–1952.
233Carta, A., M. Loriga, G. Paglietti, A. Mattana, P. L. Fiori, P. Mollicotti, L. Sechi, and S. Zannetti. 2004. Synthesis, anti-mycobacterial, anti-trichomonas and anti-candida in vitro activities of 2-substituted-6,7-difluoro-3-methylquinoxaline 1,4-dioxides. Eur. J. Med. Chem. 39:195–203
234Shin, S.Y., Bajpai, V.K., Kim, H.R. and Kang, S.C. 2007. Antibacterial activity of eicosapentaenoic acid (EPA) against foodborne and food spoilage microorganisms. LWT 40 :1515–1519
235Mercier RC, Kennedy C, Meadows C.. 2002. Antimicrobial activity of tigecycline (GAR-936) against Enterococcus faecium and Staphylococcus aureus used alone and in combination. Pharmacotherapy 22: 1517–23
236Low, D. E., J. de Azavedo, K. Weiss, T. Mazzulli, M. Kuhn, D. Church, K. Forward, G. Zhanel, A. Simor, and A. McGeer. 2002. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in Canada during. Antimicrob. Agents Chemother. 46:1295–1301
237Koo H, Rosalen PL, Cury JA, Park YK, Bowen WH. 2002. Effects of compounds found in propolis on Streptococcus mutans growth and on glucosyltransferase activity. Antimicrob Agents Chemother 46:1302–1309
238Tré-Hardy M, Vanderbist F, Traore H, Devleeschouwer MJ. 2008. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures. International Journal of Antimicrobial Agents. 31:329–336.
239Jain, R., D. Chen, R. J. White, D. V. Patel, and Z. Yuan. 2005. Bacterial peptide deformylase inhibitors: a new class of antibacterial agents. Curr. Med. Chem. 12:1607-1621
240 Ford, C. W., G. E. Zurenko, and M. R. Barbachyn. 2001. The discovery of linezolid, the first oxazolidinone antibacterial agent. Curr. Drug Targets Infect. Disord. 1:181–199.
241 Credito, K. L., and P. C. Appelbaum 2004. Activity of OPT-80, a novel macrocycle compared with those of eight other agents against selected anaerobic species. Antimicrob. Agents Chemother. 48:4430–4434.
242Lv J, Liu T T, Cai S L, Wang X, Liu L, Wang Y M. 2006. Synthesis, structure and biological activity of cobalt(Ⅱ) and copper(Ⅱ) complexes of valine-derived schiff bases. J Inorg Biochem 100(11): 1888—1896
243Zeller, V., C. Janoir, M. Kitzis, L. Gutmann, and N. J. Moreau. 1997. Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 41:1973–1978
244Prats, G., C. Roig, E. Miro, F. Navarro, and B. Mirelis. 2002. In vitro activity of the active metabolite of prulifloxacin (AF 3013) compared with six other fluoroquinolones. Eur. J. Clin. Microbiol. Infect. Dis. 21:328–334
245A. Carta, G. Paglietti, M.E.R. Nikookar, P. Sanna, L. Sechi, S. Zanetti 2002. Novel substituted quinoxaline 1,4-dioxides with in vitro antimycobacterial and anticandida .activity Eur. J. Med. Chem. 37: 355-366.
246Zaoutis T., Moore, L.S., Furness, K. and Klein, J. D. 2001. In vitro activities of linezolid, meropenem, and quinupristin-dalfopristin against group C and G streptococci, including vancomycin-tolerant isolates. Antimicrob Agents Chemother 45(7):p.1952-4
247Bozin B, Mimica-Dukic N, Simin N, Anackov G. 2006. Characterization of the volatile composition of essential oils of some lamiaceae spices and the antimicrobial and antioxidant activities of the entire oils. J Agric Food Chem. 54(5):1822-1828
248Cohen, M. A., M. D. Huband, G. B. Mailloux, S. L. Yoder, G. E. Roland, and C. L. Heifetz. 1991. In vitro antibacterial activities of the fluoroquinolones PD 117596, PD 124816, and PD 127391. Diagn. Microbiol. Infect. Dis. 14: 245–258.
249Giacometti, A., Cirioni, O., Del Prete, M. S. F. Barchiesi,F., Fortuna, M., Drenaggi, D. and Scalise, G. 2000. In vitro activities of membrane-active peptides alone and in combination with clinically used antimicrobial agents against Stenotrophomonas maltophilia. Antimicrobial Agents and Chemotherapy 44:1716–1719
250DeLoney, C. R., and N. L. Schiller. 1999. Competition of various β-lactam antibiotics for the major penicillin-binding proteins of Helicobacter pylori: antibacterial activity and effects on bacterial morphology. Antimicrob. Agents Chemother 43:2702–2709
251Nakajima, Y., J. Ishibashi, F. Yukuhiro, A. Asaoka, D. Taylor, and M. Yamakawa. 2003. Antibacterial activity and mechanism of action of tick defensin against gram-positive bacteria. Biochim. Biophys. Acta 1624:125– 130.
252Vicini, P.; Geronikaki, A.; Anastasia, K.; Incerti, M.; Zani, F. 2006. Synthesis and antimicrobial activity of novel 2-thiazolylimino-5-arylidene-4-thiazolidinones Bioorg. Med. Chem. 14:3859-3864.
253Haydon, D. J., N. R. Stokes, R. Ure, G. Galbraith, J. M. Bennett, D. R. Brown, P. J. Baker, V. V. Barynin, D. W. Rice, S. E. Sedelnikova, J. R. Heal, J. M. Sheridan, S. T. Aiwale, P. K. Chauhan, A. Srivastava, A. Taneja, I. Collins, J. Errington, and L. G. Czaplewski. 2008. An inhibitor of FtsZ with potent and selective anti-staphylococcal activity. Science 321:1673–1675
254Ashtekar, D. R., R. Costa-Periera, T. Shrinivasan, R. Iyyer, N. Vishvanathan, and W. Rittel. 1991. Oxazolidinone, a new class of synthetic antituberculosis agent: in vitro and in vivo activities of DuP-721 against Mycobacterium tuberculosis. Diagn. Microbiol. Infect. Dis. 14:465–471.
255Sohn, H. Y.; Son, K. H.; Kwon, C. S.; Kwon, G. S.; Kang, S. S. 2004. Antimicrobial and cytotoxic activity of 18 prenylated flavonoids isolated from medicinal plants: Morus alba L., Morus mongolica Schneider, Broussnetia papyrifera (L.) Vent, Sophora flavescens Ait and Echinosophora koreensis Nakai. Phytomedicine 11:666-672
256El-Emam, A. A., Al-Deeb, O. A., Al-Omar, M., Lehmann, J. 2004. Synthesis, antimicrobial, and anti-HIV-1 activity of certain 5-(1-adamantyl)-2-substituted thio-1,3,4-oxadiazoles and 5-(1-adamantyl)-3-substituted aminomethyl-1,3,4- oxadiazoline-2-thiones. Bioorg. Med. Chem. 12:5107-5113
257Nagata K, Hirai KI, Koyama J, Wada Y & Tamura T 1998. Antimicrobial activity of novel furanonaphthoquinone analogs. Antimicrobial Agents and Chemotherapy 42: 700-702.
258Allen, G. P., G. W. Kaatz, and M. J. Rybak. 2004. In vitro activities of mutant prevention concentration-targeted concentrations of fluoroquinolones against Staphylococcus aureus in a pharmacodynamic model. Int. J. Antimicrob. Agents 24:150–160
259 Hirschl, A. M., P. Apfalter, A. Makristathis, M. L. Rotter, and M. Wimmer. 2000. In vitro activities of linezolid alone and in combination with amoxicillin, clarithromycin, and metronidazole against Helicobacter pylori. Antimicrob. Agents Chemother. 44:1977–1979
260Lomovskaya, O., M. S. Warren, A. Lee, J. Galazzo, R. Fronko, M. Lee, J. Blais, D. Cho, S. Chamberland, T. Renau, R. Leger, S. Hecker, W. Watkins, K. Hoshino, H. Ishida, and V. J. Lee. 2001. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob. Agents Chemother. 45:105–116
261Hunfeld, K.-P., T. A. Wichelhaus, R. Rodel, G. Acker, V. Brade, and P. Kraiczy. 2004. Comparison of in vitro activities of ketolides, macrolides, and an azalide against the spirochete Borrelia burgdorferi. Antimicrob. Agents Chemother. 48:344–347.
262Bakri IM, Douglas CW. 2005. Inhibitory effect of garlic extract on oral bacteria. Arch Oral Biol 50: 645-651
263Giuliana, G., G. Pizzo, M. E. Milici, and R. Giangreco. 1999. In vitro activities of antimicrobial agents against Candida species. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 87:44–49
264Zhao, W. H., Z. Q. Hu, Y. Hara, and T. Shimamura. 2002. Inhibition of penicillinase by epigallocatechin gallate resulting in restoration of antibacterial activity of penicillin against penicillinase-producing Staphylococcus aureus. Antimicrob. Agents Chemother. 46:2266–2268
265Fritsche, T. R., H. S. Sader, R. Cleeland, and R. N. Jones. 2005. Comparative antimicrobial characterization of LBM415 (NVP PDF-713), a new peptide deformylase inhibitor of clinical importance. Antimicrob. Agents Chemother 49:1468–1476.
266Gomez-Lopez, A., G. Garcia-Effron, E. Mellado, A. Monzon, J. L. Rodriguez- Tudela, and M. Cuenca-Estrella. 2003. In vitro activities of three licensed antifungal agents against Spanish clinical isolates of Aspergillus spp. Antimicrob. Agents Chemother. 47:3085–3088
267Briggs, B. M., R. N. Jones, M. E. Erwin, M. S. Barrett, and D. M. Johnson. 1991. In vitro activity evaluations of cefdinir (FK 482, CI-983, PD134393). A Novel Orally Administered Cephalosporin. Diagn. Microbiol. Infect. Dis. 14:425–434.
268Hoshino, K., K. Inoue, Y. Murakami, Y. Kurosaka, K. Namba, Y. Kashimoto, S. Uoyama, R. Okumara, S. Higuchi, and T. Otani. 2008. In vitro and in vivo antibacterial activities of DC-159a, a new fluoroquinolone. Antimicrob. Agents Chemother 52:65–76
269Hegde, S. S., N. Reyes, T. Wiens, N. Vanasse, R. Skinner, J. McCullough, K. Kaniga, J. Pace, R. Thomas, J. P. Shaw, G. Obedencio, and J. K. Judice. 2004. Pharmacodynamics of telavancin (TD-6424), a novel bactericidal agent, against gram-positive bacteria. Antimicrob. Agents Chemother. 48: 3043–3050.
270Saido-Sakanaka, H., Ishibashi, J., Momotani, E., Amano, F., and Yamakawa, M. 2004. In vitro and in vivo activity of antimicrobial peptides synthesized based on the insect defensin. Peptides 25, 19-27.
271Torres, C., M. Zarazaga, C. Tenorio, A. Portillo, Y. Saenz, F. Ruiz and Baquero, F. 1998. In vitro activity of the new ketolide HMR3647 in comparison with those of macrolides and pristinamycins against Enterococcus spp Antimicrob. Agents Chemother 42:3279–3281
272Arvidsson PI, Ryder NS, Weiss HM, Gross G, Kretz O, Woessner R, Seebach D. 2003. Antibiotic and hemolytic activity of a beta2/beta3 peptide capable of folding into a 12/10-helical secondary structure. Chembiochem. 4(12):1345-1347.
273Huang, V., W. J. Brown, and M. J. Rybak. 2004. In vitro activities of a novel cephalosporin, CB-181963 (CAB-175), against methicillin-susceptible or –resistant Staphylococcus aureus and glycopeptide-intermediate susceptible staphylococci. Antimicrob. Agents Chemother. 48:2719–2723
274Wise, R., J. M. Andrews, J. P. Ashby, and D. Thornber. 1990. Ceftibuten: a new orally absorbed cephalosporin—in vitro activity against strains from the United Kingdom. Diagn. Microbiol. Infect. Dis 14:45–52
275Schito, G. C., and D. Felmingham. 2005. Susceptibility of Streptococcus pneumoniae to penicillin, azithromycin and telithromycin (PROTEKT 1999– 2003). Int. J. Antimicrob. Agents 26:479–485
276Kunin, C. M., and W. Y. Ellis. 2000. Antimicrobial activities of mefloquine and a series of related compounds. Antimicrob. Agents Chemother. 44:848– 852
277Krausse, R., and U. Ullmann. 2003. In vitro activities of new fluoroquinolones against Campylobacter jejuni and Campylobacter coli isolates obtained from humans in 1980 to 1982 and 1997 to 2001. Antimicrob. Agents Chemother. 47:2946-2950.
278Murphy, C. K., S. Mullin, M. S. Osburne, J. van Duzer, J. Siedlecki, X. Yu, K. Kerstein, M. Cynamon, and D. M. Rothstein. 2006. In vitro activity of novel rifamycins against rifamycin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 50:827–834.
279Lourens, A.C.U., , Reddy, D.,Baser, K.H.C., Viljoen, A.M. and Vuuren, S.F. V. 2004. In vitro biological activity and essential oil composition of four indigenous South African Helichrysum species. J Ethnopharmacol 95:253-258.
280Livermore, D. M., M. Warner, S. Mushtaq, S. North, and N. Woodford.. 2007. In vitro activity of the oxazolidinone RWJ-416457 against linezolid-resistant and –susceptible staphylococci and enterococci. Antimicrob. Agents Chemother. 51:1112–1114.
281Park KM, You JS, Lee HY, Baek,N.I. and Hwang J.K. 2003. Kuwanon G: an antibacterial agent from the root bark of Morus alba against oral pathogens. J Ethnopharmacol 84:181-185
282Rudolph, J.; Theis, H.; Hanke, R.; Endermann, R.; Johannsen, L.; Geschke, F.-U. 2001. seco-Cyclothialidines: New Concise Synthesis, Inhibitory Activity toward Bacterial and Human DNA Topoisomerases, and Antibacterial Properties J. Med. Chem 44, 619-626.
283Chen, D. Z., D. V. Patel, C. J. Hackbarth, W. Wang, G. Dreyer, D. C. Young, P. S. Margolis, C. Wu, Z. J. Ni, J. Trias, R. J. White, and Z. Y. Yuan. 2000. Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor. Biochemistry 39:1256–1262
284Pfaller, M. A., and R. N. Jones. 1997. A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30,254 aerobic and anaerobic pathogens isolated worldwide. Diagn. Microbiol. Infect. Dis 28:157–163
285De Lucca, A. J., and T. J. Walsh. 1999. Antifungal peptides: novel therapeutic compounds against emerging pathogens. Antimicrob. Agents Chemother. 43:1–11
286Aeschlimann, J. R., M. J. Zervos, and M. J. Rybak. 1998. Treatment of vancomycin-resistant Enterococcus faecium with RP 59500 (quinupristindalfopristin) administered by intermittent or continuous infusion, alone or in combination with doxycycline, in an in vitro pharmacodynamic infection model with simulated endocardial vegetations. Antimicrob. Agents Chemother. 42: 2710–2717.
287Thorburn, C. E., S. J. Knott, and D. I. Edwards. 1998. In vitro activities of oral b-lactams at concentrations achieved in humans against penicillin-susceptible and -resistant pneumococci and potential to select resistance. Antimicrob. Agents Chemother. 42:1973–1979.
288Eustice, D. C., P. A. Feldman, and A. M. Slee. 1988. The mechanism of action of DuP 721, a new antibacterial agent: effects on macromolecular synthesis. Biochem. Biophys. Res. Commun. 150:965–971.
289Hamilton-Miller, J. M. T., and S. Shah. 1993. Post-antibiotic effects of miocamycin, roxithromycin and erythromycin on Gram-positive cocci. Int. J. Antimicrob. Agents 2:105–109.
290Queenan, A. M., B. Foleno, C. Gownley, E. Wira, and K. Bush. 2004. Effects of inoculum and beta-lactamase activity in AmpC- and extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumonia clinical isolates tested by using National Committee for Clinical Laboratory Standards ESBL methodology. J. Clin. Microbiol. 42:269–275.
291Fernandez-Roblas, R., J. Esteban, F. Cabria, J. C. Lopez, M. S. Jimenez, and F. Soriano 2000. In vitro susceptibilities of rapidly growing mycobacteria to telithromycin (HMR 3647) and seven other antimicrobials. Antimicrob. Agents Chemother. 44:181–182.
292Gieffers, J., W. Solbach, and M. Maass. 1998. In vitro susceptibilities of Chlamydia pneumoniae strains recovered from atherosclerotic coronary arteries. Antimicrob. Agents Chemother. 42:2762–2764.
293Jones, R. N., D. J. Biedenbach, and D. M. Johnson. 2000. Cefditoren activity against nearly 1000 non-fastidious bacterial isolates and the development of in vitro susceptibility test methods. Diagn. Microbiol. Infect. Dis. 37:143–146.
294Lu LC, Chen YW, Chou CC. 2005. Antibacterial activity of propolis against Staphylococcus aureus. Int J Food Microbiol 15:213–220.
295Okamoto, K., N. Gotoh, and T. Nishino. 2001. Pseudomonas aeruginosa reveals high intrinsic resistance to penem antibiotics: penem resistance mechanisms and their interplay. Antimicrob. Agents Chemother. 45:1964– 1971
296Pag, U., M. Oedenkoven, N. Papo, Z. Oren, Y. Shai, and H.-G. Sahl. 2004. In vitro activity and mode of action of diastereomeric antimicrobial peptides against bacterial clinical isolates. J. Antimicrob. Chemother 53:230–239.
297Snydman, D. R., N. V. Jacobus, L. A. McDermott, S. Supran, G. J. Cuchural, Jr., S. Finegold, L. Harrell, D. W. Hecht, P. Iannini, S. Jenkins, C. Pierson, J. Rihs, and S. L. Gorbach. 1999. Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996. Antimicrob. Agents Chemother. 43:2417–2422.
298Vardar-Unlu G, Candan F, Sokmen A, Daferera D, Polissiou M, Sokmen M, Donmez E, Tepe B. 2003. Antimicrobial and antioxidant activity of the essential oil and methanol extracts of Thymus pectinatus Fisch. et Mey. Var. pectinatus (Lamiaceae). J Agric Food Chem 51: 63-67.
299Hilliard, J. J., R. M. Goldschmidt, L. Licata, E. Z. Baum, and K. Bush. 1999. Multiple mechanisms of action for inhibitors of histidine protein kinases from bacterial two-component systems. Antimicrob. Agents Chemother. 43: 1693–1699.
300Zhou Y, Gregor VE, Sun Z, Ayida BK, Winters GC, Murphy D, Simonsen KB, Vourloumis D, Fish S, Froelich JM, Wall D, Hermann T.. 2005. Structure-guided discovery of novel aminoglycoside mimetics as antibacterial translation inhibitors. Antimicrob Agents Chemother. 49(12):4942-4949.
301Tomioka H, Sato K, Akaki T, Kajitani H, Kawahara S, Sakatani M. 1999. Comparative in vitro antimicrobial activities of the newly synthesized quinolone HSR-903, sitafloxacin (DU-6859a), gatifloxacin (AM-1155), and levofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex. Antimicrob Agents Chemother. 43(12):3001-3004.
302Okoli AS, Okeke MI, Iroegbu CU, Ebo PU. 2002. Antibacterial activity of Harungana madagascariensis leaf extracts Phytother Res. 16(2):174-179.
303Rosen H, Hajdu R, Silver L, Kropp H, Dorso K, Kohler J, Sundelof JG, Huber J, Hammond GG, Jackson JJ, Gill CJ, Thompson R, Pelak BA, Epstein-Toney JH, Lankas G, Wilkening RR, Wildonger KJ, Blizzard TA, DiNinno FP, Ratcliffe RW, Heck JV, Kozarich JW, Hammond ML. 1999. Reduced immunotoxicity and preservation of antibacterial activity in a releasable side-chain carbapenem antibiotic. Science 283(5402):703-706.
304Silo-Suh LA, Stabb EV, Raffel SJ, Handelsman J. 1998. Target Range of Zwittermicin A, an Aminopolyol Antibiotic from Bacillus cereus. Curr Microbiol 37(1):6-11
305Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez HT. 2002. In Vitro Activities of Garenoxacin (BMS 284756) against 108 Clinical Isolates of Gardnerella vaginalis. Antimicrob Agents Chemother. 46(12):3995-3996.
306Zurenko GE, Gibson JK, Shinabarger DL, Aristoff PA, Ford CW, Tarpley WG. 2001. Oxazolidinones: a new class of antibacterials. Curr Opin Pharmacol. 1(5):470-476.
307Fuchs PC, Barry AL, Brown SD. 1998. In vitro activities of clinafloxacin against contemporary clinical bacterial isolates from 10 North American centers. Antimicrob Agents Chemother. 42(5):1274-1277.
308Fuchs PC, Jones RN, Barry AL, Thornsberry C, Ayers LW, Gavan TL, Gerlach EH. 1986. In vitro evaluation of cefixime (FK027, FR17027, CL284635): spectrum against recent clinical isolates, comparative antimicrobial activity, beta-lactamase stability, and preliminary susceptibility testing criteria. Diagn Microbiol Infect Dis. 5(2):151-162.
309Koc AN, Silici S, Ayangil D, Ferahbaş A, Cankaya S. 2005. Comparison of in vitro activities of antifungal drugs and ethanolic extract of propolis against Trichophyton rubrum and T. mentagrophytes by using a microdilution assay. Mycoses 48(3):205-210.
310Karthikeyan MS, Prasad DJ, Poojary B, Subrahmanya Bhat K, Holla BS, Kumari NS. 2006. Synthesis and biological activity of Schiff and Mannich bases bearing 2,4-dichloro-5-fluorophenyl moiety. Bioorg Med Chem 14(22):7482-7489
311Breedt J, Teras J, Gardovskis J, Maritz FJ, Vaasna T, Ross DP, Gioud-Paquet M, Dartois N, Ellis-Grosse EJ, Loh E; Tigecycline 305 cSSSI Study Group. 2005. Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam. Antimicrob Agents Chemother. 49(11):4658-4666.
312R. K. Tiwari, D. Singh, J. Singh, V. Yadav, A. K. Pathak, R. Dabur, A. K. Chillar, R. Singh, G. L.Sharma, R. Chandra and A. K. Verma 2006. Synthesis and antibacterial activity of substituted 1,2,3,4-tetrahydropyrazino [1,2-a] indoles, Bioorg. Med. Chem. Lett. 16 :413–416.
313Beyer D, Kroll HP, Endermann R, Schiffer G, Siegel S, Bauser M, Pohlmann J, Brands M, Ziegelbauer K, Haebich D, Eymann C, Brötz-Oesterhelt H. 2004. Antimicrob Agents Chemother. 2004 New class of bacterial phenylalanyl-tRNA synthetase inhibitors with high potency and broad-spectrum activity. Antimicrob Agents Chemother 48(2):525-532.
314Furneri PM, Fresta M, Puglisi G, Tempera G. 2000. Ofloxacin-loaded liposomes: in vitro activity and drug accumulation in bacteria. Antimicrob Agents Chemother. Antimicrob Agents Chemother 44(9):2458-2464.
315Ingolfsdottir, K. 2002. Molecules of Interest Usnic acid Phytochemistry 61: 729–736.
316Tepe B., Daferera D., Sokmen A., Sokmen M. and Polissiou M. 2005. Antimicrobial and antioxidant activities of the essential oil and various extracts of Salvia tomentosa Miller (Lamiaceae). Food Chemistry 90: 333–340.
317Tamura S, Miyazaki S, Tateda K, Ohno A, Ishii Y, Matsumoto T, Furuya N, Yamaguchi K. 1998. In Vivo Antibacterial Activities of Sanfetrinem Cilexetil, a New Oral Tricyclic Antibiotic. Antimicrob Agents Chemother. 42(7):1858-1861.
318Akova M, Gür D, Livermore DM, Kocagöz T, Akalin HE. 1999. In Vitro Activities of Antibiotics Alone and in Combination against Brucella melitensis at Neutral and Acidic pHs. Antimicrob Agents Chemother. 43(5):1298-1300.
319Or YS, Clark RF, Wang S, Chu DT, Nilius AM, Flamm RK, Mitten M, Ewing P, Alder J, Ma Z. 2000. J Med Chem. Mar 23;43(6):1045-9.Design, synthesis, and antimicrobial activity of 6-O-substituted ketolides active against resistant respiratory tract pathogens. J Med Chem. 43(6):1045-1049.
320Yildiz-Oren I, Yalcin I, Aki-Sener E, Ucarturk N. 2004. Synthesis and structure-activity relationships of new antimicrobial active multisubstituted benzazole derivatives. Eur J Med Chem. 39(3):291-298.
321Arias ME, Gomez JD, Cudmani NM, Vattuone MA, Isla MI. 2004. Antibacterial activity of ethanolic and aqueous extracts of Acacia aroma Gill. ex Hook et Arn. Life Sci. 75(2):191-202.
322Bradford PA, Petersen PJ, Young M, Jones CH, Tischler M, O'Connell J.2005. Antimicrob Agents Chemother. 2005. Tigecycline MIC testing by broth dilution requires use of fresh medium or addition of the biocatalytic oxygen-reducing reagent oxyrase to standardize the test method. Antimicrob Agents Chemother. 49(9):3903-3909.
323Venezuelan Antimicrobial Resistance Study Group.Pfaller MA, Jones RN, Doern GV. 1998. Multicenter evaluation of the antimicrobial activity for six broad-spectrum beta-lactams in Venezuela using the Etest method. Diagn. Microbiol. Infect. Dis. 30:45–52
324Truiti Mda C, Sarragiotto MH, de Abreu Filho BA, Nakamura CV, Dias Filho BP. 2003. In vitro antibacterial activity of a 7-O-beta-D-glucopyranosyl-nutanocoumarin from Chaptalia nutans (Asteraceae). Mem Inst Oswaldo Cruz 98(2):283-286.
325Ozden S, Atabey D, Yildiz S, Göker H.. 2005. Synthesis and potent antimicrobial activity of some novel methyl or ethyl 1H-benzimidazole-5-carboxylates derivatives carrying amide or amidine groups. Bioorg Med Chem. 13(5):1587-1597.
326Scazzocchio F, D'Auria FD, Alessandrini D, Pantanella F. 2006. Multifactorial aspects of antimicrobial activity of propolis. Microbiol Res. 161(4):327-333.
327Bråbäck M, Riesbeck K, Forsgren A. 2002. Susceptibilities of Mycobacterium marinum to gatifloxacin, gemifloxacin, levofloxacin, linezolid, moxifloxacin, telithromycin, and quinupristin-dalfopristin (Synercid) compared to its susceptibilities to reference macrolides and quinolones. Antimicrob Agents Chemother. 46(4):1114-1116.
328Saiman L, Tabibi S, Starner TD, San Gabriel P, Winokur PL, Jia HP, McCray PB Jr, Tack BF. 2001. Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis. Antimicrob Agents Chemother. 45(10):2838-2844.
329Bruni, R., Medici, A., Andreotti, E., Fantin, C., Muzzoli, M., Dehesa, M., Romagnoli, C., and Sacchetti, G. 2004. Chemical composition and biological activities of Ishpingo essential oil, a traditional Ecuadorian spice from Ocotea quixos (Lam.) Kosterm. (Lauraceae) flower calices. Food Chem. 85: 415–421.
330Hong CY. 2001. Discovery of gemifloxacin (Factive, LB20304a): a quinolone of a new generation. Farmaco 56(1-2):41-44.
331Hoban DJ, Wierzbowski AK, Nichol K, Zhanel GG. 2001. Macrolide-resistant Streptococcus pneumoniae in Canada during 1998-1999: prevalence of mef(A) and erm(B) and susceptibilities to ketolides. Antimicrob Agents Chemother. 45(7):2147-2150.
332Akasaka T, Kurosaka S, Uchida Y, Tanaka M, Sato K, Hayakawa I. 1998. Antibacterial activities and inhibitory effects of sitafloxacin (DU-6859a) and its optical isomers against type II topoisomerases. Antimicrob Agents Chemother. 42(5):1284-1287.
333Kim, S.H. Son, H.. Nam, G.. Chi, D.Y. and Kim, J. H. 2000. Synthesis and in Vitro Antibacterial Activity of 3-[N-methyl-N-(3-methyl-1,3-thiazolium-2-yl)amino]methyl Cephalosporin Derivatives. Bioorg Med Chem. 10:1143-1145.
334Peterson ML, Hovde LB, Wright DH, Hoang AD, Raddatz JK, Boysen PJ, Rotschafer JC. 1999. Fluoroquinolone resistance in Bacteroides fragilis following sparfloxacin exposure. Antimicrob Agents Chemother. 43(9):2251-2255.
335Sood R, Rao M, Singhal S, Rattan A. 2005. Activity of RBx 7644 and RBx 8700, new investigational oxazolidinones, against Mycobacterium tuberculosis infected murine macrophages. Int J Antimicrob Agents. 25(6):464-468.
336Wiles JA, Song Y, Wang Q, Lucien E, Hashimoto A, Cheng J, Marlor CW, Ou Y, Podos SD, Thanassi JA, Thoma CL, Deshpande M, Pucci MJ, Bradbury BJ. 2006. Biological evaluation of isothiazoloquinolones containing aromatic heterocycles at the 7-position: In vitro activity of a series of potent antibacterial agents that are effective against methicillin-resistant Staphylococcus aureus. Bioorg Med Chem Lett. 16(5):1277-1281.
337Mazumder R, Bhattacharya S, Mazumder A, Pattnaik AK, Tiwary PM, Chaudhary S. 2006. Antidiarrhoeal evaluation of Aegle Marmelos (Correa) Linn. root extract. Phytother Res. 20(1):82-84.
338Chen J, Falla TJ, Liu H, Hurst MA, Fujii CA, Mosca DA, Embree JR, Loury DJ, Radel PA, Cheng Chang C, Gu L, Fiddes JC. 2000. Development of protegrins for the treatment and prevention of oral mucositis: structure-activity relationships of synthetic protegrin analogues. Biopolymers 55(1):88-98.
339Vicini P, Zani F, Cozzini P, Doytchinova I. 2002. Hydrazones of 1,2-benzisothiazole hydrazides: synthesis, antimicrobial activity and QSAR investigations. Eur J Med Chem. 37(7):553-564.
340Murray PR, Niles AC. 1990. In vitro activity of meropenem (SM-7338), imipenem, and five other antibiotics against anaerobic clinical isolates. Diagn Microbiol Infect Dis. 13(1):57-61.
341Pickerill KE, Paladino JA, Schentag JJ. 2000. Comparison of the fluoroquinolones based on pharmacokinetic and pharmacodynamic parameters. Pharmacotherapy 20(4):417-428.
342Ahmad I, Aqil F. 2007. In vitro efficacy of bioactive extracts of 15 medicinal plants against ESbetaL-producing multidrug-resistant enteric bacteria. Microbiol Res. 162(3):264-275.
343Capobianco JO, Cao Z, Shortridge VD, Ma Z, Flamm RK, Zhong P. 2000. Studies of the novel ketolide ABT-773: transport, binding to ribosomes, and inhibition of protein synthesis in Streptococcus pneumoniae. Antimicrob Agents Chemother 44(6):1562-1567.
344Tsubery H, Ofek I, Cohen S, Fridkin M. 2001. N-terminal modifications of Polymyxin B nonapeptide and their effect on antibacterial activity. Peptides. 22(10):1675-1681.
345Ha KR, Psaltis AJ, Butcher AR, Wormald PJ, Tan LW. 2008. In vitro activity of mupirocin on clinical isolates of Staphylococcus aureus and its potential implications in chronic rhinosinusitis. Laryngoscope. 118(3):535-540.
346Stavri M, Schneider R, O'Donnell G, Lechner D, Bucar F, Gibbons S. 2004. The antimycobacterial components of hops (Humulus lupulus) and their dereplication. Phytother Res. 18(9):774-776.
347Chattopadhyay D, Arunachalam G, Mandal AB, Sur TK, Mandal SC, Bhattacharya SK. 2002. Antimicrobial and anti-inflammatory activity of folklore: Mallotus peltatus leaf extract. J Ethnopharmacol. 82(2-3):229-237.
348Ozturk S, Ercisli S. 2006. The chemical composition of essential oil and in vitro antibacterial activities of essential oil and methanol extract of Ziziphora persica Bunge. J Ethnopharmacol. 106(3):372-376.
349Aritaka N, Hanaki H, Cui L, Hiramatsu K. 2001. Combination effect of vancomycin and beta-lactams against a Staphylococcus aureus strain, Mu3, with heterogeneous resistance to vancomycin. Antimicrob Agents Chemother. 45(4):1292-1294.
350Goodson B, Ehrhardt A, Ng S, Nuss J, Johnson K, Giedlin M, Yamamoto R, Moos WH, Krebber A, Ladner M, Giacona MB, Vitt C, Winter J. 1999. Characterization of novel antimicrobial peptoids. Antimicrob Agents Chemother 43(6):1429-1434.
351Freile ML, Giannini F, Pucci G, Sturniolo A, Rodero L, Pucci O, Balzareti V, Enriz RD. 2003. Antimicrobial activity of aqueous extracts and of berberine isolated from Berberis heterophylla. Fitoterapia. 74(7-8):702-705.
352Pan XS, Fisher LM. 1998. DNA gyrase and topoisomerase IV are dual targets of clinafloxacin action in Streptococcus pneumoniae. Antimicrob Agents Chemother. 42(11):2810-2816.
353Jones RN, Fritsche TR, Sader HS. 2004. Antimicrobial spectrum and activity of NVP PDF-713, a novel peptide deformylase inhibitor, tested against 1,837 recent Gram-positive clinical isolates. Diagn Microbiol Infect Dis. 49(1):63-65.
354Stryjewski ME, Chu VH, O'Riordan WD, Warren BL, Dunbar LM, Young DM, Vallée M, Fowler VG Jr, Morganroth J, Barriere SL, Kitt MM, Corey GR; FAST 2 Investigator Group. 2006. Telavancin versus standard therapy for treatment of complicated skin and skin structure infections caused by gram-positive bacteria: FAST 2 study. Antimicrob Agents Chemother. 50(3):862-867.
355Oleksijew A, Meulbroek J, Ewing P, Jarvis K, Mitten M, Paige L, Tovcimak A, Nukkula M, Chu D, Alder JD. 1998. In vivo efficacy of ABT-255 against drug-sensitive and -resistant Mycobacterium tuberculosis strains. Antimicrob Agents Chemother. 42(10):2674-2677.
356McGaw LJ, Van der Merwe D, Eloff JN. 2007. In vitro anthelmintic, antibacterial and cytotoxic effects of extracts from plants used in South African ethnoveterinary medicine. Vet J. 173(2):366-372.
357Temiz O, Oren I, Sener E, Yalçin I, Uçartürk N.. 1998. Synthesis and microbiological activity of some novel 5- or 6-methyl-2-(2,4-disubstituted phenyl) benzoxazole derivatives. Farmaco 53(5):337-341.
358Aubry A, Pan XS, Fisher LM, Jarlier V, Cambau E. 2004. Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with antimycobacterial drug activity. Antimicrob Agents Chemother. 48(4):1281-1288.
359Segatore B, Setacci D, Perilli M, Franceschini N, De Santis A, Marchetti F, Amicosante G. 1999. Italian survey on comparative levofloxacin susceptibility in 334 clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 43(2):428-431.
360Doern GV, Jones RN, Pfaller MA, Kugler KC, Beach ML. 1999. Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). SENTRY Study Group (North America). Diagn Microbiol Infect Dis. 34(1):65-72.
361Chattopadhyay D, Maiti K, Kundu AP, Chakraborty MS, Bhadra R, Mandal SC, Mandal AB. 2001. Antimicrobial activity of Alstonia macrophylla: a folklore of bay islands. J Ethnopharmacol. 77(1):49-55.
362Gravestock MB, Acton DG, Betts MJ, Dennis M, Hatter G, McGregor A, Swain ML, Wilson RG, Woods L, Wookey A. 2003. New classes of antibacterial oxazolidinones with C-5, methylene O-linked heterocyclic side chains. Bioorg Med Chem Lett. 13(23):4179-4186.
363Vishnu K. Tandon,a, Dharmendra B. Yadav,a Ravindra V. Singh,b Ashok K. Chaturvedic and Praveen K. Shuklac 2005. Synthesis and biological evaluation of novel (L)-a-amino acid methyl ester, heteroalkyl, and aryl substituted 1,4-naphthoquinone derivatives as antifungal and antibacterial agents Bioorganic & Medicinal Chemistry Letters 15 (2005) 5324–5328 82(2-3):229-237.
364Fitoussi F, Doit C, Benali K, Bonacorsi S, Geslin P, Bingen E. 1998. Comparative in vitro killing activities of meropenem, imipenem, ceftriaxone, and ceftriaxone plus vancomycin at clinically achievable cerebrospinal fluid concentrations against penicillin-resistant Streptococcus pneumoniae isolates from children with meningitis. Antimicrob Agents Chemother. 42(4):942-944.
365Ince D, Zhang X, Hooper DC. 2003. Activity of and resistance to moxifloxacin in Staphylococcus aureus. Antimicrob Agents Chemother. 47(4):1410-1415.
366Baizman ER, Branstrom AA, Longley CB, Allanson N, Sofia MJ, Gange D, Goldman RC. 2000. Antibacterial activity of synthetic analogues based on the disaccharide structure of moenomycin, an inhibitor of bacterial transglycosylase. Microbiology. 12:3129-3140.
367Küçükgüzel SG, Mazi A, Sahin F, Oztürk S, Stables J. 2003. Synthesis and biological activities of diflunisal hydrazide-hydrazones. Eur J Med Chem. 38(11-12):1005-1013.
368Uzel A, Sorkun K, Onçağ O, Cogŭlu D, Gençay O, Salih B. 2005. Chemical compositions and antimicrobial activities of four different Anatolian propolis samples. Microbiol 160(2):189-195.
369Farrell DJ, File TM, Jenkins SG. 2007. Prevalence and antibacterial susceptibility of mef(A)-positive macrolide-resistant Streptococcus pneumoniae over 4 years (2000 to 2004) of the PROTEKT US Study. J Clin Microbiol. 45(2):290-293.
370Quiroga EN, Sampietro AR, Vattuone MA. 2001. Screening antifungal activities of selected medicinal plants. J Ethnopharmacol. 74(1):89-96
371Casellas JM, Tomé G, Bantar C, Bertolini P, Blázquez N, Borda N, Couto E, Cudmani N, Guerrera J, Juárez MJ, López T, Littvik A, Méndez E, Notario R, Ponce G, Quinteros M, Salamone F, Sparo M, Sutich E, Vaylet S, Wolff L. 2003. Argentinean collaborative multicenter study on the in vitro comparative activity of piperacillin-tazobactam against selected bacterial isolates recovered from hospitalized patients. Diagn Microbiol Infect Dis. 47(3):527-537.
372Yau YH, Ho B, Tan NS, Ng ML, Ding JL. 2001. High therapeutic index of factor C Sushi peptides: potent antimicrobials against Pseudomonas aeruginosa. Antimicrob Agents Chemother. 45(10):2820-2825.
373Andes D, van Ogtrop ML, Peng J, Craig WA. 2002. In vivo pharmacodynamics of a new oxazolidinone (linezolid). Antimicrob Agents Chemother. 46(11):3484-3489.
374Eliopoulos GM, Klimm K, Grayson ML. 1990. In vitro activity of sparfloxacin (AT-4140, CI-978, PD 131501), a new quinolone antimicrobial agent. Diagn Microbiol Infect Dis. 13(4):345-348.
375O'Gara EA, Hill DJ, Maslin DJ.. 2000. Activities of garlic oil, garlic powder, and their diallyl constituents against Helicobacter pylori. Appl Environ Microbiol. 66(5):2269-2273.
376Fuchs PC, Jones RN, Barry AL, Ayers LW, Gavan TL, Gerlach EH. 1986. In vitro activity of carumonam (RO 17-2301), BMY-28142, aztreonam, and ceftazidime against 7,620 consecutive clinical bacterial isolates. Diagn Microbiol Infect Dis. 5(4):345-349.
377Andes D, Marchillo K, Stamstad T, Conklin R. 2003. In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model. Antimicrob Agents Chemother. 47(10):3165-3169.
378Park BS, Lee HK, Lee SE, Piao XL, Takeoka GR, Wong RY, Ahn YJ, Kim JH.. 2006. Antibacterial activity of Tabebuia impetiginosa Martius ex DC (Taheebo) against Helicobacter pylori. J Ethnopharmacol. 105(1-2):255-262.
379Villain-Guillot P, Gualtieri M, Bastide L, Leonetti JP.. 2007. In vitro activities of different inhibitors of bacterial transcription against Staphylococcus epidermidis biofilm. Antimicrob Agents Chemother. 51(9):3117-3121.
380Tanikawa T, Asaka T, Kashimura M, Misawa Y, Suzuki K, Sato M, Kameo K, Morimoto S, Nishida A. 2001. Synthesis and antibacterial activity of acylides (3-O-acyl-erythromycin derivatives): a novel class of macrolide antibiotics. J Med Chem. 44(24):4027-4030.
381Oh H, Hedberg M, Wade D, Edlund C. 2000. Activities of synthetic hybrid peptides against anaerobic bacteria: aspects of methodology and stability. Antimicrob Agents Chemother. 44(1):68-72.
382Al-Fatimi M, Wurster M, Schröder G, Lindequist U. 2007. Antioxidant, antimicrobial and cytotoxic activities of selected medicinal plants from Yemen. J Ethnopharmacol. 111(3):657-666.
383Silici S, Kutluca S.. 2005. Chemical composition and antibacterial activity of propolis collected by three different races of honeybees in the same region. J Ethnopharmacol. 99(1):69-73.
384Chakraborty A, Brantner AH. 1999. Antibacterial steroid alkaloids from the stem bark of Holarrhena pubescens. J Ethnopharmacol. 68(1-3):339-344.
385Omri A, Suntres ZE, Shek PN. 2002. Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection. Biochem Pharmacol. 64(9):1407-1413.
386Stearne LE, van Boxtel D, Lemmens N, Goessens WH, Mouton JW, Gyssens IC. 2004. Comparative study of the effects of ceftizoxime, piperacillin, and piperacillin-tazobactam concentrations on antibacterial activity and selection of antibiotic-resistant mutants of Enterobacter cloacae and Bacteroides fragilis in vitro and in vivo in mixed-infection abscesses. Antimicrob Agents Chemother. 48(5):1688-1698.
387Phetsuksiri B, Baulard AR, Cooper AM, Minnikin DE, Douglas JD, Besra GS, Brennan PJ. 1999. Antimycobacterial activities of isoxyl and new derivatives through the inhibition of mycolic acid synthesis. Antimicrob Agents Chemother 143(5):1042-1051.
388Pestova E, Beyer R, Cianciotto NP, Noskin GA, Peterson LR. 1999. Contribution of topoisomerase IV and DNA gyrase mutations in Streptococcus pneumoniae to resistance to novel fluoroquinolones. Antimicrob Agents Chemother. 43(8):2000-2004.
389Franzblau SG, Cross C. 1986. Comparative in vitro antimicrobial activity of Chinese medicinal herbs. J Ethnopharmacol 15(3):279-288.
390Kim, B. S., J. Y. Lee, and B. K. Hwang. 2000. In vivo control and in vitro antifungal activity of rhamnolipid B, a glycilipid antibiotic, against Phytophthora capsici and Colletotrichum orbiculare. Pest. Manag. Sci. 56:1029–1035.
391Tian L, Sun Y, Li H, Zheng X, Cheng Y, Liu X, Qian B. 2005. Synthesis, characterization and biological activity of triorganotin 2-phenyl-1,2,3-triazole-4-carboxylates. J Inorg Biochem. 99(8):1646-1652.
392Takei M, Fukuda H, Yasue T, Hosaka M, Oomori Y. 1998. Inhibitory activities of gatifloxacin (AM-1155), a newly developed fluoroquinolone, against bacterial and mammalian type II topoisomerases. Antimicrob Agents Chemother. 42(10):2678-2681.
393Apfel CM, Locher H, Evers S, Takács B, Hubschwerlen C, Pirson W, Page MG, Keck W. 2001. Peptide deformylase as an antibacterial drug target: target validation and resistance development. Antimicrob Agents Chemother. 45(4):1058-1064.
394Hotoda H, Furukawa M, Daigo M, Murayama K, Kaneko M, Muramatsu Y, Ishii MM, Miyakoshi S, Takatsu T, Inukai M, Kakuta M, Abe T, Harasaki T, Fukuoka T, Utsui Y, Ohya S. 2003. Synthesis and antimycobacterial activity of capuramycin analogues. Part 1: substitution of the azepan-2-one moiety of capuramycin. Bioorg Med Chem Lett. 13(17):2829-2832.
395Xu, J.; X. Zhao; X. Han and Y. Du 2007. Antifungal activity of oligochitosan against Phytophthora capsici and other plant pathogenic fungi in vitro. Pesticide Biochem. Physiol. 87: 220-228.
396Yum JH, Kim CK, Yong D, Lee K, Chong Y, Kim CM, Kim JM, Ro S, Cho JM. 2007. In vitro activities of CG400549, a novel FabI inhibitor, against recently isolated clinical staphylococcal strains in Korea. Antimicrob Agents Chemother 51(7):2591-2593.
397Hirokawa Y, Kinoshita H, Tanaka T, Nakata K, Kitadai N, Fujimoto K, Kashimoto S, Kojima T, Kato S. 2008. Water-soluble pleuromutilin derivative with excellent in vitro and in vivo antibacterial activity against gram-positive pathogens. J Med Chem. 51(7):1991-1994.
398Göker H, Kuş C, Boykin DW, Yildiz S, Altanlar N. 2002. Synthesis of some new 2-substituted-phenyl-1H-benzimidazole-5-carbonitriles and their potent activity against Candida species. Bioorg Med Chem. 10(8):2589-2596.
399Kartsonis N, Killar J, Mixson L, Hoe CM, Sable C, Bartizal K, Motyl M. 2005. Caspofungin susceptibility testing of isolates from patients with esophageal candidiasis or invasive candidiasis: relationship of MIC to treatment outcome. Antimicrob Agents Chemother. 49(9):3616-3623.
400Wichelhaus TA, Schäfer V, Brade V, Böddinghaus B. 1999. Molecular characterization of rpoB mutations conferring cross-resistance to rifamycins on methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 43(11):2813-2816.
401Andrews JM. 2001. Determination of minimum inhibitory concentrations. J Antimicrob Chemother. 48 Suppl 1:5-16.
402Hunfeld KP, Kraiczy P, Wichelhaus TA, Schäfer V, Brade V. 2000. New colorimetric microdilution method for in vitro susceptibility testing of Borrelia burgdorferi against antimicrobial substances. Eur J Clin Microbiol Infect Dis. 19(1):27-32
403Jones RN, Ballow CH, Schentag JJ, Johnson DM, Deinhart JA. 1998. In vitro evaluation of sparfloxacin activity and spectrum against 24,940 pathogens isolated in the United States and Canada, the final analysis. Diagn Microbiol Infect Dis. 31(1):313-325
404Kim S, Kim SS, Bang YJ, Kim SJ, Lee BJ. 2003. In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines. Peptides 24(7):945-953
405Dharmaratne HR, Wijesinghe WM, Thevanasem V. 1999. Antimicrobial activity of xanthones from Calophyllum species, against methicillin-resistant Staphylococcus aureus (MRSA). J Ethnopharmacol. 66(3):339-342
406Walsh SE, Maillard JY, Russell AD, Catrenich CE, Charbonneau DL, Bartolo RG. 2003. Activity and mechanisms of action of selected biocidal agents on Gram-positive and -negative bacteria. J Appl Microbiol. 94(2):240-247
407Pinheiro ET, Gomes BP, Drucker DB, Zaia AA, Ferraz CC, Souza-Filho FJ. 2004. Antimicrobial susceptibility of Enterococcus faecalis isolated from canals of root filled teeth with periapical lesions. Int Endod J. 37(11):756-763.
408Ferreira ICFR, Calhelha RC, Estevinho LM, Queiroz M-JRP. 2004. Screening of antimicrobial activity of diarylamines in the 2,3,5-trimethylbenzo[b]thiophene series: a structure-activity evaluation study. Bioorg Med Chem Lett 14: 5831-5833.
409Apfel C, Banner DW, Bur D, Dietz M, Hirata T, Hubschwerlen C, Locher H, Page MG, Pirson W, Rossé G, Specklin JL. 2000. Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents. J Med Chem. 43(12):2324-2331.
410Segreti J, Gvazdinskas LC, Trenholme GM. 1989. In vitro activity of minocycline and rifampin against staphylococci. Diagn Microbiol Infect Dis. 12(3):253-255.
411Sokmen A., Gulluce M., Akpulat HA., Daferera D., Tepe B., Polissiou M., Sokmen M., Sahin F. 2004. The in vitro antimicrobial and antioxidant activities of the essential oils and methanol extracts of endemic Thymus spathulifolius Food Control. 15, 627–634
412Sader HS, Fritsche TR, Jones RN. 2005. Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003). Diagn Microbiol Infect Dis. 52(3):265-273
413Lübbers T, Angehrn P, Gmünder H, Herzig S, Kulhanek J. 2000. Design, synthesis, and structure-activity relationship studies of ATP analogues as DNA gyrase inhibitors. Bioorg Med Chem Lett. 10(8):821-826
414Lee JY, Moon SS, Hwang BK. 2003. Isolation and in vitro and in vivo activity against Phytophthora capsici and Colletotrichum orbiculare of phenazine-1-carboxylic acid from Pseudomonas aeruginosa strain GC-B26. Pest Manag Sci. 59(8):872-882.
415Kremer L, Douglas JD, Baulard AR, Morehouse C, Guy MR, Alland D, Dover LG, Lakey JH, Jacobs WR Jr, Brennan PJ, Minnikin DE, Besra GS. 2000. Thiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis. J Biol Chem. 275(22):16857-16864
416Aeschlimann JR, Rybak MJ. 1998. Pharmacodynamic analysis of the activity of quinupristin-dalfopristin against vancomycin-resistant Enterococcus faecium with differing MBCs via time-kill-curve and postantibiotic effect methods. Antimicrob Agents Chemother. 42(9):2188-2192
417Aoki H, Ke L, Poppe SM, Poel TJ, Weaver EA, Gadwood RC, Thomas RC, Shinabarger DL, Ganoza MC. 2002. Oxazolidinone antibiotics target the P site on Escherichia coli ribosomes. Antimicrob Agents Chemother. 46(4):1080-1085
418Kays MB, Wood KK, Miles DO. 1999. In vitro activity and pharmacodynamics of oral beta-lactam antibiotics against Streptococcus pneumoniae from southeast Missouri. Pharmacotherapy. 19(11):1308-1314.
419Ilker MF, Nüsslein K, Tew GN, Coughlin EB. 2004. Tuning the hemolytic and antibacterial activities of amphiphilic polynorbornene derivatives. J Am Chem Soc. 126(48):15870-15875
420Foks H, Pancechowska-Ksepko D, Kedzia A, Zwolska Z, Janowiec M, Augustynowicz-Kopeć E. 2005. Synthesis and antibacterial activity of 1H-pyrazolo[3,4-b]pyrazine and -pyridine derivatives. Farmaco 60(6-7):513-517.
421Kamoda O, Anzai K, Mizoguchi J, Shiojiri M, Yanagi T, Nishino T, Kamiya S. 2006. In vitro activity of a novel antimicrobial agent, TG44, for treatment of Helicobacter pylori infection. Antimicrob Agents Chemother. 50(9):3062-3069.
422Evans EW, Beach FG, Moore KM, Jackwood MW, Glisson JR, Harmon BG. 1995. Antimicrobial activity of chicken and turkey heterophil peptides CHP1, CHP2, THP1, and THP3. Vet Microbiol. 47(3-4):295-303
423Pankey G, Ashcraft D, Patel N. 2005. In vitro synergy of daptomycin plus rifampin against Enterococcus faecium resistant to both linezolid and vancomycin. Antimicrob Agents Chemother. 49(12):5166-5168
424Zhou Y, Sun Z, Froelich JM, Hermann T, Wall D. 2006. Structure-activity relationships of novel antibacterial translation inhibitors: 3,5-diamino-piperidinyl triazines. Bioorg Med Chem Lett. 16(20):5451-5456
425Tona L, Kambu K, Ngimbi N, Cimanga K, Vlietinck AJ. 1998. Antiamoebic and phytochemical screening of some Congolese medicinal plants. J Ethnopharmacol. 61(1):57-65
426Kays MB, Conklin M. 2000. Comparative in vitro activity and pharmacodynamics of five fluoroquinolones against clinical isolates of Streptococcus pneumoniae. Pharmacotherapy. 20(11):1310-1317.
427Gustafsson I, Hjelm E, Cars O. 2000. In vitro pharmacodynamics of the new ketolides HMR 3004 and HMR 3647 (Telithromycin) against Chlamydia pneumoniae. Antimicrob Agents Chemother. 44(7):1846-1849.
428Chimenti F, Bizzarri B, Manna F, Bolasco A, Secci D, Chimenti P, Granese A, Rivanera D, Lilli D, Scaltrito MM, Brenciaglia MI. 2005. Synthesis and in vitro selective anti-Helicobacter pylori activity of pyrazoline derivatives. Bioorg Med Chem Lett. 15(3):603-607.
429Lim YH, Kim IH, Seo JJ. 2007. In vitro activity of kaempferol isolated from the Impatiens balsamina alone and in combination with erythromycin or clindamycin against Propionibacterium acnes. J Appl Microbiol. 45(5):473-477.
430Peláez T, Alcalá L, Alonso R, Martín-López A, García-Arias V, Marín M, Bouza E. 2005. In vitro activity of ramoplanin against Clostridium difficile, including strains with reduced susceptibility to vancomycin or with resistance to metronidazole. Antimicrob Agents Chemother. 49(3):1157-1159.
431Li Z, Francisco GD, Hu W, Labthavikul P, Petersen PJ, Severin A, Singh G, Yang Y, Rasmussen BA, Lin YI, Skotnicki JS, Mansour TS. 2003. 2-Phenyl-5,6-dihydro-2H-thieno[3,2-c]pyrazol-3-ol derivatives as new inhibitors of bacterial cell wall biosynthesis. Bioorg Med Chem Lett. 13(15):2591-2594.
432Kelly LM, Jacobs MR, Appelbaum PC. 1999. Comparison of agar dilution, microdilution, E-test, and disk diffusion methods for testing activity of cefditoren against Streptococcus pneumoniae. J Clin Microbiol. 37(10):3296-3299.
433Maurin M, Bakken JS, Dumler JS. 2003. Antibiotic susceptibilities of Anaplasma (Ehrlichia) phagocytophilum strains from various geographic areas in the United States. Antimicrob Agents Chemother. 47(1):413-415.
434Cecchetti V, Fravolini A, Lorenzini MC, Tabarrini O, Terni P, Xin T. 1996. Studies on 6-aminoquinolones: synthesis and antibacterial evaluation of 6-amino-8-methylquinolones. J Med Chem. 19;39(2):436-445.
435Parrish NM, Houston T, Jones PB, Townsend C, Dick JD. 2001. In vitro activity of a novel antimycobacterial compound, N-octanesulfonylacetamide, and its effects on lipid and mycolic acid synthesis. Antimicrob Agents Chemother. 45(4):1143-1150.
436Orden JA, Ruiz-Santa-Quiteria JA, García S, Cid D, De La Fuente R. 2000. In vitro susceptibility of Escherichia coli strains isolated from diarrhoeic dairy calves to 15 antimicrobial agents. J Vet Med B Infect Dis Vet Public Health. 47(5):329-335.
437Dandliker PJ, Pratt SD, Nilius AM, Black-Schaefer C, Ruan X, Towne DL, Clark RF, Englund EE, Wagner R, Weitzberg M, Chovan LE, Hickman RK, Daly MM, Kakavas S, Zhong P, Cao Z, David CA, Xuei X, Lerner CG, Soni NB, Bui M, Shen LL, Cai Y, Merta PJ, Saiki AY, Beutel BA. 2003. Novel antibacterial class. Antimicrob Agents Chemother. 47(12):3831-3839.
438Pfaller MA, Messer SA, Hollis RJ, Jones RN, Doern GV, Brandt ME, Hajjeh RA. 1998. In vitro susceptibilities of Candida bloodstream isolates to the new triazole antifungal agents BMS-207147, Sch 56592, and voriconazole. Antimicrob Agents Chemother. 42(12):3242-3244.
439Bogaerts P, Berhin C, Nizet H, Glupczynski Y. 2006. Prevalence and mechanisms of resistance to fluoroquinolones in Helicobacter pylori strains from patients living in Belgium. Helicobacter. 11(5):441-445.
440Ghannoum MA, Rice LB. 1999. Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev. 12(4):501-517.
441Hong SY, Oh JE, Lee KH. 1999. Effect of D-amino acid substitution on the stability, the secondary structure, and the activity of membrane-active peptide. Biochem Pharmacol. 58(11):1775-1780.
442Dubois J, Joly JR. 1989. In vitro activity of lomefloxacin (SC 47111 or NY-198) against isolates of Legionella spp. Diagn Microbiol Infect Dis. 12(3 Suppl):89S-91S.
443Otani T, Tanaka M, Ito E, Kurosaka Y, Murakami Y, Onodera K, Akasaka T, Sato K. 2003. In vitro and in vivo antibacterial activities of DK-507k, a novel fluoroquinolone. Antimicrob Agents Chemother. 47(12):3750-3759.
444Souli M, Kontopidou FV, Koratzanis E, Antoniadou A, Giannitsioti E, Evangelopoulou P, Kannavaki S, Giamarellou H. 2006. In vitro activity of tigecycline against multiple-drug-resistant, including pan-resistant, gram-negative and gram-positive clinical isolates from Greek hospitals. Antimicrob Agents Chemother. 50(9):3166-3169.
445Hershberger E, Rybak MJ. 2000. Activities of trovafloxacin, gatifloxacin, clinafloxacin, sparfloxacin, levofloxacin, and ciprofloxacin against penicillin-resistant Streptococcus pneumoniae in an in vitro infection model. Antimicrob Agents Chemother. 44(3):598-601.
446Barrett MS, Jones RN. 1996. In vitro activity of quinupristin/dalfopristin (RP 59500) against a large collection of infrequently isolated or tested species. Diagn Microbiol Infect Dis. 25(3):147-149.
447Rodriguez-Villalobos H, Malaviolle V, Frankard J, de Mendonça R, Nonhoff C, Struelens MJ. 2006. In vitro activity of temocillin against extended spectrum beta-lactamase-producing Escherichia coli. J Antimicrob Chemother. 57(4):771-774.
448Malathum K, Coque TM, Singh KV, Murray BE. 1999. In vitro activities of two ketolides, HMR 3647 and HMR 3004, against gram-positive bacteria. Antimicrob Agents Chemother. 43(4):930-936.
449Arthur M, Depardieu F, Reynolds P, Courvalin P. 1999. Moderate-level resistance to glycopeptide LY333328 mediated by genes of the vanA and vanB clusters in enterococci. Antimicrob Agents Chemother. 43(8):1875-1880.
450Tshikalange TE, Meyer JJ, Hussein AA. 2005. Antimicrobial activity, toxicity and the isolation of a bioactive compound from plants used to treat sexually transmitted diseases. J Ethnopharmacol. 96(3):515-519.
451Cecchetti V, Fravolini A, Palumbo M, Sissi C, Tabarrini O, Terni P, Xin T. 1996. Potent 6-desfluoro-8-methylquinolones as new lead compounds in antibacterial chemotherapy. J Med Chem. 39(25):4952-4957.
452Asbell PA, Colby KA, Deng S, McDonnell P, Meisler DM, Raizman MB, Sheppard JD Jr, Sahm DF. 2008. Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates. Am J Ophthalmol. 145(6):951-958
453Küçükgüzel ŞG, Rollas S, Küçükgüzel İ, Kiraz M. 1999. Synthesis and Antimycobacterial activity of some coupling products from 4-aminobenzoic acid hydrazones. Eur. J. Med. Chem. 34: 1093-1100
454Cole AM, Darouiche RO, Legarda D, Connell N, Diamond G. 2000. Characterization of a fish antimicrobial peptide: gene expression, subcellular localization, and spectrum of activity. Antimicrob Agents Chemother. 44(8):2039-2045.
455Karaman I, Sahin F, Güllüce M, Ogütçü H, Sengül M, Adigüzel A. 2003. Antimicrobial activity of aqueous and methanol extracts of Juniperus oxycedrus L. J Ethnopharmacol. 85(2-3):231-235.
456Fukuda N, Yamase T. 1997. In vitro antibacterial activity of vanadate and vanadyl compounds against Streptococcus pneumoniae. Biol Pharm Bull. 20(8):927-930.
457Talath S. Gadad A.K. 2006. Synthesis, antibacterial and antitubercular activities of some 7-[4-(5-amino-[1,3,4]thiadiazole-2-sulfonyl)-piperazin-1-yl] fluoroquinolonic derivatives. Eur. J. Med. Chem. 918-924
458Bottari B, Maccari R, Monforte F, Ottanà R, Rotondo E, Vigorita MG. 2000. Isoniazid-related copper(II) and nickel(II) complexes with antimycobacterial in vitro activity. Part 9. Bioorg Med Chem Lett. 10(7):657-660.
459Güniz Küçükgüzel S, Rollas S, Erdeniz H, Kiraz M, Cevdet Ekinci A, Vidin A. 2000. Synthesis, characterization and pharmacological properties of some 4-arylhydrazono-2-pyrazoline-5-one derivatives obtained from heterocyclic amines. Eur. J. Med. Chem. 35(7-8):761-771.
460Sahin G, Palaska E, Ekizoğlu M, Ozalp M. 2002. Synthesis and antimicrobial activity of some 1,3,4-oxadiazole derivatives.
Farmaco. 57(7):539-542.460.
461Ba BB, Arpin C, Vidaillac C, Chausse A, Saux MC, Quentin C. 2006. Activity of gatifloxacin in an in vitro pharmacokinetic-pharmacodynamic model against Staphylococcus aureus strains either susceptible to ciprofloxacin or exhibiting various levels and mechanisms of ciprofloxacin resistance. Antimicrob Agents Chemother. 50(6):1931-1936.
462Gales AC, Jones RN. 2000. Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacte J Ethnopharmacol.ial isolates. Diagn Microbiol Infect Dis. 36(1):19-36.
463Pace JL, Krause K, Johnston D, Debabov D, Wu T, Farrington L, Lane C, Higgins DL, Christensen B, Judice JK, Kaniga K. 2003. In vitro activity of TD-6424 against Staphylococcus aureus. Antimicrob Agents Chemother. 47(11):3602-3604.
464Pfaller MA, Marco F, Messer SA, Jones RN. 1998. In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi. Diagn Microbiol Infect Dis. 30(4):251-255.
465Carrillo AJ, Guarro J. 2001. In vitro activities of four novel triazoles against Scedosporium spp. Antimicrob Agents Chemother. 45(7):2151-2153.
466Bebear CM, Renaudin H, Charron A, Gruson D, Lefrancois M, Bebear C. 2000. In vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized Antimicrob Agents Chemother. 44(9):2557-2560.
467Bébéar CM, Renaudin H, Boudjadja A, Bébéar C. 1998. In vitro activity of BAY 12-8039, a new fluoroquinolone against mycoplasmas. Antimicrob Agents Chemother. 42(3):703-704.
468Barchiesi F, Schimizzi AM, Fothergill AW, Scalise G, Rinaldi MG. 1999. In vitro activity of the new echinocandin antifungal, MK-0991, against common and uncommon clinical isolates of Candida species. Eur J Clin Microbiol Infect Dis. 18(4):302-304.
469Ho PL, Que TL, Tsang DN, Ng TK, Chow KH, Seto WH. 1999. Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong. Antimicrob Agents Chemother. 43(5):1310-1313.
470Reinert RR, Bryskier A, Lütticken R. 1998. In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany. Antimicrob Agents Chemother. 42(6):1509-1511.
471Wallace RJ Jr, Brown-Elliott BA, Crist CJ, Mann L, Wilson RW. 2002. Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria. Antimicrob Agents Chemother. 46(10):3164-3167.
472Sader HS, Jones RN, Dowzicky MJ, Fritsche TR. 2005. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit. Diagn Microbiol Infect Dis. 52(3):203-208.
473Lacy MK, Lu W, Xu X, Tessier PR, Nicolau DP, Quintiliani R, Nightingale CH. 1999. Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillin against Streptococcus pneumoniae in an in vitro model of infection. Antimicrob Agents Chemother. 43(3):672-677.
474Hancock RE. 2001. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect Dis. 1(3):156-164.
475Waites KB, Duffy LB, Dowzicky MJ. 2006. Antimicrobial susceptibility among pathogens collected from hospitalized patients in the United States and in vitro activity of tigecycline, a new glycylcycline antimicrobial. Antimicrob Agents Chemother. 50(10):3479-3484.
476Boucher HW, Wennersten CB, Eliopoulos GM. 2000. In vitro activities of the glycylcycline GAR-936 against gram-positive bacteria. Antimicrob Agents Chemother. 44(8):2225-2229.
477Dowzicky M, Nadler HL, Feger C, Talbot G, Bompart F, Pease M. 1998. Evaluation of in vitro activity of quinupristin/dalfopristin and comparator antimicrobial agents against worldwide clinical trial and other laboratory isolates. Am J Med. 104(5A):34S-42S.
478Gomi H, Jiang ZD, Adachi JA, Ashley D, Lowe B, Verenkar MP, Steffen R, DuPont HL. 2001. In vitro antimicrobial susceptibility testing of bacterial enteropathogens causing traveler's diarrhea in four geographic regions. Antimicrob Agents Chemother. 45(1):212-216.
479Gales AC, Reis AO, Jones RN. 2001. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines. J Clin Microbiol. 39(1):183-190.
480Hecht DW, Galang MA, Sambol SP, Osmolski JR, Johnson S, Gerding DN. 2007. In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004. Antimicrob Agents Chemother. 51(8):2716-2719.
481Marco F, Pfaller MA, Messer S, Jones RN. 1998. In vitro activities of voriconazole (UK-109,496) and four other antifungal agents against 394 clinical isolates of Candida spp. Antimicrob Agents Chemother. 42(1):161-163.
482Cuenca-Estrella M, Díaz-Guerra TM, Mellado E, Monzón A, Rodríguez-Tudela JL. 1999. Comparative in vitro activity of voriconazole and itraconazole against fluconazole-susceptible and fluconazole-resistant clinical isolates of Candida species from Spain. Eur J Clin Microbiol Infect Dis. 18(6):432-435.
483Sader HS, Streit JM, Fritsche TR, Jones RN. 2004. Antimicrobial activity of daptomycin against multidrug-resistant Gram-positive strains collected worldwide. Diagn Microbiol Infect Dis. 50(3):201-204.
484McGinnis MR, Pasarell L, Sutton DA, Fothergill AW, Cooper CR Jr, Rinaldi MG. 1997. In vitro evaluation of voriconazole against some clinically important fungi. Antimicrob Agents Chemother. 41(8):1832-1834.
485Oakley KL, Moore CB, Denning DW. 1999. Comparison of in vitro activity of liposomal nystatin against Aspergillus species with those of nystatin, amphotericin B (AB) deoxycholate, AB colloidal dispersion, liposomal AB, AB lipid complex, and itraconazole. Antimicrob Agents Chemother. 43(5):1264-1266.
486Pfaller MA, Diekema DJ, Messer SA, Hollis RJ, Jones RN. 2003. In vitro activities of caspofungin compared with those of fluconazole and itraconazole against 3,959 clinical isolates of Candida spp., including 157 fluconazole-resistant isolates. Antimicrob Agents Chemother. 47(3):1068-1071.
487Marco F, Pfaller MA, Messer SA, Jones RN. 1998. In vitro activity of a new triazole antifungal agent, Sch 56592, against clinical isolates of filamentous fungi. Mycopathologia. 141(2):73-77.
488Soriano F, Fernández-Roblas R, Calvo R, García-Calvo G. 1998. In vitro susceptibilities of aerobic and facultative non-spore-forming gram-positive bacilli to HMR 3647 (RU 66647) and 14 other antimicrobials. Antimicrob Agents Chemother. May;42(5):1028-1033.
489Perea S, Gonzalez G, Fothergill AW, Kirkpatrick WR, Rinaldi MG, Patterson TF. 2002. In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp. Antimicrob Agents Chemother. 46(9):3039-3041.
490Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez HT. 2003. In vitro activities of daptomycin, vancomycin, quinupristin- dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates. Antimicrob Agents Chemother. 47(1):337-341.
491Sierra JM, Ruiz J, Navia MM, Vargas M, Vila J. 2001. In vitro activity of rifaximin against enteropathogens producing traveler's diarrhea. Antimicrob Agents Chemother. 45(2):643--644.
492Ackermann G, Löffler B, Adler D, Rodloff AC. 2004. In vitro activity of OPT-80 against Clostridium difficile. Antimicrob Agents Chemother. 48(6):2280-2282.
493Fuchs PC, Barry AL, Brown SD. 2001. In vitro activities of ertapenem (MK-0826) against clinical bacterial isolates from 11 North American medical centers. Antimicrob Agents Chemother. 45(6):1915-1918.
494Gulhan Turan-Zitouni, Ahmet Ozdemir, Zafer Asım Kaplancıklı, Jean-Alain Fehrentz, Jean Martinez, Pierre Chevallet, and Gislaine Dusart 2009. Preparation of Some Thiazolyl Hydrazone Derivatives and Evaluation of Their Antibacterial Activities Phosphorus, Sulfur, and Silicon 184:2613–2623, 2009
495Roblin PM, Hammerschlag MR. 1998. In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae. Antimicrob Agents Chemother. 42(4):951-952.
496Jones RN, Biedenbach DJ. 1997. Antimicrobial activity of RU-66647, a new ketolide. Diagn Microbiol Infect Dis. 27(1-2):7-12.
497Betriu C, Rodríguez-Avial I, Sánchez BA, Gómez M, Alvarez J, Picazo JJ 2002. Spanish Group of Tigecycline. In vitro activities of tigecycline (GAR-936) against recently isolated clinical bacteria in Spain. Antimicrob Agents Chemother. 46(3):892-895.
498Machado TB, Pinto AV, Pinto MC, Leal IC, Silva MG, Amaral AC, Kuster RM, Netto-dosSantos KR. 2003. In vitro activity of Brazilian medicinal plants, naturally occurring naphthoquinones and their analogues, against methicillin-resistant Staphylococcus aureus.
Antimicrob Agents Chemother. 21(3):279-284.
499Hoban DJ, Zhanel GG, Karlowsky JA. 1999. In vitro activity of the novel ketolide HMR 3647 and comparative oral antibiotics against Canadian respiratory tract isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Diagn Microbiol Infect Dis. 35(1):37-44.
500Doern GV, Jones RN, Pfaller MA, Kugler K. 1999. Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: antimicrobial susceptibility patterns from the SENTRY antimicrobial Surveillance Program (United States and Canada, 1997). Antimicrob Agents Chemother. 43(2):385-389.
501Bachmann SP, Patterson TF, López-Ribot JL. 2002. In vitro activity of caspofungin (MK-0991) against Candida albicans clinical isolates displaying different mechanisms of azole resistance. J Clin Microbiol. 2228-2230.
502Jalava J, Kataja J, Seppälä H, Huovinen P. 2001. In vitro activities of the novel ketolide telithromycin (HMR 3647) against erythromycin-resistant Streptococcus species. Antimicrob Agents Chemother. 789-793.
503Moore CB, Walls CM, Denning DW. 2000. In vitro activity of the new triazole BMS-207147 against Aspergillus species in comparison with itraconazole and amphotericin B. Antimicrob Agents Chemother. 44(2):441-443.
504Vera-Cabrera L, Gómez-Flores A, Escalante-Fuentes WG, Welsh O. 2001. In vitro activity of PNU-100766 (linezolid), a new oxazolidinone antimicrobial, against Nocardia brasiliensis. Antimicrob Agents Chemother. 45(12):3629-3630.
505Brenwald NP, Gill MJ, Wise R. 1998. Prevalence of a putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother. 42(8):2032-2035.
506Marangon FB, Miller D, Giaconi JA, Alfonso EC. 2004. In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens. Am J Ophthalmol. 137(5):820-825.
507Lalitha P, Shapiro BL, Srinivasan M, Prajna NV, Acharya NR, Fothergill AW, Ruiz J, Chidambaram JD, Maxey KJ, Hong KC, McLeod SD, Lietman TM. 2007. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis. Arch Ophthalmol. Arch Ophthalmol. 125(6):789-793.
508Hariprasad SM, Mieler WF, Holz ER, Gao H, Kim JE, Chi J, Prince RA. 2004. Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans. Arch Ophthalmol. 122(1):42-47.
509Vemulakonda GA, Hariprasad SM, Mieler WF, Prince RA, Shah GK, Van Gelder RN. 2008. Aqueous and vitreous concentrations following topical administration of 1% voriconazole in humans. Arch Ophthalmol. 126(1):18-22.
510Koontz JL, Marcy JE. 2003. Formation of natamycin:cyclodextrin inclusion complexes and their characterization. J Agric Food Chem. 19;51(24):7106-7110.
511Li L, Wang Z, Li R, Luo S, Sun X. 2008. In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients. Am J Ophthalmol. 146(5):724-728.
512Iqbal NJ, Boey A, Park BJ, Brandt ME. 2008. Determination of in vitro susceptibility of ocular Fusarium spp. isolates from keratitis cases and comparison of Clinical and Laboratory Standards Institute M38-A2 and E test methods. Diagn Microbiol Infect Dis. 62(3):348-350.
513Lalitha P, Vijaykumar R, Prajna NV, Fothergill AW. 2008. In vitro natamycin susceptibility of ocular isolates of Fusarium and Aspergillus species: comparison of commercially formulated natamycin eye drops to pharmaceutical-grade powder. J Clin Microbiol. 46(10):3477-3478.
514Xu Y, Pang G, Gao C, Zhao D, Zhou L, Sun S, Wang B. 2009. In vitro comparison of the efficacies of natamycin and silver nitrate against ocular fungi. Antimicrob Agents Chemother. 53(4):1636-1638.
515Rosina Khan, Mohammad Zakir, Sadul H. Afaq, Abdul Latif, Asad U. Khan 2010. Activity of solvent extracts of Prosopis spicigera, Zingiber officinale and Trachyspermum ammi against multidrug resistant bacterial and fungal strains J Infect Dev Ctries 4(5):292-300
516Guarro, J., I. Pujol, C. Aguilar, and M. Ortoneda. 2002. In vitro antifungal susceptibility of nondermatophytic keratinophilic fungi. Revista Iberoamericana de Micologia, Bilbao, Spain. 142-147
517Kalanidhi Palanichamy and Krishna P. Kaliappan 2010. Discovery and Syntheses of "Superbug Challengers”—Platensimycin and Platencin Chem. Asian J. 2010, 5, 668 – 703
518Kredics L, Varga J, Kocsubé S, Rajaraman R, Raghavan A, Dóczi I, Bhaskar M, Németh TM, Antal Z, Venkatapathy N, Vágvölgyi C, Samson RA, Chockaiya M, Palanisamy M. 2009. Infectious keratitis caused by Aspergillus tubingensis. Cornea. 28(8):951-954.
519Revankar SG, Sutton DA, Sanche SE, Rao J, Zervos M, Dashti F, Rinaldi MG. 1999. Metarrhizium anisopliae as a cause of sinusitis in immunocompetent hosts. J Clin Microbiol. 37(1):195-198.
520Yücel S, Yamaç M. 2010. Selection of Streptomyces isolates from Turkish karstic caves against antibiotic resistant microorganisms. Pak J Pharm Sci. 23(1):1-6.
521Guarro J, Mendiratta DK, De Sequeira H, Rodríguez V, Thamke D, Gomes AM, Shukla AK, Menezes F, Narang P, Roldão Vieira J, Gené J. 2007. Acrophialophora fusispora: an emerging agent of human mycoses. A report of 3 new clinical cases. Diagn Microbiol Infect Dis. 59(1):85-88.
522Wilhelmus KR, Jones DB. 2001. Curvularia keratitis. Trans Am Ophthalmol Soc. 111-130
523Enrique M, Marcos JF, Yuste M, Martínez M, Vallés S, Manzanares P. 2007. Antimicrobial action of synthetic peptides towards wine spoilage yeasts. Int J Food Microbiol. 118(3):318-325.
524 0. Antimicrobial Agents
525Charvalos E, Tzatzarakis M, Tsatsakis A, Petrikkos G. 2001. Controlled release of water-soluble polymeric complexes of sorbic acid with antifungal activities. Appl Microbiol Biotechnol. 57(5-6):770-775.
526Pastor L, García-Domenech R, Gálvez J, Wolski S, García MD. 1998. New antifungals selected by molecular topology. Bioorg Med Chem Lett. 8(18):2577-2582.
527Moudgal V, Little T, Boikov D, Vazquez JA. 2005. Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis. Antimicrob Agents Chemother. 49(2):767-769.
528Arikan S, Yurdakul P, Hascelik G. 2003. Comparison of two methods and three end points in determination of in vitro activity of micafungin against Aspergillus spp. Antimicrob Agents Chemother. 47(8):2640-2643.
529Messer SA, Diekema DJ, Boyken L, Tendolkar S, Hollis RJ, Pfaller MA. 2006. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp. J Clin Microbiol. 44(2):324-326.
530Ostrosky-Zeichner L, Rex JH, Pappas PG, Hamill RJ, Larsen RA, Horowitz HW, Powderly WG, Hyslop N, Kauffman CA, Cleary J, Mangino JE, Lee J. 2003. Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States. Antimicrob Agents Chemother. 47(10):3149-3154.
531Dannaoui E, Lortholary O, Raoux D, Bougnoux ME, Galeazzi G, Lawrence C, Moissenet D, Poilane I, Hoinard D, Dromer F; YEASTS Group. 2008. Comparative in vitro activities of caspofungin and micafungin, determined using the method of the European Committee on Antimicrobial Susceptibility Testing, against yeast isolates obtained in France in 2005-2006. Antimicrob Agents Chemother. 52(2):778-781.
532Nakai T, Uno J, Ikeda F, Tawara S, Nishimura K, Miyaji M. 2003. In vitro antifungal activity of Micafungin (FK463) against dimorphic fungi: comparison of yeast-like and mycelial forms. Antimicrob Agents Chemother. 47(4):1376-1381.
533Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Buitrago MJ, Monzon A, Rodriguez-Tudela JL. 2006. Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi. Antimicrob Agents Chemother. 50(3):917-921.
534Paphitou NI, Ostrosky-Zeichner L, Paetznick VL, Rodriguez JR, Chen E, Rex JH. 2002. In vitro antifungal susceptibilities of Trichosporon species. Antimicrob Agents Chemother. 46(4):1144-1146.
535Odabasi Z, Paetznick VL, Rodriguez JR, Chen E, Ostrosky-Zeichner L. 2004. In vitro activity of anidulafungin against selected clinically important mold isolates Antimicrob Agents Chemother. 48(5):1912-1915.
536Pfaller MA, Diekema DJ, Ostrosky-Zeichner L, Rex JH, Alexander BD, Andes D, Brown SD, Chaturvedi V, Ghannoum MA, Knapp CC, Sheehan DJ, Walsh TJ. 2008. Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints. J Clin Microbiol. 46(8):2620-2629.
537Kuhn DM, George T, Chandra J, Mukherjee PK, Ghannoum MA. 2002. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother. 46(6):1773-1780
538González GM, Tijerina R, Najvar LK, Bocanegra R, Luther M, Rinaldi MG, Graybill JR. 2001. Correlation between antifungal susceptibilities of Coccidioides immitis in vitro and antifungal treatment with caspofungin in a mouse model. Antimicrob Agents Chemother. 45(6):1854-1859.
539Heyn K, Tredup A, Salvenmoser S, Müller FM. 2005. Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani. Antimicrob Agents Chemother. 49(12):5157-5159.
540Serena C, Fernández-Torres B, Pastor FJ, Trilles L, Lazéra Mdos S, Nolard N, Guarro J. 2005. In vitro interactions of micafungin with other antifungal drugs against clinical isolates of four species of Cryptococcus. Antimicrob Agents Chemother. 49(7):2994-2996.
541Richard H. Baltz 2008. Biosynthesis and Genetic Engineering of Lipopeptide Antibiotics Related to Daptomycin Current Topics in Medicinal Chemistry 2008, 8, 618-638
542Engelhardt K, Degnes KF, Kemmler M, Bredholt H, Fjaervik E, Klinkenberg G, Sletta H, Ellingsen TE, Zotchev SB. 2010. Production of a new thiopeptide antibiotic, TP-1161, by a marine Nocardiopsis species. Appl Environ Microbiol. 76(15):4969-4976.
543Vicente CM, Santos-Aberturas J, Guerra SM, Payero TD, Martín JF, Aparicio JF. 2009. PimT, an amino acid exporter controls polyene production via secretion of the quorum sensing pimaricin-inducer PI-factor in Streptomyces natalensis. Microb Cell Fact. 8;8:33.
544Khan R, Islam B, Akram M, Shakil S, Ahmad A, Ali SM, Siddiqui M, Khan AU. 2009. Antimicrobial activity of five herbal extracts against multi drug resistant (MDR) strains of bacteria and fungus of clinical origin. Molecules. 4;14(2):586-597.
545Guinea J, Peláez T, Alcalá L, Ruiz-Serrano MJ, Bouza E. 2005. Antifungal susceptibility of 596 Aspergillus fumigatus strains isolated from outdoor air, hospital air, and clinical samples: analysis by site of isolation. Antimicrob Agents Chemother. 49(8):3495-3497.
546Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Garcia-Effron G, Rodriguez-Tudela JL. 2004. In vitro activities of ravuconazole and four other antifungal agents against fluconazole-resistant or -susceptible clinical yeast isolates. Antimicrob Agents Chemother. 48(8):3107-3111.
547Theuretzbacher U. 2004. Pharmacokinetics/pharmacodynamics of echinocandins. Eur J Clin Microbiol Infect Dis. 23(11):805-812.
548Pai MP, Jones AL, Mullen CK. 2007. Micafungin activity against Candida bloodstream isolates: effect of growth medium and susceptibility testing method. Diagn Microbiol Infect Dis. 58(1):129-132.
549Serena C, Pastor FJ, Ortoneda M, Capilla J, Nolard N, Guarro J. 2004. In vitro antifungal susceptibilities of uncommon basidiomycetous yeasts. Antimicrob Agents Chemother. 48(7):2724-2726.
550Serena C, Ortoneda M, Capilla J, Pastor FJ, Sutton DA, Rinaldi MG, Guarro J. 2003. In vitro activities of new antifungal agents against Chaetomium spp. and inoculum standardization. Antimicrob Agents Chemother. 47(10):3161-3164.
551González GM, Sutton DA, Thompson E, Tijerina R, Rinaldi MG. 2001. In vitro activities of approved and investigational antifungal agents against 44 clinical isolates of basidiomycetous fungi. Antimicrob Agents Chemother. 45(2):633-635.
552Mariné M, Serena C, Pastor J, Quindós G, Carrillo AJ, Guarro J. 2007. In vitro activity of micafungin combined with itraconazole against Candida spp. Int J Antimicrob Agents. 30(5):463-465.
553Cantón E, Pemán J, Sastre M, Romero M, Espinel-Ingroff A. 2006. Killing kinetics of caspofungin, micafungin, and amphotericin B against Candida guilliermondii. Antimicrob Agents Chemother. 50(8):2829-2832.
554Andes DR, Diekema DJ, Pfaller MA, Marchillo K, Bohrmueller J. 2008. In vivo pharmacodynamic target investigation for micafungin against Candida albicans and C. glabrata in a neutropenic murine candidiasis model. Antimicrob Agents Chemother. 52(10):3497-3503.
555Marco F, Danés C, Almela M, Jurado A, Mensa J, de la Bellacasa JP, Espasa M, Martínez JA, Jiménez de Anta MT. 2003. Trends in frequency and in vitro susceptibilities to antifungal agents, including voriconazole and anidulafungin, of Candida bloodstream isolates. Results from a six-year study (1996-2001). Diagn Microbiol Infect Dis. 46(4):259-264.
556Kahn JN, Hsu MJ, Racine F, Giacobbe R, Motyl M. 2006. Caspofungin susceptibility in Aspergillus and non-Aspergillus molds: inhibition of glucan synthase and reduction of beta-D-1,3 glucan levels in culture. Antimicrob Agents Chemother. 50(6):2214-2216.
557Quindós G, Ruesga MT, Martín-Mazuelos E, Salesa R, Alonso-Vargas R, Carrillo-Muñoz AJ, Brena S, San Millán R, Pontón J. 2004. In-vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts. Rev Iberoam Micol. 21(2):63-69.
558Joseph JM, Jain R, Danziger LH. 2007. Micafungin: a new echinocandin antifungal. Pharmacotherapy. 27(1):53-67.
559Zhanel GG, Karlowsky JA, Zelenitsky SA, Turik MA, Hoban DJ. 1998. Susceptibilities of Candida species isolated from the lower gastrointestinal tracts of high-risk patients to the new semisynthetic echinocandin LY303366 and other antifungal agents. Antimicrob Agents Chemother. 42(9):2446-2448.
560Ortoneda M, Capilla J, Pastor FJ, Pujol I, Yustes C, Serena C, Guarro J. 2004. In vitro interactions of approved and novel drugs against Paecilomyces spp. Antimicrob Agents Chemother. 48(7):2727-2729.
561Niimi K, Maki K, Ikeda F, Holmes AR, Lamping E, Niimi M, Monk BC, Cannon RD. 2006. Overexpression of Candida albicans CDR1, CDR2, or MDR1 does not produce significant changes in echinocandin susceptibility. Antimicrob Agents Chemother. 50(4):1148-1155.
562Kahn JN, Garcia-Effron G, Hsu MJ, Park S, Marr KA, Perlin DS. 2007. Acquired echinocandin resistance in a Candida krusei isolate due to modification of glucan synthase. Antimicrob Agents Chemother. 51(5):1876-1878.
563Ernst EJ. 2001. Investigational antifungal agents. Pharmacotherapy. 21(8 Pt 2):165S-174S.
564Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Monzon A, Buitrago MJ, Rodriguez-Tudela JL. 2009. Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds. Antimicrob Agents Chemother. 53(5):2192-2195.
565Maligie MA, Selitrennikoff CP. 2005. Cryptococcus neoformans resistance to echinocandins: (1,3)beta-glucan synthase activity is sensitive to echinocandins. Antimicrob Agents Chemother. 49(7):2851-2856.
566Barrett D. 2002. From natural products to clinically useful antifungals. Biochim Biophys Acta. 1587(2-3):224-233.
567Andes D, Diekema DJ, Pfaller MA, Prince RA, Marchillo K, Ashbeck J, Hou J. 2008. In vivo pharmacodynamic characterization of anidulafungin in a neutropenic murine candidiasis model. Antimicrob Agents Chemother. 52(2):539-550.
568Melo AS, Colombo AL, Arthington-Skaggs BA. 2007. Paradoxical growth effect of caspofungin observed on biofilms and planktonic cells of five different Candida species. Antimicrob Agents Chemother. 51(9):3081-3088.
569Cuenca-Estrella M, Alastruey-Izquierdo A, Alcazar-Fuoli L, Bernal-Martinez L, Gomez-Lopez A, Buitrago MJ, Mellado E, Rodriguez-Tudela JL. 2008. In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans. Antimicrob Agents Chemother. 52(3):1136-1139.
570Shuford JA, Piper KE, Steckelberg JM, Patel R. 2007. In vitro biofilm characterization and activity of antifungal agents alone and in combination against sessile and planktonic clinical Candida albicans isolates. Diagn Microbiol Infect Dis. 57(3):277-281.
571Di Bonaventura G, Spedicato I, Picciani C, D'Antonio D, Piccolomini R. 2004. In vitro pharmacodynamic characteristics of amphotericin B, caspofungin, fluconazole, and voriconazole against bloodstream isolates of infrequent Candida species from patients with hematologic malignancies. Antimicrob Agents Chemother. 48(11):4453-4456.
572Barchiesi F, Spreghini E, Maracci M, Fothergill AW, Baldassarri I, Rinaldi MG, Scalise G. 2004. In vitro activities of voriconazole in combination with three other antifungal agents against Candida glabrata. Antimicrob Agents Chemother. 48(9):3317-3322.
573Serena C, Pastor FJ, Gilgado F, Mayayo E, Guarro J. 2005. Efficacy of micafungin in combination with other drugs in a murine model of disseminated trichosporonosis. Antimicrob Agents Chemother. 49(2):497-502.
574Trilles L, Fernández-Torres B, Lazéra Mdos S, Wanke B, Guarro J. 2004. In vitro antifungal susceptibility of Cryptococcus gattii. J Clin Microbiol. 42(10):4815-4857.
575Trilles L, Fernández-Torres B, Dos Santos Lazéra M, Wanke B, de Oliveira Schubach A, de Almeida Paes R, Inza I, Guarro J. 2005. In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phases. Antimicrob Agents Chemother. 49(9):3952-3954.
576Hasenoehrl A, Galic T, Ergovic G, Marsic N, Skerlev M, Mittendorf J, Geschke U, Schmidt A, Schoenfeld W. 2006. In vitro activity and in vivo efficacy of icofungipen (PLD-118), a novel oral antifungal agent, against the pathogenic yeast Candida albicans. Antimicrob Agents Chemother. 50(9):3011-3018.
577Park BJ, Park JC, Taguchi H, Fukushima K, Hyon SH, Takatori K. 2006. Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts. Biochem Biophys Res Commun. 347(2):401-405.
578Selvakumar D, Miyamoto M, Furuichi Y, Komiyama T. 2006. Inhibition of fungal beta-1,3-glucan synthase and cell growth by HM-1 killer toxin single-chain anti-idiotypic antibodies. Antimicrob Agents Chemother. 50(9):3090-3097.
579Yang YL, Wang AH, Wang CW, Cheng WT, Li SY, Lo HJ; TSARY Hospitals. 2008. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006. Diagn Microbiol Infect Dis. 61(2):175-180.
580Ikeda F, Tanaka S, Ohki H, Matsumoto S, Maki K, Katashima M, Barrett D, Aoki Y. 2007. Role of micafungin in the antifungal armamentarium. Curr Med Chem. 14(11):1263-1275.
581Fernández-Torres B, Inza I, Guarro J. 2005. Evaluation of disk diffusion method for determining eberconazole susceptibility of dermatophytes and influence of culture medium. Antimicrob Agents Chemother. 49(5):2116-2118.
582Garcia-Effron G, Katiyar SK, Park S, Edlind TD, Perlin DS. 2008. A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility. Antimicrob Agents Chemother. 52(7):2305-2312.
583Baddley JW, Marr KA, Andes DR, Walsh TJ, Kauffman CA, Kontoyiannis DP, Ito JI, Balajee SA, Pappas PG, Moser SA. 2009. Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network. J Clin Microbiol. 47(10):3271-3275.
584Samra Z, Yardeni M, Peled N, Bishara J. 2005. Species distribution and antifungal susceptibility of Candida bloodstream isolates in a tertiary medical center in Israel. Eur J Clin Microbiol Infect Dis. 24(9):592-595.
585Pfaller MA, Diekema DJ, Sheehan DJ. 2006. Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing. Clin Microbiol Rev. 19(2):435-447.
586Desnos-Ollivier M, Bretagne S, Raoux D, Hoinard D, Dromer F, Dannaoui E; European Committee on Antibiotic Susceptibility Testing. 2008. Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing. Antimicrob Agents Chemother. 52(9):3092-3098.
587Rodríguez MM, Pastor FJ, Calvo E, Salas V, Sutton DA, Guarro J. 2009. Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection. Antimicrob Agents Chemother. 53(12):5022-5025.
588Wiederhold NP, Grabinski JL, Garcia-Effron G, Perlin DS, Lee SA. 2008. Pyrosequencing to detect mutations in FKS1 that confer reduced echinocandin susceptibility in Candida albicans. Antimicrob Agents Chemother. 52(11):4145-4148.
589Fritz JM, Brielmaier BD, Dubberke ER. 2008. Micafungin for the prophylaxis and treatment of Candida infections. Expert Rev Anti Infect Ther. ;6(2):153-162.
590Wattanaphansak S, Singer RS, Gebhart CJ. 2009. In vitro antimicrobial activity against 10 North American and European Lawsonia intracellularis isolates. Vet Microbiol. 134(3-4):305-310.
591Hannan PC, Windsor HM, Ripley PH. 1997. In vitro susceptibilities of recent field isolates of Mycoplasma hyopneumoniae and Mycoplasma hyosynoviae to valnemulin (Econor), tiamulin and enrofloxacin and the in vitro development of resistance to certain antimicrobial agents in Mycoplasma hyopneumoniae. Res Vet Sci. 63(2):157-160.
592Jones RN, Fritsche TR, Sader HS, Ross JE. 2006. Activity of retapamulin (SB-275833), a novel pleuromutilin, against selected resistant gram-positive cocci. Antimicrob Agents Chemother. 50(7):2583-2586.
593Lobová D, Smola J, Cizek A. 2004. Decreased susceptibility to tiamulin and valnemulin among Czech isolates of Brachyspira hyodysenteriae. J Med Microbiol. 53(Pt 4):287-291.
594Vicca J, Stakenborg T, Maes D, Butaye P, Peeters J, de Kruif A, Haesebrouck F. 2004. In vitro susceptibilities of Mycoplasma hyopneumoniae field isolates. Antimicrob Agents Chemother. 48(11):4470-4472.
595Gautier-Bouchardon AV, Reinhardt AK, Kobisch M, Kempf I. 2002. In vitro development of resistance to enrofloxacin, erythromycin, tylosin, tiamulin and oxytetracycline in Mycoplasma gallisepticum, Mycoplasma iowae and Mycoplasma synoviae. Vet Microbiol. 88(1):47-58.
596Pankuch GA, Lin G, Hoellman DB, Good CE, Jacobs MR, Appelbaum PC. 2006. Activity of retapamulin against Streptococcus pyogenes and Staphylococcus aureus evaluated by agar dilution, microdilution, E-test, and disk diffusion methodologies. Antimicrob Agents Chemother. 50(5):1727-1730.
597Rohde J, Kessler M, Baums CG, Amtsberg G. 2004. Comparison of methods for antimicrobial susceptibility testing and MIC values for pleuromutilin drugs for Brachyspira hyodysenteriae isolated in Germany. Vet Microbiol. 102(1-2):25-32.
598Nicholas RA, Ayling RD. 2003. Mycoplasma bovis: disease, diagnosis, and control. Res Vet Sci. 74(2):105-112.
599Valks, M., and D. G. S. Burch. 2002. Comparative activity and resistance development of tiamulin and other antimicrobials against avian mycoplasma.
600Keizo Yamaguchi,Haruki Domon, Shuichi Miyazaki, Kazuhiro Tateda, Akira Ohno, Kazuhiro Ishii, Tetsuya Matsumoto,and Nobuhiko Furuya 1998. In Vitro and In Vivo Antibacterial Activities of CS-834, a New Oral Carbapenem Antimicrobial Agents and Chemotherapy Mar. 1998, p. 555–563
601Gentry DR, McCloskey L, Gwynn MN, Rittenhouse SF, Scangarella N, Shawar R, Holmes DJ. 2008. Genetic characterization of Vga ABC proteins conferring reduced susceptibility to pleuromutilins in Staphylococcus aureus. Antimicrob Agents Chemother. 52(12):4507-4509.
602Biedenbah DJ, ones RN, vezic-Schoenfeld Z, Paukner S, Novak R. 0. In Vitro Antibacterial Spectrum of BC-3205, a Novel Pleuromutilin Derivative for Oral Use in HumansCAP. abriva Therapeutics AG
603Hidalgo A, Carvajal A, García-Feliz C, Osorio J, Rubio P. 2009. Antimicrobial susceptibility testing of Spanish field isolates of Brachyspira hyodysenteriae. Res Vet Sci. 87(1):7-12.
604Biedenbah DJ, ones RN, vezic-Schoenfeld Z, Paukner S, Novak R. 0. In Vitro Antibacterial Spectrum of BC-7013, a Novel Pleuromutilin Derivative for Topical Use in Humans. abriva Therapeutics AG
605Gerchman I, Lysnyansky I, Perk S, Levisohn S. 2008. In vitro susceptibilities to fluoroquinolones in current and archived Mycoplasma gallisepticum and Mycoplasma synoviae isolates from meat-type turkeys. Vet Microbiol. 131(3-4):266-26.
606Islam KM, Klein U, Burch DG. 2009. The activity and compatibility of the antibiotic tiamulin with other drugs in poultry medicine--A review. Poult Sci. 88(11):2353-235.
607Hu C, Zou Y. 2009. Mutilins derivatives: from veterinary to human-used antibiotics. Mini Rev Med Chem. 9(12):1397-106.
608H.B. Koh1, Y. Kang1, H.Y. Song1, U. Klein2 2006. Sensitivity testing of swine respiratory pathogens in Korea. rtis Animal Health
609Fu LQ, Jiang ZT, Cai Z, Liu X, He HL, Yang YS. 2009. Water-soluble phosphate prodrugs of pleuromutilin analogues with potent in vivo antibacterial activity against Gram-positive pathogens. Bioorganic & Medicinal Chemistry Letters 19：5407–5410.
610Godinho KS, Rae A, Windsor GD, Tilt N, Rowan TG, Sunderland SJ. 2005. Efficacy of tulathromycin in the treatment of bovine respiratory disease associated with induced Mycoplasma bovis infections in young dairy calves. Vet Ther. 6(2):96-112.
611Long KS, Hansen LH, Jakobsen L, Vester B. 2006. Interaction of pleuromutilin derivatives with the ribosomal peptidyl transferase center. Antimicrob Agents Chemother. 50(4):1458-1462.
612Pringle M, Poehlsgaard J, Vester B, Long KS. 2004. Mutations in ribosomal protein L3 and 23S ribosomal RNA at the peptidyl transferase centre are associated with reduced susceptibility to tiamulin in Brachyspira spp. isolates. Mol Microbiol. 54(5):1295-1306.
613Miller K, Dunsmore CJ, Fishwick CW, Chopra I. 2008. Linezolid and tiamulin cross-resistance in Staphylococcus aureus mediated by point mutations in the peptidyl transferase center. Antimicrob Agents Chemother. 52(5):1737-1742.
614Long KS, Poehlsgaard J, Hansen LH, Hobbie SN, Böttger EC, Vester B. 2009. Single 23S rRNA mutations at the ribosomal peptidyl transferase centre confer resistance to valnemulin and other antibiotics in Mycobacterium smegmatis by perturbation of the drug binding pocket. Antimicrob Agents Chemother. 71(5):1218-1227.
615Locke JB, Hilgers M, Shaw KJ. 2009. Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700). Antimicrob Agents Chemother. 53(12):5265-5274.
616Tsuchiya K, Kondo M, Nagatomo H. 1978. SCE-129, antipseudomonal cephalosporin: in vitro and in vivo antibacterial activities. Antimicrob Agents Chemother. 13(2):137-145
617King A, Shannon K, Phillips I. 1980. In vitro antibacterial activity and susceptibility of cefsulodin, an antipseudomonal cephalosporin, to beta-lactamases. Antimicrob Agents Chemother. 17(2):165-169.
618Eloff JN, Katerere DR, McGaw LJ. 2008. The biological activity and chemistry of the southern African Combretaceae. J Ethnopharmacol. 119(3):686-699.
619Azoulay-Dupuis E, Mohler J, Bédos JP. 2004. Efficacy of BB-83698, a novel peptide deformylase inhibitor, in a mouse model of pneumococcal pneumonia. Antimicrob Agents Chemother. 48(1):80-85
620Teo JW, Thayalan P, Beer D, Yap AS, Nanjundappa M, Ngew X, Duraiswamy J, Liung S, Dartois V, Schreiber M, Hasan S, Cynamon M, Ryder NS, Yang X, Weidmann B, Bracken K, Dick T, Mukherjee K. 2006. Peptide deformylase inhibitors as potent antimycobacterial agents. Antimicrob Agents Chemother. 50(11):3665-3673.
621Margolis PS, Hackbarth CJ, Young DC, Wang W, Chen D, Yuan Z, White R, Trias J. 2000. Peptide deformylase in Staphylococcus aureus: resistance to inhibition is mediated by mutations in the formyltransferase gene. Antimicrob Agents Chemother. 44(7):1825-1831.
622Apfel CM, Locher H, Evers S, Takács B, Hubschwerlen C, Pirson W, Page MG, Keck W. 2001. Peptide deformylase as an antibacterial drug target: target validation and resistance development. Antimicrob Agents Chemother. 45(4):1058-1064.
623Chen D, Hackbarth C, Ni ZJ, Wu C, Wang W, Jain R, He Y, Bracken K, Weidmann B, Patel DV, Trias J, White RJ, Yuan Z. 2004. Peptide deformylase inhibitors as antibacterial agents: identification of VRC3375, a proline-3-alkylsuccinyl hydroxamate derivative, by using an integrated combinatorial and medicinal chemistry approach. Antimicrob Agents Chemother. 48(1):250-261.
624Shi W, Duan Y, Qian Y, Li M, Yang L, Hu W. 2010. Design, synthesis, and antibacterial activity of 2,5-dihydropyrrole formyl hydroxyamino derivatives as novel peptide deformylase inhibitors. Bioorg Med Chem Lett. 20(12):3592-3595.
625Vik A, Hedner E, Charnock C, Samuelsen O, Larsson R, Gundersen LL, Bohlin L. 2006. (+)-agelasine D: improved synthesis and evaluation of antibacterial and cytotoxic activities. J Nat Prod. 69(3):381-386.
626Sahl HG, Pag U, Bonness S, Wagner S, Antcheva N, Tossi A. 2005. Mammalian defensins: structures and mechanism of antibiotic activity. J Leukoc Biol. 77(4):466-475.
627Zhang L, Benz R, Hancock RE. 1999. Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides. Biochemistry. 38(25):8102-8111.
628Kuzina LV, Miller TA, Cooksey DA. 2006. In vitro activities of antibiotics and antimicrobial peptides against the plant pathogenic bacterium Xylella fastidiosa. Lett Appl Microbiol. 42(5):514-520.
629Doyle J, Brinkworth CS, Wegener KL, Carver JA, Llewellyn LE, Olver IN, Bowie JH, Wabnitz PA, Tyler MJ. 2003. nNOS inhibition, antimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modifications. The solution structure of a modified citropin 1.1. Eur J Biochem. 270(6):1141-1153.
630Nir-Paz R, Prévost MC, Nicolas P, Blanchard A, Wróblewski H. 2002. Susceptibilities of Mycoplasma fermentans and Mycoplasma hyorhinis to membrane-active peptides and enrofloxacin in human tissue cell cultures. Antimicrob Agents Chemother. 46(5):1218-1225.
631Makovitzki A, Viterbo A, Brotman Y, Chet I, Shai Y. 2007. Inhibition of fungal and bacterial plant pathogens in vitro and in planta with ultrashort cationic lipopeptides. Appl Environ Microbiol. 73(20):6629-6636.
632Zelezetsky I, Pag U, Sahl HG, Tossi A. 2005. Tuning the biological properties of amphipathic alpha-helical antimicrobial peptides: rational use of minimal amino acid substitutions. Peptides 26(12):2368-2376.
633Tang.YL, Shi.YH, Zhao. W, Hao. G, Le.GW. 2009. Discovery of a novel antimicrobial peptide using membrane binding-based approach. Food Control. 149–156.
634Peschel A, Jack RW, Otto M, Collins LV, Staubitz P, Nicholson G, Kalbacher H, Nieuwenhuizen WF, Jung G, Tarkowski A, van Kessel KP, van Strijp JA. 2001. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J Exp Med. 193(9):1067-1076.
635Haynes SR, Hagins SD, Juban MM, Elzer PH, Hammer RP. 2005. Improved solid-phase synthesis of alpha,alpha-dialkylated amino acid-rich peptides with antimicrobial activity. J Pept Res. 66(6):333-347.
636Rizzello CG, Losito I, Gobbetti M, Carbonara T, De Bari MD, Zambonin PG. 2005. Antibacterial activities of peptides from the water-soluble extracts of Italian cheese varieties. J Dairy Sci. 88(7):2348-2360.
637Kozlov SA, Vassilevski AA, Feofanov AV, Surovoy AY, Karpunin DV, Grishin EV. 2006. Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity. J Biol Chem. 281(30):20983-20992
638Park SC, Kim MH, Hossain MA, Shin SY, Kim Y, Stella L, Wade JD, Park Y, Hahm KS. 2008. Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions. Biochim Biophys Acta. 1778(1):229-241.
639Fehri LF, Sirand-Pugnet P, Gourgues G, Jan G, Wróblewski H, Blanchard A. 2005. Resistance to antimicrobial peptides and stress response in Mycoplasma pulmonis. Antimicrob Agents Chemother. 49(10):4154-4165.
640Cardile V, Russo A, Formisano C, Rigano D, Senatore F, Arnold NA, Piozzi F. 2009. Essential oils of Salvia bracteata and Salvia rubifolia from Lebanon: Chemical composition, antimicrobial activity and inhibitory effect on human melanoma cells. J Ethnopharmacol. 126(2):265-272.
641Mamolo MG, Falagiani V, Zampieri D, Vio L, Banfi E, Scialino G. 2003. Synthesis and antimycobacterial activity of (3,4-diaryl-3H-thiazol-2-ylidene)-hydrazide derivatives. Farmaco. 58(9):631-637.
642Tan Sema, Guner VA, Ergene A. 2005. Antimicrobial activity of 4-substituted-styryl-2-azetidinones. Turkish J. Pharm. Sci, (1), 11-15
643Karali N., Ilhan E., Gursoy A., Kiraz M.: 1998. New cyclohexylidenehydrazide and 4-aza-1-thiaspiro [4.5] decan-3-one derivatives of 3-phenyl-4 (3H)-quinazolinones Farmaco. 53, 346-349.
644Chande MS, Verma RS, Barve PA, Khanwelkar RR, Vaidya RB, Ajaikumar KB. 2005. Facile synthesis of active antitubercular, cytotoxic and antibacterial agents: a Michael addition approach. Eur. J. Med. Chem. 40(11):1143-1148.
645Ozkirimli S, Kazan F, Tunali Y. 2009. Synthesis, antibacterial and antifungal activities of 3-(1,2,4-triazol-3-yl)-4-thiazolidinones. J Enzyme Inhib Med Chem. 24(2):447-452.
646Steinbach WJ, Schell WA, Blankenship JR, Onyewu C, Heitman J, Perfect JR. 2004. In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus. Antimicrob Agents Chemother. 48(5):1664-1669.
647Cruz MC, Goldstein AL, Blankenship J, Del Poeta M, Perfect JR, McCusker JH, Bennani YL, Cardenas ME, Heitman J. 2001. Rapamycin and less immunosuppressive analogs are toxic to Candida albicans and Cryptococcus neoformans via FKBP12-dependent inhibition of TOR. Antimicrob Agents Chemother. 45(11):3162-3170.
648Del Poeta M, Cruz MC, Cardenas ME, Perfect JR, Heitman J. 2000. Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans. Antimicrob Agents Chemother. 44(3):739-746.
649Sugita T, Tajima M, Ito T, Saito M, Tsuboi R, Nishikawa A. 2005. Antifungal activities of tacrolimus and azole agents against the eleven currently accepted Malassezia species. J Clin Microbiol. 43(6):2824-2829.
650Carman RJ, Wilkins TD. 1991. In vitro susceptibility of rabbit strains of Clostridium spiroforme to antimicrobial agents. Vet Microbiol. 28(4):391-397.
651Poirel L, Girlich D, Naas T, Nordmann P. 2001. OXA-28, an extended-spectrum variant of OXA-10 beta-lactamase from Pseudomonas aeruginosa and its plasmid- and integron-located gene. Antimicrob Agents Chemother. 45(2):447-453.
652Livermore DM. 1995. beta-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev. 8(4):557-584.
653Ankli A, Heinrich M, Bork P, Wolfram L, Bauerfeind P, Brun R, Schmid C, Weiss C, Bruggisser R, Gertsch J, Wasescha M, Sticher O. 2002. Yucatec Mayan medicinal plants: evaluation based on indigenous uses. J Ethnopharmacol. 79(1):43-52.
654Hamilton-Miller JM. 2003. Chemical and microbiologic aspects of penems, a distinct class of beta-lactams: focus on faropenem. Pharmacotherapy. 23(11):1497-1507.
655Naureen A, Saqib M, Muhammad F, Ahmad R, Muhammad G, Asi MN, Hussain MH, Lodhi LA, Khan MS, Thibault FM 2010. Antimicrobial susceptibility of 41 Burkholderia mallei isolates from spontaneous outbreaks of equine glanders in Punjab, Pakistan. J Eq Vet Sci 30:134-141.
656Vidaillac C, Leonard SN, Sader HS, Jones RN, Rybak MJ. 2009. In vitro activity of ceftaroline alone and in combination against clinical isolates of resistant gram-negative pathogens, including beta-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother. 53(6):2360-2366.
657Poirel L, Naas T, Nicolas D, Collet L, Bellais S, Cavallo JD, Nordmann P. 2000. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother. 44(4):891-897.
658Njume C, Afolayan AJ, Ndip RN. 2009. An overview of antimicrobial resistance and the future of medicinal plants in the treatment of Helicobacter pylori infections. Afr. J. Pharm. Pharmacol. 3(13): 685-699.
659Kataoka D, Tanaka Y. 2003. The Clinical Aspects of β-Lactam-Resistant Stenotrophomonas maltophilia. Yonago Acta medica 46:91–102.
660Giuliani F, Docquier JD, Riccio ML, Pagani L, Rossolini GM. 2005. OXA-46, a new class D beta-lactamase of narrow substrate specificity encoded by a blaVIM-1-containing integron from a Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother. 49(5):1973-1980.
661Nakano M, Yasuda M, Yokoi S, Takahashi Y, Ishihara S, Deguchi T. 2001. In vivo selection of Pseudomonas Aeruginosa with decreased susceptibilities to fluoroquinolones during fluoroquinolone treatment of urinary tract infection. Urology. 58(1):125-128.
662Nakajima S, Graham DY, Hattori T, Bamba T. 2000. Strategy for treatment of Helicobacter pylori infection in adults. II. Practical policy in 2000. Curr Pharm Des. 6(15):1515-1529.
663Amundsen SK, Fero J, Hansen LM, Cromie GA, Solnick JV, Smith GR, Salama NR. 2008. Helicobacter pylori AddAB helicase-nuclease and RecA promote recombination-related DNA repair and survival during stomach colonization. Mol Microbiol. 69(4):994-1007.
664Weldhagen GF, Poirel L, Nordmann P. 2003. Ambler class A extended-spectrum beta-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact. Antimicrob Agents Chemother. 47(8):2385-2392.
665Ferguson, D. 2007. A study of clinical strains of Pseudomonas aeruginosa and the investigation of antibiotic resistance mechanisms in the multidrug resistant strain PA13. Ph.D. Thesis, Dublin City University, Ireland.
666Bicalho B, Gonçalves RAC, Zibordi AP, Manfio GP, Marsaioli A 2003. Antimicrobial compounds of fungi vectored by Clusia ssp. (Clusiaceae) pollinating bees. 746-751.
667Ballell L, Field RA, Duncan K, Young RJ. 2005. New small-molecule synthetic antimycobacterials. Antimicrob Agents Chemother. Antimicrob Agents Chemother. 49(6):2153-2163.
668Marchetti O, Moreillon P, Glauser MP, Bille J, Sanglard D. 2000. Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans. Antimicrob Agents Chemother. 44(9):2373-2381.
669Binet R, Maurelli AT. 2005. Frequency of spontaneous mutations that confer antibiotic resistance in Chlamydia spp. Antimicrob Agents Chemother. 49(7):2865-2873.
670Kuroda M, Kuroda H, Oshima T, Takeuchi F, Mori H, Hiramatsu K. 2003. Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Mol Microbiol. 49(3):807-821.
671Halouska S, Chacon O, Fenton RJ, Zinniel DK, Barletta RG, Powers R. 2007. Use of NMR metabolomics to analyze the targets of D-cycloserine in mycobacteria: role of D-alanine racemase. J Proteome Res. 6(12):4608-4614.
672McBride SM, Sonenshein AL. 2011. Identification of a genetic locus responsible for antimicrobial peptide resistance in Clostridium difficile. Infect Immun. 79(1):167-176.
673Baum EZ, Crespo-Carbone SM, Klinger A, Foleno BD, Turchi I, Macielag M, Bush K. A 2007. MurF inhibitor that disrupts cell wall biosynthesis in Escherichia coli. Antimicrob Agents Chemother. 51(12):4420-4426.
674Wong RS, McMurry LM, Levy SB. 2000. Intergenic' blr gene in Escherichia coli encodes a 41-residue membrane protein affecting intrinsic susceptibility to certain inhibitors of peptidoglycan synthesis. Mol Microbiol. 37(2):364-370.
675M. Badrul Alam, Ronok Zahan, Mahedi Hasan, M. Maruf Khan, M. Saifur Rahman, Nargis S. Chowdhury and M. Ekramul Haque 2011. Thank You, a Good Research Antioxidant, Antimicrobial and Toxicity Studies of the Different Fractions of Fruits of Terminalia belerica Roxb Global Journal of Pharmacology 5(1): 07-17
676Markovich S, Yekutiel A, Shalit I, Shadkchan Y, Osherov N. 2004. Genomic approach to identification of mutations affecting caspofungin susceptibility in Saccharomyces cerevisiae. Antimicrob Agents Chemother. 48(10):3871-3876.
677Lewy DS, Gauss CM, Soenen DR, Boger DL. 2002. Fostriecin: chemistry and biology. Curr Med Chem. 9(22):2005-2032.
678Wicklow DT, Jordan AM, Gloer JB. 2009. Antifungal metabolites (monorden, monocillins I, II, III) from Colletotrichum graminicola, a systemic vascular pathogen of maize. Mycol Res. 113(Pt 12):1433-1442.
679Matthews RC, Rigg G, Hodgetts S, Carter T, Chapman C, Gregory C, Illidge C, Burnie J. 2003. Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90. Antimicrob Agents Chemother. 47(7):2208-2216.
680El-Ghorab A, Shaaban HA, El-Massry KF, Shibamoto T. 2008. Chemical composition of volatile extract and biological activities of volatile and less-volatile extracts of juniper berry (Juniperus drupacea L.) fruit. J Agric Food Chem. 56(13):5021-5025.
681El-Massry KF, El-Ghorab AH, Shaaban HA, Shibamoto T. 2009. Chemical compositions and antioxidant/antimicrobial activities of various samples prepared from Schinus terebinthifolius leaves cultivated in Egypt. J Agric Food Chem. 57(12):5265-5270.
682S Dewanjee, M Kundu, A Maiti, R Majumdar, A Majumdar SC Mandal. 2007. In Vitro Evaluation of Antimicrobial Activity of Crude Extract from Plants Diospyros peregrina, Coccinia grandis and Swietenia macrophylla. Tropical Journal of Pharmaceutical Research 6 (3): 773-778.
683Ali-Shtayeh MS, Abu Ghdeib SI. 1999. Antifungal activity of plant extracts against dermatophytes. Mycoses. ;42(11-12):665-672.
684Koc AN, Silici S, Ayangil D, Ferahbaş A, Cankaya S. 2005. Comparison of in vitro activities of antifungal drugs and ethanolic extract of propolis against Trichophyton rubrum and T. mentagrophytes by using a microdilution assay. Mycoses. 48(3):205-210.
685Gupta AK, Kohli Y. 2003. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity. Br J Dermatol. 149(2):296-305.
686Silva MR, Oliveira JG Jr, Fernandes OF, Passos XS, Costa CR, Souza LK, Lemos JA, Paula JR. 2005. Antifungal activity of Ocimum gratissimum towards dermatophytes. Mycoses. 48(3):172-175.
687Güner V, Yildirir S, Ozçelik B, Abbasoğlu U. 2000. Synthesis and antimicrobial activity of 1,4-diaryl-2-azetidinones. Farmaco 55(2):147-150.
688Perrins N, Bond R. 2003. Synergistic inhibition of the growth in vitro of Microsporum canis by miconazole and chlorhexidine. Vet Dermatol. 14(2):99-102.
689Koroishi AM, Foss SR, Cortez DA, Ueda-Nakamura T, Nakamura CV, Dias Filho BP. 2008. In vitro antifungal activity of extracts and neolignans from Piper regnellii against dermatophytes. J Ethnopharmacol. 117(2):270-277
690KP Bhusari, ND Amnerkar, PB Khedekar, MK Kale, RP Bhole. 2008. Synthesis and In Vitro Antimicrobial Activity of Some New 4-Amino-N-(1,3-Benzothiazol-2-yl) benzenesulphonamide Derivatives. Asian J. Research Chem. 1(2):,53-57.
691R. E. Campbell, J. H. Lilley, V. Panyawachira and S. Kanchanakhan 2001. In vitro screening of novel treatments for Aphanomyces invadans. Aquacult. Res 32:223–233.
692Arya S, Kumar VL. 2005. Antiinflammatory efficacy of extracts of latex of Calotropis procera against different mediators of inflammation. Mediators Inflamm. 2005(4):228-232.
693Pauli A. 2006. Anticandidal low molecular compounds from higher plants with special reference to compounds from essential oils. Med Res Rev. 26(2):223-268.
694Arikan S, Hasçelik G. 2002. Comparison of NCCLS microdilution method and Etest in antifungal susceptibility testing of clinical Trichosporon asahii isolates. Diagn Microbiol Infect Dis. 43(2):107-111.
695Kuiate JR, Mouokeu S, Wabo HK, Tane P. 2007. Antidermatophytic triterpenoids from Syzygium jambos (L.) Alston (Myrtaceae). Phytother Res. 21(2):149-152.
696Obame LC, Koudou J, Kumulungui BS, Bassole IHN, Edou P, Ouattara AS, Traore AS 2007. Antioxidant and antimicrobial activities of Canarium schweinfurthii engl. essential oil from centrafrican republic. Afr. J. Biotechnol. 6(20): 2319-2323.
697Li XC, Jacob MR, Khan SI, Ashfaq MK, Babu KS, Agarwal AK, Elsohly HN, Manly SP, Clark AM. 2008. Potent in vitro antifungal activities of naturally occurring acetylenic acids. Antimicrob Agents Chemother. 52(7):2442-2448.
698Osborne CS, Leitner I, Hofbauer B, Fielding CA, Favre B, Ryder NS. 2006. Biological, biochemical, and molecular characterization of a new clinical Trichophyton rubrum isolate resistant to terbinafine. Antimicrob Agents Chemother. 50(6):2234-2236.
699Mungra DC, Patel MP, Patel RG. 2009. An efficient one-pot synthesis and in vitro antimicrobial activity of new pyridine derivatives bearing the tetrazoloquinoline nucleus. ARKIVOC. 64-74.
700Sung WS, Jung HJ, Park K, Kim HS, Lee IS, Lee DG. 2007. 2,5-dimethyl-4-hydroxy-3(2H)-furanone (DMHF); antimicrobial compound with cell cycle arrest in nosocomial pathogens. Life Sci. 80(6):586-591.
701Havlickova B, Friedrich M. 2008. The advantages of topical combination therapy in the treatment of inflammatory dermatomycoses. Mycoses. Suppl 4:16-26.
702Kokil GR, Rewatkar PV, Gosain S, Aggarwal S, Verma A, Kalra A, Thareja S. 2010. Synthesis and In Vitro Evaluation of Novel 1, 2, 4-Triazole Derivatives as Antifungal Agents. Letters in Drug Design & Discovery 7:46-49.
703Fontenelle RO, Morais SM, Brito EH, Brilhante RS, Cordeiro RA, Nascimento NR, Kerntopf MR, Sidrim JJ, Rocha MF. 2008. Antifungal activity of essential oils of Croton species from the Brazilian Caatinga biome. J Appl Microbiol. 104(5):1383-1390.
704Tafesh A, Najami N, Jadoun J, Halahlih F, Riepl H, Azaizeh H. 2011. Synergistic antibacterial effects of polyphenolic compounds from olive mill wastewater. Evid Based Complement Alternat Med. 2011:431021.
705Mistik S, Ferahbas A, Koc AN, Ayangil D, Ozturk A. 2006. What defines the quality of patient care in tinea pedis? J Eur Acad Dermatol Venereol. 20(2):158-165.
706Bokhari FM. 2009. Antifungal activity of some medicinal plants used in Jeddah, Saudi Arabia. Mycopath. 7(1): 51-57.
707López-Aroche U, Salinas-Sánchez DO, Mendoza de Gives P, López-Arellano ME, Liébano-Hernández E, Valladares-Cisneros G, Arias-Ataide DM, Hernández-Velázquez V. 2008. In vitro nematicidal effects of medicinal plants from the Sierra de Huautla, Biosphere Reserve, Morelos, Mexico against Haemonchus contortus infective larvae. J Helminthol. 82(1):25-31.
708Sadeghi-Nejad B. Deokule SS. 2009. Antidermatophytic activities of Ixora brachiate Roxb. African Journal of Biochemistry Research Vol.3 (10), pp.344-348.
709Sadeghi-Nejad B. Deokule SS. 2010. Antidermatophytic Activity of Pogostemon parviflorus Benth. Iranian Journal of Pharmaceutical Research 9 (3): 279-285.
710Bajpai VK, Yoon JI, Kang SC. 2009. Antioxidant and antidermatophytic activities of essential oil and extracts of Magnolia liliflora Desr. Food Chem Toxicol. 47(10):2606-2612.
711de Souza AC, Kato L, da Silva CC, Cidade AF, de Oliveira CM, Silva Mdo R. 2010. Antimicrobial activity of Hymenaea martiana towards dermatophytes and Cryptococcus neoformans. Mycoses. 53(6):500-503.
712Abdoul-Latif F, Edou P, Eba F, Mohamed N, Ali A, Djama S, Obame LC, Bassolé I, Dicko M. 2010. Antimicrobial and antioxidant activities of essential oil and methanol extract of Jasminum sambac from Djibouti. African Journal of Plant Science, Vol.4(3)pp.38-43.
713Kavitha A, Prabhakar P, Vijayalakshmi M, Venkateswarlu Y. 2010. Purification and biological evaluation of the metabolites produced by Streptomyces sp. TK-VL_333. Res Microbiol. 161(5):335-345.
714Mistry B, Jauhari S. 2010. Synthesis and characterization of some quinoline based azetidinone and thiazolidinones as antimicrobial agents. Archives of Applied Science Research 2(6):332-343.
715Patel NB, Shaikh AR. 2011. Synthesis of new 1,3-oxazolyl-7-chloroquinazolin-4(3h)ones and evaluation of their antimicrobial activities. Acta Poloniae Pharmaceutica ñ Drug Research Vol.68 No.2 pp.223-230.
716Sander P, Belova L, Kidan YG, Pfister P, Mankin AS, Böttger EC. 2002. Ribosomal and non-ribosomal resistance to oxazolidinones: species-specific idiosyncrasy of ribosomal alterations. Mol Microbiol. 46(5):1295-1304.
717Mahady GB. 2005. Medicinal plants for the prevention and treatment of bacterial infections. Curr Pharm Des. 11(19):2405-2427.
718Okunade AL, Elvin-Lewis MP, Lewis WH. 2004. Natural antimycobacterial metabolites: current status. Phytochemistry. 65(8):1017-1032.
719Chung EY, Byun YH, Shin EJ, Chung HS, Lee YH, Shin S. 2009. Antibacterial effects of vulgarone B from Artemisia iwayomogi alone and in combination with oxacillin. Arch Pharm Res. 32(12):1711-1719.
720Chakravorty S, Aladegbami B, Motiwala AS, Dai Y, Safi H, Brimacombe M, Helb D, Alland D. 2008. Rifampin resistance, Beijing-W clade-single nucleotide polymorphism cluster group 2 phylogeny, and the Rv2629 191-C allele in Mycobacterium tuberculosis strains. J Clin Microbiol. 46(8):2555-2560.
721Iwasa K, Lee DU, Kang SI, Wiegrebe W. 1998. Antimicrobial activity of 8-alkyl- and 8-phenyl-substituted berberines and their 12-bromo derivatives. J Nat Prod. 61(9):1150-1153.
722Kim BS, Moon SS, Hwang BK. 2000. Structure elucidation and antifungal activity of an anthracycline antibiotic, daunomycin, isolated from Actinomadura roseola. J Agric Food Chem. 48(5):1875-1881.
723Park HJ, Lee JY, Hwang IS, Yun BS, Kim BS, Hwang BK. 2006. Isolation and antifungal and antioomycete activities of staurosporine from Streptomyces roseoflavus strain LS-A24. J Agric Food Chem. 54(8):3041-3046.
724Duffin PM, Seifert HS. 2009. ksgA mutations confer resistance to kasugamycin in Neisseria gonorrhoeae. Int J Antimicrob Agents. 33(4):321-327.
725Kim YS, Kim HM, Chang C, Hwang IC, Oh H, Ahn JS, Kim KD, Hwang BK, Kim BS. 2007. Biological evaluation of neopeptins isolated from a Streptomyces strain. Pest Manag Sci. 63(12):1208-1214.
726Evans GA. 2002. The Oxazolidinones. Curr Infect Dis Rep. 4(1):17-27.
727Leon LD, Siverio F, Lo pez MM, Rodrıguez A. 2008. Comparative efficiency of chemical compounds for in vitro and in vivo activity against Clavibacter michiganensis subsp. michiganensis, the causal agent of tomato bacterial canker. Crop Protection 1277– 1283.
728Ochi K, Kim JY, Tanaka Y, Wang G, Masuda K, Nanamiya H, Okamoto S, Tokuyama S, Adachi Y, Kawamura F. 2009. Inactivation of KsgA, a 16S rRNA methyltransferase, causes vigorous emergence of mutants with high-level kasugamycin resistance. Antimicrob Agents Chemother. 53(1):193-201.
729Kehrenberg C, Schwarz S, Jacobsen L, Hansen LH, Vester B. 2005. A new mechanism for chloramphenicol, florfenicol and clindamycin resistance: methylation of 23S ribosomal RNA at A2503. Mol Microbiol. 57(4):1064-1073.
730Kondo S, Hotta K. 1999. Semisynthetic aminoglycoside antibiotics: Development and enzymatic modifications. J Infect Chemother. 5(1):1-9.
731Manam RR, Teisan S, White DJ, Nicholson B, Grodberg J, Neuteboom ST, Lam KS, Mosca DA. 2005. Lajollamycin, a nitro-tetraene spiro-beta-lactone-gamma-lactam antibiotic from the marine actinomycete Streptomyces nodosus. J Nat Prod. 68(2):240-243.
732Roberts LM. 2004. Australian Ganoderma : Identification ,Growth & antibacterial properties.
733Tabarez MR. 2005. Discovery of the new antimicrobial compound 7-O-malonyl macrolactin A. Druckjahr
734Sato M, Tanaka H, Yamaguchi R, Kato K, Etoh H. 2004. Synergistic effects of mupirocin and an isoflavanone isolated from Erythrina variegata on growth and recovery of methicillin-resistant Staphylococcus aureus. Int J Antimicrob Agents. 24(3):241-246.
735Sanglard D, Ischer F, Marchetti O, Entenza J, Bille J. 2003. Calcineurin A of Candida albicans: involvement in antifungal tolerance, cell morphogenesis and virulence. Mol Microbiol. Mol Microbiol. 48(4):959-976.
736Angehrn P, Buchmann S, Funk C, Goetschi E, Gmuender H, Hebeisen P, Kostrewa D, Link H, Luebbers T, Masciadri R, Nielsen J, Reindl P, Ricklin F, Schmitt-Hoffmann A, Theil FP. 2004. New antibacterial agents derived from the DNA gyrase inhibitor cyclothialidine. J Med Chem. 47(6):1487-1513.
737Greenberg, W. A., E. S. Priestley, P. S. Sears, P. B. Alper, C. Rosenbohm, M. Hendrix, S.-C. Hung, and C.-H. Wong. 1999. Design and synthesis of new aminoglycoside antibiotics containing neamine as an optimal core structure: correlation of antibiotic activity with in vitro inhibition of translation. J. Am. Chem. Soc. 121:6527–6541.
738Wong, H. 2003. Molecular biology of the entomopathogenic fungus Beauveria bassiana: Insect-cuticle degrading enzymes and development of a new selection marker for fungal transformation. Tesis de Doctorado. Universidad Ruperto-Carola. Heidelberg, Alemania. 147 pp.
739Tsubery H, Ofek I, Cohen S, Eisenstein M, Fridkin M. 2002. Modulation of the hydrophobic domain of polymyxin B nonapeptide: effect on outer-membrane permeabilization and lipopolysaccharide neutralization. Mol Pharmacol. 62(5):1036-1042.
740Kheadr EE. 2006. Impact of acid and oxgall on antibiotic susceptibility of probiotic lactobacilli. Afr J Agri Res 1(5), 172-181.
741Kheadr, E. E., N. Bernoussi, C. Lacroix, and I. Fliss. 2004. Comparison of the sensitivity of commercial strains and infant isolates of bifidobacteria to antibiotics and bacteriocins. Int. Dairy J. 14:1041–1053.
742Pietschmann S, Hoffmann K, Voget M, Pison U. 2008. Synergistic effects of Miconazole and Polymyxin B on microbial pathogens. Vet Res Commun. 33:489–505.
743Walsh AG, Matewish MJ, Burrows LL, Monteiro MA, Perry MB, Lam JS. 2000. Lipopolysaccharide core phosphates are required for viability and intrinsic drug resistance in Pseudomonas aeruginosa. Mol Microbiol. 35(4):718-727.
744Haddad J, Kotra LP, Llano-Sotelo B, Kim C, Azucena EF Jr, Liu M, Vakulenko SB, Chow CS, Mobashery S. 2002. Design of novel antibiotics that bind to the ribosomal acyltransfer site. J. Am. Chem. Soc. 124(13):3229-3237.
745SW Doughty, R Goodman, J Luck. 2004. Evaluating alternative antibiotics for control of European Foulbrood disease. Australian Government. Rural industries Research and development corporation.
746Atta HM, El-Sehrawi MH, Bahobail A.S. 2011. Antifungal Macrodiode Production By Streptomyces albidoflavus-143: Fermentation, Purification and Biological Activities. Journal of American Science 7(3):13- 22.
747Ho SW, Jung D, Calhoun JR, Lear JD, Okon M, Scott WR, Hancock RE, Straus SK. 2008. Effect of divalent cations on the structure of the antibiotic daptomycin. Eur Biophys J. 37(4):421-433.
748Ji Y, Yin D, Fox B, Holmes DJ, Payne D, Rosenberg M. 2004. Validation of antibacterial mechanism of action using regulated antisense RNA expression in Staphylococcus aureus. FEMS Microbiol Lett. 231(2):177-184.
749Tomasinsig L, Skerlavaj B, Papo N, Giabbai B, Shai Y, Zanetti M. 2006. Mechanistic and functional studies of the interaction of a proline-rich antimicrobial peptide with mammalian cells. J Biol Chem. 281(1):383-391.
750Xu Y, Wang Y, Yan L, Liang RM, Dai BD, Tang RJ, Gao PH, Jiang YY. 2009. Proteomic analysis reveals a synergistic mechanism of fluconazole and berberine against fluconazole-resistant Candida albicans: endogenous ROS augmentation. J Proteome Res. 8(11):5296-5304.
751Bhadury P, Mohammad BT, Wright PC. 2006. The current status of natural products from marine fungi and their potential as anti-infective agents. J Ind Microbiol Biotechnol. 33(5):325-537.
752Arie, T., Kobayashi, Y., Okada, G., Kono, Y., and Yamaguchi, I. 1998. Control of soilborne clubroot disease of cruciferous plants by epoxydon from Phoma glomerata. Plant Pathol. 47, 743-748
753Charvalos E, Tzatzarakis M, Tsatsakis A, Petrikkos G. 2001. Controlled release of water-soluble polymeric complexes of sorbic acid with antifungal activities. Appl Microbiol Biotechnol. 57(5-6):770-775.
754Cabañas R, Abarca ML, Bragulat MR, Cabañes FJ. 2009. In vitro activity of imazalil against Penicillium expansum: comparison of the CLSI M38-A broth microdilution method with traditional techniques. Int J Food Microbiol. 31;129(1):26-29.
755Kiso T, Fujita K, Ping X, Tanaka T, Taniguchi M. 2004. Screening for microtubule-disrupting antifungal agents by using a mitotic-arrest mutant of Aspergillus nidulans and novel action of phenylalanine derivatives accompanying tubulin loss. Antimicrob Agents Chemother. 48(5):1739-1748.
756Naik SR, Gupte TE. 2009. Probable mechanism(s) of antifungal activity of HA-2-91-A tetraene antibiotic. Jan. Indian Journal of Biotechnology Vol 8. pp 91-96.
757Koontz JL, Marcy JE. 2003. Formation of natamycin:cyclodextrin inclusion complexes and their characterization. 51(24):7106-7110. J Agric Food Chem.
758Vanden Bossche H, Engelen M, Rochette F. 2003. Antifungal agents of use in animal health--chemical, biochemical and pharmacological aspects. J Vet Pharmacol Ther. 26(1):5-29.
759Pfaller MA, Messer SA, Georgopapadakou N, Martell LA, Besterman JM, Diekema DJ. 2009. Activity of MGCD290, a Hos2 histone deacetylase inhibitor, in combination with azole antifungals against opportunistic fungal pathogens. J Clin Microbiol. 47(12):3797-804.
760Novartis. 2008. Scientific Publications, Denagard.
761Vicca, J 2005. Virulence and antimicrobial susceptibility of Mycoplasma hyopneumoniae isolates from pigs. PhD thesis, Faculty of Veterinary Medicine, Ghent University ISBN 90-5864-086-8, pp. 219.
762Blasi F, Braga P, Cazzola M, Cosentini R, Tarsia P. 2002. Therapies in development for community-acquired pneumonia. Expert Opin Investig Drugs. 11(4):545-552.
763Hidalgo A, Carvajal A, Pringle M, Rubio P, Fellström C. 2010. Characterization and epidemiological relationships of Spanish Brachyspira hyodysenteriae field isolates. Epidemiol Infect. 138(1):76-85.
764Post KW, Songer JG. 2004. Antimicrobial susceptibility of Clostridium difficile isolated from neonatal pigs with enteritis. Anaerobe. 10(1):47-50.
765Sivakumar PM, Priya S, Doble M. 2009. Synthesis, biological evaluation, mechanism of action and quantitative structure-activity relationship studies of chalcones as antibacterial agents. Chem Biol Drug Des. 73(4):403-415.
766Alsterholm M, Karami N, Faergemann J. 2010. Antimicrobial activity of topical skin pharmaceuticals - an in vitro study. Acta Derm Venereol. 90(3):239-245.
767Ahirrao P. 2008. Recent developments in antitubercular drugs. Mini Rev Med Chem. 8(14):1441-151.
768de la Fuente AJ, Tucker AW, Navas J, Blanco M, Morris SJ, Gutiérrez-Martín CB. 2007. Antimicrobial susceptibility patterns of Haemophilus parasuis from pigs in the United Kingdom and Spain. Vet Microbiol. 120(1-2):184-191.
769Brooks G, Burgess W, Colthurst D, Hinks JD, Hunt E, Pearson MJ, Shea B, Takle AK, Wilson JM, Woodnutt G. 2001. Pleuromutilins. Part 1. The identification of novel mutilin 14-carbamates. Bioorg Med Chem. 9(5):1221-1231..
770jianshi tao& paul schimmel 2000. Inhibitors of Aminoacyl-tRNA Synthetase as Novel Anti-infectives Exp.opin.invest.drugs 9(8)1767-1775
771Agnoletti F, Ferro T, Guolo A, Marcon B, Cocchi M, Drigo I, Mazzolini E, Bano L. 2009. A survey of Clostridium spiroforme antimicrobial susceptibility in rabbit breeding. Vet Microbiol. 136(1-2):188-191.
772Lykkeberg AK, Halling-Sørensen B, Jensen LB. 2007. Susceptibility of bacteria isolated from pigs to tiamulin and enrofloxacin metabolites. Vet Microbiol. 121(1-2):116-124.
773Yibin G, Jiang Z, Hong Z, Gengfa L, Liangxi W, Guo W, Yongling L. 2005. A synthesized cationic tetradecapeptide from hornet venom kills bacteria and neutralizes lipopolysaccharide in vivo and in vitro. Biochem Pharmacol. 70(2):209-219.
774Rhee MK, Kowalski RP, Romanowski EG, Mah FS, Ritterband DC, Gordon YJ. 2004. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa. Am J Ophthalmol. 138(2):226-230.
775Trafny EA. 1998. Susceptibility of adherent organisms from Pseudomonas aeruginosa and Staphylococcus aureus strains isolated from burn wounds to antimicrobial agents. Int J Antimicrob Agents. 10(3):223-228.
776Jain J, Arora S, Rajwade JM, Omray P, Khandelwal S, Paknikar KM. 2009. Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use. Mol Pharm. 6(5):1388-1401.
777Natarajan P, Katta S, Andrei I, Babu Rao Ambati V, Leonida M, Haas GJ. 2008. Positive antibacterial co-action between hop (Humulus lupulus) constituents and selected antibiotics. Phytomedicine. 15(3):194-201.
778Iwao E, Yokoyama Y, Yamamoto K, Hirayama F, Haga K. 2003. In vitro and in vivo anti- Helicobacter pylori activity of Y-904, a new fluoroquinolone. J Infect Chemother. 9(2):165-171.
779Giamarellou H, Poulakou G. 2009. Multidrug-resistant Gram-negative infections: what are the treatment options? Drugs. 69(14):1879-1901.
780Kline T, Holub D, Therrien J, Leung T, Ryckman D. 2001. Synthesis and characterization of the colistin peptide polymyxin E1 and related antimicrobial peptides. J Pept Res. 57(3):175-187.
781Fernández L, Gooderham WJ, Bains M, McPhee JB, Wiegand I, Hancock RE. 2010. Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS. Antimicrob Agents Chemother. 54(8):3372-3382.
782Pongpech P, Amornnopparattanakul S, Panapakdee S, Fungwithaya S, Nannha P, Dhiraputra C, Leelarasamee A. 2010. Antibacterial activity of carbapenem-based combinations againts multidrug-resistant Acinetobacter baumannii. J Med Assoc Thai. 93(2):161-171.
783Smith PA, Roberts TC, Romesberg FE. 2010. Broad-spectrum antibiotic activity of the arylomycin natural products is masked by natural target mutations. Chem Biol. 17(11):1223-1231.
784Jain P, Jain S, Prasad KN, Jain SK, Vyas SP. 2009. Polyelectrolyte coated multilayered liposomes (nanocapsules) for the treatment of Helicobacter pylori infection. Mol Pharm. 6(2):593-603.
785Mohan MC, Srinivasulu M, Rangaswamy V. 2010. Effect of Pharmaceutical Compounds Alone and In Combination on Microbial Activity. Developmental Microbiology and Molecular Biology ISSN 0976-5867 Volume 1, Number 1, pp. 55-63.
786Jayaraman P, Sakharkar MK, Lim CS, Tang TH, Sakharkar KR. 2010. Activity and interactions of antibiotic and phytochemical combinations against Pseudomonas aeruginosa in vitro. Int J Biol Sci. 6(6):556-568.
787Behera B, Mathur P, Das A, Kapil A, Gupta B, Bhoi S, Farooque K, Sharma V, Misra MC. 2010. Evaluation of susceptibility testing methods for polymyxin. Int J Infect Dis. 14(7):e596-601.
788Yeung AT, Bains M, Hancock RE. 2011. The sensor kinase CbrA is a global regulator that modulates metabolism, virulence, and antibiotic resistance in Pseudomonas aeruginosa. J Bacteriol. 193(4):918-931
789Ochsner UA, Young CL, Stone KC, Dean FB, Janjic N, Critchley IA. 2005. Mode of action and biochemical characterization of REP8839, a novel inhibitor of methionyl-tRNA synthetase. Antimicrob Agents Chemother. 49(10):4253-4262.
790Paulander W, Maisnier-Patin S, Andersson DI. 2007. Multiple mechanisms to ameliorate the fitness burden of mupirocin resistance in Salmonella typhimurium. Mol Microbiol. 64(4):1038-1048.
791HR Kien. 2009. Investigating bacterial biofilms in chronic Rhinosinusitis: an in vitro study, in vivo animal study and a examination of biofilms in human CRS. School of Medicine : Surgery
792Suaib Luqman, Suchi Srivastava, Mahendra P. Darokar, and Suman P.S. Khanuja 2005. Detection of Antibacterial Activity in Spent Roots of Two Genotypes of Aromatic Grass Vetiveria zizanioides Pharmaceutical Biology 2005, Vol. 43, No. 8, pp. 732–736
793Jakeline Trejos Jiménez, Shane O’Connell, Henry Lyons, Benjamin Bradley,Michael Hall 2009. Antioxidant, antimicrobial, and tyrosinase inhibition activities of acetone extract of Ascophyllum nodosum Chemical Papers 64 (4) 434–442 (2010)
794Goldman RC, Scaglione F. 2004. The macrolide-bacterium interaction and its biological basis. Curr Drug Targets Infect Disord. 4(3):241-260.
795Ondeyka J, Harris G, Zink D, Basilio A, Vicente F, Bills G, Platas G, Collado J, Gonzáez A, de la Cruz M, Martin J, Kahn JN, Galuska S, Giacobbe R, Abruzzo G, Hickey E, Liberator P, Jiang B, Xu D, Roemer T, Singh SB. 2009. Isolation, structure elucidation, and biological activity of virgineone from Lachnum Wirgineum using the genome-wide Candida albicans fitness test. J Nat Prod. 72(1):136-141.
796Segvić Klarić M, Kosalec I, Mastelić J, Piecková E, Pepeljnak S. 2007. Antifungal activity of thyme (Thymus vulgaris L.) essential oil and thymol against moulds from damp dwellings. Lett Appl Microbiol. 44(1):36-42.
797Rahman, A., Kang, S.C. 2009. In vitro control of food-borne and food spoilage bacteria by essential oil and ethanol extracts of Lonicera japonica Thunb. Food Chemistry. 116: 670–675.
798Smith WL, Edlind TD. 2002. Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation. Antimicrob Agents Chemother. 46(11):3532-3539.
799Li RK, Rinaldi MG. 1999. In vitro antifungal activity of nikkomycin Z in combination with fluconazole or itraconazole. Antimicrob Agents Chemother. 43(6):1401-1405.
800Zawadzke LE, Wu P, Cook L, Fan L, Casperson M, Kishnani M, Calambur D, Hofstead SJ, Padmanabha R. 2003. Targeting the MraY and MurG bacterial enzymes for antimicrobial therapeutic intervention. Anal Biochem. 314(2):243-252.
801Castiglione F, Lazzarini A, Carrano L, Corti E, Ciciliato I, Gastaldo L, Candiani P, Losi D, Marinelli F, Selva E, Parenti F. 2008. Determining the structure and mode of action of microbisporicin, a potent lantibiotic active against multiresistant pathogens. Chem Biol. 15(1):22-31.
802Møretrø, T., M.A. Daeschel. 2004. Wine is bactericidal to foodborne pathogens. J. Food Sci. 69:M251-M257.
803Onishi J, Meinz M, Thompson J, Curotto J, Dreikorn S, Rosenbach M, Douglas C, Abruzzo G, Flattery A, Kong L, Cabello A, Vicente F, Pelaez F, Diez MT, Martin I, Bills G, Giacobbe R, Dombrowski A, Schwartz R, Morris S, Harris G, Tsipouras A, Wilson K, Kurtz MB. 2000. Discovery of novel antifungal (1,3)-beta-D-glucan synthase inhibitors. Antimicrob Agents Chemother. 44(2):368-377.
804Jiang B, Xu D, Allocco J, Parish C, Davison J, Veillette K, Sillaots S, Hu W, Rodriguez-Suarez R, Trosok S, Zhang L, Li Y, Rahkhoodaee F, Ransom T, Martel N, Wang H, Gauvin D, Wiltsie J, Wisniewski D, Salowe S, Kahn JN, Hsu MJ, Giacobbe R, Abruzzo G, Flattery A, Gill C, Youngman P, Wilson K, Bills G, Platas G, Pelaez F, Diez MT, Kauffman S, Becker J, Harris G, Liberator P, Roemer T. 2008. PAP inhibitor with in vivo efficacy identified by Candida albicans genetic profiling of natural products. Chem Biol. 15(4):363-374.
805Mircus G, Hagag S, Levdansky E, Sharon H, Shadkchan Y, Shalit I, Osherov N. 2009. Identification of novel cell wall destabilizing antifungal compounds using a conditional Aspergillus nidulans protein kinase C mutant. J Antimicrob Chemother. 64(4):755-763.
806Donat S, Streker K, Schirmeister T, Rakette S, Stehle T, Liebeke M, Lalk M, Ohlsen K. 2009. Transcriptome and functional analysis of the eukaryotic-type serine/threonine kinase PknB in Staphylococcus aureus. J Bacteriol. 191(13):4056-4069.
807Marini NJ, Baliga R, Taylor MJ, White S, Simpson P, Tsai L, Baird EE. 2003. DNA binding hairpin polyamides with antifungal activity. Chem Biol. 10(7):635-644.
808Bugg TD, Lloyd AJ, Roper DI. 2006. Phospho-MurNAc-pentapeptide translocase (MraY) as a target for antibacterial agents and antibacterial proteins. Infect Disord Drug Targets. 6(2):85-106.
809Zhang L, Scott MG, Yan H, Mayer LD, Hancock RE. 2000. Interaction of polyphemusin I and structural analogs with bacterial membranes, lipopolysaccharide, and lipid monolayers. Biochemistry. 39(47):14504-14514.
810Mangoni ML, Papo N, Mignogna G, Andreu D, Shai Y, Barra D, Simmaco M. 2003. Ranacyclins, a new family of short cyclic antimicrobial peptides: biological function, mode of action, and parameters involved in target specificity. Biochemistry. 42(47):14023-14035.
811Togashi N, Shiraishi A, Nishizaka M, Matsuoka K, Endo K, Hamashima H, Inoue Y. 2007. Antibacterial activity of long-chain fatty alcohols against Staphylococcus aureus. Molecules. 12(2):139-148
812Milewski S, Mignini F, Prasad R, Borowski E. 2001. Unusual susceptibility of a multidrug-resistant yeast strain to peptidic antifungals. Antimicrob Agents Chemother. 45(1):223-228.
813P. Rattanachaikunsopon and P. Phumkhachorn 2009. Shallot (Allium ascalonicum L.) oil: Diallyl sulfide content and antimicrobial activity against food-borne pathogenic bacteria African Journal of Microbiology Research Vol. 3(11) pp. 747-750, November, 2009
814Pina-Vaz C, Sansonetty F, Rodrigues AG, Costa-Oliveira S, Tavares C, Martinez-de-Oliveira J. 2001. Cytometric approach for a rapid evaluation of susceptibility of Candida strains to antifungals. Clin Microbiol Infect. 7(11):609-618.
815Susanna Esposito, Nicola Principi 2002. Emerging Resistance to Antibiotics against Respiratory Bacteria: Impact on Therapy of Community-Acquired Pneumonia in Children Drug Resistance Updates 5 (2002) 73–87
816Atta H.M.; El-Sehrawi, M.H.; Awny, N.M. and El-Mesady, N.I. 2001. Cirramycin-B Antibiotic Production By Streptomyces Cyaneus-AZ-13Zc: Fermentation, Purification and Biological Activities. New York Science Journal 4(2): 35-42.
817Ica T, Ciftci A, Savasan S, Diker KS. 2009. Metronidazole Resistance of Campylobacter jejuni and Campylobacter coli from Different Animal Species. Kafkas Univ Vet Fak Derg. 15 (4): 629-632.
818Merriam CV, Citron DM, Tyrrell KL, Warren YA, Goldstein EJ. 2006. In vitro activity of azithromycin and nine comparator agents against 296 strains of oral anaerobes and 31 strains of Eikenella corrodens. Antimicrob Agents Chemother. 28(3):244-248.
819Iwaki K, Koya-Miyata S, Kohno K, Ushio S, Fukuda S. 2006. Antimicrobial activity of Polygonum tinctorium Lour: extract against oral pathogenic bacteria. Journal of Natural Medicine. 60:121-125.
820Helena Albano, Catarina Pinho, Daniela Leite, Joana Barbosa, Joana Silva, Luísa Carneiro, Rui Magalhães, Tim Hogg, Paula Teixeira 2008. Evaluation of a bacteriocin-producing strain of Pediococcus acidilactici as a biopreservative for "Alheira", a fermented meat sausage Food Control Volume 20, Issue 8, August 2009, Pages 764-770
821Shaddox LM, Walker C. 2009. Microbial testing in periodontics: value, limitations and future directions. Periodontol 2000. 50:25-38.
822D Schönberg-Norio. 2009. Campylobacter Infections of Domestic Origin in Finland. Academic Dissertation
823Inatsu S, Ohsaki A, Nagata K. 2006. Idebenone acts against growth of Helicobacter pylori by inhibiting its respiration. Antimicrob Agents Chemother. 50(6):2237-2239.
824Nagata K, Inatsu S, Tanaka M, Sato H, Kouya T, Taniguchi M, Fukuda Y. 2010. The bifidogenic growth stimulator inhibits the growth and respiration of Helicobacter pylori. Helicobacter. 15(5):422-429.
825Tremblay, C., C. Gaudreau, M. Lorange. 2003. Epidemiology and antimicrobial susceptibilities of 111 Campylobacter fetus subsp. Fetus strains isolated in Quebec, Canada, from 1983 to 2000. J. Clin. Microbiol. 41:463–466.
826Yin MC, Chao CY. 2008. Anti-Campylobacter, anti-aerobic, and anti-oxidative effects of roselle calyx extract and protocatechuic acid in ground beef Int J Food Microbiol. 127(1-2):73-77.
827Funke G, Ramos CP, Collins MD. 1995. Identification of some clinical strains of CDC coryneform group A-3 and A-4 bacteria as Cellulomonas species and proposal of Cellulomonas hominis sp. nov. for some group A-3 strains. J Clin Microbiol. Aug;33(8):2091-2097.
828Natalie C. Berard, Richard A. Holley,Tim A. McAllister, Kim H. Ominski,Karin M. Wittenberg,Kristen S. Bouchard,Jenelle J. Bouchard, and Denis O. Krause 2008. Potential To Reduce Escherichia coli Shedding in Cattle Feces by Using Sainfoin (Onobrychis viciifolia) Forage, Tested In Vitro and In Vivo APPLIED AND ENVIRONMENTAL MICROBIOLOGY Feb. 2009, p. 1074–1079
829Miljković-Selimović B, Babić T, Kocić B, Ristić L. 2009. Antimicrobial susceptibility profiles of thermophilic campylobacters isolated from patients in the town of Nis. Vojnosanit Pregl. 66(7):522-526.
830Hirota M, Totsu T, Adachi F, Kamikawa K, Watanabe J, Kanegasaki S, Nakata K. 2001. Comparison of antimycobacterial activity of grepafloxacin against Mycobacterium avium with that of levofloxacin: accumulation of grepafloxacin in human macrophages. J Infect Chemother. 7(1):16-21.
831Zanoni RG, Rossi M, Giacomucci D, Sanguinetti V, Manfreda G. 2007. Occurrence and antibiotic susceptibility of Helicobacter pullorum from broiler chickens and commercial laying hens in Italy. Int J Food Microbiol. 116(1):168-173.
832Aslim B, Yucel N 2008. In vitro antimicrobial activity of essential oil from endemic Origanum minutiflorum on ciprofloxacin-resistant Campylobacter spp. Food Chem. 107: 602-606
833Rodríguez-Avial I, Rodríguez-Avial C, López O, Culebras E, Picazo JJ. 2006. In vitro activity of tigecycline (GAR-936) and other antimicrobials against tetracycline- and ciprofloxacin-resistant Campylobacter clinical isolates. Int J Antimicrob Agents. 27(4):303-306.
834Voravuthikunchai S, Lortheeranuwat A, Jeeju W, Sririrak T, Phongpaichit S, Supawita T. 2004. Effective medicinal plants against enterohaemorrhagic Escherichia coli O157:H7. J Ethnopharmacol. 94(1):49-54.
835Ousssalah M, Caillet S, Saucier L, and Lacroix M. 2007. Inhibitory eVects of selected plant essential oils on the growth of four pathogenic bacteria: E. coli O157:H7, Salmonella Typhimurium,Staphylococcus aureus and Listeria monocytogenes. J. Food control. 18:414-420.
836Spiros Paramithiotis, Ioulita Melissari, Eleftherios H. Drosinos 2005. In vitro assessment of properties associated with the survival through the gastro-intestinal tract of staphylococci isolated from traditional sausage fermentation Food Microbiology 23 (2006) 663–671
837Mohan Thakare 2004. Pharmalogical Screening of some Medicinal Plants as Antimicrobial and Feed Additives
838Shin SY, Bajpai VK, Kim HR, Kang SC. 2007. Antibacterial activity of bioconverted eicosapentaenoic (EPA) and docosahexaenoic acid (DHA) against foodborne pathogenic bacteria. Int J Food Microbiol. 113(2):233-236.
839Burt S. 2004. Essential oils: their antibacterial properties and potential applications in foods--a review. Int J Food Microbiol. 94(3):223-253.
840Canan Karaalp, Ayse Nur Yurtman, and N. Ulku Karabay Yavasoglu 2008. Evaluation of antimicrobial properties of Achillea L. flower head extracts Pharmaceutical Biology 2009; 47(1): 86–91
841Oke F., Aslim B., Oztirk S., Altundag S. 2009. Essential oil composition, antimicrobial and antioxidant activities of Satureja cuneifolia Ten. Food Chem. 112, 874-879.
842Nakamura S, Hatanaka A. 2002. Green-leaf-derived C6-aroma compounds with potent antibacterial action that act on both Gram-negative and Gram-positive bacteria. J Agric Food Chem. 50(26):7639-7644.
843Demirci, F., K. Guven, B. Demirci, M.Y. Dadandi and K.H.C. Baser. 2008. Antibacterial acitivity of two Phlomis essential oils against food pathogens. Food Cont. 19: 1159–1164.
844Al-Zoreky NS. 2009. Antimicrobial activity of pomegranate (Punica granatum L.) fruit peels. Int J Food Microbiol. 134(3):244-248.
845Bajpai, V.K.; Rahman, A.; Choi, U.K.; Youn, S.J.; Kang, S.C. 2007. Inhibitory parameters of the essential oil and various extracts of Metasequoia glyptostroboides Miki ex Hu to reduce food spoilage and food-borne pathogens. Food Chem. 105, 1061-1066.
846Bajpai VK, Rahman A, Kang SC. 2008. Chemical composition and inhibitory parameters of essential oil and extracts of Nandina domesticaThunb. to control food-borne pathogenic and spoilage bacteria. Int J Food Microbiol. 125(2):117-122.
847SP Voravuthikunchai, S Limsuwan, Sopapol O, Subhadhirasakul S. 2006. Antibacterial activity of extracts from family Zingiberaceae against foodborne pathogens. Journal of Food Safety 26:325–334.
848Li Q, Sherwood JS, Logue CM. 2007. Antimicrobial resistance of Listeria spp. recovered from processed bison. Lett Appl Microbiol. 44(1):86-91.
849Low AS, MacKenzie FM, Gould IM, Booth IR. 2001. rotected environments allow parallel evolution of a bacterial pathogen in a patient subjected to long-term antibiotic therapy. Mol Microbiol. 42(3):619-630.
850Kubo I, Fujita K. 2001. Naturally occurring anti-Salmonella agents. J Agric Food Chem. 49(12):5750-5754.
851Raju Gautam, Arvind Saklani, Sanjay M. Jachak 2007. Indian Medicinal Plants as A Source of Antimycobacterial Agents Journal of Ethnopharmacology 110 (2007) 200–234
852Shigemi Terakubo, Hiromu Takemura, Hiroyuki Yamamoto, Hideaki Ikejima, Hiroyuki Kunishima, Keiji Kanemitsu, Mitsuo Kaku, Jingoro Shimada 2001. Antimicrobial Activity of Everninomicin against Clinical Isolates of Enterococcus spp., Staphylococcus spp., and Streptococcus spp. Tested by Etest J Infect Chemother (2001) 7:263–266
853G. Mandalari, C. Bisignano, M. D’Arrigo, G. Ginestra, A. Arena, A. Tomaino and M.S.J. Wickham 2010. Antimicrobial potential of polyphenols extracted from almond skins Applied Microbiology Letters in Applied Microbiology ISSN 0266-8254
854Georgios Sotiroudis, Eleni Melliou, Theodore G. Sotiroudis and Ioanna Chinou 2008. Chemical analysis,antioxidant and antimicrobial actvity of three greek cucumber (cucumis sativus ) cultivars Journal of Food Biochemistry 34 (2010) 61–78
855Samy A. Selim 2011. Chemical composition, antioxidant and antimicrobial activity of the essential oil and methanol extract of the Egyptian lemongrass Cymbopogon proximus Stapf Grasas y Aceites
856Henie, E.F. P., Zaiton, H. and Suhaila, M. 2009. Bacterial membrane disruption in food pathogens by Psidium guajava leaf extracts International Food Research Journal 16: 297 -311 (2009)
857B Stephen Inbaraj, T H Kao, T Y Tsai, C P Chiu, RKumar, and B H Chen 2011. The Synthesis and Characterization of Poly(γ -Glutamic Acid)-Coated Magnetite Nanoparticles and Their Effects on Antibacterial Activity and Cytotoxicity Nanotechnology 22 (2011) 075101 (9pp)
858Lucia Rivas , Mary J. McDonnell , Catherine M. Burgess , Martin O'Brien , Alberto Navarro-Villa , Séamus Fanning , Geraldine Duffy 2010. Inhibition of verocytotoxigenic Escherichia coli in model broth and rumen systems by carvacrol and thymol International Journal of Food Microbiology 139 (2010) 70–78
859Sharif M. Al-Reza, Atiqur Rahman & Sun Chul Kang 2009. Chemical composition and inhibitory effect of essential oil and organic extracts of Cestrum nocturnum L. on food-borne pathogens International Journal of Food Science and Technology 2009, 44, 1176–1182
860Batool Sadeghi-Nejad, Fariba Shiravi, Somayeh Ghanbari, Mastaneh Alinejadi, Majid Zarrin 2010. Antifungal activity of Satureja khuzestanica (Jamzad) leaves extracts Jundishapur Journal of Microbiology (2010); 3(1): 36-40 36
861Pongsak Rattanachaikunsopon and Parichat Phumkhachorn 2010. Contents and antibacterial activity of flavonoids extracted from leaves of Psidium guajava Journal of Medicinal Plants Research Vol. 4(5), pp. 393-396, 4 March, 2010
862Dilek Keskin, Dilek Oskay and Mustafa Oskay 2010. Antimicrobial Activity of Selected Plant Spices Marketed in the West Anatolia International Journal of Agriculture & Biology 12: 916–920
863Atiqur Rahman, Sharif M Al-Reza, Jung In Yoon and Sun Chul Kang 2009. In Vitro Inhibition of Foodborne Pathogens by Volatile Oil and Organic Extracts of Poncirus trifoliata Rafin. Seeds Society of Chemical Industry 89: 876–881
864Atiqur Rahman, Eun Lyang Kim and Sun Chul Kang 2009. Antibacterial and Antioxidant Properties of Ailanthus altissima Swingle Leave Extract to Reduce Foodborne Pathogens and Spoiling Bacteria Journal of Food Safety 29 (2009): 499–510
865Ju-Sung Park and Gyu-Hee Lee 2011. Volatile Compounds and Antimicrobial and Antioxidant Activities of the Essential Oils of the Needles of Pinus densiflora and Pinus thunbergii Society of Chemical Industry 91: 703–709
866Carla C.C.R. de Carvalho, and Maria José Caramujo 2008. Ancient Procedures for the High-Tech World: Health Benefits and Antimicrobial Compounds from the Mediterranean Empires The Open Biotechnology Journal 235-246
867Vivek K. Bajpai, Hak Ryul Kim, Ching Tsang Hou and Sun Chul Kang 2009. Bioconverted Products of Essential Fatty Acids as Potential Antimicrobial Agents New Biotechnology Volume 26, Numbers 3/4 October 2009
868L.A. Sanchez, M. Hedstrom, M.A. Delgado and O.D. Delgado 2010. Production, Purification and Characterization of Serraticin A, A Novel Cold-Active Antimicrobial Produced by Serratia proteamaculans 136 Journal of Applied Microbiology 109 (2010): 936–945
869Emma Huitric, Peter Verhasselt, Koen Andries, and Sven E. Hoffner 2007. In Vitro Antimycobacterial Spectrum of a Diarylquinoline ATP Synthase Inhibitor Antimicrobial Agents and Chemotherapy Nov. 2007, p. 4202–4204
870Lluis Ballell, Robert A. Field, Ken Duncan, and Robert J. Young 2005. New Small-Molecule Synthetic Antimycobacterials Antimicrobial Agents and Chemotherapy June 2005, p. 2153–2163
871LiyanaArachchige Sanjeewani Rupika Herath 2010. Development and Evaluation of Low Density Polyethylene-Based Antimicrobial Food Packaging Films Containing Natural Agents
872Joris Michiels 0. Effect of Essential Oils on Gut Bacteria and Functionality in the Pig
873Leena Suojala 2010. Bovine Mastitis Caused by Escherichia coli - Clinical, Bacteriological and Therapeutic Aspects
874Supayang Piyawan Voravuthikunchai, Souwalak Phongpaichit, and Sanan Subhadhirasakul 2005. Evaluation of Antibacterial Activities of Medicinal Plants Widely Used Among AIDS Patients in Thailand Pharmaccutical Biology Vol. 43, No. 8, pp. 701-706
875YuJie Fu, YuanGang Zu, LiYan Chen, XiaoGuang Shi, Zhe Wang, Su Sun and Thomas Efferth 2007. Antimicrobial Activity of Clove and Rosemary Essential Oils Alone and in Combination Phytotherapy Research
876Marta Cristina Teixeira Duarte, Ewerton Eduardo Leme, Camila Delarmelina, Andressa Almeida Soares, Glyn Mara Figueira, Adilson Sartoratto 2006. Activity of Essential Oils from Brazilian Medicinal Plants on Escherichia coli Journal of Ethnopharmacology 111 (2007) 197–201
877Wentao Xu, Wei Qu, Kunlun Huang, Feng Guo, Jiajia Yang, Heng Zhao, YunBo Luo 2006. Antibacterial Effect of Grapefruit Seed Extract on Food-borne Pathogens and Its Application in the Preservation of Minimally Processed Vegetables Postharvest Biology and Technology 45 (2007): 126–133
878Karin Yvonne Gfeller 0. Molecular analysis of antimicrobial resistance determinants of commensal lactobacilli. Diss. ETH No. 14951
879Na Guo, Jingbo Liu, Xiuping Wu, Xingming Bi, Rizeng Meng, Xuelin Wang, Hua Xiang, Xuming Deng and Lu Yu 2009. Antifungal Activity of Thymol Against Clinical Isolates of Fluconazole-Sensitive and -Resistant Candida
albicans Journal of Medical Microbiology (2009), 58, 1074–1079
880Stella Y. Y. Wong, Irene R. Grant, Mendel Friedman, Christopher T. Elliott, and Chen Situ 2008. Antibacterial Activities of Naturally Occurring Compounds against Mycobacterium avium subsp. paratuberculosis Applied and Environmental Microbiology 5986–5990
881V.K. Bajpai, A. Rahman, N.T. Dung, M.K. Huh, and S.C. Kang 2008. In vitro Inhibition of Food Spoilage and Foodborne Pathogenic Bacteria by Essential Oil and Leaf Extracts of Magnolia liliflora Desr JOURNAL OF FOOD SCIENCE Vol. 73, Nr. 6, 2008
882Dusan Misic, Irena Zizovic, Marko Stamenic, Ruzica Asanin, Mihailo Ristic, Slobodan D. Petrovic, Dejan Skala 2008. Antimicrobial Activity of Celery Fruit Isolates and SFE Process Modeling Biochemical Engineering Journal 42 (2008): 148–152
883J.R. Soberon, M.A. Sgariglia, D.A. Sampietro, E.N. Quiroga and M.A. Vattuone 2006. Antibacterial Activity of Plant Extracts from Northwestern Argentina Journal of Applied Microbiology 102 (2007): 1450–1461
884Surasak Limsuwan, Sanan Subhadhirasakul, and Supayang Piyawan Voravuthikunchai 2009. Medicinal Plants with Significant Activity against Important Pathogenic Bacteria Pharmaceutical Biology 47(8): 683–689
885Calugi C, Trabocchi A, Guarna A. 2011. Novel small molecules for the treatment of infections caused by Candida albicans: a patent review (2002 -- 2010). Expert Opin Ther Pat. 21(3):381-397.
886Galgóczy L, Bácsi A, Homa M, Virágh M, Papp T, Vágvölgyi C. 2011. In vitro antifungal activity of phenothiazines and their combination with amphotericin B against different Candida species. Mycoses. doi: 10.1111/j.1439-0507.2010.02010.x.
887S. Chusri and S.P. Voravuthikunchai 2008. Detailed Studies on Quercus Infectoria Olivier (Nutgalls) as An Alternative Treatment for Methicillin-Resistant Staphylococcus aureus Infections Journal of Applied Microbiology 1364-5072 (2008)
888H. Yoshimura, M. Ishimaru, Y.S. Endoh and A. Kojima 2000. Antimicrobial Susceptibilities of Enterococci Isolated from Faeces of Broiler and Layer Chickens Letters in Applied Microbiology 2000, 31, 427 - 432
889H. L. Rocchetta, C. J. Boylan, J. W. Foley, P. W. Iversen, D. L. Letourneau, C. L. Mcmillian, P. R. Contag, D. E. Jenkins, and T. R. Parr, JR. 2001. Validation of a Noninvasive, Real-Time Imaging Technology Using Bioluminescent Escherichia coli in the Neutropenic Mouse Thigh Model of Infection Antimicrobial Agents and Chemotherapy 129–137
890Simjee S., Heffron A.L., Agnoletti F., Pridmore A., Pradella G. 2008. Pharmacodynamics of Avilamycin towards Strains of Clostridium perfringens Isolated from Epizootic Rabbit Enteropathy Pathology and Hygiene June 10-13, 2008
891Kamel Chaieb, Bochra Kouidhi, Hanene Jrah, Kacem Mahdouani and Amina Bakhrouf 2011. Antibacterial Activity of Thymoquinone, an Active Principle of Nigella sativa and Its Potency to Prevent Bacterial Biofilm Formation BMC Complementary and Alternative Medicine
892J. Fausto Rivero-Cruz 2008. Antimicrobial Compounds Isolated from Haematoxylon brasiletto Journal of Ethnopharmacology 119 (2008) 99–103
893Mihriban Korukluoglu, Yasemin Sahan, Aycan Yigit, Reyhan Karakas 2006. Antifungal Activity of Olive Leaf (Olea Europaea L.) Extracts from the Trilye Region of Turkey Annals of Microbiology 56 (4) 359-362 (2006)
894Vivek K. Bajpai • Nguyen Thi Dung • Hwa-Jin Suh • Sun Chul Kang 2010. Antibacterial Activity of Essential Oil and Extracts of Cleistocalyx operculatus Buds Against the Bacteria of Xanthomonas spp. Journal of the American Oil Chemists' Society 87:1341–1349
895Nutcha Sanla-Ead, Panchuti Phoopuritham, Panuwat Suppakul 0. Antimicrobial and Antioxidant Activities of Betel Oil
896A. Laciar, M. L. Vaca Ruiz, R. Carrizo Flores, J. R. Saad 2009. Antibacterial and Antioxidant Activities of the Essential Oil of Artemisia echegarayi Hieron. (Asteraceae) Revista Argentina de Microbiología 41: 226-231
897Arzu Cansaran, Nazime Mercan Dogan, Mehtap Öztekin and Gülümser Acar 2010. Antimicrobial Activity of Various Extracts of Centaurea cankiriense A. Duran and H. Duman African Journal of Microbiology Research 4 (8): 608-612
898Mihriban Korukluoglu, Yasemin Sahan, Aycan Yigit, Elif Tumay Ozer and Seref GÜcer 2006. antibacterial activity and chemical constitutions of olea europaeal. leaf extracts Journal of Food Processing and Preservation 34 (2010) 383–396
899Beatrice Olawumi Temilade Ifesan, Nantiya Joycharat & Supayang Piyawan Voravuthikunchai 2009. Themode ofantistaphylococcal action ofEleutherineamericana FEMS Immunol Med Microbiol 57 (2009) 193–201
900Bjorn Christian Schirmer and Solveig Langsrud 2010. Evaluation of Natural Antimicrobials on Typical Meat Spoilage Bacteria In Vitro and in Vacuum-Packed Pork Meat Journal of Food Science 98-102
901Dokyung Lee, Jaewoong Hwang, Hwanjin Yang, Soek Jang, Eunhye Baek, Mijin Kim, Junghyun Kim, Sangjin Lee and Namjoo Ha 2007. Assessment of Bacterial Contamination of Raw Meats Sold in Korea, 2007 Journal of Enviromental Toxicology Vol. 22, No. 4, 313 - 320
902Hafedh Hajlaoui, Najla Trabelsi, Emira Noumi, Mejdi Snoussi, Hanen Fallah, Riadh Ksouri, Amina Bakhrouf 2009. Biological Activities of the Essential Oils and Methanol Extract of Tow Cultivated Mint Species (Mentha longifolia and Mentha pulegium) Used in the Tunisian Folkloric Medicine World J Microbiol Biotechnol (2009) 25:2227–2238
903G. S. El-Baroty, H. H. Abd El-Baky, R. S. Farag and M. A. Saleh 2010. Characterization of Antioxidant and Antimicrobial Compounds of Cinnamon and Ginger Essential Oils African Journal of Biochemistry Research Vol. 4(6), pp. 167-174
904Marina Soković , Jasmina Glamočlija, Petar D. Marin, Dejan Brkić and Leo J. L. D. van Griensven 2010. Antibacterial Effects of the Essential Oils of Commonly Consumed Medicinal Herbs Using an In Vitro Model Molecules 15:7532-7546
905Eliana Harue Endo, Diogenes Aparıcio Garcia Cortez, Tania Ueda-Nakamura, Celso Vataru Nakamura, Benedito Prado Dias Filho 2010. Potent Antifungal Activity of Extracts and Pure Compound Isolated from Pomegranate Peels and Synergism with Fluconazole against Candida albicans Research in Microbiology 161 (2010) 534 - 540
906Eunhye Baek, Dokyung Lee, Seok Jang, Hyangmi An, Mijin Kim, Kyungjae Kim, Kangoh Lee, and Namjoo Ha 2009. Antibiotic Resistance and Assessment of Food-borne Pathogenic Bacteria in Frozen Foods Archives of Pharmacal Research Vol 32, No 12, 1749-1757
907Do Kyung Lee, Jae Ung Hwang, Eun Hye Baek, Kang Oh Lee, Kyung Jae Kim, and Nam Joo Ha 2008. New Antimicrobial Drug Resistance and Epidemiological Typing Patterns of Staphylococci from Clinical Isolates and Raw Meats Arch Pharm Res Vol 31, No 8, 1016-1022
908Deog Yong Lee, Yeon-Soo Seo, Nabin Rayamajhi, Mi Lan Kang, Su In Lee, and Han Sang Yoo 2009. Isolation, Characterization, and Evaluation of Wild Isolates of Lactobacillus reuteri from Pig Feces The Journal of Microbiology December 2009, p. 663-672
909Manish Goswami, Suhas H. Mangoli, and Narendra Jawali 2007. Effects of Glutathione and Ascorbic Acid on Streptomycin Sensitivity of Escherichia coli Antimicrobial Agents and Chemotherapy Mar. 2007, p. 1119–1122
910Petros A. Maragkoudakis, Konstantinos C. Mountzouris, Dimitris Psyrras, Silvia Cremonese, Jana Fischer, Mette D. Cantor, Effie Tsakalidou 2009. Functional Properties of Novel Protective Lactic Acid Bacteria and Application in Raw Chicken Meat against Listeria monocytogenes and Salmonella enteritidis International Journal of Food Microbiology 130 (2009) 219–226
911Nuha Abdel-Rahman Mehdawi 2010. Curcumin Based Diazoles and Oxazoles with Potential Antibacterial Activities
912B. Baurhoo, C.A. Ruiz-Feria, X. Zhao 2008. Purified Lignin: Nutritional and Health Impacts on Farm Animals—A Review Animal Feed Science and Technology 144 (2008) 175–184
913Shin-Hee Kim, Cheng-i Wei 2007. Antibiotic Resistance and Caco-2 Cell Invasion of Pseudomonas aeruginosa Isolates from Farm Environments and Retail Products International Journal of Food Microbiology 115 (2007) 356–363
914Abdollah Ghasemi Pirbalouti, Parvin Jahanbazi, Shekoofeh Enteshari, Fatemeh Malekpoor, and Behzad Hamedi 2010. Antimicrobial Activity of Some Iranian Medicinal Plants Arch. Biol. Sci. 62 (3), 633-642
915Qun-Li Luo, Jing-Ya Li, Zhi-Ying Liu, Ling-Ling Chen, Jia Li, Zhen Qian, Qiang Shen, Yu Li, Gerald H. Lushington, Qi-Zhuang Ye, and Fa-Jun Nan 2003. Discovery and Structural Modification of Inhibitors of Methionine Aminopeptidases from Escherichia coli and Saccharomyces cerevisiae J. Med. Chem. 2003, 46, 2631-2640
916Ana Patrícia Serra Peyroteo Guedes 2009. Essential Oils from Plants and in Vitro Shoot Cultures of Hypericum androsaemum L., H. perforatum L. and H. undulatum Schousboe ex. Wild
917Tanja Lehtolainen 2004. Escherichia coli mastitis
Bacterial Factors and Host Response
918Cindy Chepngeno Korir 2004. Biochemical and Molecular Characterization of Streptococcus pneumoniae Strains Resistant to Beta-Lactam Antibiotics
919Mrs. Ifesan Beatrice Olawumi Temilade 2009. Effect of Eleutherine americana Merr. Extracts on Food Poisoning Staphylococcus aureus and Its Application in Food Systems
920Sung Jae Shin, Sang Gyun Kang, Rayamajhi Nabin, Mi Lan Kang, Han Sang Yoo 2005. Evaluation of the Antimicrobial Activity of Florfenicol against Bacteria Isolated from Bovine and Porcine Respiratory Disease Veterinary Microbiology 106 (2005) 73–77
921Pamela J. Burton, Clyde Thornsberry, Y. Cheung Yee, Jeffrey L. Watts, Robert J. Yancey, Jr. 1996. Interpretive Criteria for Antimicrobial Susceptibility Testing of Ceftiofur against Bacteria Associated with Swine Respiratory Disease J Vet Diagn Invest 8:464-468 (1996)
922P. Das, S. Mukherjee and R. Sen 2008. Antimicrobial Potential of a Lipopeptide Biosurfactant Derived from a Marine Bacillus circulans Journal of Applied Microbiology 104 (2008) 1675–1684
923Jorg Andra, Daniel Monreal, GuillermoMartinez de Tejada, Claudia Olak, Gerald Brezesinski, Susana Sanchez Gomez, Torsten Goldmann, Rainer Bartels, Klaus Brandenburg, and Ignacio Moriyon 2007. Rationale for the Design of Shortened Derivatives of the NK-lysin-derived Antimicrobial Peptide NK-2 with Improved Activity against Gram-negative Pathogens Journal of Biological Chemistry Vol. 282, No. 20, pp. 14719-14728
924Mariola Andrzejewska, Lilian Yepez-Mulia, Amparo Tapia, Roberto Cedillo-Rivera, Agnieszka E. Laudy, Bohdan J. Starosciak, Zygmunt Kazimierczuk 2004. Synthesis, and Antiprotozoal and Antibacterial Activities of S-substituted 4,6-dibromo- and 4,6-dichloro-2-mercaptobenzimidazoles European Journal of Pharmaceutical Sciences 21 (2004) 323–329
925Kaushiki Mazumdar, Kumkum Ganguly, K. Asok Kumar, N. K. Dutta, A. N. Chakrabarty, Sujata G. Dastidar 2003. Antimicrobial Potentiality of a New Non-Antibiotic: the Cardiovascular Drug Oxyfedrine Hydrochloride Microbiological Research (2003) 158, 259–264
926Isao Kubo, Ken-ichi Fujita, Aya Kubo, Ken-ichi Nihei, and Tetsuya Ogura 2004. Antibacterial Activity of Coriander Volatile Compounds against Salmonella choleraesuis J. Agric. Food Chem. 2004, 52, 3329-3332
927Ellen W. Evans, F. Gwen Beach, Kristi M. Moore, Mark W. Jackwood, John R. Glisson, Barry G. Harmon 1995. Antimicrobial Activity of Chicken and Turkey Heterophil Peptides CHP1, CHP2, THP1, and THP3 Veterinary Microbiology 47(1995) 295-303
928Kim A. Brogden, Gwen Nordholm, Mark Ackermann 2007. Antimicrobial Activity of Cathelicidins BMAP28, SMAP28, SMAP29, and PMAP23 against Pasteurella multocida is More Broad-Spectrum than Host Species Specific Veterinary Microbiology 119 (2007) 76–81
929Misagh Alipour, Majed Halwani, Abdelwahab Omri, Zacharias E. Suntres 2008. Antimicrobial Effectiveness of Liposomal Polymyxin B against Resistant Gram-negative Bacterial Strains International Journal of Pharmaceutics 355 (2008) 293–298
930M. Coulet, M. Van Borssum Waalkes, P. Cox and J. Lohuis 2002. In Vitro and In Vivo Pharmacodynamic Properties of the Fluoroquinolone Ibafloxacin J. vet. Pharmacol. Therap. 25, 401–411, 2002
931Maria Carbone, Maria Teresa Fera, Maria Grazia Pennisi, Marisa Masucci, Angela De Sarro, Concetta Macri 1999. Activity of Nine Fluoroquinolones against Strains of Bordetella bronchiseptica International Journal of Antimicrobial Agents 12(1999) 355-358
932M. Hernández-Pérez, R.M. Rabanal, A. Arias, M.C. de La Torre and B. Rodríguez 1999. Aethiopinone, an Antibacterial and Cytotoxic Agent from Salvia aethiopis Roots Pharmaceutical Biology 1999, Vol. 37, No. 1, pp. 17–21
933Barbara Orzeszko, Zygmunt Kazimierczuk, Jan Krzysztof Maurin, Agnieszka Ewa Laudy, Bohdan Jerzy Starosciak, Juhani Vilpo, Leena Vilpo, Jan Balzarini, Andrzej Orzeszko 2004. Novel Adamantylated Pyrimidines and Their Preliminary Biological Evaluations IL FARMACO 59 (2004) 929–937
934C. Prats, G. EL Korchi, M. Giralt, C. Cristofol, J. Pena, I. Zorrilla, J. Saborit and B. Perez 2005. PK and PK/PD of Doxycycline in Drinking Water after Therapeutic Use in Pigs J. vet. Pharmacol. Therap. 28, 525–530
935César Bustos, Jose L Del Pozo 2010. Emerging Agents to Combat Complicated and Resistant Infections: Focus on Ceftobiprole Infection and Drug Resistance 2010:3 5–14
936Krzysztof SZCZEPANOWICZ, Joanna STEFAŃSKA, Robert P. SOCHA, Piotr WARSZYŃSKI 2010. Preparation of Silver Nanoparticles Via Chemical Reduction and Their Antimicrobial Activity Physicochenical Problems of Mineral Processing 45:85-98
937Donald J. Bade, Ellen S. Portis, Caroline Keane, John Hallberg, Lawrence Bryson, Mike Sweeney, Pamela L. Boner 2009. In Vitro Susceptibility of Ceftiofur Against Streptococcus equi subsp zooepidemicus and subsp equi Isolated From HorsesWith Lower Respiratory Disease in Europe Since 2002 Veterinary Therapeutics Vol. 10, No. 4, E1-E10
938Rebecca L. Penland, M(ASCP); Kirk R. Wilhelmus, MD 1996. Stenotrophomonas maltophilia Ocular Infections Arch Ophthalmol 1996; 114: 433-436
939Zygmunt Kazimierczuk, Malgorzata Chalimoniuk, Agnieszka Ewa Laudy, Rosa Moo-Puc, Roberto Cedillo-Rivera, Bohdan Jerzy Starosciak, and Stanislaw J. Chrapusta 2010. Synthesis and Antimicrobial and Nitric Oxide Synthase Inhibitory Activities of Novel Isothiourea Derivatives Archives of Pharmacal Research Vol 33, No 6, 821-830
940W. David Wilson, BVMS, MRCVS, MS 2001. Rational Selection of Antimicrobials for Use in Horses AAEP Proceedings Vol. 47, 75-93
941Jonathan Santas, Marıa Pilar Almajano & Rosa Carbo 2010. Antimicrobial and Antioxidant Activity of Crude Onion (Allium cepa, L.) Extracts International Journal of Food Science and Technology 2010, 45, 403–409
942R. A. Stein, R. M. Goetz, G. M. Ganea 2009. Ceftobiprole: a New β-lactam Antibiotic Clinical Practice June 2009, 63, 6, 930–943
943Jose A. Castillo, M. Rosa Infante, Angels Manresa, M. Pilar Vinardell, Montserrat Mitjans, and Pere Clapes 2006. Chemoenzymatic Synthesis and Antimicrobial and Haemolytic Activities of Amphiphilic Bis(phenylacetylarginine) Derivatives ChemMedChem 2006, 1, 1091 – 1098
944Piotr Przybylski, Krystian Pyta, Joanna Stefanska, Ma1gorzata Ratajczak-Sitarz, Andrzej Katrusiak, Adam Huczynski, Bogumil Brzezinski 2009. Synthesis, Crystal Structures and Antibacterial Activity Studies of Aza-Derivatives of Phytoalexin from Cotton Plant – Gossypol European Journal of Medicinal Chemistry 44 (2009) 4393–4403
945Ana M. Carmona-Ribeiro, Débora B. Vieira and Nilton Lincopan 2006. Cationic Surfactants and Lipids as Anti-Infective Agents Anti-Infective Agents in Medicinal Chemistry 2006, 5, 33-54
946Dawn Merton Boothe, DVM, PhD, DACVIM, DACVCP 2010. Interpreting Culture and susceptibility data in critical Care: Perks and Pitfalls Journal of Veterinary Emergency and Critical Care 20(1):110–131
947Daniel TW Chu 1999. Recent Developments in Macrolides and Ketolides Current Opinion in Microbiology 1999, 2:467–474
948Christopher S Shain and Guy W Amsden 2002. Telithromycin: The First of the Ketolides Ann Pharmacother 36:452-64
949Franco Chimenti, Bruna Bizzarri, Adriana Bolasco, Daniela Secci, Paola Chimenti, Simone Carradori, Arianna Granese, Daniela Rivanera, Daniela Lilli, Alessandra Zicari, M. Maddalena Scaltrito and Francesca Sisto 2007. A Novel Class of Selective Anti-Helicobacter pylori Agents 2-oxo-2H-chromene-3-carboxamide Derivatives Bioorganic & Medicinal Chemistry Letters 17 (2007) 3065–3071
950George G Zhanel & Daryl J Hoban 2002. Ketolides in the Treatment of Respiratory Infections Expert Opin. Pharmacother. (2002) 3(3):277-297
951Kerry L. Tomlin, Scott R.D. Clark, Howard Ceri 2004. Green and Red Fluorescent Protein Vectors for Use in Biofilm Studies of the Intrinsically Resistant Burkholderia cepacia Complex Journal of Microbiological Methods 57 (2004) 95– 106
952Masakatsu Tsuji, Yoshikazu Ishii, Akira Ohno, Shuichi Miyazaki, and Keizo Yamaguchi 1998. In Vitro and In Vivo Antibacterial Activities of S-4661, a New Carbapenem Antimicrobial Agents and Chemotherapy Vol. 42, No. 1, p. 94–99
953Lisbeth Truelstrup Hansen, John W. Austin, Tom A. Gill 2001. Antibacterial Effect of Protamine in Combination with EDTA and Refrigeration International Journal of Food Microbiology 66(2001) 149–161
954George G. Zhanel, Aleksandra K. Wierzbowski, Tamiko Hisanaga, and Daryl J. Hoban 2004. The Use of Ketolides in Treatment of Upper Respiratory Tract Infections Current Infectious Disease Reports 2004, 6:191–199
955Dong-Hyeon Kwon and Chung-Dar Lu 2007. Polyamine Effects on Antibiotic Susceptibility in Bacteria Antimicrobial Agents and Chemotherapy June 2007, p. 2070–2077
956Meyer S Balter MD FRCPC, Jacques La Forge MD FRCPC CSPQ, Donald E Low MD FRCPC, Lionel Mandell MD FRCPC, Ronald F Grossman MD FRCPC FACP and the Chronic Bronchitis Working Group on behalf of the Canadian Thoracic Society and the Canadian Infectious Disease Society 2003. Canadian Guidelines for the Management of Acute Exacerbations of Chronic Bronchitis Canadian Respiratory Journal 10(Suppl B):3B-32B
957Hanna Billstrom 2008. Molecular Epidemiology of Clinical Enterococcus faecium
958C.M. Bebear, H. Renaudin, A. Bryskier, and C. Bebear 2000. Comparative Activities of Telithromycin (HMR 3647), Levofloxacin, and Other Antimicrobial Agents against Human Mycoplasmas Antimicrobial Agents and Chemotherapy July 2000, p. 1980–1982
959Zahid H. Chohan, & Claudiu T. Supuran 2005. In-Vitro Antibacterial and Cytotoxic Activity of Cobalt (ii), Copper (ii), Nickel (ii) and Zinc (ii) Complexes of the Antibiotic Drug Cephalothin (Keflin) Journal of Enzyme Inhibition and Medicinal Chemistry 20(5): 463–468
960Supaluk Prachayasittikul, Saowapa Suphapong, Apilak Worachartcheewan, Ratana Lawung, Somsak Ruchirawat and Virapong Prachayasittikul 2009. Bioactive Metabolites from Spilanthes acmella Murr. Molecules 2009, 14, 850-867
961J. Spížek . T. Řezanka 2004. Lincomycin, Clindamycin and Their Applications Appl Microbiol Biotechnol (2004) 64: 455–464
962Saeed U. Rehman, Zahid H. Chohan, Farzana Gulnaz, & Claudiu T. Supuran 2005. In-Vitro Antibacterial, Antifungal and Cytotoxic Activities of Some Coumarins and Their Metal Complexes Journal of Enzyme Inhibition and Medicinal Chemistry 20(4); 333-340
963Keizo Yamaguchi 2001. Evaluation of in-vitro and in-vivo Antibacterial Activity of Tosufloxacin Tosilate Journal of Infection and Chemotherapy 7:205–217
964Shaheen Faizi, Rashid Ali Khan, Najma Rasool Mughal, Mariam Shafique Malik, Kaneez-e-Sayyeda Sajjadi and Aqeel Ahmad 2008. Antimicrobial Activity of Various Parts of Polyalthia longifolia var. pendula: Isolation of Active Principles from the Leaves and the Berries Phytotherapy Research 22:907–912
965G. Funke, C. Nietznik 2005. Minimal Inhibitory Concentrations of Linezolid against Clinical Isolates of Coryneform Bacteria European Journal of Clinical Microbiology & Infectious Diseases 24:612–614
966Vijaya Manohar, Cass Ingram, Judy Gray, Nadeem A. Talpur, Bobby W. Echard, Debasis Bagchi, and Harry G. Preuss 2001. Antifungal Activities of Origanum Oil against Candida albicans Molecular and Cellular Biochemistry 228: 111–117, 2001
967Thipamon Patharakorn, Teerakul Arpornsuwan, Nuanchawee Wetprasit, Amornrat Promboon and Sunanta Ratanapo 2010. Antibacterial Activity and Cytotoxicity of the Leaf Essential Oil of Morus rotunbiloba Koidz Journal of Medicinal Plants Research 4(9):837-843
968Alapati Kavitha, Peddikotla Prabhakar, Manchala Narasimhulu, Muvva Vijayalakshmi, Yenamandra Venkateswarlu, Karanam Venkateswara Rao, Venkata Balaraju Subba Raju 2010. Isolation, Characterization and Biological Evaluation of Bioactive Metabolites from Nocardia levis MK-VL_113 Microbiological Research 165 (2010):199—210
969Supaluk Prachayasittikul, Prasit Buraparuangsang, Apilak Worachartcheewan, Chartchalerm Isarankura-Na-Ayudhya, Somsak Ruchirawat and Virapong Prachayasittikul 2008. Antimicrobial and Antioxidative Activities of Bioactive Constituents from Hydnophytum formicarum Jack Molecules 13:904-921
970Supaluk Prachayasittikul, Orapin Wongsawatkul, Thummaruk Suksrichavalit, Somsak Ruchirawat, Virapong Prachayasittikul 2010. Bioactivity Evaluation of Eclipta prostrata Linn: A Potential Vasorelaxant European Journal of Scientific Research Vol.44 No.2 (2010), pp.167-176
971Supaluk Prachayasittikul, Puttirat Saraban, Rungrot Cherdtrakulkiat, Somsak Ruchirawat, Virapong Prachayasittikul 2010. New Bioactive Triterpenoids and Antimalarial Activity of Diospyros rubra Lec. EXCLI Journal 2010;9:1-10
972Syed Mohammad Khalid, Shakeel Ahmad Khan, Muhammad Arif, Shoana Shafiq and Zafar Saeed Saify 1992. In Vitro Antibacterial Studies of Some Newly Synthesized Phenacyl-thiosemicarbazones Pakistan Journal of Pharmaceutical Sciences 5(2):161-166
973Mustafa Oskay, Dilek Oskay and Fatih Kalyoncu 2009. Activity of Some Plant Extracts Against Multi-Drug Resistant Human Pathogens Iranian Journal of Pharmaceutical Research 8 (4):293-300
974Supaluk Prachayasittikul, Patumporn Manam, Maneekarn Chinworrungsee, Chartchalerm Isarankura-Na-Ayudhya, Somsak Ruchirawat and Virapong Prachayasittikul 2009. Bioactive Azafluorenone Alkaloids from Polyalthia debilis (Pierre) Finet & Gagnep Molecules 14:4414-4424
975Supaluk Prachayasittikul, Ketkaew Buttrawong, Apilak Worachartcheewan, Somsak Ruchirawat, Virapong Prachayasittikul 2009. Isolation of Bioactive Metabolites from Root Extracts of Polyalthia Debilis European Journal of Scientific Research 596-603
976Zahid H. Chohan, Claudiu T. Supuran 2006. Metalloantibiotics: Synthesis, Characterization and In-vitro Antibacterial Studies on Cobalt (II), Copper (II), Nickel (II) and Zinc (II) Complexes with Cloxacillin Journal of Enzyme Inhibition and Medicinal Chemistry 21(4): 441–448
977Keun Hyeung LEE, Sung Yu HONG, Jong Eun OH, Mi yun KWON, Jeong Hyeok YOON, Ji hye LEE, Bok Luel LEE and Hong Mo MOON 1998. Identification and Characterization of the Antimicrobial Peptide Corresponding to C-terminal b-sheet Domain of Tenecin 1, an Antibacterial Protein of Larvae of Tenebrio molitor Biochemistry Journal 334:99-105
978Katy V. Newell, Derek P. Thomas, Dimitris Brekasis and Mark S. B. Paget 2006. The RNA Polymerase-binding Protein RbpA Confers Basal Levels of Rifampicin Resistance on Streptomyces coelicolor Molecular Microbiology 60(3):687-696
979Jan Heeres, Lieven Meerpoel, and Paul Lewi 2010. Conazoles Molecules 2010, 15, 4129-4188
980Mathieu Ballouche, Pierre Cornelis and Christine Baysse 2009. Iron Metabolism: A Promising Target for Antibacterial Strategies Recent Patents on Anti-Infective Drug Discovery 4:190-205
981Zoe Heather, Matthew T. G. Holden, Karen F. Steward, Julian Parkhill, Lijiang Song, Gregory L. Challis, Carl Robinson, Nicholas Davis-Poynter and Andrew S. Waller 2008. A Novel Streptococcal Integrative Conjugative Element Involved in Iron Acquisition Molecular Microbiology (2008) 70(5), 1274–1292
982Tomás Rezanka, Jaroslav Spízek and Karel Sigler 2007. Medicinal Use of Lincosamides and Microbial Resistance to Them Anti-Infective Agents in Medicinal Chemistry 6:133-144
983Lo´ ra´ nt Hatvani, La´ szlo´ Manczinger, La´ szlo´ Kredics, Andra´ s Szekeres, Zsuzsanna Antal and Csaba Va´gvo¨ lgyi 2006. Production of Trichoderma Strains with Pesticide-polyresistance by Mutagenesis and Protoplast Fusion Antonie van Leeuwenhoek 89:387–393
984Ioannis Stergiopoulos, Johannes GM van Nistelrooy, Gert HJ Kema and Maarten A De Waard 2003. Multiple Mechanisms Account for Variation in Base-line Sensitivity to Azole Fungicides in Field Isolates of Mycosphaerella graminicola Pest Management Science 59:1333–1343
985A. M Sridhara, K. R Venugopala Reddy, K. R Venugopala Reddy, B. Chidananda, Yaragola Prasad, G. Satish Kumar, S.G. Vadiraj, Prosenjit Bose, Sanath Kumar Goud, S.K.Peethambar 2010. Synthesis and Antimicrobial Activity of Phthalazine Substituted 1,2,4-triazolo- [3,4-b]-1,3,4-thiadiazoles A-and 7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines Der Pharma Chemica 2(5):201-211
986Mario Schirra, Salvatore D’AQUINO, Amedeo Palma, Salvatore Marceddu, Alberto Angioni, Paolo Cabras, Barbara Scherm, and Quirico Migheli 2005. Residue Level, Persistence, and Storage Performance of Citrus Fruit Treated with Fludioxonil Journal of Agricultural And Food Chemistry 53:6718-6724
987S.W. Son, H.Y. Kim, G.J. Choi, G.J. Choi, K.S. Jang, S.O. Lee, S. Lee, N.D. Sung and J.-C. Kim 2008. Bikaverin and Fusaric Acid from Fusarium oxysporum Show Antioomycete Activity against Phytophthora infestans Journal of Applied Microbiology 104 (2008):692–698
988Hans-Peter Lipp 2010. Clinical Pharmacodynamics and Pharmacokinetics of the Antifungal Extended-Spectrum Triazole Posaconazole: an Overview British Journal of Clinical Pharmacology 70:4, 471–480
989D. Jagadeesh Prasad, Mithun Ashok, Prakash Karegoudar, Boja Poojary,B. Shivarama Holla, Nalilu Sucheta Kumari 2009. Synthesis and Antimicrobial Activities of Some New Triazolothiadiazoles Bearing 4-methylthiobenzyl Moiety European Journal of Medicinal Chemistry 44 (2009):551-557
990S. Karuppusamy and K.M. Rajasekaran 2009. High Throughput Antibacterial Screening of Plant Extracts by Resazurin Redox with Special Reference to Medicinal Plants of Western Ghats Global Journal of Pharmacology 3 (2): 63-68, 2009
991I. Orhan, B. Sener, T. Atici and P. Palittapongarnpim 2002. In Vitro Antimycobacterial Potential of Some Fresh-water Macroalgae and Aqueous Plants Pharmaceutical Biology 2002, Vol. 40, No. 8, pp. 568-569
992Doris Lechner, Simon Gibbons, Franz Bucar 2008. Modulation of Isoniazid Susceptibility by Flavonoids in Mycobacterium Phytochemistry Letters 1 (2008) 71–75
993Michael J. Pucci, Maria Ackerman, Jane A. Thanassi, Carolyn M. Shoen, and Michael H. Cynamon 2010. In Vitro Antituberculosis Activities of ACH-702, a Novel Isothiazoloquinolone, against Quinolone-Susceptible and Quinolone-Resistant Isolates Antimicrobial Agents and Chemotherapy Aug. 2010, p. 3478–3480
994Andre Bryskier, John Lowther 2002. Fluoroquinolones and Tuberculosis Expert Opin. Investig. Drugs (2002) 11(2): 233-258
995Nageshwar R. Budha, Richard E. Lee and Bernd Meibohm 2008. Biopharmaceutics, Pharmacokinetics and Pharmacodynamics of Antituberculosis Drugs Current Medicinal Chemistry 2008, 15, 809-825
996M. Analise Zaunbrecher, R. David Sikes, Jr., Beverly Metchock, Thomas M. Shinnick, and James E. Posey 2009. Overexpression of the Chromosomally Encoded Aminoglycoside Acetyltransferase eis Confers Kanamycin Resistance in Mycobacterium tuberculosis PNAS Vol. 106, No. 47, 20004–20009
997Sapna K. Deo and Sylvia Daunert 2001. Luminescent Proteins from Aequorea victoria: Applications in Drug Discovery and in High Throughput Analysis Fresenius J Anal Chem (2001) 369 :258–266
998Arvind S. Negi, Jonnala K. Kumar, Suaib Luqman, Dharmendra Saikia, and Suman P.S. Khanuja 2010. Antitubercular Potential of Plants: A Brief Account of Some Important Molecules Medicinal Research Reviews Vol. 30, No. 4, 603--645, 2010
999Julien Poissy, Alexandra Aubry, Christine Fernandez, Marie-Catherine Lott, Aurelie Chauffour, Vincent Jarlier, Robert Farinotti, and Nicolas Veziris 2010. Should Moxifloxacin Be Used for the Treatment of Extensively Drug-Resistant Tuberculosis? An Answer from a Murine Model Antimicrobial Agents and Chemotherapy Nov. 2010, p. 4765–4771
1000Leszek Guz and Alicja Kozinska 2004. Antibiotic Susceptibility of Aeromonas hydrophila and A. sobria Isolated from Farmed Carp (Cyprinus Carpio L.) Bull Vet Inst Pulawy 48, 391-395, 2004
1001Nina M. Haste, Lauge Farnaes, Varahenage R. Perera, William Fenical, Victor Nizet and Mary E. Hensler 2011. Bactericidal Kinetics of Marine-Derived Napyradiomycins against Contemporary Methicillin-Resistant Staphylococcus aureus Marine Drugs 2011, 9, 680-689
1002Sunday Akidarju Mamza, Godwin Onyemaechi Egwu & Gideon Dauda Mshelia 2010. Beta‐Lactamase Escherichia coli and Staphylococcus aureus Isolated from Chickens in Nigeria Veterinaria Italiana 46 (2), 155‐165
1003David D. Boehr, Paul R. Thompson, and Gerard D. Wright 2001. Molecular Mechanism of Aminoglycoside Antibiotic Kinase APH(3')-IIIa The Journal of Biological Chemistry Vol. 276, No. 26, Issue of June 29, pp. 23929–23936
1004Xie Xianfei, Cai Xiaoqiang, Zhu Shunying, Zou Guolin 2007. Chemical Composition and Antimicrobial Activity of Essential Oils of Chaenomeles speciosa from China Food Chemistry 100 (2007) 1312–1315
1005Lilach Chen, Mariana Hainrichson, Dmitry Bourdetsky, Amram Mor, Sima Yaron, Timor Baasov 2008. Structure–Toxicity Relationship of Aminoglycosides: Correlation of 20-Amine Basicity with Acute Toxicity in Pseudo-Disaccharide Scaffolds Bioorganic & Medicinal Chemistry 16 (2008) 8940–8951
1006Celia García, Estibaliz Ugalde, Idoia Monteagudo, Ana Saez, Jesús Agüero, Luis Martinez-Martinez, Eduardo Miñambres 2007. Isolation of Mycoplasma hominis in Critically Ill Patients with Pulmonary Infections: Clinical and Microbiological Analysis in an Intensive Care Unit Intensive Care Med (2007) 33:143–147
1007Chinnaswamy Jagannath, Martin R. Emanuele, Robert L. Hunter 2000. Activity of Poloxamer CRL-1072 against Drug-Sensitive and Resistant Strains of Mycobacterium tuberculosis in Macrophages and in Mice International Journal of Antimicrobial Agents 15 (2000) 55–63
1008Andrew M. Bailey, Ian T. Paulsen, and Laura J. V. Piddock 2008. RamA Confers Multidrug Resistance in Salmonella enterica via Increased Expression of acrB, Which Is Inhibited by Chlorpromazine Antimicrobial Agents and Chemotherapy Oct. 2008, p. 3604–3611
1009M. Drago . M. M. Scaltrito . G. Morace . GISIA-2 Group 2004. In Vitro Activity of Voriconazole and Other Antifungal Agents against Clinical Isolates of Candida glabrata and Candida krusei Eur J Clin Microbiol Infect Dis (2004) 23: 619–624
1010Susan L. Pendland, Jennifer L. Prause, Melinda M. Neuhauser, Nicole Boyea, Jodi M. Hackleman, and Larry H. Danziger 2000. In Vitro Activities of a New Ketolide, ABT-773, Alone and in Combination with Amoxicillin, Metronidazole, or Tetracycline against Helicobacter pylori Antimicrobial Agents and Chemotherapy Sept. 2000, p. 2518–2520
1011M Behnia, A Haghighi, H Komeilizadeh, SJ Seyyed Tabaei, A Abadi 2008. In Vitro Antiamoebic Activity of Iranian Allium sativum in Comparison With Metronidazole against Entamoeba histolytica Iranian J Parasitol Vol. 3, No.4, 2008, pp. 32-38
1012Shilpakala Sainath Rao, Raghavachari Raghunathan, Ramesh Ekambaram, Malathi Raghunathan 2009. In Vitro Activities of the Newly Synthesised ER-2 against Clinical Isolates of Mycobacterium tuberculosis Susceptible or Resistant to Antituberculosis Drugs International Journal of Antimicrobial Agents 34 (2009) 451–453
1013Denis A. Mitchison, and Geraint R. Davies 2008. Assessment of the Efficacy of New Anti-Tuberculosis Drugs The Open Infectious Diseases Journal 2008, 2, 59-76
1014Lin Ma, Lingyun Yang, Yun Liu, Guanying Shi, Congjun Yang, Chunyu Zhou, Weichang Xu, Ke Tao, Taiping Hou 2010. Microbial Transformation of Neomycin by a Mutant of Neomycin-Producing Streptomyces fradiae African Journal of Biotechnology Vol. 9(49), pp. 8445-8453, 6 December, 2010
1015W John Looney, Masashi Narita, Kathrin Mühlemann 2009. Stenotrophomonas maltophilia: an Emerging Opportunist Human Pathogen Lancet Infect Dis 2009, Vol. 9, 312–323
1016Leena Gupta, Naresh Sunduru, Aditya Verma, Saumya Srivastava, Suman Gupta, Neena Goyal, Prem M.S. Chauhan 2010. Synthesis and Biological Evaluation of New [1,2,4]triazino[5,6-b] indol-3-ylthio-1,3,5-triazines and [1,2,4]triazino[5,6-b]indol-3-ylthio-pyrimidines against Leishmania donovani European Journal of Medicinal Chemistry 45 (2010) 2359-2365
1017Shailendra Singh, Neelam Bharti, and Prabhu P. Mohapatra 2009. Chemistry and Biology of Synthetic and Naturally Occurring Antiamoebic Agents Chemical Reviews 2009, 109, 1900–1947
1018N. M. Bolder, J. A. Wagenaar, F. F. Putirulan, K. T. Veldman, and M. Sommer 1999. The Effect of Flavophospholipol (Flavomycin) and Salinomycin Sodium (Sacox) on the Excretion of Clostridium perfringens, Salmonella enteritidis, and Campylobacter jejuni in Broilers After Experimental Infection Poultry Science 78:1681–1689
1019Jae Kyung Sohng, Tokutaro Yamaguchi, Chi Nam Seong, Keun Sik Baik, Seong Chan Park, Hyo Jeong Lee, So Young Jang, Jaya Ram Simkhada, and Jin Cheol Yoo 2008. Production, Isolation and Biological Activity of Nargenicin from Nocardia sp. CS682 Arch Pharm Res Vol 31, No 10, 1339-1345, 2008
1020Kithsiri Herath, Guy Harris, Hiranthi Jayasuriya, Deborah Zink, Scott Smith, Francisca Vicente, Gerald Bills, Javier Collado, Antonio González, Bo Jiang, Jennifer Nielsen Kahn, Stefan Galuska, Robert Giacobbe, George Abruzzo, Emily Hickey, Paul Liberator, Deming Xu, Terry Roemer, Sheo B. Singh 2009. Isolation, Structure and Biological Activity of Phomafungin, a Cyclic Lipodepsipeptide from a Widespread Tropical Phoma sp. Bioorganic & Medicinal Chemistry 17 (2009) 1361–1369
1021Adam Huczynski, Joanna Stefanska, Piotr Przybylski, Bogumil Brzezinski, and Franz Bartl 2008. Synthesis and Antimicrobial Properties of Monensin A Esters Bioorganic & Medicinal Chemistry Letters 18 (2008) 2585–2589
1022V. R. Fajt, M. D. Apley, J. A. Roth, D. E. Frank, K. A. Brogden, T. L. Skogerboe, V. K. Shostrom, Y. L. Chin 2003. The Effects of Danofloxacin and Tilmicosin on Neutrophil Function and Lung Consolidation in Beef Heifer Calves with Induced Pasteurella (Mannheimia) haemolytica pneumonia J. vet. Pharmacol. Therap. 26, 173–179, 2003.
1023Kunikazu Yamane, Jun-ichi Wachino, Satowa Suzuki, Kouji Kimura, Naohiro Shibata, Haru Kato, Keigo Shibayama, Toshifumi Konda, and Yoshichika Arakawa 2007. New Plasmid-Mediated Fluoroquinolone Efflux Pump, QepA, Found in an Escherichia coli Clinical Isolate Antimicrobial Agents and Chemotherapy Sept. 2007, p. 3354–3360
1024E. Salvucci, E.M. Hebert, F. Sesma and L. Saavedra 2010. Combined Effect of Synthetic Enterocin CRL35 with Cell Wall, Membrane-Acting Antibiotics and Muranolytic Enzymes against Listeria Cells Letters in Applied Microbiology 51 (2010) 191–195
1025Daniel Lowicki, Adam Huczynski, Joanna Stefanska, Bogumil Brzezinski 2010. Structural Characterization and Antibacterial Activity against Clinical Isolates of Staphylococcus of N-phenylamide of Monensin A and Its 1:1 Complexes with Monovalent Cations European Journal of Medicinal Chemistry 45 (2010) 4050-4057
1026Do Kyung Lee, Yuna Kim, Kun Sup Park, Jae Wook Yang, Kyungjae Kim and Nam Joo Ha 2007. Antimicrobial Activity of Mupirocin, Daptomycin, Linezolid, Quinupristin/Dalfopristin and Tigecycline against Vancomycin-Resistant Enterococci (VRE) from Clinical Isolates in Korea (1998 and 2005) Journal of Biochemistry and Molecular Biology Vol. 40, No. 6, November 2007, pp. 881-887
1027Jun Lin, Teddi Wolff, Alan Erickson, David Francis 2009. Effect of Bacitracin on Tetracycline Resistance in Escherichia coli and Salmonella Veterinary Microbiology 138 (2009) 353–360
1028Virginie Zarrouk, Bulent Bozdogan, Roland Leclercq, Louis Garry, Claude Carbon, and Bruno Fantin 2000. Influence of Resistance to Streptogramin A Type Antibiotics on the Activity of Quinupristin-Dalfopristin In Vitro and in Experimental Endocarditis Due to Staphylococcus aureus Antimicrobial Agents and Chemotherapy May 2000, p. 1168–1173
1029Tarja Suomalainen, Pia Sigvart-Mattila, Jaana Matto, Soile Tynkkynen 2008. In Vitro and In Vivo Gastrointestinal Survival, Antibiotic Susceptibility and Genetic Identification of Propionibacterium freudenreichii ssp. shermanii JS International Dairy Journal 18 (2008) 271–278
1030A. Kojima, A. Morioka, M. Kijima, K. Ishihara, T. Asai, T. Fujisawa, Y. Tamura, and T. Takahashi 2010. Classification and Antimicrobial Susceptibilities of Enterococcus Species Isolated from Apparently Healthy Food-Producing Animals in Japan Zoonoses and Public Health 57 (2010) 137–141
1031Brit Aase, Gunhild Sundheim, Solveig Langsrud, Liv Marit Rørvik 2000. Occurrence of and a Possible Mechanism for Resistance to a Quaternary Ammonium Compound in Listeria monocytogenes International Journal of Food Microbiology 62 (2000) 57–63
1032Jurg Dreier, Eva Amantea, Laurenz Kellenberger, and Malcolm G. P. Page 2007. Activity of the Novel Macrolide BAL19403 against Ribosomes from Erythromycin-Resistant Propionibacterium acnes Antimicrobial Agents and Chemotherapy Dec. 2007, p. 4361–4365
1033Azmi Johari Saiful, Mohtar Mastura, Suhaili Zarizal, Mohamed Isa Mazurah, Mustafa Shuhaimi and Abdul Manaf Ali 2008. Efflux Genes and Active Efflux Activity Detection in Malaysian Clinical Isolates of Methicillin-Resistant
Staphylococcus aureus (MRSA) Journal of Basic Microbiology 2008, 48, 245–251
1034Noel J. de Souza, Shrikant V. Gupte, Prasad K. Deshpande, Vijaya N. Desai, Satish B. Bhawsar, Ravindra D. Yeole, Milind C. Shukla, Jacob Strahilevitz, David C. Hooper, Bulent Bozdogan, Peter C. Appelbaum, Michael R. Jacobs, Nitin Shetty, Mahesh V. Patel, Rasendrakumar Jha, and Habil F. Khorakiwala 2005. A Chiral Benzoquinolizine-2-carboxylic Acid Arginine Salt Active against Vancomycin-Resistant Staphylococcus aureus J. Med. Chem. 2005, 48, 5232-5242
1035Jacek Lewicki 0. Tylosin: A Review of Pharmacokinetics, Residues in Food Animals and Analytical Methods
1036Jenni Korhonen 2010. Antibiotic Resistance of Lactic Acid Bacteria Dissertations in Forestry and Natural Sciences
1037Sheng Chen 2004. Characterization and Molecular Mechanisms of Antimicrobial Resistance in Foodborne Pathogens
1038E.A. Christensen, K. Joho and K.R. Matthews 2008. Streptogramin Resistance Patterns and Virulence Determinants in Vancomycin-Susceptible Enterococci
Isolated from Multi-Component Deli Salads Journal of Applied Microbiology 104 (2008) 1260–1265
1039Gregor Blaha, Güliz Gürel, Susan J. Schroeder, Peter B. Moore and Thomas A. Steitz 2008. Mutations Outside the Anisomycin-Binding Site Can Make Ribosomes Drug-Resistant J. Mol. Biol. (2008) 379, 505–519
1040Nigel A. Evans, MA, PhD 2005. Tulathromycin: An Overview of a New Triamilide Antimicrobial for Livestock Respiratory Disease Veterinary Therapeutics Vol. 6, No. 2, Summer 2005
1041Manon Paradis, L. Abbey, B. Baker, M. Coyne, M. Hannigan, D. Joffe, B. Pukay, A. Trettien, S. Waisglass and J. Wellington 2001. Evaluation of the Clinical Efficacy of Marbofloxacin(Zeniquin) Tablets for the Treatment of Canine Pyoderma: an Open Clinical Trial Veterinary Dermatology 2001, 12, 163-169
1042K. L. Carlson, K. R. Kuskie, M. K. Chaffin, M. C. Libal, S. Giguère, S. D. Lawhon, and N. D. Cohen 2010. Antimicrobial Activity of Tulathromycin and 14 Other Antimicrobials Against Virulent Rhodococcus
equi In Vitro Veterinary Therapeutics Vol. 11, No. 2, Summer 2010
1043Michael T. Sweeney, Gordon W. Brumbaugh, Jeffrey L. Watts 2008. In Vitro Activities of Tulathromycin and Ceftiofur Combined with Other Antimicrobial Agents Using
Bovine Pasteurella multocida and Mannheimia haemolytica Isolates Veterinary Therapeutics Vol. 9, No. 3, Fall 2008
1044Joseph M. Blondeau 2009. New Concepts in Antimicrobial Susceptibility Testing: the Mutant Prevention Concentration and Mutant Selection Window Approach Veterinary Dermatology 20, 383–396.
1045Axel Dalhoff, Will Stubbings, and Sabine Schubert 2011. Comparative In Vitro Activities of the Novel Antibacterial Finafloxacin against Selected Gram-Positive and Gram-Negative Bacteria Tested in Mueller-Hinton Broth and Synthetic Urine Antimicrobial Agents and Chemotherapy Apr. 2011, p. 1814–1818
1046Thomas Lila, Thomas E. Renau, Lori Wilson, Jay Philips, Georges Natsoulis, M. Jamie Cope, William J. Watkins, and Jerry Buysse 2003. Molecular Basis for Fungal Selectivity of Novel Antimitotic Compounds Antimicrobial Agents and Chemotherapy July 2003, p. 2273–2282
1047F. E. Goda, A. R. Maarouf and E. R. EL-Bendary 2003. Synthesis and Antimicrobial Evaluation of New Isoxazole and Pyrazole Derivatives Saudi Pharmaceutical Journal Vol. 11, No. 3, July 2003
1048David A. Stevens 2000. Drug Interaction Studies of a Glucan Synthase Inhibitor (LY 303366) and a Chitin Synthase Inhibitor (Nikkomycin Z) for Inhibition and Killing of Fungal Pathogens Antimicrobial Agents and Chemotherapy Sept. 2000, p. 2547–2548
1049George P. Nora, B.S., M.S. 2007. The Synthesis and In Vitro Testing of Structrally Novel Isoxazolidine Antibacterial Agents Via an Acylnitroso Diels-Alder Reaction
1050Anthony J De Lucca 2000. Antifungal Peptides: Potential Candidates for the Treatment of Fungal Infections Exp. Opin. Invest. Drugs (2000) 9(2):273-299
1051Elizabeth A. Stone, PharmD, Horatio B. Fung, PharmD, BCPS, and Harold L. Kirschenbaum, MS, PharmD 2002. Caspofungin: An Echinocandin Antifungal Agent Clinical Therapeutics Vol. 24, No. 3, 2002
1052A.J. De Lucca, T.E. Cleveland, and D.E. Wedge 2005. Plant-Derived Antifungal Proteins and Peptides Can. J. Microbiol. 51: 1001–1014 (2005)
1053Xiaoli Liu, Mouming Zhao, Jinshui Wang and Wei Luo 2009. Antimicrobial and Antioxidant Activity of Emblica Extracts Obtained by Supercritical Carbon Dioxide Extraction and Methanol Extraction Journal of Food Biochemistry 33 (2009) 307–330.
1054Fatma E. Goda and Farid A Badria 2005. Synthesis and Biological Evaluation of Certain New Substituted Pyrido[2,3-d]Pyrimidin-4(1H)-One and Pyrido[2,3-d]Triazolo[3,4-b]Pyrimidine Analogs Saudi Pharmaceutical Journal Vol. 13, No. 2-3 April-July 2005
1055Oliver Hendricks 2006. Antimicrobial Effects of selected Non-antibiotics on Sensitivity and Invasion of Gram-positive Bacteria
1056Jing Li, Jing Dong, Jia-Zhang Qiu, Jian-Feng Wang, Ming-Jing Luo, Hong-En Li, Bing-Feng Leng, Wen-Zhi Ren and Xu-Ming Deng 2011. Peppermint Oil Decreases the Production of Virulence- Associated Exoproteins by Staphylococcus aureus Molecules 16: 1642-1654
1057Eric V. Stabb and Jo Handelsman 1998. Genetic Analysis of Zwittermicin A Resistance in Escherichia coli : Effects on Membrane Potential and RNA Polymerase Molecular Microbiology (1998) 27(2), 311–322
1058V. Padmavathi, K. Mahesh, G. Dinneswara Reddy, A. Padmaja 2010. Synthesis and Bioassay of Pyrrolyl Oxazolines and Thiazolines European Journal of Medicinal Chemistry 45 (2010) 3178-3183
1059Pier Giovanni Baraldi, Maria Giovanna Pavani, Maria del Carmen Nunez, Patrizia Brigidi, Beatrice Vitali, Roberto Gambari and Romeo Romagnoli 2002. Antimicrobial and Antitumor Activity of N-Heteroimmine-1,2,3- dithiazoles and Their Transformation in Triazolo-, Imidazo-, and Pyrazolopirimidines Bioorganic & Medicinal Chemistry 10 (2002) 449–456
1060Yigong Ge, Stacey Difuntorum, Sofia Touami, Ian Critchley, Roland Burli, Vernon Jiang, Ken Drazan, and Heinz Moser 2002. In Vitro Antimicrobial Activity of GSQ1530, a New Heteroaromatic Polycyclic Compound Antimicrobial Agents and Chemotherapy Oct. 2002, p. 3168–3174
1061Natarajan Raman, Arumugam Sakthivel, Ramaraj Jeyamurugan 2010. Synthesis, Characterization and Biological Activities of Homo-binuclear Cu(II) and Zn(II) Complexes Derived from 2-hydroxy-5-methyl-1,3- benzenedicarboxaldehyde Derivatives Central European Journal of Chemistry 8(1), 2010, 96–107
1062Porto TS, Rangel R, Furtado NA, de Carvalho TC, Martins CH, Veneziani RC, Da Costa FB, Vinholis AH, Cunha WR, Heleno VC, Ambrosio SR. 2009. Pimarane-type diterpenes: antimicrobial activity against oral pathogens. Molecules. 14(1):191-199.
1063Saeed Tajbakhsh, Khosro Mohammadi, Iman Deilami, Keivan Zandi, Moradali Fouladvand, Elissa Ramedani and Golandam Asayesh 2008. Antibacterial Activity of Indium Curcumin and Indium Diacetylcurcumin African Journal of Biotechnology Vol. 7 (21), pp. 3832-3835, 5 November, 2008
1064M. Abdul Alim Al-Bari, Alam Khan, Bytul M. Rahman, M. Kudrat-E-Zahan, M. Ashik Mossadik and M. Anwar Ul Islam 2007. In vitro Antimicrobial Properties and Cytotoxic Activities of (Two Novel Deleted) Chromium Complexes Research Journal of Agriculture and Biological Sciences 3(6): 599-604, 2007
1065Farid A. Badria, Adel N. Guirguis, Sanja Perovic, Renate Steffen, Werner E.G. Muller, Heinz C Schroder 1998. Sarcophytolide: a New Neuroprotective Compound from the Soft Coral Sarcophyton glaucum Toxicology 131 (1998) 133–143
1066Tarik El-Sayed Ali 2009. Synthesis and Antibacterial Activity of Some New Thiadiaza/Triazaphospholes, Thiadiaza/Triaza/Tetrazaphosphinines and Thiadiaza/Tetrazaphosphepines Containing 1,2,4-triazinone Moiety European Journal of Medicinal Chemistry 44 (2009) 4539–4546
1067Alam Khan, Moizur Rahman, and Md Shariful Islam 2009. Antibacterial, Antifungal and Cytotoxic Activities of Salviasperanol Isolated from Amorphophallus
campanulatus Pharmaceutical Biology 2009; 47(12): 1187–1191
1068Greenberg M, Urnezis P, Tian M. 2007. Compressed mints and chewing gum containing magnolia bark extract are effective against bacteria responsible for oral malodor. J Agric Food Chem. 55(23):9465-9459.
1069Donald T. Wicklow and Stephen M. Poling 2008. Antimicrobial Activity of Pyrrocidines from Acremonium zeae Against Endophytes and Pathogens of Maize
1070Deepak singh, Manish Srivastava, A.K. Gyananchandran and P.D.Gokulan 2010. Synthesis and Biological Evaluation of Some New Phenylthiazole Derivatives for their Antimicrobial
Activities Journal of Current Pharmaceutical Research 04 (2010) 16-19
1071Stephen Y Gbedema, Francis Adu, Marcel T Bayor, Vivian E Arhin-Sam, Kofi Annan. 2010. In vitro antimicrobial study of the efficacy of toothpaste formulated from garcinia kola stem wood extract. International Journal of Pharmacy and pharmaceutical sciences Vol 2, Issue 2
1072Jun Wang, Andrew Galgoci, Srinivas Kodali, Kithsiri B. Herath, Hiranthi Jayasuriya, Karen Dorso, Francisca Vicente, Antonio Gonzalez, Doris Cully, David Bramhill, and Sheo Singh 2003. Discovery of a Small Molecule That Inhibits Cell Division by Blocking FtsZ, a Novel Therapeutic Target of Antibiotics The Journal of Biological Chemistry Vol. 278, No. 45, Issue of November 7, pp. 44424–44428, 2003
1073Sökmen A, Sökmen M, Daferera D, Polissiou M, Candan F, Unlü M, Akpulat HA. 2004. The in vitro antioxidant and antimicrobial activities of the essential oil and methanol extracts of Achillea biebersteini Afan. (Asteraceae). Phytother Res. 18(6):451-456.
1074Jianglin Zhao, Yan Mou, Tijiang Shan, Yan Li, Ligang Zhou, Mingan Wang and Jingguo Wang 2010. Antimicrobial Metabolites from the Endophytic Fungus Pichia guilliermondii Isolated from Paris polyphylla var. yunnanensis Molecules 2010, 15, 7961-7970
1075Zorica Stojanović-Radić, Marija Nešić, Ljiljana Čomić, Niko Radulović 2010. Antimicrobial Activity and Cytotoxicity of Commercial Rosemary Essential Oil (Rosmarinus officinalis L.) Biologica Nyssana 83-88
1076Ulyana Muñoz Acuña, Nikola Jancovski and Edward J. Kennelly 2009. Polyisoprenylated Benzophenones from Clusiaceae: Potential Drugs and Lead Compounds Current Topics in Medicinal Chemistry 2009, 9, 1560-1580
1077K. Tayung, D. K. Jha, D. C. Deka 2007. Isolation and Identification of Antimicrobial Agent-Producing Bacterium from Taxus baccata Rhizosphere Antagonistic against Clinically Significant Microbes Indian J. Microbiol. 47:317–322
1078Arvind M. Dhople, Anita A. Dhople, Maria A. Ibanez 1997. Comparative In Vitro Activities of Rifamycin Analogues against Rifampin-Sensitive and Rifampin-Resistant Mycobacterium tuberculosis International Journal of Antimicrobial Agents 8(1997) 209-214
1079Kevin W Garey, Miguel Salazar, Dhara Shah, Richard Rodrigue, and Herbert L DuPont 2008. Rifamycin Antibiotics for Treatment of Clostridium difficile–Associated Diarrhea Ann Pharmacother 2008;42:827-35
1080Haruaki Tomioka 2003. Type II Pneumocytes in the Evaluation of Drug Antimycobacterial Activity Expert Opin. Pharmacother. (2003) 4(2):127-139
1081David M Rothstein, Christo Shalish, Christopher K Murphy, Andrew Sternlicht & Lee Ann Campbell 2006. Development Potential of Rifalazil and Other Benzoxazinorifamycins Expert Opin. Investig. Drugs (2006) 15(6):603-623
1082David M Rothstein, Arthur D Hartman, Michael H Cynamon & Barry I Eisenstein 2003. Development Potential of Rifalazil Expert Opin. Investig. Drugs (2003) 12(2):255-271
1083Alessia Bacchi and Giancarlo Pelizzi 1998. Comprehensive Study on Structure-Activity Relationships of Rifamycins: Discussion of Molecular and Crystal Structure and Spectroscopic and Thermochemical Properties of Rifamycin O J. Med. Chem. 1998, 41, 2319-2332
1084R. Sood, T. Bhadauriya, M. Rao, R. Gautam, S. Malhotra, T. K. Barman, D. J. Upadhyay and A. Rattan 2006. Antimycobacterial Activities of Oxazolidinones: A Review Infectious Disorders - Drug Targets 2006, 6, 343-354
1085Madiyarov RS, Bektemirov AM, Ibadova GA, Abdukhalilova GK, Khodiev AV, Bodhidatta L, Sethabutr O, Mason CJ. 2010. Antimicrobial resistance patterns and prevalence of class 1 and 2 integrons in Shigella flexneri and Shigella sonnei isolated in Uzbekistan. Gut Pathog. 2(1):18.
1086Glenn W. Kaatz, Varsha V. Moudgal, Susan M. Seo, and Jette E. Kristiansen 2003. Phenothiazines and Thioxanthenes Inhibit Multidrug Efflux Pump Activity in Staphylococcus aureus Antimicrobial Agents and Chemotherapy Feb. 2003, p. 719–726
1087Adriano Brandelli, Delmar Bizani, Márcia Martinelli, Valter Stefani, Annelise Engel Gerbase 2004. Antimicrobial Activity of 1,4-Naphthoquinones by Metal Complexation Brazilian Journal of Pharmaceutical Sciences vol. 40, n. 2, abr./jun.,247-253
1088Hans J. Vogel, David J. Schibli, Weiguo Jing, Elke M. Lohmeier-Vogel, Raquel F. Epand, and Richard M. Epand 2002. Towards a Structure–Function Analysis of Bovine Lactoferricin and Related Tryptophan- and
Arginine-Containing Peptides Biochem. Cell Biol. 80: 49–63 (2002)
1089Hou Z, Lu J, Fang C, Zhou Y, Bai H, Zhang X, Xue X, Chen Y, Luo X. 2011. Underlying mechanism of in vivo and in vitro activity of C-terminal-amidated thanatin against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli. J Infect Dis. 15;203(2):273-282.
1090Yu-Jing Zhu, Kang-Kang Song, Zhi-Cong Li, Zhe-Zhen Pan, Yun-Ji Guo, Jing-Jing Zhou, Qin Wang, Bo Liu, and Qing-Xi Chen 2009. Antityrosinase and Antimicrobial Activities of trans-Cinnamaldehyde Thiosemicarbazone J. Agric. Food Chem. 2009, 57, 5518–5523
1091Souâd Akroum, Dalila Satta, Korrichi Lalaoui 2009. Antimicrobial, Antioxidant, Cytotoxic Activities and Phytochemical Screening of Some Algerian Plants European Journal of Scientific Research Vol.31 No.2 (2009), pp.289-295
1092Norio Yokose, Kazuo Dan 2007. Pasteurella multocida Sepsis, Due to a Scratch from a Pet Cat, in a Post-Chemotherapy Neutropenic Patient with Non-Hodgkin Lymphoma International Journal of Hematology 2007;85:146-148
1093Mallika Kumarihamy, Frank R. Fronczek, Daneel Ferreira, Melissa Jacob, Shabana I. Khan, and N. P. Dhammika Nanayakkara 2010. Bioactive 1,4-Dihydroxy-5-phenyl-2-pyridinone Alkaloids from Septoria pistaciarum J. Nat. Prod. 2010, 73, 1250–1253
1094Wilson R. Cunha, Geilton X. de Matos, Maria Goreti M. Souza, Marcos G. Tozatti, Márcio L. Andrade e Silva, Carlos H. G. Martins, Rosangela da Silva, and Ademar A. Da Silva Filho 2010. Evaluation of the Antibacterial Activity of the Methylene Chloride Extract of Miconia ligustroides, Isolated Triterpene Acids, and Ursolic Acid Derivatives Pharmaceutical Biology 2010; 48(2): 166–169
1095D V R N Bhikshapathi, D R Krishna and V Kishan 2010. Anti-HIV, Anti-Tubercular and Mutagenic Activities of Borrelidin Indian Journal of Biotechnology Vol 9, July 2010, pp 265-270
1096Ken Ishiyama, Hirohito Yamazaki, Yasuko Senda, Hiromasa Yamauchi, Shinji Nakao 2010. Leuconostoc Bacteremia in Three Patients with Malignancies J Infect Chemother
1097A. Samie, T. Tambani, E. Harshfield, E. Green, J. N. Ramalivhana and P. O. Bessong 2010. Antifungal Activities of Selected Venda Medicinal Plants against Candida albicans, Candida krusei and
Cryptococcus neoformans Isolated from South African AIDS Patients African Journal of Biotechnology Vol. 9 (20), pp. 2965-2976, 17 May, 2010
1098Severiano ME, Simão MR, Porto TS, Martins CH, Veneziani RC, Furtado NA, Arakawa NS, Said S, de Oliveira DC, Cunha WR, Gregório LE, Ambrósio SR. 2010. Anticariogenic properties of ent-pimarane diterpenes obtained by microbial transformation. Molecules. 15(12):8553-8566.
1099Shigetaka Shimizu, Mamoru Suzuki, Akio Tomoda, Sadao Arai, Haruhiko Taguchi, Tomoko Hanawa and Shigeru Kamiya 2004. Phenoxazine Compounds Produced by the Reactions with Bovine Hemoglobin Show Antimicrobial Activity Against Non-tuberculosis Mycobacteria Tohoku J. Exp. Med. 2004,203,47-52
1100Georgios Chamilos, Russell E. Lewis, and Dimitrios P. Kontoyiannis 2006. Lovastatin Has Significant Activity against Zygomycetes and Interacts Synergistically with Voriconazole Antimicrobial Agents and Chemotherapy Jan. 2006, p. 96–103
1101Ronen Ben-Ami, Russell E. Lewis, Jeffrey Tarrand, Konstantinos Leventakos, and Dimitrios P. Kontoyiannis 2010. Antifungal Activity of Colistin against Mucorales Species In Vitro and in a Murine Model of Rhizopus oryzae Pulmonary Infection Antimicrobial Agents and Chemotherapy Jan. 2010, p. 484–490
1102Hakan Ozer, Munevver Sokmen, Medine Gulluce, Ahmet Adiguzel, Fikrettin Sahin, Atalay Sokmen, Hamdullah Kilic, and Ozlem Baris 2007. Chemical Composition and Antimicrobial and Antioxidant Activities of the Essential Oil and Methanol Extract of Hippomarathrum microcarpum (Bieb.) from Turkey J. Agric. Food Chem. 2007, 55, 937-942
1103S Krishnan-Natesan 2009. Terbinafine: a Pharmacological and Clinical Review Expert Opin. Pharmacother. (2009) 10(16):2723-2733
1104Holly Hoffman, Erika J . Ernst, Michael E. Klepser 2001. A Review of Itraconazole Spectrum of Activity and Dosage Formulations Journal of Infectious Disease Pharmacotherapy Vol. 5(1) 2001
1105George G Zhanel, Tamiko Hisanaga, Aleksandra Wierzbowski, Daryl J Hoban 2006. Telithromycin in the Treatment of Acute Bacterial Sinusitis, Acute Exacerbations of Chronic Bronchitis, and Community-Acquired Pneumonia Therapeutics and Clinical Risk Management 2006:2(1) 59–75
1106Wenliang Zhang, Lu Yu, Wenchuan Leng, Xiaokui Wang, Lingling Wang, Xuming Deng, Jian Yang, Tao Liu, Junping Peng, Jin Wang, Song Li, Qi Jin 2007. cDNA Microarray Analysis of the Expression Profiles of Trichophyton rubrum in Response to Novel Synthetic Fatty Acid Synthase Inhibitor PHS11A Fungal Genetics and Biology 44 (2007) 1252–1261
1107James E. Frampton and Lesley J. Scott 2008. Posaconazole
A Review of its Use in the Prophylaxis of Invasive Fungal Infections Drugs 2008; 68 (7): 993-1016
1108Hanna Kruszewska, Tomasz Zareba and Stefan Tyski 0. Estimation of Antimicrobial Activity of Selected Non-Antibiotic Products
1109K. Mazumdar, K. Asok Kumar, N.K. Dutta 2010. Potential Role of the Cardiovascular Non-Antibiotic (Helper Compound) Amlodipine in the Treatment of Microbial Infections: Scope and Hope for the Future International Journal of Antimicrobial Agents 36 (2010) 295–302
1110Blackwell Verlag GmbH 2009. Poster Presentations Mycoses 52 (Suppl. 1), 29–123
1111Darren Abbanat, Mark Macielag & Karen Bush 2003. Novel Antibacterial Agents for the Treatment of Serious Gram-Positive Infections Expert Opin. Investig. Drugs (2003) 12(3):379-399
1112Shu-Wen Lin, Peggy L Carver, and Daryl D DePestel 2006. Dalbavancin: A New Option for the Treatment of Gram-Positive Infections The Annals of Pharmacotherapy Vol. 40, 449-460
1113George G Zhanel, Tamiko Hisanaga, Kim Nichol, Aleksandra Wierzbowski & Daryl J Hoban 2003. Ketolides: an Emerging Treatment for Macrolide-Resistant Respiratory Infections, Focusing on
S. pneumoniae Expert Opin. Emerging Drugs (2003) 8(2):297-321
1114Mehraban Falahati, Mohammad Shabani, Maryam M A. Rodaki, Fereshteh Jahaniani, Kamran Porshang Bagheri, Soltan Ahmed Ebrahimi 2006. Interaction Between Ketoconazole, Amphotericin B and Terbinafin and Three Diazenumdiolates in Concomitant Uses against Some Fugal Species DARU Volume 14, No. 2, 2006, 87-92
1115Gail E. Mcelhaney-feser, Robert E. Raulli, and Ronald L. Cihlar 1998. Synergy of Nitric Oxide and Azoles against Candida Species In Vitro Antimicrobial Agents and Chemotherapy Sept. 1998, p. 2342–2346
1116Navarro-García VM, Rojas G, Avilés M, Fuentes M, Zepeda G. 2011. In vitro antifungal activity of coumarin extracted from Loeselia mexicana Brand. Mycoses. doi: 10.1111/j.1439-0507.2010.01993.x.
1117Olusola Adeyanju, Olajide O. Olutayo, Afolayan Michael and Arifalo K. M. 2011. Preliminary phytochemical and antimicrobial screening of the leaf extract Pilostigma reticulatum (dc) Hochst. African Journal of Pure and Applied Chemistry Vol. 5(3), pp. 43-46
1118Varvara Pokrovskaya, Valery Belakhov, Mariana Hainrichson, Sima Yaron, and Timor Baasov 2009. Design, Synthesis, and Evaluation of Novel Fluoroquinolone-Aminoglycoside Hybrid Antibiotics Journal of Medicinal Chemistry 52:2243–2254
1119Caren L. Freel Meyers, Markus Oberthur, Lutz Heide, Daniel Kahne, and Christopher T. Walsh 2004. Assembly of Dimeric Variants of Coumermycins by Tandem Action of the Four Biosynthetic Enzymes CouL, CouM, CouP, and NovN Biochemistry 43:15022-15036
1120Zeljko Debeljak, Armin Skrbo, Ivona Jasprica, Ana Mornar, Vanda Plecko, Mihajlo Banjanac, and Marica Medic´-Saric 2007. QSAR Study of Antimicrobial Activity of Some 3-Nitrocoumarins and Related Compounds Journal of Chemical Information and Modeling 47:918-926
1121Khisimuzi Mdluli and Zhenkun Ma 2007. Mycobacterium tuberculosis DNA Gyrase as a Target for Drug Discovery Infectious Disorders - Drug Targets 7:159-168
1122Laura J.V. Piddock 2002. Fluoroquinolone Resistance in Salmonella Serovars Isolated from Humans and Food Animals FEMS Microbiology Reviews 26 (2002) 3-16
1123Christine Anderle, Susanne Hennig, Bernd Kammerer, Shu-Ming Li, Ludger Wessjohann, Bertolt Gust, and Lutz Heide 2007. Improved Mutasynthetic Approaches for the Production of Modified Aminocoumarin Antibiotics Chemistry & Biology 14:955–967
1124Raied Taha Al- Naama 2009. Evaluation of in-vitro Inhibitory Effect of Honey on some Microbial Isolate Journal of Bacteriology Research 1(6):064-067
1125Fouad Al Momani, Ahmad S. Alkofahi and Nizar M. Mhaidat 2011. Altholactone Displays Promising Antimicrobial Activity. Molecules. 16, 4560-4566
1126Edelberto Silva, Jorge A Díaz, María J Arias, Angela P Hernández, Andrés de la Torre 2010. Comparative in vitro Study of the Antimicrobial Activities of Different Commercial Antibiotic Products for Intravenous Administration BMC Clinical Pharmacology 10:3
1127Ron A. Miller 2007. Development of Standardized Antimicrobial Susceptibility Testing Methods and Aeromonas Salmonicida Epidemiologic Cutoff Values for Antimicrobial Agents Used in Aquaculture
1128Pedro I. da S. Maia, Angélica Graminha, Fernando R. Pavan,c Clarice Q. F. Leite, Alzir A. Batista, Davi F. Back, Ernesto S. Lang, Javier Ellena, Sebastião de S. Lemos,f Heloisa S. Salistre-de-Araujog and Victor M. Deflon 2010. Palladium(II) Complexes with Thiosemicarbazones. Syntheses, Characterization and Cytotoxicity against Breast Cancer Cells and Anti-Mycobacterium tuberculosis Activity Journal of Brazilian Chemical Society 1177-1186
1129Klaus-Peter Hunfeld and Volker Brade 2006. Antimicrobial susceptibility of Borrelia burgdorferi sensu lato: What we know, what we don’t know, and what we need to know Wiener Klinische Wochenschrift 118/21–22: 659–668
1130Shannon D. Putnam, Helio S. Sader, David J. Farrell, Douglas J. Biedenbach, Mariana Castanheira 2011. Antimicrobial characterisation of solithromycin (CEM-101), a novel fluoroketolide: activity against staphylococci and enterococci. International Journal of Antimicrobial Agents 37: 39–45
1131Lawrence Onyango A. Manguro, Jacob O. Midiwo, Lutz F. Tietze, and Pang Hao 2011. Triterpene Saponins of Maesa lanceolata Leaves ARKIVOC 172-198
1132Robert Jay Snyder, DPM, FACFAS, CWS; Michael M. Cohen, DPM, FACFAS, FACFAO; Craig Sun, DPM; and James Livingston, BS 2001. Osteomyelitis in the Diabetic Patient: Diagnosis and Treatment Part 2: Medical, Surgical, and Alternative Treatments Ostomy/Wound Management 47(3):24–41
1133A. Walkty, M. DeCorby, P. R. S. Lagace´-Wiens, J. A. Karlowsky, D. J. Hoban, and G. G. Zhanel 2011. In Vitro Activity of Ceftazidime Combined with NXL104 versus Pseudomonas aeruginosa Isolates Obtained from Patients in Canadian Hospitals (CANWARD 2009 Study). Antimicrob Agents Chemother. p. 2992–2994
1134Sang-Suk Kim, Ji-Young, Kim, Nam Ho Lee, and Chang-Gu Hyun 2008. Antibacterial and Anti-inflammatory Effects of Jeju Medicinal Plants against Acne-inducing Bacteria The Journal of General and Applied Microbiology 54:101-106
1135Xiaoli Liu, Mingsheng Dong, Xiaohong Chen, Mei Jiang ,Xin Lv, Jianzhong Zhou 2008. Antimicrobial Activity of An Endophytic Xylaria sp.YX-28 and Identification of its Antimicrobial Compound 7-amino-4-methylcoumarin Applied Microbiology and Biotechnology 78:241–247
1136Jiachuan Lei, Jianqing Yu, Huaidong Yu, Zhixiong Liao 2008. Composition, Cytotoxicity and Antimicrobial Activity of Essential Oil from Dictamnus dasycarpus Food Chemistry 107 (2008) 1205–1209
1137A.B. Essop, R.L. van Zyl, S.F. van Vuuren, D.Mulholland, A.M. Viljoen 2008. The in vitro pharmacological activities of 12 South African Hermannia species Journal of Ethnopharmacology 119 (2008) 615–619
1138Jihua Wang, Jianglin Zhao, Hao Liu, Ligang Zhou, Zhilong Liu 1, Jingguo Wang 2, Jianguo Han 3, Zhu Yu 3 and Fuyu Yang 2010. Chemical Analysis and Biological Activity of the Essential Oils of Two Valerianaceous Species from China: Nardostachys chinensis and Valeriana officinalis Molecules 15:6411-6422
1139G. Özek, T. Özek, G. Işcan, K.H.C. Başer, E. Hamzaoglu, A. Duran 2007. Comparison of Hydrodistillation and Microdistillation Methods for the Analysis of Fruit Volatiles of Prangos pabularia Lindl., and Evaluation of Its Antimicrobial Activity South African Journal of Botany 73 (2007) 563–569
1140H. M. Heyman, A. A. Hussein, J. J. M. Meyer, N. Lall 2009. Antibacterial Activity of South African Medicinal Plants against Methicillin Resistant Staphylococcus aureus Pharmaceutical Biology, 47(1): 67–71
1141G.B. Mahady 2005. Medicinal Plants for the Prevention and Treatment of Bacterial Infections Current Pharmaceutical Design 11:2405-2427
1142Bhuwan B. Mishra, Desh D. Singh, Navneet Kishore, Vinod K. Tiwari, Vyasji Tripathi 2010. Antifungal Constituents Isolated from the Seeds of Aegle Marmelos Phytochemistry 71 (2010) 230–234
1143Aneesa Moolla 2005. A Phytochemtcal and Pharmacological Investigation of Indigenous Agathosma Species
1144Bankole Munir A, Shittu Lukeman A. J, Ahmed Titilade.A, Bankole Marian N, Shittu Remilekun K, Kpela Terkula, Ashiru Oladapo A. 2007. Synergistic Antimicrobial Activities of Phytoestrogens in Crude Extracts of Two Sesame Species Against Some Common Pathogenic Microorganisms The African Journal of Traditional (2007) 4 (4): 427-433
1145Jürgen Reichling, Paul Schnitzler, Ulrike Suschke, Reinhard Saller 2009. Essential Oils of Aromatic Plants with Antibacterial, Antifungal, Antiviral, and Cytotoxic Properties – an Overview Forsch Komplementmed 16:79–90
1146F. A. Santos, E. M. A. F. Bastos, A. B. R. A. Maia, M. Uzeda, M. A. R. Carvalho, L. M. Farias1 and E. S. A. Moreira 2003. Brazilian Propolis: Physicochemical Properties, Plant Origin and Antibacterial Activity on Periodontopathogens Phytotherapy Research 17:285–289 (2003)
1147Firas A. Al-Bayati 2008. Synergistic Antibacterial Activity between Thymus vulgaris and Pimpinella anisum Essential Oils and Methanol Extracts Journal of Ethnopharmacology 116 (2008) 403–406
1148Samson Sibanda, Grace Chigwada, Melvin Poole, Ephraim T. Gwebu, Joseph A. Noletto, Jennifer M. Schmidt, Angela I. Rea, William N. Setzer 2004. Composition and Bioactivity of the Leaf Essential Oil of Heteropyxis dehniae from Zimbabwe Journal of Ethnopharmacology 92 (2004) 107–111
1149Nick Kalogeropoulos, Spyros J. Konteles, Elena Troullidou, Ioannis Mourtzinos, Vaios T. Karathanos 2009. Chemical Composition, Antioxidant Activity and Antimicrobial Properties of Propolis Extracts from Greece and Cyprus Food Chemistry 116 (2009) 452–461
1150L. Drago, E. De Vecchi, L. Nicola and M.R. Gismondo 2007. In vitro Antimicrobial Activity of a Novel Propolis Formulation (Actichelated propolis) Journal of Applied Microbiology 103 (2007) 1914–1921
1151El-Mahmood Muhammad Abubakar 2009. The use of Psidium guajava Linn. in treating wound, skin and soft tissue infections Scientific Research and Essay 4 (6):605-611
1152S. Shin and C.-A. Kang 2003. Antifungal activity of the essential oil of Agastache rugosa Kuntze and its synergism with ketoconazole Letters in Applied Microbiology 36:111–115
1153Pongsak RATTANACHAIKUNSOPON and Parichat PHUMKHACHORN 2009. Protective Effect of Clove Oil-Supplemented Fish Diets on Experimental Lactococcus garvieae Infection in Tilapia Bioscience Biotechnology & Biochemistry 73 (9):2085–2089
1154Sutatip Bhamarapravati, Siriyaporn Juthapruth, Warocha Mahachai and Gail Mahady 2006. Antibacterial Activity of Boesenbergia rotunda (L.) Mansf. and Myristica fragrans Houtt. against Helicobacter pylori Songklanakarin Journal of Science and Technology 28:157-163
1155K. K. Sharma, R. Saikia, J. Kotoky, J. C. Kalita, J. Das 2011. Evaluation of Antidermatophytic activity of Piper betle, Allamanda cathertica and their combination: an in vitro and in vivo study International Journal of PharmTech Research 644-651
1156Mohd Sajjad Ahmad Khan & Iqbal Ahmad 2011. Antifungal Activity of Essential Oils and their Synergy with Fluconazole against Drug-resistant Strains of Aspergillus fumigatus and Trichophyton rubrum Applied Microbiology and Biotechnology 90:1083–1094
1157A.F. Begnami, M.C.T. Duarte, V. Furletti, V.L.G. Rehder 2010. Antimicrobial Potential of Coriandrum Sativum L. against Different Candida species in vitro Food Chemistry 118 (2010) 74–77
1158K. Hussain, Z. Ismail, A. Sadikun and P. Ibrahim 2009. Antioxidant, Anti-TB Activities, Phenolic and Amide Contents of Standardised Extracts of Piper sarmentosum Roxb Natural Product Research 238–249
1159Abdel-majeed Zouhir, Ehab Kheadr, Imane Tahiri, Jeannette Ben Hamida and Ismail Fliss 2008. Combination with Plant Extracts Improves the Inhibitory Action of Divergicin M35 against Listeria Monocytogenes Journal of Food Quality 31 (2008) 13–33
1160D. Zonenschain, A. Rebecchi and L. Morelli 2008. Erythromycin- and Tetracycline-resistant Lactobacilli in Italian Fermented Dry Sausages Journal of Applied Microbiology 1365-2672
1161A. Moolla, A.M. Viljoen 2008. 'Buchu' – Agathosma betulina and Agathosma crenulata (Rutaceae): A review Journal of Ethnopharmacology 413–419
1162Liang Zhu, Ying-Juan Tian, Li Yang, Jian-Gou Jiang 2011. Chemical composition and antimicrobial activities of essential oil of Blumea megacephala. EXCLI Journal 10:62-68
1163Gulhan Vardar-Unlu, Sibel Silici, Mehmet Unlu 2008. Composition and in Vitro Antimicrobial Activity of Populus Buds and Poplar-type Propolis World J Microbiol Biotechnol 24:1011–1017
1164Mahmud Tareq Hassan Khan, Arjumand Ather, Kenneth D. Thompson, Roberto Gambari 2005. Extracts and Molecules from Medicinal Plants against Herpes Simplex Viruses Antiviral Research 67 (2005) 107–119
1165Sibel Silici, Mehmet U nlu, Gulhan Vardar-Unlu 2007. Antibacterial Activity and Phytochemical Evidence for the Plant Origin of Turkish Propolis from Different Regions World J Microbiol Biotechnol 23:1797–1803
1166Kang-Ju Kim, Hyeon-Hee Yu, Jung-Dan Cha, Se-Jeong Seo, Na-Young Choi and Yong-Ouk You 2005. Antibacterial Activity of Curcuma longa L. against Methicillin-resistant Staphylococcus aureus Phytotherapy Research 19:599–604
1167Peng Xu, Yuan-Yuan Zhang, Yong-Xue Sun, Jian-Hua Liu, Bing Yang, Yu-Zhong Wang and Yu-Liang Wang 2009. Novel Pleuromutilin Derivatives with Excellent Antibacterial Activity Against Staphylococcus aureus Chemical Biology & Drug Design 73: 655–660
1168Phil B. Alper, Martin Hendrix, Pamela Sears, and Chi-Huey Wong 1998. Probing the Specificity of Aminoglycoside-Ribosomal RNA Interactions with Designed Synthetic Analogs Journal of the American Chemical Society 120:1965-1978
1169Jorg Pietruszka 2003. Synthesis and Properties of Oligocyclopropyl-Containing Natural Products and Model Compounds Chemical Reviews 103:1051-1070
1170Mohamed I. Ali, Maged S. Ahmad 1 and Wael N Hozzein 2009. WA52-A Macrolide Antibiotic Produced by Alkalophile Nocardiopsis Dassonvillei WA52 Australian Journal of Basic and Applied Sciences 3(2): 607-616
1171Li Huang, Yu-hong Xiao, Xiao-dong Xing, Fang Li, Sai Ma, Ling-ling Qi, Ji-hua Chen 2011. Antibacterial activity and cytotoxicity of two novel crosslinking antibacterial monomers on oral pathogens. Arch Oral Biol. 56:367-373
1172Samir A. Ross, Raquel Rodrıguez-Guzman, Mohamed M. Radwan, Melissa Jacob, Yuanqing Ding, Xing-Cong Li, Daneel Ferreira, and Susan P. Manly 2008. Sorocenols G and H, Anti-MRSA Oxygen Heterocyclic Diels-Alder-Type Adducts from Sorocea muriculata Roots Journal of Natural Products 71:1764–1767
1173MARIA DAGLIA, ADELE PAPETTI, PIETRO GRISOLI, CAMILLA ACETI, CESARE DACARRO, AND GABRIELLA GAZZANI 2007. Antibacterial Activity of Red and White Wine against Oral Streptococci Journal of Agricultural and Food Chemistry 55:5038-5042
1174N. Kondori, L. Baltzer, G.T. Dolphin, I. Mattsby-Baltzer 2011. Fungicidal activity of human lactoferrin-derived peptides based on the antimicrobial αβ region. International Journal of Antimicrobial Agents 37: 51–57
1175Isabel Rivero-Cruz, Georgina Duarte, Andr´es Navarrete, Robert Bye, Edelmira Linares, and Rachel Mata 2011. Chemical Composition and Antimicrobial and Spasmolytic Properties of Poliomintha longiflora and Lippia graveolens Essential Oils Journal of Food Science 1750-3841
1176Soriful ISLAM, Atikur RAHMAN, Mominul Islam SHEIKH, Mostafizur RAHMAN, Abu Hena Mostofa JAMAL, Firoz ALAM 2010. In vitro Antibacterial Activity of Methanol Seed Extract of Elettaria cardamomum (L.) Maton. Agriculturae Conspectus Scientifi cus Vol. 75 No. 3 (113-117)
1177Jie Feng, Andre′anne Lupien, He′le`ne Gingras, Jessica Wasserscheid, Ken Dewar, Danielle Le′gare′, and Marc Ouellette 2009. Genome sequencing of linezolid-resistant Streptococcus pneumoniae mutants reveals novel mechanisms of resistance. Genome Research 19:1214–1223
1178K.R.Aneja and Radhika Joshi 2009. Antimicrobial Activity of Amomum subulatum and Elettaria cardamomum Against Dental Caries Causing Microorganisms Ethnobotanical Leaflets 13: 840-49,
1179Purshotam Kaushik, Pankaj Goyal, Abhishek Chauhan and Garima Chauhan 2010. In Vitro Evaluation of Antibacterial Potential of Dry Fruit Extracts of Elettaria cardamomum Maton (Chhoti Elaichi) Iranian Journal of Pharmaceutical Research 9 (3): 287-292
1180Natta, L., Orapin, K., Krittika, N. and Pantip, B. 2008. Essential oil from five Zingiberaceae for anti food-borne bacteria International Food Research Journal 15(3)
1181M. A. Dib, M. Bendahou, A. Bendiabdellah, N. Djabou, H. Allali, B. Tabti, J. Paolini and J. Costa 2010. Partial chemical composition and antimicrobial activity of Daucus crinitus Desf. extracts. GRASAS Y ACEITES JULIO-SEPTIEMBRE, 61 (3),271-278
1182Vila R, Santana AI, Pérez-Rosés R, Valderrama A, Castelli MV, Mendonca S, Zacchino S, Gupta MP, Cañigueral S. 2010. Composition and biological activity of the essential oil from leaves of Plinia cerrocampanensis, a new source of alpha-bisabolol. Bioresour Technol. 101(7):2510-4.
1183Aiyegoro OA, Afolayan AJ, Okoh AI. 2009. Synergistic interaction of Helichrysum pedunculatum leaf extracts with antibiotics against wound infection associated bacteria. Biol Res. 42(3):327-38.
1184N.Q. Liu, F. Van der Kooy , R. Verpoorte 2009. Artemisia afra: A potential flagship for African medicinal plants? South African Journal of Botany 75: 185–195
1185Mahady GB, Pendland SL, Stoia A, Hamill FA, Fabricant D, Dietz BM, Chadwick LR. 2005. In Vitro Susceptibility of Helicobacter pylori to Botanical Extracts used Traditionally for the Treatment of Gastrointestinal Disorders. Phytother Res. 19(11):988-91.
1186Har Krishan Bhalla & Sons 2011. Journal of Biologically Active Products from Nature JBAPN
1187Liesel Brenda GENDE, Ignazio FLORIS, Rosalia FRITZ, Martin Javier EGUARAS 2008. Antimicrobial activity of cinnamon (Cinnamomum zeylanicum) essential oil and its main components against Paenibacillus larvae from Argentine. Bulletin of Insectology 61 (1): 1-4
1188Alviano WS, Alviano DS, Diniz CG, Antoniolli AR, Alviano CS, Farias LM, Carvalho MA, Souza MM, Bolognese AM. 2008. In vitro antioxidant potential of medicinal plant extracts and their activities against oral bacteria based on Brazilian folk medicine. Arch Oral Biol. 53(6):545-52.
1189Filoche SK, Soma K, Sissons CH. 2005. Antimicrobial effects of essential oils in combination with chlorhexidine digluconate. Oral Microbiol Immunol. 20(4):221-5.
1190Huanhuan Qu, Yongmin Zhang, Yan Wang, Baixue Li and Wenji Sun 2008. Antioxidant and antibacterial activity of two compounds (forsythiaside and forsythin) isolated from Forsythia suspensa. Journal of Pharmacy and pharmacology 60: 261–266
1191Azza A. Abou Zeid, Mona A. Shalaby and Mohamed Ibrahim M. Abdel Aziz 2010. Control of some multi-resistant bacterial infecting respiratory system using certain essential oils and plant extracts. PROCEEDING OF FIFTH SCIENTIFIC ENVIRONMENTAL CONFERENCE ZAGAZIG UNI., 87 - 105
1192Rajesh K Verma, Leena Chaurasia and Sadhana Katiyar 2008. Potential antifungal plants for controlling building fungi Natural product radiance vol.7(4) pp,374-387
1193Shreaz S, Sheikh RA, Rimple B, Hashmi AA, Nikhat M, Khan LA. 2010. Anticandidal activity of cinnamaldehyde, its ligand and Ni(II) complex: effect of increase in ring and side chain. Microb Pathog. 49(3):75-82.
1194Agarwal V, Lal P, Pruthi V. 2008. Prevention of Candida albicans biofilm by plant oils. Mycopathologia. 165(1):13-9
1195ATIQUR RAHMAN and SUN CHUL KANG 2009. Inhibition of foodborne pathogens and spoiling bacterial by essential oil and extracts of erigeron ramosus (walt.) B.S.P. Journal of Food Safety 29: 176–189.
1196Firas A. Al-Bayati, and Muthanna J. Mohammed 2009. Isolation, identification, and purification of cinnamaldehyde from Cinnamomum zeylanicum bark oil. An antibacterial study Pharmaceutical Biology, 47(1): 61–66
1197Feresin GE, Tapia A, Gimenez A, Ravelo AG, Zacchino S, Sortino M, Schmeda-Hirschmann G. 2003. Constituents of the Argentinian medicinal plant Baccharis grisebachii and their antimicrobial activity J Ethnopharmacol. 89(1):73-80.
1198Wang YC, Huang TL. 2005. Screening of anti-Helicobacter pylori herbs deriving from Taiwanese folk medicinal plants. FEMS Immunol Med Microbiol. 43(2):295-300.
1199Kalpesh B. Ishnava, Yogesh N. Mahida and J. S. S. Mohan 2010. In vitro assessments of antibacterial potential of Commiphora wightii (Arn.) Bhandari. gum extract Journal of Pharmacognosy and Phytotherapy Vol. 2(7), pp. 91-96
1200Barrajón-Catalán E, Fernández-Arroyo S, Saura D, Guillén E, Fernández-Gutiérrez A, Segura-Carretero A, Micol V. 0. Cistaceae aqueous extracts containing ellagitannins show antioxidant and antimicrobial capacity, and cytotoxic activity against human cancer cells. Food Chem Toxicol. 48(8-9):2273-82.
1201Yogesg Mahida and J S S Mohan 2007. Screening of plants for their potential antibacterial activity against Staphylococcus and Salmonella spp. Natural product radiance Vol.6(4). pp.301-305
1202Soberón JR, Sgariglia MA, Sampietro DA, Quiroga EN, Sierra MG, Vattuone MA. 2010. Purification and identification of antibacterial phenolics from Tripodanthus acutifolius leaves. J Appl Microbiol. 108(5):1757-68.
1203Cruz JM, Domínguez JM, Domínguez H, Parajó JC. 2001. Antioxidant and antimicrobial effects of extracts from hydrolysates of lignocellulosic materials. J Agric Food Chem. 49(5):2459-64.
1204S. Ravi Kiran, P. Sita Devi, K. Janardhan Reddy 2008. Evaluation of in Vitro Antimicrobial Activity of Leaf and Stem Essential Oils of Chloroxylon swietenia DC. World J Microbiol Biotechnol (2008) 24:1909–1914
1205D. Fraternale, L. Giamperi, A. Bucchini, D. Ricci, F. Epifano, S. Genovese, and M. Curini 2005. Composition and antifungal activity of essential oil of salvia sclarea from Italy. Chemistry of Natural Compounds Vol. 41, No. 5
1206Yee YK, Koo MW. 2000. Anti-Helicobacter pylori activity of Chinese tea: in vitro study. Aliment Pharmacol Ther. 14(5):635-8.
1207Tiwari TP, Bharti SK, Kaur HD, Dikshit RP, Hoondal GS. 2005. Synergistic antimicrobial activity of tea & antibiotic Indian J Med Res. 122(1):80-4.
1208Kim MH, Park SC, Kim JY, Lee SY, Lim HT, Cheong H, Hahm KS, Park Y. 2006. Purification and characterization of a heat-stable serine protease inhibitor from the tubers of new potato variety "Golden Valley". Biochem Biophys Res Commun. 346(3):681-6.
1209Aurelie Furiga , Aline Lonvaud-Funel , Cecile Badet 2009. In vitro study of antioxidant capacity and antibacterial activity on oral anaerobes of a grape seed extract Food Chemistry. 113: 1037–1040
1210Parkar SG, Stevenson DE, Skinner MA. 2008. The potential influence of fruit polyphenols on colonic microflora and human gut health Int J Food Microbiol. 124(3):295-8.
1211Rufián-Henares JA, de la Cueva SP. 2009. Antimicrobial Activity of Coffee MelanoidinssA Study of Their Metal-Chelating Properties J Agric Food Chem. 57(2):432-8.
1212Kajiya K, Hojo H, Suzuki M, Nanjo F, Kumazawa S, Nakayama T. 2004. Relationship between Antibacterial Activity of (+)-Catechin Derivatives and Their Interaction with a Model Membrane J Agric Food Chem. 52(6):1514-9.
1213Rurián-Henares JA, Morales FJ. 2008. Antimicrobial activity of melanoidins against Escherichia coli is mediated by a membrane-damage mechanism. J Agric Food Chem. 56(7):2357-62.
1214Yoda Y, Hu ZQ, Zhao WH, Shimamura T. 2004. Different susceptibilities of Staphylococcus and Gram-negative rods to epigallocatechin gallate. J Infect Chemother. 10(1):55-8.
1215Doughari, J. H, El-mahmood, A. M. and Tyoyina, I 2008. Antimicrobial activity of leaf extracts of Senna obtusifolia (L). African Journal of Pharmacy and Pharmacology Vol. 2(1), pp. 007-013
1216Furiga A, Lonvaud-Funel A, Dorignac G, Badet C. 2008. In vitro anti-bacterial and anti-adherence effects of natural polyphenolic compounds on oral bacteria. J Appl Microbiol. 105(5):1470-6.
1217Chowdhury B, Adak M, Bose SK. 2003. Flurbiprofen, a unique non-steroidal anti-inflammatory drug with antimicrobial activity against Trichophyton, Microsporum and Epidermophyton species. Lett Appl Microbiol. 37(2):158-61.
1218Bamuamba K, Gammon DW, Meyers P, Dijoux-Franca MG, Scott G. 2008. Anti-mycobacterial activity of five plant species used as traditional medicines in the Western Cape Province (South Africa). J Ethnopharmacol. 117(2):385-90.
1219M. Yusha’u, M. M. Hamza, and N. Abdullahi 2010. Antibacterial activity of Adansonia digitata stem bark extracts on some clinical bacterial isolates. International Journal of Biomedical and Health Sciences Vol. 6, No. 3
1220Rajaei A, Barzegar M, Mobarez AM, Sahari MA, Esfahani ZH. 2010. Antioxidant, anti-microbial and antimutagenicity activities of pistachio (Pistachia vera) green hull extract. Food and Chemical Toxicology 48: 107–112
1221Liz Rafael, Neiva Teresinha, J. C. Moritz, I. G. Maria, M. Dalmarco Eduardo, S. Fröde Tânia 2009. Evaluation of antimicrobial and antiplatelet aggregation effects of Solidago chilensis Meyen. International Journal of Green Pharmacy
1222Schaller M, Borelli C, Berger U, Walker B, Schmidt S, Weindl G, Jäckel A. 2009. Susceptibility testing of amorolfine, bifonazole and ciclopiroxolamine against Trichophyton rubrum in an in vitro model of dermatophyte nail infection. Med Mycol. 7(7):753-8.
1223Akash P.Dahake, Vishal D.Joshi, Arun B.Joshi Pharmacy college, Rampura, Kakanpur, Godhara, Panchmahal, Gujarat, India. K.N.V. Pharmacy College - Metoda, Rajkot, Gujarat, India. N.G.S.M Institute of Pharm.Sciences, Paneer, Dearalaktte, Mangalore, India. 2009. Antimicrobial Screening of Different Extract of Anacardium occidentale Linn. Leaves. International Journal of ChemTech Research Vol.1, No.4, pp 856-858,
1224S. Prabhu, L. Joelri Michael Raj, S. John Britto, S.R. Senthilkumar 2010. Antibacterial activity and Preliminary phytochemical analysis of leaf extract of Canavalia rosea (Sw.) DC. (Beach Bean). S. John Britto et al. / Int. J. Res. Pharm. Sci. Vol-1, Issue-4, 428-434
1225Feng Xu, Linling Li, Xiaohua Huang, Hua Cheng, Yan Wang and Shuiyuan Cheng 2010. Antioxidant and antibacterial properties of the leaves and stems of Premna microphylla. Journal of Medicinal Plants Research Vol. 4(23), pp. 2544-2550
1226Campos FF, Johann S, Cota BB, Alves TM, Rosa LH, Caligiorne RB, Cisalpino PS, Rosa CA, Zani CL. 2010. Antifungal activity of trichothecenes from Fusarium sp. against clinical isolates of Paracoccidioides brasiliensis. Mycoses.
1227Mincoff PC, Garcia Cortez DA, Ueda-Nakamura T, Nakamura CV, Dias Filho BP. 2006. Isolation and characterization of a 30 kD antifungal protein from seeds of Sorghum bicolor. Res Microbiol. 157(4):326-32.
1228Spengler G. 2007. Attempts to reduce drug resistance of bacteria and cancer cells. Orv Hetil. 148(22):1037-40.
1229S. Chanda, B.R.M. Vyas, Y. Vaghasiya, H. Patel 2010. Global resistance trends and the potential impact of Methicillin Resistant Staphylococcus aureus (MRSA) and its solutions Formatex
1230David E. Stevenson , Shanthi G. Parkar, Jingli Zhang, Roger A. Stanley, Dwayne J. Jensen, Janine M. Cooney 2007. Combinatorial enzymic synthesis for functional testing of phenolic acid esters catalysed by Candida antarctica lipase B (Novozym 435®) Enzyme and Microbial Technology 40: 1078–1086
1231Cho HW, Oh CH, Lee JS, Lee SC, Choi JH, Cho JH. 2003. Synthesis and Antibacterial Activities of 4-Pyrrolidinylthio Carbapenems: Containing Heteroaromatics as a Side Chain. Arch Pharm (Weinheim). 336(11):495-503.
1232Chung JY, Choo JH, Lee MH, Hwang JK. 2006. Anticariogenic activity of macelignan isolated from Myristica fragrans (nutmeg) against Streptococcus mutans. Phytomedicine. 13(4):261-266.
1233Cristani M, D'Arrigo M, Mandalari G, Castelli F, Sarpietro MG, Micieli D, Venuti V, Bisignano G, Saija A, Trombetta D. 2007. Interaction of four monoterpenes contained in essential oils with model membranes: implications for their antibacterial activity. J Agric Food Chem. 55(15):6300-6308.
1234Kubo I, Fujita K, Kubo A, Nihei K, Lunde CS. 2003. Modes of antifungal action of (2E)-alkenals against Saccharomyces cerevisiae. J Agric Food Chem. 51(14):3951-3957.
1235Bektas Tepe , H. Askin Akpulat , Munevver Sokmen , Dimitra Daferera , Onder Yumrutas , Enes Aydin , Moschos Polissiou , Atalay Sokmen 2006. Screening of the antioxidative and antimicrobial properties of the essential oils of Pimpinella anisetum and Pimpinella flabellifolia from Turkey Food Chemistry 97: 719–724
1236F. Sharififar , M.H. Moshafi , S.H. Mansouri, M. Khodashenas, M. Khoshnoodi 2007. In vitro evaluation of antibacterial and antioxidant activities of the essential oil and methanol extract of endemic Zataria multiflora Boiss Food Control 18: 800–805
1237Vladimir Mihailovi, Nenad Vukovi, Neda Niiforovi, Slavica Soluji, Milan Mladenovi, Pavle Maskovic and Milan S. Stankovic 2011. Studies on the antimicrobial activity and chemical composition of the essential oils and alcoholic extracts of Gentiana asclepiadea L. Journal of Medicinal Plants Research Vol. 5(7), pp. 1164-1174
1238Saïdana D, Mahjoub MA, Boussaada O, Chriaa J, Chéraif I, Daami M, Mighri Z, Helal AN. 2008. Chemical composition and antimicrobial activity of volatile compounds of Tamarix boveana (Tamaricaceae). Microbiol Res. 163(4):445-455.
1239C. A. Obafemi, T. O. Sulaimon, D. A. Akinpelu, T. A. Olugbade 2006. Antimicrobial activity of extracts and a germacranolidetype sesquiterpene lactone from Tithonia diversifolia leaf extract. African Journal of Biotechnology Vol. 5 (12), pp. 1254-1258
1240M.P. Raghavendra, S. Satish and K.A. Raveesha 2006. In vitro evaluation of anti-bacterial spectrum and phytochemical analysis of Acacia nilotica Journal of Agricultural Technology 2(1): 77-88.
1241Arhin F, Bélanger O, Ciblat S, Dehbi M, Delorme D, Dietrich E, Dixit D, Lafontaine Y, Lehoux D, Liu J, McKay GA, Moeck G, Reddy R, Rose Y, Srikumar R, Tanaka KS, Williams DM, Gros P, Pelletier J, Parr TR Jr, Far AR. 2006. A new class of small molecule RNA polymerase inhibitors with activity against rifampicin-resistant Staphylococcus aureus. Bioorg Med Chem. 14(17):5812-5832.
1242Ravi Kiran S, Bhavani K, Sita Devi P, Rajeswara Rao BR, Janardhan Reddy K. 2006. Composition and larvicidal activity of leaves and stem essential oils of Chloroxylon swietenia DC against Aedes aegypti and Anopheles stephensi. Bioresour Technol. 97(18):2481-2484.
1243Mohamed Fawzy Ramadan and Mohsen Mohamed selim Asker 2009. Antimicrobial and antivirial impact of novel quercetin-enriched lecithin. Journal of Food Biochemistry 33: 557–571.
1244Rúa J, Fernández-Álvarez L, de Castro C, Del Valle P, de Arriaga D, García-Armesto MR. 2011. Antibacterial activity against foodborne Staphylococcus aureus and antioxidant capacity of various pure phenolic compounds. Foodborne Pathog Dis. 8(1):149-157.
1245IDRIS ARSLAN AND ALI CELIK 2008. Chemical composition and antistaphylococcal activity of an endemic salvia chrysophylla stapf. nanturally disributed debizli province (TURKEY) and its vicinity Pak. J. Bot. 40(4): 1799-1804
1246Boussaada O, Ammar S, Saidana D, Chriaa J, Chraif I, Daami M, Helal AN, Mighri Z. 2008. Chemical composition and antimicrobial activity of volatile components from capitula and aerial parts of Rhaponticum acaule DC growing wild in Tunisia. Microbiol Res. 163(1):87-95
1247Pereira RM, Andrades NE, Paulino N, Sawaya AC, Eberlin MN, Marcucci MC, Favero GM, Novak EM, Bydlowski SP. 2007. Synthesis and characterization of a metal complex containing naringin and Cu, and its antioxidant, antimicrobial, antiinflammatory and tumor cell cytotoxicity. Molecules. 12(7):1352-1366.
1248O'Donnell G, Poeschl R, Zimhony O, Gunaratnam M, Moreira JB, Neidle S, Evangelopoulos D, Bhakta S, Malkinson JP, Boshoff HI, Lenaerts A, Gibbons S. 2009. Bioactive pyridine-N-oxide disulfides from Allium stipitatum. J Nat Prod. 72(3):360-365.
1249Maria L.M. Bouzada, Rodrigo L. Fabri, Mauro Nogueira, Tatiana U.P. Konno, Gizele G. Duarte, and Elita Scio 2009. Antibacterial, cytotoxic and phytochemical screening of some traditional medicinal plants in Brazil. Pharmaceutical Biology 47(1): 44–52
1250Gordon KA, Jones RN; SENTRY Participant Groups (Europe, Latin America, North America). 2003. Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America: comparison report to Europe and Latin America. Results from the SENTRY Antimicrobial Surveillance Program (2000). Diagn Microbiol Infect Dis. 45(4):295-301.
1251Song JH, Yang TC, Chang KW, Han SK, Yi HK, Jeon JG. 2007. In vitro effects of a fraction separated from Polygonum cuspidatum root on the viability, in suspension and biofilms, and biofilm formation of mutans streptococci. J Ethnopharmacol. 112(3):419-425.
1252Takahashi N, Ishihara K, Kimizuka R, Okuda K, Kato T. 2006. The effects of tetracycline, minocycline, doxycycline and ofloxacin on Prevotella intermedia biofilm. Oral Microbiol Immunol. 21(6):366-371.
1253Ethnobotanical survey and antibacterial activity of some plants used in Guinean traditional medicine. 2007. Magassouba FB, Diallo A, Kouyaté M, Mara F, Mara O, Bangoura O, Camara A, Traoré S, Diallo AK, Zaoro M, Lamah K, Diallo S, Camara G, Traoré S, Kéita A, Camara MK, Barry R, Kéita S, Oularé K, Barry MS, Donzo M, Camara K, Toté K, Berghe DV, Totté J, Pieters L, Vlietinck AJ, Baldé AM. J Ethnopharmacol. 114(1):44-53.
1254Mominul Islam SHEIKH, Soriful ISLAM, Atikur RAHMAN, Mostafizur RAHMAN, Mashiur RAHMAN, Mizanur RAHMAN, Abdur RAHIM, Firoz ALAM, 2010. Control of Some Human Pathogenic Bacteria by Seed Extracts of Cumin (Cuminum cyminum L.). Agriculturae Conspectus Scientifi cus Vol. 75 No. 1 (39-44)
1255Isiaka A. Ogunwande , Nureni O. Olawore, Oluranti O. Ogunmola, Tameka M. Walker, Jennifer M. Schmid3, and William N. Setzer 2007. Cytotoxic Effects of Taxodium distichum Oils. Pharmaceutical Biology Vol. 45, No. 2, pp. 106–110
1256I. Che´raif, H. Ben Jannet, M. Hammami, M.L. Khouja, Z. Mighri 2007. Chemical composition and antimicrobial activity of essential oils of Cupressus arizonica Greene. Biochemical Systematics and Ecology 35: 813-820
1257Mylarappa B. Ningappa, B.L. Dhananjaya, R. Dinesha, R. Harsha, Leela Srinivas 2009. Potent Antibacterial Property of APC Protein from Curry Leaves (Murraya koenigii L.) Food Chemistry
1258Manvi Malwal and Renu Sarin 2011. Antimicrobial efficacy of Murraya koenigii (linn.) spreng. roots extracts Indian journal of natural products resources Vol 2(1) pp.48-51
1259Elliott RL, Pireh D, Griesgraber G, Nilius AM, Ewing PJ, Bui MH, Raney PM, Flamm RK, Kim K, Henry RF, Chu DT, Plattner JJ, Or YS. 1998. J Med Chem. 1998 May 7;41(10):1651-9. Anhydrolide macrolides. 1. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbamate erythromycin A analogues. J Med Chem. 41(10):1651-1659.
1260Majekodunmi O. Fatope, Ruchi G. Marwah, Anthony K. Onifade, John E. Ochei, and Yaqoub Khalfan S. Al Mahroqi 2006. 13C NMR Analysis and Antifungal and Insecticidal Activities of Oman Dill Herb Oil Pharmaceutical Biology, Vol. 44, No. 1, pp. 44–49
1261Tally FP, Zeckel M, Wasilewski MM, Carini C, Berman CL, Drusano GL, Oleson FB Jr. 1999. Daptomycin : a novel agent for gram-positive infections Expert Opin Investig Drugs. 8(8):1223-1238.
1262Yunes Panahi, Morteza Sattari, Ahmad Pour Babaie, Fatemeh Beiraghdar, Reza Ranjbar, Ali Hedaiat joo and Mohsen Bigdeli 2011. The Essential Oils Activity of Eucalyptus polycarpa, E. largiflorence, E. malliodora and E. camaldulensis on Staphylococcus aureus Iranian Journal of Pharmaceutical Research 10 (1): 43-48
1263Duraipandiyan V, Indwar F, Ignacimuthu S. 2010. Antimicrobial activity of confertifolin from Polygonum hydropiper. Pharm Biol. 48(2):187-190.
1264Cermelli C, Fabio A, Fabio G, Quaglio P. 2008. Effect of eucalyptus essential oil on respiratory bacteria and viruses. Curr Microbiol. 56(1):89-92.
1265Schelz Z, Molnar J, Hohmann J. 2006. Antimicrobial and antiplasmid activities of essential oils Fitoterapia. 77(4):279-285.
1266Wyatt RM, Hodges LD, Kalafatis N, Wright PF, Wynne PM, Macrides TA. 2005. Phytochemical analysis and biological screening of leaf and twig extracts from Kunzea ericoides. Phytother Res. 19(11):963-970.
1267Rukayadi Y, Lee K, Lee MS, Yong D, Hwang JK. 2009. Synergistic anticandidal activity of xanthorrhizol in combination with ketoconazole or amphotericin B. FEMS Yeast Res. 9(8):1302-1311.
1268Ocaña V, Silva C, Nader-Macías ME. 2006. Antibiotic susceptibility of potentially probiotic vaginal lactobacilli. Infect Dis Obstet Gynecol.
1269K. Sinan Dayisoylu, Ahmet D. Duman, M. Hakki Alma and Metin Digrak 2009. Antimicrobial activity of the essential oils of rosin from cones of Abies cilicica subsp. cilicica African Journal of Biotechnology Vol. 8 (19), pp. 5021-5024
1270Biljana Blazekovic, Gordana Stanic, Stjepan Pepeljnjak and Sanda Vladimir-Knezevic 2011. In Vitro Antibacterial and Antifungal Activity of Lavandula ´ intermedia Emeric ex Loisel. ‘Budrovka’ Molecules. 16:4241-4253
1271VALERIA RADULESCU, CRINA SAVIUC, CARMEN CHIFIRIUC, ELIZA OPREA, DIANA CAROLINA ILIES, LUMINITA MARUTESCU, VERONICA LAZAR 2011. Chemical Composition and Antimicrobial Activity of Essential Oil from Shoots Spruce (Picea abies L) REV. CHIM. (Bucharest)
1272Ishiguro M, Tanaka R, Namikawa K, Nasu T, Inoue H, Nakatsuka T, Oyama Y, Imajo S. 1997. 5,6-Cis-penems: broad-spectrum anti-methicillin-resistant Staphylococcus aureus beta-lactam antibiotics. J Med Chem. 40(14):2126-2132.
1273Jeong SI, Lim JP, Jeon H. 2007. Chemical composition and antibacterial activities of the essential oil from Abies koreana. Phytother Res. 21(12):1246-1250.
1274Pachanawan A, Phumkhachorn P, and Rattanachaikunsopon P 2008. Prophylactic effect of Andrographis paniculata extracts against Streptococcus agalactiae infection in Nile tilapia (Oreochromis niloticus) J. Biosci. Bioeng 106, 419–424
1275Otvos L Jr, Wade JD, Lin F, Condie BA, Hanrieder J, Hoffmann R. 2005. Designer Antibacterial Peptides Kill Fluoroquinolone-Resistant Clinical Isolates J Med Chem. 48(16):5349-5359.
1276Suzuki T, Swoboda JG, Campbell J, Walker S, Gilmore MS. 2011. In vitro antimicrobial activity of wall teichoic acid biosynthesis inhibitors against Staphylococcus aureus isolates. Antimicrob Agents Chemother. 55(2):767-774.
1277Cudic M, Condie BA, Weiner DJ, Lysenko ES, Xiang ZQ, Insug O, Bulet P, Otvos L Jr. 2002. Development of Novel Antibacterial Peptides that Kill Resistant Isolates Peptides 23(12):2071-2083.
1278Agarwal SK, Verma S, Singh SS, Tripathi AK, Khan ZK, Kumar S. 2000. Antifeedant and antifungal activity of chromene compounds isolated from Blepharispermum subsessile. J Ethnopharmacol. 71(1-2):231-234.
1279Pucci MJ, Podos SD, Thanassi JA, Leggio MJ, Bradbury BJ, Deshpande M. 2011. In Vitro and In Vivo Profiles of ACH-702, an Isothiazoloquinolone, against Bacterial Pathogens. Antimicrob Agents Chemother. 55(6):2860-2871.
1280Miyazawa M, Hashimoto Y. 2002. Antimicrobial and bactericidal activities of esters of 2-endo-hydroxy-1,8-cineole as new aroma chemicals. J Agric Food Chem. 50(12):3522-3526.
1281Miller WH, Seefeld MA, Newlander KA, Uzinskas IN, Burgess WJ, Heerding DA, Yuan CC, Head MS, Payne DJ, Rittenhouse SF, Moore TD, Pearson SC, Berry V, DeWolf WE Jr, Keller PM, Polizzi BJ, Qiu X, Janson CA, Huffman WF. 2002. Discovery of Aminopyridine-Based Inhibitors of Bacterial Enoyl-ACP Reductase (FabI). Eur. J. Med. Chem. 45, 3246-3256
1282Niyomkam P, Kaewbumrung S, Kaewnpparat S, Panichayupakaranant P. 2010. Antibacterial activity of Thai herbal extracts on acne involved microorganism. Pharm Biol. 48(4):375-380.
1283Huang H, Wu D, Tian WX, Ma XF, Wu XD. 2008. Antimicrobial effect by extracts of rhizome of Alpinia officinarum Hance may relate to its inhibition of beta-ketoacyl-ACP reductase. J Enzyme Inhib Med Chem. 23(3):362-368.
1284Vivek K. Bajpai, Atiqur Rahman, Savita Shukla, Archana Mehta, Shruti Shukla, S. M. Yassir Arafat, M. Mizanur Rahman, and Zennat Ferdousi 2009. Antibacterial Activity of Leaf Extracts of Pongamia pinnata from India Pharmaceutical Biology 2009; 47(12): 1162–1167
1285Tiwatt Kuljanabhagavad, Nongluksna Sriubolmas and Nijsiri Ruangrungsi 2010. Chemical composition and antimicrobial activity of the essential oil from heracleum siamicum. J Health Res 24(2): 55-60
1286Areej M. Al-Taweel, Kadriya S. El-Deeb and Maged S. Abdel-Kader 2008. GC/MS analysis, anti-inflammatory and anti-microbial activities of the volatile constitutents of three clematis species growing in saudi arabia. Saudi Pharmaceutical Journal Vol. 16, No. 2
1287M.N. Rahmoun, M. Benabdallah, D.Villemin, K. Boucherit B. Mostefa-Kara, C Ziani-Cherif and N. Choukchou-Braham 2010. Antimicrobial screening of the Algerian Lawsonia inermis (henna) Der Pharma Chemica 2(6): 320-326
1288Anjana Sharma , Virendra Kumar Patel , Padmini Ramteke 2009. Identification of vibriocidal compounds from medicinal plants using chromatographic fingerprinting World J Microbiol Biotechnol 25:19–25
1289Rani P, Khullar N. 2004. Antimicrobial evaluation of some medicinal plants for their anti-enteric potential against multi-drug resistant Salmonella typhi.
Phytother Res. 18(8):670-673.
1290Arshad N, Zitterl-Eglseer K, Hasnain S, Hess M. 2008. Effect of Peganum harmala or its beta-carboline alkaloids on certain antibiotic resistant strains of bacteria and protozoa from poultry. Phytother Res. 22(11):1533-1538.
1291Humphrey AJ, Beale MH. 2006. Strigol: biogenesis and physiological activity. Phytochemistry. 67(7):636-40.
1292Nannapaneni R, Chalova VI, Story R, Wiggins KC, Crandall PG, Ricke SC, Johnson MG. 2009. Ciprofloxacin-sensitive and ciprofloxacin-resistant Campylobacter jejuni are equally susceptible to natural orange oil-based antimicrobials. J Environ Sci Health B. 44(6):571-577.
1293Kuyper LF, Baccanari DP, Jones ML, Hunter RN, Tansik RL, Joyner SS, Boytos CM, Rudolph SK, Knick V, Wilson HR, Caddell JM, Friedman HS, Comley JC, Stables JN. 1996. High-Affinity Inhibitors of Dihydrofolate Reductase: Antimicrobial and Anticancer Activities of 7,8-Dialkyl-1,3-diaminopyrrolo[3,2-f]quinazolines with Small Molecular Size. J Med Chem. 39(4):892-903.
1294Lall N, Meyer JJ. 1999. In vitro inhibition of drug-resistant and drug-sensitive strains of Mycobacterium tuberculosis by ethnobotanically selected South African plants. J Ethnopharmacol. 66(3):347-354.
1295S.F. van Vuuren, A.M. Viljoen, R.L. van Zyl , F.R. van Heerden, K. Hu¨snu¨ C. Bas¸er 2006. The antimicrobial, antimalarial and toxicity profiles of helihumulone, leaf essential oil and extracts of Helichrysum cymosum (L.) D. Don subsp. cymosum South African Journal of Botany 72:287 – 290
1296Alma MH, Nitz S, Kollmannsberger H, Digrak M, Efe FT, Yilmaz N. 2004. Chemical composition and antimicrobial activity of the essential oils from the gum of Turkish pistachio (Pistacia vera L.). J Agric Food Chem. 52(12):3911-3914.
1297Lee JW, Ji YJ, Lee SO, Lee IS. 2007. Effect of Saliva miltiorrhiza bunge on antimicrobial activity and resistant gene regulation against methicillin-resistant Staphylococcus aureus (MRSA). J Microbiol. 45(4):350-357.
1298Lin RD, Chin YP, Lee MH. 2005. Antimicrobial activity of antibiotics in combination with natural flavonoids against clinical extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae. Phytother Res. 19(7):612-617.
1299G.P.P. Kamatou, A.M. Viljoen, A.C. Figueiredo, P.M. Tilney, R.L. Van Zyl, J.G. Barroso, L.G. Pedro, S.F. Van Vuuren 2007. Trichomes, essential oil composition and biological activities of Salvia albicaulis Benth. and S. dolomitica Codd, two species from the Cape region of South Africa. South African Journal of Botany 73:102–108
1300Xiao J, Liu Y, Zuo YL, Li JY, Ye L, Zhou XD. 2006. Effects of Nidus Vespae extract and chemical fractions on the growth and acidogenicity of oral microorganisms. Arch Oral Biol. 51(9):804-813.
1301S. O. Ogbonnia, N. V. Enwuru, E. U. Onyemenem, G. A. Oyedele and C. A. Enwuru 2008. Phytochemical evaluation and antibacterial profile of Treculia africana Decne bark extract on gastrointestinal bacterial pathogens. African Journal of Biotechnology Vol. 7 (10), pp. 1385-1389
1302O. A. Aiyegoro, A. J. Afolayan and A. I. Okoh 2009. In vitro antibacterial activities of crude extracts of the leaves of Helichrysum longifolium in combination with selected antibiotics African Journal of Pharmacy and Pharmacology Vol. 3(6). pp. 293-300
1303 0. Overview of the use of aromatic plants and their essential oils to treat microbial infections.
1304A. O. T. Ashafa and A. J. Afolayan 2009. Screening the root extracts from Biden pilosa L. var. radiata (Asteraceae) for antimicrobial potentials Journal of Medicinal Plants Research Vol. 3(8), pp. 568-572
1305Edziri Hayet, Mastouri Maha, Ammar Samia, Matieu Mata, Patrich Gros, Hiar Raida, Mahjoub Mohamed Ali, Ali Si Mohamed, Laurent Gutmann, Zine Mighri, Aouni Mahjoub 2008. Antimicrobial, antioxidant, and antiviral activities of Retama raetam (Forssk.) Webb flowers growing in Tunisia World J Microbiol Biotechnol 24:2933–2940
1306van Vuuren SF. 2008. Antimicrobial activity of South African medicinal plants. J Ethnopharmacol. 119(3):462-472.
1307Cushnie TP, Lamb AJ. 2005. Detection of galangin-induced cytoplasmic membrane damage in Staphylococcus aureus by measuring potassium loss. J Ethnopharmacol. 01(1-3):243-248.
1308Mativandlela SP, Meyer JJ, Hussein AA, Houghton PJ, Hamilton CJ, Lall N. 2008. Activity against Mycobacterium smegmatis and M. tuberculosis by extract of South African medicinal plants. Phytother Res. 22(6):841-845.
1309Kawo, A.H., Mustapha, A., Abdullahi, B.A., Rogo, L.D., Gaiya, Z.A. and Kumurya, A.S. 2009. Phytochemical properties and antibacterial activities of the leaf and the latex extracts of calotropis procera(AIT.F) AIT.F Bayero Journal of Pure and Applied Sciences 2(1): 34 -40
1310M. Mashiar Rahman, M. Mominul Islam Sheikh, Shamima Akhtar Sharmin, M. Soriful Islam, M. Atikur Rahman, M. Mizanur Rahman and M. F. Alam 2009. Antibacterial Activity of Leaf Juice and Extracts of Moringa oleifera Lam. against Some Human Pathogenic Bacteria CMU. J. Nat. Sci. Vol. 8(2)
1311Venkata Ratnam, k and R.R. Venkata Raju 2009. Preliminary Phytochemical and Antimicrobial Properties of Pueraria tuberosa (Willd.) DC: A Potential Medicinal Plant Ethnobotanical Leaflets 13: 1051-1059
1312A. O. T. Ashafa and A. J. Afolayan 2009. Assessment of the antimicrobial activity of the root extracts from Chrysocoma ciliata L. African Journal of Microbiology Research Vol. 3(11) pp. 700-703
1313Veeramuthu Duraipandiyan, Savarimuthu Ignacimuthu, Mariadhas Velanarasu 2008. Antibacterial and antifungal activity of Syzygium lineare wall. International Journal of Integrative biology Vol. 3, No. 3
1314Neli Lokho Pfoze, Yogendra Kumar, Berington Myrboh, Ranjan Kumar Bhagobaty and Santa Ram Joshi 2010. In vitro antibacterial activity of alkaloid extract from stem bark of Mahonia manipurensis Takeda Journal of Medicinal Plants Research Vol. 5(5), pp. 859-861
1315Atiqur Rahman, M. Amzad Hossain, Sun Chul Kang 2009. Control of phytopathogenic fungi by the essential oil and methanolic extracts of Erigeron ramosus (Walt.) B.S.P. Eur J Plant Pathol 128:211–219
1316E. A. Adewusi and A. J. Afolayan 2009. Antibacterial, antifungal and antioxidant activity of the roots and leaves of Pelargonium reniforme Curtis (Geraniaceae) African Journal of Biotechnology Vol. 8 (22), pp. 6425-6433
1317Yiğit D, Yiğit N, Ozgen U. 2009. An investigation on the anticandidal activity of some traditional medicinal plants in Turkey Mycoses. 52(2):135-140.
1318Rosato A, Piarulli M, Corbo F, Muraglia M, Carone A, Vitali ME, Vitali C. 2010. In vitro synergistic antibacterial action of certain combinations of gentamicin and essential oils. Curr Med Chem. 17(28):3289-3295.
1319Liu X, Han Y, Peng K, Liu Y, Li J, Liu H. 2011. Effect of traditional Chinese medicinal herbs on Candida spp. from patients with HIV/AIDS. Adv Dent Res. 23(1):56-60.
1320Rijo P, Simões MF, Duarte A, Rodríguez B. 2009. Isopimarane diterpenoids from Aeollanthus rydingianus and their antimicrobial activity. Phytochemistry. 70(9):1161-1165
1321Rebai BEN AMMAR, Soumaya KILANI, Ines BOUHLEL, Ines SKANDRANI, Aicha NAFFETI, Jihed BOUBAKER, Mohamed BEN, SGHAIER, Wissem BHOURI, Amor MAHMOUD, Leila CHEKIR-GHEDIRA, Kamel GHEDIRA 2007. Antibacterial and cytotoxic activities of extracts from (Tunisian) Rhamnus alaternus (Rhamnaceae) Annals of Microbiology 57 (3) 453-460
1322Ruddock PS, Charland M, Ramirez S, López A, Neil Towers GH, Arnason JT, Liao M, Dillon JA. 2011. Antimicrobial activity of flavonoids from Piper lanceaefolium and other Colombian medicinal plants against antibiotic susceptible and resistant strains of Neisseria gonorrhoeae. Sex Transm Dis. 38(2):82-88.
1323Whitener CJ, Park SY, Browne FA, Parent LJ, Julian K, Bozdogan B, Appelbaum PC, Chaitram J, Weigel LM, Jernigan J, McDougal LK, Tenover FC, Fridkin SK. 2004. Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure. Clin Infect Dis. 38(8):1049-1055.
1324Vats Manisha, Sharma Neha and Sardana Satish 2009. Antimicrobial Activity of Stem Bark Extracts of Nyctanthes arbortristis linn. (Oleaceae) International Journal of Pharmacognosy and Phytochemical Research 1(1): 12-14
1325Pietrella D, Angiolella L, Vavala E, Rachini A, Mondello F, Ragno R, Bistoni F, Vecchiarelli A. 2011. Beneficial effect of Mentha suaveolens essential oil in the treatment of vaginal candidiasis assessed by real-time monitoring of infection. BMC Complement Altern Med. 11:18.
1326Sharif M. Al-Reza , Atiqur Rahman, Yunus Ahmed, Sun Chul Kang 2010. Inhibition of plant pathogens in vitro and in vivo with essential oil and organic extracts of Cestrum nocturnum L. Pesticide Biochemistry and Physiology 96:86–92
1327Pramod Singh, Jagmohan S. Negi, M. S. M. Rawat, Geeta Joshi nee Pant and A. K.Bishoyi 2011. Syntheses, Characterization and Antimicrobial Activity of 3-(Aminophenyl)-1,3- Diphenylpropanones, Novel Aza-michael Products International Journal of ChemTech Research Vol. 3, No.2, pp 584-589
1328Rahmanullah Siddiqi, Shahina Naz, Samia Ahmad & Syed Asad Sayeed 2011. Antimicrobial activity of the polyphenolic fractions derived from Grewia asiatica, Eugenia jambolana and Carissa carandas International Journal of Food Science and Technology 46, 250–256
1329Jasmine R, Selvakumar BN, Daisy P, Ignacimuthu S. 2010. Activity of Eugenia jambolana, an ethnomedical plant, against drug-resistant bacteria. Pharm Biol. 48(4):405-410.
1330Bektas Tepe, Dimitra Daferera, Munevver Sokmen, Moschos Polissiou and Atalay Sokmen 2004. The in vitro antioxidant and antimicrobial activities of the essential oil and various extracts of Origanum syriacum L var bevanii. J Sci Food Agric 84:1389–1396
1331Mevy JP, Bessiere JM, Dherbomez M, Viano J. 2002. Composition and some biological activities of the essential oils from an African pasture grass: Elionurus elegans Kunth. J Agric Food Chem. 50(15):4240-4243.
1332Camacho-Corona Mdel R, Ramírez-Cabrera MA, Santiago OG, Garza-González E, Palacios Ide P, Luna-Herrera J. 2008. Activity against drug resistant-tuberculosis strains of plants used in Mexican traditional medicine to treat tuberculosis and other respiratory diseases. Phytother Res. 22(1):82-85.
1333Gulhan Vardar-Unlu ,Mehmet Unlu ,Erol Donmez and Nilufer Vural 2007. Chemical composition and in vitro antimicrobial activity of the essential oil of Origanum minutiflorum O Schwarz & PH Davis Journal of the Science of Food and Agriculture 87:255–259
1334Tulin Askun , Gulendam Tumen, Fatih Satil, Mustafa Ates 2009. In vitro activity of methanol extracts of plants used as spices against Mycobacterium tuberculosis and other bacteria Food Chemistry. 116: 289–294
1335Inouye S, Uchida K, Yamaguchi H. 2001. In-vitro and in-vivo anti-Trichophyton activity of essential oils by vapour contact. Mycoses. 44(3-4):99-107.
1336D'Auria FD, Tecca M, Strippoli V, Salvatore G, Battinelli L, Mazzanti G. 2005. Antifungal activity of Lavandula angustifolia essential oil against Candida albicans yeast and mycelial form Med Mycol. 43(5):391-396.
1337Tsung-Hsien Tsai, Tzung-Hsun Tsai, Wen-Huey Wu, Jonathon Te-Peng Tseng, Po-Jung Tsai 2010. In vitro antimicrobial and anti-inflammatory effects of herbs against Propionibacterium acnes Food Chemistry 119:964–968
1338Saeid Mahdavi Omran, Seddigheh Esmaeilzadeh, Zahra Rahmani 2009. Laboratory study of anticandidal activity of thyme, pennyroyal and lemon essential oils by micro dilution method JJM. 3(4): 161-167.
1339A.Vijayalakshmi, A. Tripura and V. Ravichandiran 2011. Development and Evaluation of Anti-Acne Products from Terminalia arjuna Bark International Journal of ChemTech Research Vol. 3, No.1, pp 320-327,
1340Adeniyi, C.B.A.,Odumosu, B.T., Aiyelaagbe, O.O. and Kolude, B. 2010. In-vitro Antimicrobial Activities of Methanol Extracts of Zanthoxylum xanthoxyloides and Pseudocedrela kotschyi Afr. J. Biomed. Res 13:61 - 68
1341Pongsak Rattanachaikunsopon, Parichat Phumkhachorn 2010. Potential of cinnamon (Cinnamomum verum) oil to control Streptococcus iniae infection in tilapia (Oreochromis niloticus) Fish Sci 76:287–293
1342Rukayadi Y, Han S, Yong D, Hwang JK. 2011. In vitro activity of xanthorrhizol against Candida glabrata, C. guilliermondii, and C. parapsilosis biofilms. Med Mycol. 49(1):1-9.
1343Zoraghi R, See RH, Axerio-Cilies P, Kumar NS, Gong H, Moreau A, Hsing M, Kaur S, Swayze RD, Worrall L, Amandoron E, Lian T, Jackson L, Jiang J, Thorson L, Labriere C, Foster L, Brunham RC, McMaster WR, Finlay BB, Strynadka NC, Cherkasov A, Young RN, Reiner NE. 2011. Identification of pyruvate kinase in methicillin-resistant Staphylococcus aureus as a novel antimicrobial drug target. Antimicrob Agents Chemother. 55(5):2042-2053.
1344Ahmet Adiguzel, Hakan Ozer, Hamdullah Kilic and Bulent Cetin 2007. Screening of Antimicrobial Activity of Essential Oil and Methanol Extract of Satureja hortensis on Foodborne Bacteria and Fungi Czech J. Food Sci. Vol. 25, No. 2: 81–89
1345Medine Gulluce, Munevver Sokmen,Fikrettin S¸ ahin,Atalay Sokmen, Ahmet Adiguzel and Hakan Ozer 2004. Biological activities of the essential oil and methanolic extract of Micromeria fruticosa (L) Druce ssp serpyllifolia (Bieb) PH Davis plants from the eastern Anatolia region of Turkey J Sci Food Agric 84:735–741
1346Hayouni el A, Chraief I, Abedrabba M, Bouix M, Leveau JY, Mohammed H, Hamdi M. 2008. Tunisian Salvia officinalis L. and Schinus molle L. essential oils: their chemical compositions and their preservative effects against Salmonella inoculated in minced beef meat. Int J Food Microbiol. 125(3):242-251
1347Rattanachaikunsopon P, Phumkhachorn P. 2010. Use of asiatic pennywort Centella asiatica aqueous extract as a bath treatment to control columnaris in Nile tilapia. J Aquat Anim Health. 22(1):14-20.
1348Işcan G, Kirimer N, Kürkcüoğlu M, Başer KH, Demirci F. 2002. Antimicrobial screening of Mentha piperita essential oils. J Agric Food Chem. 50(14):3943-3946.
1349Huang Guangrong, Jiang Jiaxin, Dai Dehui 2008. Antioxidative and antibacterial activity of the methanol extract of Artemisia anomala S. Moore African Journal of Biotechnology Vol. 7 (9), pp. 1335-1338
1350GS Kumar, KN Jayaveera, CK Ashok Kumar, Umachigi P Sanjay, BM Vrushabendra Swamy, DV Kishore Kumar. 2007. Antimicrobial effects of Indian medicinal plants against acne-inducing bacteria Tropical Journal of Pharmaceutical Research 6 (2): 717-723
1351Mahboubi M, Ghazian Bidgoli F. 2010. In vitro synergistic efficacy of combination of amphotericin B with Myrtus communis essential oil against clinical isolates of Candida albicans. Phytomedicine. 17(10):771-774.
1352Rosato A, Vitali C, De Laurentis N, Armenise D, Antonietta Milillo M. 2007. Antibacterial effect of some essential oils administered alone or in combination with Norfloxacin. Phytomedicine. 14(11):727-732
1353Flesar J, Havlik J, Kloucek P, Rada V, Titera D, Bednar M, Stropnicky M, Kokoska L. 2010. In vitro growth-inhibitory effect of plant-derived extracts and compounds against Paenibacillus larvae and their acute oral toxicity to adult honey bees. Vet Microbiol. 145(1-2):129-133.
1354A. M. El-Mahmood, O. B. Ogbonna and M. Raji 2010. The antibacterial activity of Azadarichta indica (neem) seeds extracts against bacterial pathogens associated with eye and ear infections Journal of Medicinal Plants Research Vol. 4(14), pp. 1414-1421
1355Quiroga EN, Sampietro DA, Sgariglia MA, Soberón JR, Vattuone MA. 2009. Antimycotic activity of 5'-prenylisoflavanones of the plant Geoffroea decorticans, against Aspergillus species. Int J Food Microbiol. 132(1):42-46.
1356SaiRam M, Ilavazhagan G, Sharma SK, Dhanraj SA, Suresh B, Parida MM, Jana AM, Devendra K, Selvamurthy W. 2000. Anti-microbial activity of a new vaginal contraceptive NIM-76 from neem oil (Azadirachta indica). J Ethnopharmacol. 71(3):377-382.
1357Moreno S, Scheyer T, Romano CS, Vojnov AA. 2006. Antioxidant and antimicrobial activities of rosemary extracts linked to their polyphenol composition. Free Radic Res. 40(2):223-231.
1358Saravolatz LD, Stein GE, Johnson LB. 2011. Ceftaroline: a novel cephalosporin with activity against methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 52(9):1156-1163.
1359Ajjanna M. Sridhara, Kallam R. Venugopala Reddy, Jathi Keshavayya, Dasannana Malige S. Ambika, Vadiraj S. Gopinath, Prosenjit Bose, Sanath Kumar Gouda and Sanenahalli K. Peethambar 2011. Synthesis, Antimicrobial and Cytotoxicity Studies of Some Novel Modified Strobilurin Derivatives. J. Braz. Chem. Soc. Vol. 22, No. 5, 849-856
1360Ananthagiri Komuraiah, Krishna Bolla, Kollu Narasimha Rao, A. Ragan, V. S. Raju and M. A. Singara Charya 2009. Antibacterial studies and phytochemical constituents of South Indian Phyllanthus species. African Journal of Biotechnology Vol. 8 (19), pp. 4991-4995
1361Malmsten M, Kasetty G, Pasupuleti M, Alenfall J, Schmidtchen A. 2011. Highly selective end-tagged antimicrobial peptides derived from PRELP. PLoS One. 6(1):e16400.
1362Bayram Y, Korkoca H, Aypak C, Parlak M, Cikman A, Kilic S, Berktas M. 2011. Antimicrobial susceptibilities of Brucella isolates from various clinical specimens. Int J Med Sci. 8(3):198-202.
1363Rachel R. Butorac, Salem S. Al-Deyab and Alan H. Cowley 2011. Antimicrobial Properties of Some Bis(Iminoacenaphthene (BIAN)-Supported N-Heterocyclic Carbene Complexes of Silver and Gold. Molecules. 16, 2285-2292
1364M. Abu Osman, M. Abdul Aziz, M. Rowshanul Habib, M. Rezaul Karim 2011. Antimicrobial Investigation on Manilkara zapota (L.) P. Royen. Int. J. Drug Dev. & Res. 3 (1): 185-190
1365Kuete V, Kamga J, Sandjo LP, Ngameni B, Poumale HM, Ambassa P, Ngadjui BT. 2011. Antimicrobial activities of the methanol extract, fractions and compounds from Ficus polita Vahl. (Moraceae). BMC Complement Altern Med. 11:6.
1366S. Ghosh, D. Ghosh, P. K. Bag, S. C. Bhattacharya and A. Saha 2011. Aqueous synthesis of ZnTe/dendrimer nanocomposites and their antimicrobial activity: implications in therapeutics. Nanoscale 3, 1139–1148
1367Rahul V. Patel, Premlata Kumari, K. H. Chikhalia 2010. Design, synthesis and antimicrobial screening of s-Triazinyl piperazine and piperidine derivatives. International Journal of Advances in Pharmaceutical Sciences 1:395-403
1368Carvalho TC, Simão MR, Ambrósio SR, Furtado NA, Veneziani RC, Heleno VC, Da Costa FB, Gomes BP, Souza MG, Borges dos Reis E, Martins CH. 2011. Antimicrobial activity of diterpenes from Viguiera arenaria against endodontic bacteria. Molecules. 16(1):543-551.
1369Neil Poulter, Matthew Donaldson, Geraldine Mulley, Luis Duque,Nicholas Waterfield, Alex G. Shard, Steve Spencer, A. Tobias A. Jenkinsa and Andrew L. Johnson 2011. Plasma deposited metal Schiff-base compounds as antimicrobials. New J. Chem.
1370Erico Silva Loreto, Debora Alves Nunes Mario, Janio Morais Santurio, Sydney Hartz Alves,Cristina Wayne Nogueira and Gilzon Zeni 2010. In vitro antifungal evaluation and structure–activity relationship of diphenyl diselenide and synthetic analogues. Blackwell Verlag GmbH
1371Malcolm G. P. Page, Clothilde Dantier, Eric Desarbre, Be´range`re Gaucher, Klaus Gebhardt, and Anne Schmitt-Hoffmann 2011. In Vitro and In Vivo Properties of BAL30376, a β-Lactam and Dual β-Lactamase Inhibitor Combination with Enhanced Activity against Gram-Negative Bacilli That Express Multiple β-Lactamases. Antimicrob Agents Chemother. p. 1510–1519
1372V. K. Bajpai , S.C Kang 2011. Potential role of leaf essential oil and extracts of metasequoia glyptostroboides miki ex hu to inhibit the growth of Listeria Monocytogenes spp.. Journal of Food Biochemistry 35: 289–302.
1373Mariner K, McPhillie M, Trowbridge R, Smith C, O'Neill AJ, Fishwick CW, Chopra I. 2011. Activity of and development of resistance to corallopyronin A, an inhibitor of RNA polymerase. Antimicrob Agents Chemother. 55(5):2413-2416.
1374S. Rehman, Tariq Mir, A. Kour, P. H. Qazi, P. Sultan1 and A. S. Shawl 2011. In vitro antimicrobial studies of Nodulisporium specie: An endophytic fungus. Journal of Yeast and Fungal Research Vol. 2(4), pp. 53 - 58
1375Maksum Radji, Atiek Sumiati, Renita Rachmayani and Berna Elya 2011. Isolation of fungal endophytes from Garcinia mangostana and their antibacterial activity. African Journal of Biotechnology Vol. 10(1), pp. 103-107
1376Nichol KA, Adam HJ, Hussain Z, Mulvey MR, McCracken M, Mataseje LF, Thompson K, Kost S, Lagacé-Wiens PR, Hoban DJ, Zhanel GG; Canadian Antimicrobial Resistance Alliance (CARA). 2011. Comparison of community-associated and health care-associated methicillin-resistant Staphylococcus aureus in Canada: results of the CANWARD 2007–2009 study. Diagn Microbiol Infect Dis. 69(3):320-325.
1377Nargis S. Chowdhury, M. Badrul Alam, Ronok Zahan, Seema Sultana, Kamrun Nahar and M. Ekramul Haque 2011. Antimicrobial and toxicity studies of different fractions of the aerial parts of the Mikania cordata. Int. J. of Pharm. & Life Sci. (IJPLS) Vol. 2, Issue 3:592-598
1378Shachi Singh, Swapnil, S.K.Verma 2011. Antibacterial properties of Alkaloid rich fractions obtained from various parts of Prosopis juliflora, International Journal of Pharma Sciences and Research (IJPSR) ISVol.2(3),114-120
1379Saggiorato M., Scandurra S., Pradella G., Bacchin C., Guolo A., Agnoletti F. 2008. Apramycin, colistin, neomycin and paramomycin MIC distribution from clinical isolates of klebsiella pneumoniae Pathology and Hygiene
1380Yi-Chih Chang, Yu-Chih Wang, I-Kuan Wang, Chuen-Fu Lin, Hsiao-Li Chuang,Yi-Ying Wu, Tung-Ching Chung, Ter-Hsin Chen 2012. Ciprofloxacin and tetracycline susceptibility of lactobacilli isolated from indigenous children’s feces African Journal of Microbiology Research 245-250
1381Tshepiso J. Makhafola, Jacobus N. Eloff 2012. Five Ochna species have high antibacterial activity and more than ten antibacterial compounds South African Journal of Science
1382Haidar Kadum Yakob, Shaida F. Sulaiman and Abd M. Uyub 2012. Antioxidant and Antibacterial Activity of Ludwigia octovalvis on Escherichia coli O157: H7 and Some Pathogenic Bacteria World Applied Sciences Journal 22-29
1383Nuntaree Chaichanawongsaroj, Sumet Amonyingcharoen, Panan Pattiyathanee, Ratha-korn Vilaichone and Yong Poovorawan 2012. Anti-Helicobacter pylori and anti-internalization activities of Thai folk remedies used to treat gastric ailments Journal of Medicinal Plants Research 1389-1393
1384Olajide Olutayo, Afolayan Michael, Adewusi Adepoju John, Adeyanju Olusola 2012. Antimicrobial activity and Elemental analysis of Cassia siberiana leaves Using Atomic Absorption Spectrometer Scholars Research Library 9-18
1385Ronald N. Jones, Arthur L. Barry, and Richard R. Packer 1985. BMY28142, Cefbuperazone (T-1982), and Sch 34343 Antimicrobial Activity Against 94 Anaerobes Compared to Seven Other Antimicrobial Agents DIAGN MICROBIOL INFECT DIS 3:263-268
1386JACOB P. SOSNA, PATRICK R. MURRAY, AND GERALD MEDOFF 1978. Comparison of the In Vitro Activities of HR756 with Cephalothin, Cefoxitin, and Cefamandole ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 876-879
1387Nunilo Cremades, Adria´n Vela´zquez-Campoy, Marta Martı´nez-Ju´lvez†, Jose´ L. Neira, Inmaculada Pe´rez-Dorado, Juan Hermoso, Pilar Jime´nez, Angel Lanas, Paul S. HoffmanOE, and Javier Sancho 2009. Discovery of Specific Flavodoxin Inhibitors as Potential Therapeutic Agents against Helicobacter pylori Infection American Chemical Society chemmical biology
1388Joel E. Mortensen, David G. Moore, Jill E. Clarridge, and Edward J. Young 1986. Antimicrobial Susceptibility of Clinical Isolates of Brucella DIAGN MICROBIOL INFECT DIS 5:163-169
1389PETER C. FUCHS, RONALD N. JONES, CLYDE THORNSBERRY, ARTHUR L.BARRY, E. HUGH GERLACH, AND HERBERT M. SOMMERS 1981. Cefinenoxime (SCE-1365), a new Cephalosporin: In Vitro Activity, Comparison with Other Antimicrobial Agents, Beta-Lactamase Stability, and Disk Diffusion Testing with Tentative Interpretive Criteria ANTIMICROBLAL AGENTS AND CHEMOTHERAPY 747-759
1390Joseph L. Kuti, Pharm.D., Naomi R. Florea, Pharm.D., Charles H. Nightingale, Ph.D., and David P. Nicolau, Pharm.D., FCCP 2004. Pharmacodynamics of Meropenem and Imipenem Against Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa PHARMACODYNAMICS OF MEROPENEM AND IMIPENEM 9-15
1391By R. E. Gianneechini, C. Concha and A. Franklin 2002. Antimicrobial Susceptibility of Udder Pathogens Isolated from Dairy Herds in the West Littoral Region of Uruguay Antimicrobial susceptibility of udder pathogens 43:31-41
1392Amel Bourouis, Hela Chihi, Nehed Ben-Achour, Chérifa Belhadj, Mohamed Ben-Moussa and Omrane Belhadj 2010. Biochemical characterization of a cefotaximehydrolysing β-lactamase encoded by a conjugative plasmid African Journal of Biotechnology 9 (20):2932-2937
1393Masood Ghane, Nima Bahador, Majid Baserisalehi and Mina Eghbali 2011. A comparative study on antimicrobial susceptibility of campylobacter spp. Isolates from fecal samples of domestic animals and poultry in Tonekabon and Shiraz, Iran Journal of Paramedical Sciences
1394M. Lerma，L. Cebrián, M. J. Giménez, P. Coronel, M. Gimeno, L. Aguilar, J. García de Lomas 2008. β-lactam susceptibility of Escherichia coli isolates from urinary tract infections exhibiting different resistance phenotypes Rev Esp Quimioter 21(3):149-152
1395Da-Qiang Wu, Jing Ye, Hong-Yu Ou, Xue Wei, Xianqing Huang, Ya-Wen He and Yuquan Xu 2011. Genomic analysis and temperature-dependent transcriptome profiles of the rhizosphere originating strain Pseudomonas aeruginosa M18 BMC Genomics 12:438
1396Tomoari Kuriyama, DDS, PhD, Tadahiro Karasawa, MD, PhD, Kiyomasa Nakagawa, DDS, PhD, Yasumasa Saiki, DDS, PhD, Etsuhide Yamamoto, DDS, PhD, and Shinichi Nakamura, MD, PhD, Kanazawa, Japan 0. Bacteriologic features and antimicrobial susceptibility in isolates from orofacial odontogenic infections SCHOOL OF MEDICINE KANAZAWA UNIVERSITY
1397Westermeyer, R., Roy, A., Mitchell, M., Merchant, D.V.M.S.R. 2010. In Vitro Comparison of Staphylococcus pseudintermedius Susceptibility to Common Cephalosporins Used in Dogs Veterinary therapeutics: research in applied veterinary medicine
1398Takashi KITAHARA, Nao KOYAMA, Junichi MATSUDA, Yuko AOYAMA, Yoichi HIRAKATA, Shimeru KAMIHIRA, Shigeru KOHNO, Mikiro NAKASHIMA, and Hitoshi SASAKIa 2004. Antimicrobial Activity of Saturated Fatty Acids and Fatty Amines against Methicillin-Resistant Staphylococcus aureus Biol. Pharm. Bull 27(9):1321—1326
1399Thomas M. File Jr, Richard B. Thomson Jr, James S. Tan, Sara-Jane Salstrom, George A. Jacobs, Lynette Johnson, and Lulu Tan 1986. In Vitro Susceptibility of the Bacteroides fragilis Group in Community Hospitals DIAGN MICROBIOL INFECT DIS 5:317-322
1400Prasit Tharavichitkul, M.Sc., Banyoung Khantawa, M.Sc., Vilai Bousoung, M.Sc., Manasanon Boonchoo, M.Sc. 2005. Activity of Fosfomycin Against Extended-Spectrum- β-Lactamase-Producing Klebsiella pneumoniae and Escherichia coli in Maharaj Nakorn Chiang Mai Hospital J Infect Dis Antimicrob Agents 22:121-26
1401M.Z. Hoque, F. Akter, K.M. Hossain, M.S.M. Rahman, M.M. Billah and K.M.D. Islam 2010. Isolation, Identification and Analysis of Probiotic Properties of Lactobacillus Spp. From Selective Regional Yoghurts World Journal of Dairy & Food Sciences 5 (1): 39-46
1402Hala I. Al-Jaber, Mustafa M. El-Abadelah, Salim S. Sabri, Tale H. Al-Tel, andWolfgang Voelter 2009. Thienopyridone Antibacterials V. Synthesis of Some N(7)-Azacyclohexyl-4-oxothieno[2,3-b]pyridine-5-carboxylic Acids and Related Congeners Verlag der Zeitschrift für Naturforschung 1625–1632
1403Fereshteh Eftekhar, Seyed Mehdi Hosseini-Mazinani2, Soheila Ghandili, Minoo Hamraz and Shahrzad Zamani 2005. PCR detection of plasmid mediated TEM, SHV and AmpC β-lactamases in community and nosocomial urinary isolates of Escherichia coli IRANIAN JOURNAL of BIOTECHNOLOGY
1404MICHAEL C. BACH, LEON D. SABATH, AND MAXWELL FINLAND 1973. Susceptibility of Nocardia asteroides to 45 Antimicrobial Agents In Vitro ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 1-8
1405JUDITH AXELROD, BURT R. MEYERS, AND SHALOM Z. HIRSCHMAN 1971. Cephapirin: In Vitro Antibacterial Spectrum APPLIED MICROBIOLOGY 904-908
1406MICHAEL H. CYNAMONt AND GREGORY S. PALMER 1981. In Vitro Susceptibility of Nocardia asteroides to NFormimidoyl Thienamycin and Several Cephalosporins ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 841-842
1407Rajendran Vijayabharathi, Per Bruheim, Trygve Andreassen, Duraisamy Senthil Raja, Palanisamy Bruntha Devi, Sathyaseelan Sathyabama, and Venkatesan Brindha Priyadarisini 2011. Assessment of Resistomycin, as an Anticancer Compound Isolated and Characterized from Streptomyces aurantiacus AAA5 The Journal of Microbiology 920-926
1408WENDELL H. HALL, ELIZABETH A. SCHIERL, AND JAMES E. MACCANI 1979. Comparative Susceptibility of Penicillinase-Positive and Negative Neisseria gonorrhoeae to 30 Antibiotics ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 562-567
1409INGO STOCK AND BERND WIEDEMANN 2001. Natural Antibiotic Susceptibilities of Edwardsiella tarda, E. ictaluri, and E. hoshinae American Society for Microbiology 2245–2255
1410SUSANNE S. WEAVER, BARBARA M. LEBLANC, AND GERALD P. BODEY 1979. BL-S786 (Ceforanide), a New Parenteral Cephalosporin: In Vitro Studies ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 318-322
1411ISI AL-Adham, AJ Dinning, IM Eastwood, P Austin3 and PJ Collier 1998. Cell membrane effects of some common biocides Journal of Industrial Microbiology & Biotechnology 21:6–10
1412SHANMUGAM HEMAISWARYA, RATHINAM RAJA, CHINNATHAMBI ANBAZHAGAN AND VENKATESAN THIAGARAJAN 2009. Antimicrobial and Mutagenic Properties of the Root Tubers of Gloriosa Superba Linn. (Kalihari) Pak. J. Bot. 41(1): 293-299
1413MAXWELL FINLAND, CAROL GARNER, CLARE WILCOX, AND LEON D. SABATH 1976. Susceptibility of Pneumococci and Haemophilus influenzae to Antibacterial Agents ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 274-287
1414HAROLD C. NEU 1974. Cefamandole, a Cephalosporin Antibiotic with an Unusually Wide Spectrum of Activity ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 177-182
1415SMITH SHADOMY 1971. In Vitro Antifungal Activity of Clotrimazole (Bay b 5097) INFECTION AND IMMUNITY 143-148
1416R. J. HOLT AND R. L. NEWMAN 1972. Laboratory assessment of the antimycotic drug clotrimazole J. clin. Path. 25: 1089-1097
1417Shivani Singh, Jack D. Sobel, Pallavi Bhargava, Dina Boikov, and Jose A. Vazquez 2002. Vaginitis Due to Candida krusei: Epidemiology, Clinical Aspects, and Therapy Clinical Infectious Diseases 35: 1066–70
1418HAROLD C. NEU AND KWUNG P. FU 1978. Cefuroxime, a Beta-Lactamase-Resistant Cephalosporin with a Broad Spectrum of Gram-Positive and -Negative Activity ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 657-664
1419Ryu Kawachi, Takahiro Akashi, Yuka Kamitani, Arleen Sy, Usamas Wangchaisoonthorn, Takuya Nihira* and Yasuhiro Yamada 2000. Identification of an AfsA homologue (BarX) from Streptomyces virginiae as a pleiotropic regulator controlling autoregulator biosynthesis, virginiamycin biosynthesis and virginiamycin M1 resistance Molecular Microbiology 36(2): 302±313
1420Iva Sovadinova , Edmund F. Palermo , Michael Urban , Philomene Mpiga , Gregory A. Caputo 3 and Kenichi Kuroda 2011. Activity and Mechanism of Antimicrobial Peptide-Mimetic Amphiphilic Polymethacrylate Derivatives Polymers 3: 1512-1532
1421Smith Shadomy, Hong Wang, and H. Jean Shadomy 1988. Further In Vitro Studies with Oxiconazole Nitrate DIAGN IVflCROBIOL INFECT DIS 9: 231-237
1422Farooq Anwar, Muhammad Ali, Abdullah Ijaz Hussain and Muhammad Shahid 2009. Antioxidant and antimicrobial activities of essential oil and extracts of fennel (Foeniculum vulgare Mill.) seeds from Pakistan Flavour and fragrance Journal
1423Céline Rivière, Van Nguyen Thi Hong, Luc Pieters, Bieke Dejaegher, Yvan Vander Heyden, Minh Chau Van, Joëlle Quetin-Leclercq 2009. Polyphenols isolated from antiradical extracts of Mallotus metcalfianus Polyphenols isolated from antiradical extracts of Mallotus metcalfianus 70(2009): 91–99
1424Byeong Joo Seo, Mi Ran Mun, Rejish Kumar V. J, Chul-Joong Kim, Insun Lee, Young-Hyo Chang, Yong-Ha Park 2010. Bile tolerant Lactobacillus reuteri isolated from pig feces inhibits enteric bacterial pathogens and porcine rotavirus Vet Res Commun 34:323–333
1425Serge Messier, Robert Higgins, Camille Moore 1990. Minimal inhibitory concentrations of five antimicrobials against Treponema hyodysen teriae and Treponema innocens J Vet Diagn Invest 2: 330-333
1426GLORIA MONTENEGRO, MARIANA C PORTALUPPI, FRANCISCO A SALAS and MARÍA F DÍAZ 2009. Biological properties of the Chilean native moss Sphagnum magellanicum Biological Research 42: 233-237
1427KAZUHISA KITAI, MAMORU KASHIAZAKI, YOSHIKAZU ADACHI, TSUNEO KUME, AND AKIRA ARAKAWA 1979. In Vitro Activity of 39 Antimicrobial Agents Against Treponema hyodysenteriae ANTimicRosAL AGENTS AND CmMOTHEXAPY 392-395
1428B. K. Diggles1, G. A. Moss, J. Carson2, C. D. Anderson 2000. Luminous vibriosis in rock lobster Jasus verreauxi (Decapoda: Palinuridae) phyllosoma larvae associated with infection byVibrio harveyi 43: 127–137
1429B.A. Iwalokun, G.O. Gbenle, S.I. Smith, A. Ogunledun, K.A. Akinsinde, and E.A. Omonigbehin 2001. Epidemiology of Shigellosis in Lagos, Nigeria: Trends in Antimicrobial Resistance Journal of Health, Population and Nutrition 19(3):183-190
1430Peter Pfister, Natascia Corti, Sven Hobbie, Christian Bruell, Raz Zarivach, Ada Yonath, and Erik C. Bo¨ ttger 2005. 23S rRNA base pair 2057–2611 determines ketolide susceptibility and fitness cost of the macrolide resistance mutation 2058A3G Proceedings of the National Academy of Sciences 5180–5185
1431ALEXANDER A. LEVITAN 1967. In Vitro Antibacterial Activity of Kasugamycin American Society for Microbiology 750-753
1432O. Pruvost, P. Roumagnac, C. Gaube, F. Chiroleu and L. Gagnevin 2005. New media for the semiselective isolation and enumeration of Xanthomonas campestris pv. mangiferaeindicae, the causal agent of mango bacterial black spot Journal of Applied Microbiology 99: 803–815
1433YY Leung, KW Choi, KM Ho, EWL Kun 2005. Disseminated cutaneous infection with Mycobacterium chelonae mimicking panniculitis in a patient with dermatomyositis Hong Kong Medical Journal 11:515-9
1434WENDELL H. HALL, BONNIE J. OPFER, AND DALE N. GERDING 1980. Comparative Activities of the Oxa-fB-Lactam LY127935, Cefotaxime, Cefoperazone, Cefamandole, and Ticarcillin Against Multiply Resistant Gram-Negative Bacilli ANTMCROBIAL AGENTS AND CHEMOTHERAPY 273-279
1435MYRON W. FISHER, ARTHUR B. HILLEGAS, AND PATSY L. NAZEERI 1971. Susceptibility In Vitro and In Vivo of Pseudomonas pseudomallei to Rifampin and Tetracyclines APPLIED MICROBIOLOGY 13-16
1436Xiaolong Chen, Yuguo Zheng, and Yinchu Shen 2007. Natural Products with Maleic Anhydride Structure: Nonadrides, Tautomycin, Chaetomellic Anhydride, and Other Compounds Chemical Reviews 107: 1777-1830
1437EDWARD D. O'DONNELL, EARL H. FREIMER, GERALD L. GILARDI, AND ROBERTA RAEDER 1982. Comparative In Vitro Activities of N-Formimidoyl Thienamycin and Moxalactam Against Nonfermentative Aerobic Gram-Negative Rods ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 673-675
1438JOHN M. STAMM, ROLAND L. GIROLAMI, NATHAN L. SHIPKOWITZ, AND ROBERT R. BOWER 1981. Antimicrobial Activity of Cefmenoxime (SCE-1365) ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 454-460
1439AKIRA ITO, KEIJI HIRAI, MATSUHISA INOUE, HIROSHI KOGA, SEIGO SUZUE, TSUTOMU IRIKURA, AND SUSUMU MITSUHASHI 1980. In Vitro Antibacterial Activity of AM-715, a New Nalidixic Acid Analog ANTIMICROBIL AGENTS AND CHEMOTHERAPY 103-108
1440P. Losito, A. Vergara, T. Muscariello, and A. Ianieri 2005. Antimicrobial Susceptibility of Environmental Staphylococcus aureus Strains Isolated from a Pigeon Slaughterhouse in Italy Poultry Science 84:1802–1807
1441Chandan Singh, Santosh K. Singh, Gopal Nath and N.P. Rai 2011. Anti-mycobacterial activity of Piper longum L. fruit extracts against multi drug resistant Mycobacterium Spp. International Journal of Phytomedicine 353-361
1442Koen Andries, Peter Verhasselt, Jerome Guillemont, Hinrich W. H. Go¨hlmann, Jean-Marc Neefs, Hans Winkler, Jef Van Gestel,1 Philip Timmerman,1 Min Zhu,3 Ennis Lee,4 Peter Williams, Didier de Chaffoy,1 Emma Huitric, Sven Hoffner, Emmanuelle Cambau, Chantal Truffot-Pernot, Nacer Lounis, Vincent Jarlier 2005. A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis SCIENCE
1443David Burch 2005. Problems of antibiotic resistance in pigs in the UK In Practice 27: 37-43
1444T. G. Nagaraja, K. F. Lechtenberg , and M. M. Chengappa 1998. Antibiotic Susceptibility of Fusobacterium Necrophorum Isolated from Liver Abscesses Cattlemen’s Day 44-48
1445Lanckriet, Anouk, Timbermont, Leen, De Gussem, Maarten, Marien, Maja, Vancraeynest, Dieter, Haesebrouck, Freddy, Ducatelle, Richard, Van Immerseel, Filip 2009. The effect of commonly used anticoccidials and antibiotics in a subclinical necrotic enteritis model Avian Pathology
1446Victor Kuete, Bathe´le´my Ngameni, Jean G. Tangmouo, Jean-Michel Bolla, Sandrine Alibert-Franco, Bonaventure T. Ngadjui, and Jean-Marie Page`s 2010. Efflux Pumps Are Involved in the Defense of Gram-Negative Bacteria against the Natural Products Isobavachalcone and Diospyrone ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 1749–1752
1447LUDO VERBIST 1976. Comparison of the Antibacterial Activity of Nine Cephalosporins Against Enterobacteriaceae and Nonfermentative Gram-Negative Bacilli ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 657-663
1448R. Zbinden, V. Pünter, and A. von Graevenitz 2002. In Vitro Activities of BAL9141, a Novel Broad-Spectrum Pyrrolidinone Cephalosporin, against Gram-Negative Nonfermenters ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 871–874
1449DAVID NADJAR, ROGER LABIA, CLAUDE CERCEAU, CHANTAL BIZET, ALAIN PHILIPPON, AND GUILLAUME ARLET 2001. Molecular Characterization of Chromosomal Class C β-Lactamase and Its Regulatory Gene in Ochrobactrum anthropi ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2324–2330
1450Dominique Serge Ngono Bikobo,Jeanne Louise Nkot,Paul Mosset,Alex de Théodore Atchade,Joseph thierry Ndongo,René Pemha and Dieudonné Emmanuel Pegnyemb 2011. Acylsteryl Glycosides and other Constituents from Campylospermumu Densiflorum (OCHNACEAE) RASAYAN Journal of Chemistry Vol.4, No.4 (2011), 753-763
1451Delphine Girlich, Thierry Naas, and Patrice Nordmann 2004. OXA-60, a Chromosomal, Inducible, and Imipenem-Hydrolyzing Class D β-Lactamase from Ralstonia pickettii ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 4217–4225
1452 2011. GRAM-POSITIVE ANAEROBIC COCCI Identification and clinical relevance
1453Fernanda S. Almeida, Viviane Nakano and Mario J. Avila-Campos 2007. Occurrence of enterotoxigenic and nonenterotoxigenic Bacteroides fragilis in calves and evaluation of theirantimicrobial susceptibility FEMS Microbiol Lett 1574-6968
1454Philippe Ulsemer, Kawe Toutounian, Jens Schmidt, Uwe Karsten, and Steffen Goletz 2011. Preliminary Safety Evaluation of a New Bacteroides xylanisolvens Isolate Applied and Environmental Microbiology 528–535
1455J.M. Hansen, H. Fjeldsøe-Nielsen, S. Sulim, M. Kemp and J.J. Christensen 2009. Actinomyces species: A Danish Survey on Human Infections and Microbiological Characteristics The Open Microbiology Journal 113-120
1456Sophie Joly, Connie Maze, Paul B. McCray, Jr., and Janet M. Guthmiller 2004. Human β-Defensins 2 and 3 Demonstrate Strain-Selective Activity against Oral Microorganisms JOURNAL OF CLINICAL MICROBIOLOGY 1024–1029
1457Ellie J. C. Goldstein, Diane M. Citron, C. Vreni Merriam, Yumi A. Warren, Kerin L. Tyrrell, and Helen T. Fernandez 2004. In Vitro Activities of the New Semisynthetic Glycopeptide Telavancin (TD-6424), Vancomycin, Daptomycin, Linezolid, and Four Comparator Agents against Anaerobic Gram-Positive Species and Corynebacterium spp. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2149–2152
1458Argelia Almaguer-Flores, Jazmin-Yunuen Moreno-Borjas, Araceli Salgado-Martinez, Marco-Antonio Sanchez-Reyes, Eulalio Alcantara-Maruri and Laurie-Ann Ximenez-Fyvie 0. Proportion of antibiotic resistance in subgingival plaque samples from Mexican subjects Joumal of Clinical Periodontology
1459MARYAM I. DANESHVAR, DANNIE G. HOLLIS, ARNOLD G. STEIGERWALT, ANNE M. WHITNEY, LAURA SPANGLER, MICHAEL P. DOUGLAS, JEAN G. JORDAN, JOHN P. MACGREGOR, BERTHA C. HILL, FRED C. TENOVER, DON J. BRENNER, AND ROBBIN S. WEYANT 2001. Assignment of CDC Weak Oxidizer Group 2 (WO-2) to the Genus Pandoraea and Characterization of Three New Pandoraea Genomospecies JOURNAL OF CLINICAL MICROBIOLOGY 1819–1826
1460ELLIE J. C. GOLDSTEIN, DIANE M. CITRON, C. VRENI MERRIAM, YUMI WARREN, AND KERIN TYRRELL 1999. Activities of Telithromycin (HMR 3647, RU 66647) Compared to Those of Erythromycin, Azithromycin, Clarithromycin, Roxithromycin, and Other Antimicrobial Agents against Unusual Anaerobes ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2801–2805
1461Vincent Cattoir, Alexandre Varca, Gilbert Greub, Guy Prod’hom, Patrick Legrand and Reto Lienhard 2010. In vitro susceptibility of Actinobaculum schaalii to 12 antimicrobial agents and molecular analysis of fluoroquinolone resistance Journal of Antimicrobial Chemotherapy 2514–2517
1462HARUMI KATSURA, RYO-ICHI TSUKIYAMA, AKIKO SUZUKI, AND MAKIO KOBAYASHI 2001. In Vitro Antimicrobial Activities of Bakuchiol against Oral Microorganisms ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 3009–3013
1463Sandeep Sharma, Inshad Ali Khan, Intzar Ali, Furqan Ali, Manoj Kumar, Ashwani Kumar, Rakesh Kamal Johri, Sheikh Tasduq Abdullah, Sarang Bani, Anjali Pandey, Krishan Avtar Suri, Bishan Datt Gupta, Naresh Kumar Satti, Prabhu Dutt, and Ghulam Nabi Qazi 2009. Evaluation of the Antimicrobial, Antioxidant, and Anti-Inflammatory Activities of Hydroxychavicol for Its Potential Use as an Oral Care Agent ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 216–222
1464Yaya Rukayadi, Kwanghyung Lee, Sunghwa Han, Dongeun Yong, and Jae-Kwan Hwang 2009. In Vitro Activities of Panduratin A against Clinical Staphylococcus Strains ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 4529–4532
1465Jae-Kwan Hwang, Yaya Rukayadi 0. CHALLENGES AND OPPORTUNITIES IN APPLYING TEMULAWAK (Curcuma xanthorrhiza Roxb.) FOR INDUSTRIAL ORAL CARE PRODUCTS
1466Lois M. Ednie, Ashok Rattan, Michael R. Jacobs, and P. C. Appelbaum 2003. Antianaerobe Activity of RBX 7644 (Ranbezolid), a New Oxazolidinone, Compared with Those of Eight Other Agents ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 1143–1147
1467Wolfgang Haas, Chris M. Pillar, Gary E. Zurenko, Jacqueline C. Lee, Lynne S. Brunner, and Timothy W. Morris 2009. Besifloxacin, a Novel Fluoroquinolone, Has Broad-Spectrum In Vitro Activity against Aerobic and Anaerobic Bacteria ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 3552–3560
1468CARMEN BETRIU, ANA SA´NCHEZ, MARI´A LUISA PALAU, MARI´A GO´ MEZ, AND JUAN J. PICAZO 2001. In Vitro Activities of MK-0826 and 16 Other Antimicrobials against Bacteroides fragilis Group Strains ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2372–2374
1469DIANNE B. HOELLMAN, LINDA M. KELLY, MICHAEL R. JACOBS, AND PETER C. APPELBAUM 2001. Comparative Antianaerobic Activity of BMS 284756 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 589–592
1470RIAL D. ROLFE AND SYDNEY M. FINEGOLD 1981. Comparative In Vitro Activity of New Beta-Lactam Antibiotics Against Anaerobic Bacteria ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 600-609
1471Trine R H Nielsen,Victor Kuete,Anna K Jäger,Jacobus J Marion Meyer,Namrita Lall 2012. Antimicrobial activity of selected South African medicinal plants BMC Complementary and Alternative Medicine 2012, 12:74
1472C. A. S. VIDAL, E. O. SOUSA, FABÍOLA F. G. RODRIGUES, ADRIANA R. CAMPOS,S. R. LACERDA and J. G. M. COSTA 2012. Phytochemical Screening and Synergistic Interactions between Aminoglycosides, Selected Antibiotics and Extracts from the bryophyte octoblepharum albidum Hedw(CALYMPERACEAE) Archives of Biological Sciences 64 (2), 465-470
1473DIANNE B. HOELLMAN, SHEILA K. SPANGLER, MICHAEL R. JACOBS, AND PETER C. APPELBAUM 1998. In Vitro Activities of Cefminox against Anaerobic Bacteria Compared with Those of Nine Other Compounds ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 495–501
1474Kim L. Credito, Lois M. Ednie, and Peter C. Appelbaum 2008. Comparative Antianaerobic Activities of Doripenem Determined by MIC and Time-Kill Analysis ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 365–373
1475Lee-Jene Teng, Po-Ren Hsueh, Jui-Chang Tsai, Shwu-Jen Liaw, Shen-Wu Ho, and Kwen-Tay Luh 2002. High Incidence of Cefoxitin and Clindamycin Resistance among Anaerobes in Taiwan ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2908–2913
1476David R. Snydman, Nilda V. Jacobus and Laura A. McDermott 2005. Evaluation of the in vitro activity of NVP-LMB415 against clinical anaerobic isolates with emphasis on the Bacteroides fragilis group Journal of Antimicrobial Chemotherapy 55, 1024–1028
1477Kaori Tanaka, Hiroshige Mikamo, Ken’ichi Nakao, and Kunitomo Watanabe 2006. In Vitro Antianaerobic Activity of DX-619, a New Des-Fluoro(6) Quinolone ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 3908–3913
1478HERIN OH, NAGWA EL AMIN, TODD DAVIES, PETER C. APPELBAUM, AND CHARLOTTA EDLUND 2001. gyrA Mutations Associated with Quinolone Resistance in Bacteroides fragilis Group Strains ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 1977–1981
1479HANNAH M. WEXLER, DENISE MOLITORIS, AND SYDNEY M. FINEGOLD 2000. In Vitro Activities of MK-826 (L-749,345) against 363 Strains of Anaerobic Bacteria ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2222–2224
1480Kenneth E. Aldridge, Michael Gelfand, L. Barth Reller, Leona W. Ayers, Carl L. Pierson, Fritz Schoenknecht, Richard C. Tilton, Jeanette Wilkinst, Amy Henderberg, Denise D. Schiro, Marlene Johnson, Aileen Janney, and Charles V. Sanders 1994. A Five-Year Multicenter Study of the Susceptibility of the Bacteroides fragilis Group Isolates to Cephalosporins, Cephamins, Penicillins, Clindamycin, and Metronidazole in the United States Diagnostic Microbiology and Infectious Disease 18:235-241
1481Mitchell J. Schwaber, Patti M. Raney, J. Kamile Rasheed, James W. Biddle, Portia Williams, John E. McGowan, Jr., and Fred C. Tenover 2004. Utility of NCCLS Guidelines for Identifying Extended-Spectrum -Lactamases in Non-Escherichia coli and Non-Klebsiella spp. of Enterobacteriaceae JOURNAL OF CLINICAL MICROBIOLOGY 294–298
1482P. Panichayupakaranant, S. Tewtrakul, S. Yuenyongsawad 2010. Antibacterial, anti-inflammatory and anti-allergic activities of standardised pomegranate rind extract Food Chemistry 400–403
1483A. JOHN DE BRITTO AND D. HERIN SHEEBA GRACELIN 2011. Azadiracta Indica A Juss. - A Potential Antimicrobial Agent Against Xanthomonas Campestris International Journal of Applied Biology and Pharmaceutical Technology 374-378
1484Haifeng Gao, Chao Luo, Lan Wang, Jihua Wang, Bingbing Zheng, Youliang Peng and Ligang Zhou 2012. Preparative separation of 3-O-methylkaempferol from Caragana leucophloea by high-speed counter-current chromatography and its antimicrobial activity Journal of Medicinal Plants Research 6(11): 2081-2087
1485S. C. Sati and Savita Joshi 2011. Antibacterial Activities of Ginkgo biloba L. Leaf Extracts The Scientific World Journal 2237–2242
1486Nai-Xun Chin, Jian-Wei Gu, Wei Fang, and Harold C. Neu 1992. In vitro Activity of Cefquinome, a New Cephalosporin, Compared with Other Cephalosporin Antibiotics Diagn Microbiol Infect Dis 15:331-337
1487S. Nanjunda Swamy, Basappa, B.S. Priya, B. Prabhuswamy, B.H. Doreswamy, J. Shashidhara Prasad, Kanchugarakoppal S. Rangappa 2006. Synthesis of pharmaceutically important condensed heterocyclic 4,6-disubstituted-1,2,4-triazolo- 1,3,4-thiadiazole derivatives as antimicrobials European Journal of Medicinal Chemistry 41(2006): 531–538
1488Stephen G. Jenkins 1989. Activity of Cefotaxime/ Desacetylcefotaxime with Two Aminoglycosides Against Gram- Negative Pathogens: An Example of Interactive Synergy Diagn Microbiol Infect Dis 12:51-55
1489Hee Jin Park, Jung Yeop Lee, Surk Sik Moon, Byung Kook Hwang 2003. Isolation and anti-oomycete activity of nyasol from Anemarrhena asphodeloides rhizomes Phytochemistry 64(2003): 997–1001
1490B. S. Priya, Basappa, S. Nanjunda Swamy and Kanchugarakoppal S. Rangappa 2005. Synthesis and characterization of novel 6-fluoro-4-piperidinyl-1,2-benzisoxazole amides and 6-fluoro-chroman-2-carboxamides: antimicrobial studies Bioorganic & Medicinal Chemistry 13(2005): 2623–2628
1491Alison M. Clarke, S. Janet V. Zemcov, and Maria M. Hubinette 1994. Comparative in vitro Activity of FK-037, a New Cephalosporin Antibiotic Diagn Microbiol Infect Dis 20:27-32
1492A. Bauernfeind 1991. Comparative Antimicrobial Spectrum and Activity of Ceftibuten Against Clinical Isolates from West Germany Diagn Microbiol Infect Dis 14: 63-7
1493R. Suhas, S. Chandrashekar, D. Channe Gowda 2011. Synthesis of elastin based peptides conjugated to benzisoxazole as a new class of potent antimicrobials e A novel approach to enhance biocompatibility European Journal of Medicinal Chemistry 46(2011): 704-711
1494Ludo Verbist, Jan Jacobs, and Koen Hens 1991. Comparative Antimicrobial Activity of Ceftibuten Against Multiply-Resistant Microorganisms from Belgium Diagn Microbiol Infect Dis 14:53-6
1495Manuela Reyes-Estebanez, Elizabeth Herrera-Parra, Jairo Cristóbal-Alejo, Gabriela Heredia-Abarca, Blondy Canto-Canché, Irma Medina-Baizaba and Marcela Gamboa-Angulo 2011. Antimicrobial and nematicidal screening of anamorphic fungi isolated from plant debris of tropical areas in Mexico African Journal of Microbiology Research 5(9): 1083-1089
1496Wimonrat Tongpoothorn, Saksit Chanthai, Manop Sriuttha, Kanda Saosang, Chalerm Ruangviriyachai 2012. Bioactive properties and chemical constituents of methanolic extract and its fractions from Jatropha curcas oil Industrial Crops and Products 36(2012): 437–444
1497Inès Hammami, Mohamed Ali Triki and Ahmed Rebai 2011. Chemical compositions, antibacterial and antioxidant activities of essential oil and various extracts of Geranium sanguineum L. flowers Archives of Applied Science Research 3(3):135-144
1498B.S. Priya, S. Nanjunda Swamy, M.V. Tejesvi, Basappa a, G. Sarala, S.L. Gaonkar, S. Naveen, J. Shashidhara Prasad, K.S. Rangappa 2006. Synthesis, characterization, antimicrobial and single crystal X-ray crystallographic studies of some new sulfonyl, 4-chloro phenoxy benzene and dibenzoazepine substituted benzamides European Journal of Medicinal Chemistry 41(2006): 1262-1270
1499Ren-Bo An, Hyun-Chul Kim, Sung-Hee Lee, GiI-Saeng Jeong, Dong-Hwan Sohn, Hyun Park, Dong-Yeul Kwon, John Hwa Lee, and Youn-Chul Kim 2006. A New Monoterpene Glycoside and Antibacterial Monoterpene Glycosides from Paeonia suffruticosa Archives of Pharmacal Research 815-820
1500Banfeng Ruan, Yupeng Tian, Hongping Zhou, Jieying Wu, Zhaodi Liu, Chenhao Zhu, Jiaxiang Yang, Hailiang Zhu 2009. Synthesis, crystal structure and in vitro antibacterial activity of two novel silver(I) complexes Journal of Organometallic Chemistry 694 (2009): 2883-2887
1501Osamu Kisanuki, Hiroshi Yajima, Tomohiro Umeda, and Yoshinori Takakura 2007. Experimental study of calcium phosphate cement impregnated with dideoxy-kanamycin B Journal of Orthopaedic Science 12:281-288
1502Jianjun Zhang, Katherine Keller, Jon Y Takemoto, Mekki Bensaci, Anthony Litke, Przemyslaw Greg Czyryca and Cheng-Wei Tom Chang 2009. Synthesis and combinational antibacterial study of 500-modified neomycin The Journal of Antibiotics 62:539-544
1503Nayeemulla Shariff1, M. S. Sudarshana1, S. Umesha and P. Hariprasad 2006. Antimicrobial activity of Rauvolfia tetraphylla and Physalis minima leaf and callus extracts African Journal of Biotechnology 5(10):946-950
1504Ronald N. Jones, Martha J. Bale, Daryl Hoban, and Meridith E.Erwin 1993. In vitro Antimicrobial Activity of Tioconazole and Its Concentrations in Vaginal Fluids Following Topical (Vagistat-1 6.5%) Application Diagnostic Microbiology and Infectious Disease 17: 45-51
1505Uma Sundaram, M. Marimuthu and P. Gurumoorthi 2012. Antibacterial Activity of Velvet Bean (Mucuna pruriens Linn.) Seed Extracts against Human and Plant Pathogens International Journal of Medicobiological Research 1(6): 301-304
1506C. N. Park, D. Lee1, W. Kim, Y. Hong, J. S. Ahn and B. S. Kim 2007. Antifungal activity of salaceyin A against Colletotrichum orbiculare and Phytophthora capsici Journal of Basic Microbiology 47: 332–339
1507Giuseppe Celenzaa, Bernardetta Segatorea, Domenico Setaccia, Pierangelo Bellio, Fabrizia Brisdelli,Marisa Piovano, Juan A. Garbarino, Marcello Nicoletti, Mariagrazia Perilli, Gianfranco Amicosante 2012. In vitro antimicrobial activity of pannarin alone and in combination with antibiotics against methicillin-resistant Staphylococcus aureus clinical isolates Phytomedicine 19(2012):596-602
1508Sirus Bidarigh, Alireza Massiha, Mohammad R. M. Khoshkholgh Pahlaviani Khosro Issazadeh, Panah Z. Muradov, Ebrahim Azarpour1 2012. Antimicrobial (Screening) properties of Various Plant Extracts from Ocimum basilicum L. and Nerium oleander L. against Fungal Common Rots of Potato In vitro Bioassay Journal of Basic and Applied Scientific Research 2(7): 6810-6815
1509L. X. Bonfietti, M. W. Szeszs, M. R. Chang, M. A. Martins, S. R. B. S. Pukinskas, M. O. Nunes, G. H. Pereira, A. M. M. Paniago, S. U. Purisco, M. S. C. Melhem 2012. Ten-Year Study of Species Distribution and Antifungal Susceptibilities of Candida Bloodstream Isolates at a Brazilian Tertiary Hospital Mycopathologia
1510L. Shiva Kumar and H.D. Revanasiddappa 2011. Synthesis, characterization, antimicrobial, DNA binding, and oxidative cleavage activities of Cu(II) and Co(II) complexes with 2-(2-hydroxybenzylideneamino)isoindoline-1,3-dione Journal of Coordination Chemistry 699–714
1511William R. Schwan, M. Shahjahan Kabir, Maren Kallaus, Sarah Krueger, Aaron Monte, James M. Cook 2012. Synthesis and minimum inhibitory concentrations of SK-03-92 against Staphylococcus aureus and other gram-positive bacteria Journal of Infection and Chemotherapy 18:124–126
1512Al Hajjar Nadim1, Flaviu Pitu, Emoke Pall, Florina Pitu, Ilie Suarasan, Calin. Popa1 and Nicodim Fiţ 2012. In vitro effect of ozonated saline on microorganisms involved in pancreatic and peripancreatic necrosis infection in severe acute pancreatitis African Journal of Microbiology Research 6(3): 611-616
1513K.K. Schultz, E.L. Strait, B.Z. Erickson, N. Levy 2012. Optimization of an antibiotic sensitivity assay for Mycoplasma hyosynoviae and susceptibility profiles of field isolates from 1997 to 2011 Veterinary Microbiology 158(2012):104-108
1514Veeramuthu Duraipandiyan, Naif Abdullah Al-Harbi, Savarimuthu Ignacimuthu and Chinnasamy Muthukumar 2012. Antimicrobial activity of sesquiterpene lactones isolated from traditional medicinal plant, Costus speciosus (Koen ex.Retz.) Sm BMC Complementary and Alternative Medicine 12:13
1515Mahsa Abdolhosseini, Seshagiri R. Nandula, Jonathan Song, Helmut Hirt, Sven-Ulrik Gorr 2012. Lysine substitutions convert a bacterial-agglutinating peptide into a bactericidal peptide that retains anti-lipopolysaccharide activity and low hemolytic activity Peptides 35(2012):231-238
1516Richa Arora, Sunil Mundra, Ashish Yadav, Ravi B. Srivastava and Tsering Stobdan 2012. Antimicrobial activity of seed, pomace and leaf extracts of sea buckthorn (Hippophae rhamnoides L.) against foodborne and food spoilage pathogens African Journal of Biotechnology 11(45):10424-10430
1517K.K. Nyirenda, J.D.K.Saka, D.Naidoo, V.J.Maharaj, C.J.F.Muller 2012. Antidiabetic,anti-oxidantandantimicrobialactivitiesof Fadogia ancylantha extracts fromMalawi Journal of Ethnopharmacology 143(2012):372–376
1518Malek Besbesa, Amel Omria, Imed Cheraifb, Mejda Daamic, Hichem Ben Jannet,Maha Mastourid, Mahjoub Aounia, and Boulbaba Selmia 2012. Chemical Composition and Antimicrobial Activity of Essential Oils from Scabiosa arenaria Forssk. Growing Wild in Tunisia Chemistry and Biodiversity 9(2012):829-839
1519Emmanuel MouafoTekwu, AnatoleConstantPieme, Ve´ronique Penlap Beng 2012. InvestigationsofantimicrobialactivityofsomeCameroonianmedicinalplant extracts againstbacteriaandyeastwithgastrointestinalrelevance Journal of Ethnopharmacology 142(2012):265–273
1520Lila Boulekbache-Makhlouf, Sakina Slimani, Khodir Madani 2012. Total phenolic content, antioxidant and antibacterial activities of fruits of Eucalyptus globulus cultivated in Algeria Industrial Crops and Products 41(2013):85-89
1521Yazmín Rosas-Pi˜nón, Alicia Mejía, Gloria Díaz-Ruiz, María Isabel Aguilar, Sobeida Sánchez-Nieto, J. Fausto Rivero-Cruz 2012. Ethnobotanical survey and antibacterial activity of plants used in the Altiplane region of Mexico for the treatment of oral cavity infections Journal of Ethnopharmacology 141(2012):860-865
1522Verónica Vogta, Diego Cifuente, Carlos Tonn, Liliana Sabini, Susana Rosas 2012. Antifungal activity in vitro and in vivo of extracts and lignans isolated from Larrea divaricata Cav. against phytopathogenic fungus Industrial Crops and Products 42(2013):583-586
1523H.N. Krishna Kumar, Kokila, G. Bhavyashree and Jyoti Bala Chauhan 2012. Phytochemical Screening and Antibacterial Activity of Stachytarpheta indica Global Journal of Pharmacology 6(1):04-07
1524Brandon Findlay, George G. Zhanel, Frank Schweizer 2012. Investigating the antimicrobial peptide ‘window of activity’ using cationic lipopeptides with hydrocarbon and fluorinated tails International Journal of Antimicrobial Agents 40(2012):36-42
1525Christian Agyare, George Asumeng Koffuor, Vivian Etsiapa Boamah, Francis Adu, Kwesi Boadu Mensah, and Louis Adu-Amoah 2012. Antimicrobial and Anti-Inflammatory Activities of Pterygota macrocarpa and Cola gigantea (Sterculiaceae) Evidence-Based Complementary and Alternative Medicine 1-9
1526Bowei Zhang, Tao Shangguan, Huiming Ma, Xin Huang and Yong Zhang 2012. Lysis of mastitis pathogens isolated from dairy cow milk samples by purified recombinant lysostaphin African Journal of Biotechnology 11(20):4649-4659
1527Cemil Kurekci, Sharon L. Bishop‐Hurley, Philip E. Vercoe, Zoey Durmic,Rafat A. M. Al Jassim and Christopher S. McSweeney 2011. Screening of Australian Plants for Antimicrobial Activity against Campylobacter jejuni Phytotherapy Research 26(2012):186-190
1528Karina Andrade de Prince1, Renata Sordi, Fernando Rogério Pavan, Adolfo Carlos Barreto Santos, Angela R. Araujo, Sergio R.A. Leite, Clarice Q. F. Leite 2011. ANTI-MYCOBACTERIUM TUBERCULOSIS ACTIVITY OF FUNGUS PHOMOPSIS STIPATA Brazilian Journal of Microbiology (2012):224-229
1529Rumbidzai Mangoyi, Washington Mafukidze, Kerstin Marobela and Stanley Mukanganyama 2012. Antifungal Activities and Preliminary Phytochemical Investigation of Combretum Species from Zimbabwe Microbial and Biochemical Technology 4(2):037-044
1530Anjali Sharma, Sonal Gupta, Indira P. Sarethy, Shweta Dang, Reema Gabrani 2012. Green tea extract: Possible mechanism and antibacterial activity on skin pathogens Food Chemistry 135(2012):672-675
1531Wei-Cai Zeng, Zeng Zhang, Hong Gao, Li-Rong Jia and Qiang He 2012. Chemical Composition, Antioxidant, and Antimicrobial Activities of Essential Oil from Pine Needle (Cedrus deodara) Journal of Food Science 824-829
1532Olufunmiso Olusola Olajuyigbe, Anthony Jide Afolayan 2012. In Vitro Antibacterial and Time-Kill Assessment of Crude Methanolic Stem Bark Extract of Acacia mearnsii De Wild against Bacteria in Shigellosis Molecules 17:2103-2118
1533Azza Taher Taher and Sahar Mahmoud Abou-Seri 2012. Synthesis and Bioactivity Evaluation of New 6-Aryl-5-cyano Thiouracils as Potential Antimicrobial and Anticancer Agents Molecules 17:9868-9886
1534José Guilherme Prado Martin, Ernani Porto1, Cristina Bani Corrêa, Severino Matias de Alencar, Eduardo Micotti da Gloria, Ingridy Simone Ribeiro Cabral, Lígia Maria de Aquino 2011. Antimicrobial potential and chemical composition of agro-industrial wastes Journal of Natural Products 5(2012):27-36
1535Chaima Alaoui Jamali, Laila El Bouzidi, Khalid Bekkouche, Hassani Lahcen, Mohammed Markouk, Hans Wohlmuth, David Leach and Abdelaziz Abbad 2012. Chemical Composition and Antioxidant and Anticandidal Activities of Essential Oils from Different Wild Moroccan Thymus Species Chemistry and Biodiversity 9(2012):1188-1197
1536Olufunmiso O. Olajuyigbe, Anthony J. Afolayan 2012. Pharmacological Assessment of the Medicinal Potential of Acacia mearnsii De Wild.: Antimicrobial and Toxicity Activities International Journal of Molecular Sciences 13: 4255-4267
1537Graciliana Lopes, Carla Sousa, Luı´s R. Silva, Euge´ nia Pinto, Paula B. Andrade1, Joa˜o Bernardo, Teresa Mouga, Patrı´cia Valenta˜o 2012. Can Phlorotannins Purified Extracts Constitute a Novel Pharmacological Alternative for Microbial Infections with Associated Inflammatory Conditions? Plos One 7(2): e31145
1538Suk-Ho Ban, Jeong-Eun Kim, Santosh Pandit and Jae-Gyu Jeon 2012. Influences of Dryopteris crassirhizoma Extract on the Viability, Growth and Virulence Properties of Streptococcus mutans Molecules 17:9231-9244
1539Lingyun Zhong, Ligang Zhou, Yaming Zhou, Yuanquan Chen, Peng Sui, Jingguo Wang and Mingan Wang 2012. Antimicrobial flavonoids from the twigs of Populus nigra\ Populus deltoides Natural Product Research 26(4):307–313
1540T. Kalaivani, M. Sasirekha, D. Arunraj, V. Palanichamy and C. Rajasekaran 2012. In Vitro Evaluation of Antibacterial Activity of Phytochemical Extracts from aerial parts of Bacopa monnieri (L.) Wettest (Scorphulariaceae) Journal of Pharmacy Research 5(3):1636-1639
1541M.O. Omidiran, R.A. Baiyewu, I.T. Ademola, O.C. Fakorede, E.O. Toyinbo, O.J. Adewumi and E.A. Adekunle 2012. Phytochemical Analysis, Nutritional Composition and Antimicrobial Activities of White Mulberry (Morus alba) Pakistan Journal of Nutrition 11(5): 456-460
1542Marc A. Fox, Joanne E. Thwaite, David O. Ulaeto, Timothy P. Atkins, Helen S. Atkins 2012. Design and characterization of novel hybrid antimicrobial peptides based on cecropin A, LL-37 and magainin II Peptides 33(2012):197–205
1543S. de Rapper, S.F. Van Vuuren, G.P.P. Kamatou, A.M. Viljoen and E. Dagne 2012. The additive and synergistic antimicrobial effects of select frankincense and myrrh oils – a combination from the pharaonic pharmacopoeia Letters in Applied Microbiology 54:352–358
1544Ingo Sobottka, Karl Wegscheider, Ludwig Balzer, Rainer H. Böger, Olaf Hallier, Ina Giersdorf, Thomas Streichert, Munif Haddad, Ursula Platzer, and Georg Cachovan 2012. Microbiological Analysis of a Prospective, Randomized, Double-Blind Trial Comparing Moxifloxacin and Clindamycin in the Treatment of Odontogenic Infiltrates and Abscesses Antimicrobial Agents and Chemotherapy 56(5):2565
1545 0.
1546O. O. Olajuyigbe and A. J. Afolayan 2012. Antimicrobial potency of the ethanolic crude bark extract of Ziziphus mucronata Willd. subsp. mucronata Willd. African Journal of Pharmacy and Pharmacology 6(10):724-730
1547Luis E. Diaz, Diego R. Munoz, Rosa E. Prieto, Sergio A. Cuervo, Diego L. Gonzalez , Juan D. Guzman and Sanjib Bhakta 2012. Antioxidant, Antitubercular and Cytotoxic Activities of Piper imperiale Molecules 17:4142-4157
1548Suhaib Ibrahim Alkhamaiseh, Muhammad Taher, Farediah Ahmad, Haitham Qaralleh, Osama Yousef Althunibat, Deny Susanti and Solachuddin Jauhari Arief Ichwan 2012. The phytochemical content and antimicrobial activities of Malaysian Calophyllum canum (stem bark) Pakistan Journal of Pharmaceutical Sciences 25:555-563
1549Nur Salwani Bakar, Noraziah Mohamad Zin and Dayang Fredalina Basri 2012. Synergy of flavone with vancomycin and oxacillin against vancomycin-intermediate Staphylococcus aureus Pakistan Journal of Pharmaceutical Sciences 25:633-638
1550Marijana Kosani´c, Branislav Rankovi´c and Tatjana Stanojkovi´ 2012. Antioxidant, Antimicrobial, and Anticancer Activity of 3 Umbilicaria Species Journal of Food Science 71:20-25
1551Muhammad Hanif, Muhammad Saleem, Muhammad Tahir Hussain, Nasim Hasan Rama, Sumera Zaib, Muhammad Adil M. Aslam, Peter G. Jones and Jamshed Iqbal 2012. Synthesis, Urease Inhibition, Antioxidant and Antibacterial Studies of Some 4-Amino-5-aryl-3H-1,2,4-triazole-3-thiones and their 3,6-Disubstituted 1,2,4-Triazolo[3,4-b]1,3,4-thiadiazole Derivatives Journal of the Brazilian Chemical Society 23(5):854-860
1552Xing-Yue Ji, Si-Yang Li, Shuai Meng, Chun-Ling Xiao, Xue-Fu You, Zhuo-Rong Li 2012. Synthesis and antimycobacterial activity of ternatolide Journal of Chinese Pharmaceutical Sciences 21(2012):265–268
1553Simplice Joel Ndendoung Tatsimo, Jean de Dieu Tamokou, Léopold Havyarimana, Dezső Csupor, Peter Forgo, Judit Hohmann, Jules-Roger Kuiate and Pierre Tane 2012. Antimicrobial and antioxidant activity of kaempferol rhamnoside derivatives from Bryophyllum pinnatum BMC Research Notes 5:158
1554Jamshed Iqbal, Sumera Zaib, Umar Farooq, Afsar Khan, IrumBibi and Saba Suleman 2012. Antioxidant, Antimicrobial, and Free Radical Scavenging Potential of Aerial Parts of Periploca aphylla and Ricinus communis ISRN Pharmacology 2012:1-6
1555LEONOR L. LO´ PEZ TE´ VEZ, MARI´A S. ISLAS, JUAN J. MARTI´NEZ MEDINA, MAXIMILIANO DIEZ, OSCAR E. PIRO, EDUARDO E. CASTELLANO, EVELINA G. FERRER and PATRICIA A.M. WILLIAMS 2012. Structural, spectral and potentiometric characterization, and antimicrobial activity studies of [Zn(phen)2(cnge)(H2O)](NO3)2EH2O Journal of Coordination Chemistry 65(13):2304–2318
1556Antoinette Labuschagn´e, Ahmed A. Hussein, Benjam´ın Rodr´ıguez and Namrita Lall 2012. Synergistic Antimycobacterial Actions of Knowltonia vesicatoria (L.f) Sims Evidence-Based Complementary and Alternative Medicine
1557Owhe-Ureghe, U. B., Ogiehor, S. I. and Ehwarieme, D. A. 2012. In vitro susceptibility testing of Yersinia species to eight plant extracts and three natural antimicrobial agents African Journal of Biotechnology 11(42):10008-10014
1558Morasa Sheikhy, Amir R. Jalilian, Aytak Novinrooz, Farahnaz Motamedi-Sedeh 2012. Synthesis and in vitro antibacterial evaluation of some thiosemicarbazides and thiosemicarbazones Journal of Biomedical Science and Engineering 5:39-42
1559Madhavan Sivasankaran Nair, Dasan Arish, Raphael Selwin Joseyphus 2012. Synthesis, characterization, antifungal, antibacterial and DNA cleavage studies of some heterocyclic Schiff base metal complexes Journal of Saudi Chemical Society (2012)16:83–88
1560Fethi Bel Hadj Kether, Mohamed Ali Mahjoub, Samia Ammar Mahjoub, Karima Belhaj Salah, Ahmed Noureddine Helal and Zine Mighri 2012. Chemical composition, in vitro antifungal and antioxidant activities of essential oil from Cotula coronopifolia L. growing in Tunisia African Journal of Microbiology Research 6(20):4388-4395
1561Nobuko Araki, Katsunori Yanagihara, Yoko Matsukawa, Yosuke Harada, Yohei Migiyama, Kentaro Nagaoka, Koichi Yamada, Yoshitomo Morinaga, Hiroo Hasegawa, Shigeru Kohno, Shimeru Kamihira 2012. Molecular characterization of quinolone-insensitive Streptococcus pneumoniae isolates from Japanese patients Journal of Infection and Chemotherapy
1562P Sireesha and CR Setty 2012. Detection of various types of resistance patterns and their correlation with minimal inhibitory concentrations against clindamycin among methicillin-resistant Staphylococcus aureus isolates Indian Journal of Medical Microbiology 30(2):165-9
1563Sabzar Ahmad Dar, A. R. Yousuf, Farooq Ahmad Ganai, Poonam Sharma, Naresh Kumar and Rambir Singh 2012. Bioassay guided isolation and identification of anti-inflammatory and anti-microbial compounds from Urtica dioica L. (Urticaceae) leaves African Journal of Biotechnology 11(65):12910-12920
1564Anilrudh A. Venugopal and Stuart Johnson 2012. Fidaxomicin: A Novel Macrocyclic Antibiotic Approved for Treatment of Clostridium difficile Infection Clinical Infectious Diseases 54(4):568–74
1565Radoš Pavlovic, Jelena Mladenovic, Blaga Radovanovic, Gordana Acamovic-Ðokovic1, Jasmina Zdravkovic, Milan Zdravkovic 2012. Phenolic compounds and biological activity of Capsicum annuum L. African Journal of Biotechnology 11(45):10446-10450
1566Manu Chaudhary and Anurag Payasi 2012. Alternative approach to increase antibiotic sensitivity of coagulase +ve and -ve Staphylococcus spp in planktonic and sessile cells Journal of Pharmacy Research 5(1):316-320
1567MOHAMED M. IBRAHIM, SALIH AL-JUAID, MAHMOUD A. MOHAMED and M.H. YASSIN 2012. Synthesis, characterization, and antimicrobial activities of barbital-based alkaline earth metal complexes: the X-ray crystal structure of [Ba2H(Barb)5] (Barb^5,5-diethyl barbiturate) Journal of Coordination Chemistry 65(17):2957–2971
1568Muhammad Riaz, Nasir Rasool, Iftikhar Hussain Bukhari, Muhammad Shahid, Ameer Fawad Zahoor, Mazhar Amjad Gilani and Muhammad Zubair 2012. Antioxidant, antimicrobial and cytotoxicity studies of Russelia equisetiformis African Journal of Microbiology Research 6(27):5700-5707
1569DANKA BUKVIČKI, M. VELJIĆ, MARINA SOKOVIĆ, SLAVICA GRUJIĆ and P. D. MARIN 2012. ANTIMICROBIAL ACTIVITY OF METHANOL EXTRACTS OF Abietinella abietina, Neckera crispa, Platyhypnidium riparoides, Cratoneuron filicinum AND Campylium protensum MOSSES Archives of Biological Sciences 64(3):911-916
1570Rondla Rohini, P. Muralidhar Reddy, Kanne Shanker, Kodipelli Kanthaiah, Vadde Ravinder and Anren Hu 2011. Synthesis of Mono, Bis-2-(2-Arylideneaminophenyl) Indole Azomethines as Potential Antimicrobial Agents Archives of Pharmacal Research 34(7):1077-1084
1571Salha H.M. Al-Zahrani 2012. Antibacterial activities of gallic acid and gallic acid methyl ester on methicillin-resistant Staphylococcus aureus Journal of American Science 8(2):7-12
1572Samy Selim, Sahar El Alfy, Meshref Al-Ruwaili, Amin Abdo and Soad Al Jaouni 2012. Susceptibility of imipenem-resistant Pseudomonas aeruginosa to flavonoid glycosides of date palm (Phoenix dactylifera L.) tamar growing in Al Madinah, Saudi Arabia African Journal of Biotechnology 11(2):416-422
1573C. Dipankar, S. Murugan 2012. The green synthesis, characterization and evaluation of the biological activities of silver nanoparticles synthesized from Iresine herbstii leaf aqueous extracts Colloids and Surfaces B 98(2012):112–119
1574Kiran Singh, Yogender Kumar, Parvesh Puri, Chetan Sharma and Kamal Rai Aneja 2012. Thermal, Spectral, Fluorescence, and Antimicrobial Studies of Cobalt, Nickel, Copper, and Zinc Complexes Derived from4-[(5-Bromo-thiophen-2-ylmethylene)-amino]- 3-mercapto-6-methyl-5-oxo-[1,2,4]triazine International Journal of Inorganic Chemistry 2012:1-9
1575P. Zarghami Moghaddam, M. Mazandarani, M. R. Zolfaghari, M. T. Badeleh and E. A. Ghaemi 2012. Antibacterial and antioxidant activities of root extract of Onosma dichroanthum Boiss. in north of Iran African Journal of Microbiology Research 6(8):1776-1781
1576V. Patil, A. Bandivadekar and D. Debjani 2012. Inhibition of Propionibacterium acnes lipase by extracts of Indian medicinal plants International Journal of Cosmetic Science 34:234–239
1577Tulin Askun, Gulendam Tumen, Fatih Satıl and Didem Karaarslan 2012. Active constituents of some Satureja L. species and their biological activities African Journal of Microbiology Research 6(22):4623- 4633
1578Aline B. M. Vaz, Luciana R. Brandão, Mariana L. A. Vieira, Raphael S. Pimenta, Paula B. Morais, Marcos E. G. Sobral, Luiz H. Rosa and Carlos A. Rosa 2012. Diversity and antimicrobial activity of fungal endophyte communities associated with plants of Brazilian savanna ecosystems African Journal of Microbiology Research 6(13):3173-3185
1579Valtcho D. Zheljazkov, Tess Astatkie, Alexander N. Hristov 2012. Lavender and hyssop productivity, oil content, and bioactivity as a function of harvest time and drying Industrial Crops and Products 36(2012):222–228
1580Khan, Salman A. , Asiri, Abdullah M. 2012. Novel Steroidal (6R)-Spiro-1,3,4-thiadiazoline Derivatives as Anti-bacterial Agents Chinese Journal of Chemistry 30:1901—1905
1581Andrea Coccia, Antonio Carraturo, Luciana Mosca, Alessandra Masci, Andrea Bellini, Maurizio Campagnaro and Eugenio Lendaro 2012. Effects of methanolic extract of sour cherry (Prunus cerasus L.) on microbial growth International Journal of Food Science and Technology 47:1620–1629
1582Tahereh Sadat Jafarzadeh Kashi1 Solmaz Eskandarion, Mehdi Esfandyari-Manesh, Seyyed Mahmoud, Amin Marashi, Nasrin Samadi, Seyyed Mostafa Fatemi, Fatemeh Atyabi, Saeed Eshraghi, Rassoul Dinarvand 2012. Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing method International Journal of Nanomedicine 2012(7):221–234
1583Julian J Goodman, Stanley I Martin 2012. Critical appraisal of ceftaroline in the management of community-acquired bacterial pneumonia and skin infections Therapeutics and Clinical Risk Management 2012(8):149–156
1584K. BATCIOGLU, Z. YILMAZ, B. SATILMIS, A.B. UYUMLU, H.S. ERKAL, N. YUCEL, S. GUNAL, M. SERIN, H. DEMIRTAS 2012. Investigation of in vivo radioprotective and in vitro antioxidant and antimicrobial activity of garlic (Allium Sativum) European Review for Medical and Pharmacological Sciences 16(3):47-57
1585A. Muralikrishna, B.C. Venkatesh, V. Padmavathi, A. Padmaja, P. Kondaiah, N. Siva Krishna 2012. Synthesis, antimicrobial and cytotoxic activities of sulfone linked bis heterocycles European Journal of Medicinal Chemistry 54(2012):605-614
1586Baya Berka-Zougali, Mohamed-Amine Ferhat, Aicha Hassani , Farid Chemat and Karim S. Allaf 2012. Comparative Study of Essential Oils Extracted from Algerian Myrtus communis L. Leaves Using Microwaves and Hydrodistillation International Journal of Molecular Sciences 13:4673-4695
1587Moyo, Busani, Masika, Patrick Julius and Muchenje, Voster 2012. Antimicrobial activities of Moringa oleifera Lam leaf extracts African Journal of Biotechnology 11(11):2797-2802
1588S. Siavash Saei-Dehkordi, Aziz A. Fallah, Mahbubeh Heidari-Nasirabadi and Mehran Moradi 2012. Chemical composition, antioxidative capacity and interactive antimicrobial potency of Satureja khuzestanica Jamzad essential oil and antimicrobial agents against selected food-related microorganisms International Journal of Food Science and Technology 47:1579–1585
1589Vijender Singh Beniwal, Parmjit Arora 2012. Synergistically Active and Safe Fixed Dose Combination of Meropenem and Sulbactam IIOAB Letters 1:2012
1590Y. L. N. Murthy, Abdul Rajack, M. Taraka Ramji, J. Jeson babu, Ch. Praveen, K. Aruna Lakshmi 2012. Design, solvent free synthesis, and antimicrobial evaluation of 1,4 dihydropyridines Bioorganic & Medicinal Chemistry Letters 22(2012):6016–6023
1591Rabia Alghazeer, Hussein El-Saltani, Nabil A. Saleh, Asma Al-Najjar, Mahboba B. Naili, Fatma Hebail and Howida El-Deeb 2012. Antioxidant and Antimicrobial Activities of Cynara scolymus L. Rhizomes Modern Applied Science 6(7):54-63
1592Eileen C.J. Smith, Neale Wareham, Mire Zloh, Simon Gibbons 2008. 2β-Acetoxyferruginol—A new antibacterial abietane diterpene from the bark of Prumnopitys andina Phytochemistry Letters 1(2008):49–53
1593Varadharajan Subhadra Devi, Ushanandhini, Kuppusamy AsokKumar, Muthuswamy UmaMaheswari, AndichettiarThirumalaisamy Sivashanmugham, Puliyath Jagannath 2011. Synergistic Antibacterial Activity of Cassia auriculata L. Flowers and Ofloxacin Bangladesh Journal of Microbiology 28(2):92-94
1594Liang Ouyang, Yuhui Huang, Yuwei Zhao, Gu He, Yongmei Xie, Jie Liu, Jun He, Bo Liu, Yuquan Wei 2012. Preparation, antibacterial evaluation and preliminary structure–activity relationship (SAR) study of benzothiazol- and benzoxazol-2-amine derivatives Bioorganic & Medicinal Chemistry Letters 22(2012):3044–3049
1595Hayet Edziri, Maha Mastouri, Mohamed Ali Mahjoub, Zine Mighri, Aouni Mahjoub and Luc Verschaeve 2012. Antibacterial, Antifungal and Cytotoxic Activities of Two Flavonoids from Retama raetam Flowers Molecules 17:7284-7293
1596Ayşe Gül Özseven, Emel Sesli Çetin, Buket Cicioğlu Arıdoğan and Levent Özseven 2012. In vitro synergistic activity of carbapenems in combination with other antimicrobial agents against multidrug-resistant Acinetobacter baumannii African Journal of Microbiology Research 6(12):2985-2992
1597Puchakayala Muralidhar Reddy, Rondla Rohini, Edulla Ravi Krishna, Anren Hu and Vadde Ravinder 2012. Synthesis, Spectral and Antibacterial Studies of Copper(II) Tetraaza Macrocyclic Complexes International Journal of Molecular Sciences 13:4982-4992
1598Roger B. Clark, Diana K. Hunt, Minsheng He, Catherine Achorn, Chi-Li Chen, Yonghong Deng, Corey Fyfe, Trudy H. Grossman, Philip C. Hogan, William J. O’Brien, Louis Plamondon, Magnus Rönn, Joyce A. Sutcliffe, Zhijian Zhu and Xiao-Yi Xiao 2012. Fluorocyclines. 2. Optimization of the C-9 Side-Chain for Antibacterial Activity and Oral Efficacy Journal of Medicinal Chemistry 55:606−622
1599Geanne K.N. Santos, Kamilla A. Dutra, Rosângela A. Barros, Claudio A.G. da Câmara, Diana D. Lira, Norma B. Gusmão, Daniela M.A.F. Navarro 2012. Essential oils from Alpinia purpurata (Zingiberaceae): Chemical composition, oviposition deterrence, larvicidal and antibacterial activity Industrial Crops and Products 40(2012):254–260
1600Z. GLIŃSKI, J. JAROSZ 1994. DEFENSIVE STRATEGIES OF THE HONEYBEE (APIS MELLIFERA L.) AS A SOCIAL INSECT Apiacta 3,1994
1601Neha Pandit, Rajeev K. Singla and Birendra Shrivastava 2012. Current Updates on Oxazolidinone and Its Significance International Journal of Medicinal Chemistry
1602Gangaru Bhaskar, Yuvaraj Arun, Chandrasekar Balachandran, Chandrasekara Saikumar, Paramasivan T. Perumal 2012. Synthesis of novel spirooxindole derivatives by one pot multicomponent reaction and their antimicrobial activity European Journal of Medicinal Chemistry 51(2012):79e91
1603Zorica D. Petrović, Ljiljana Čomić, Olgica Stefanović, Dušica Simijonović, Vladimir P. Petrović 2012. Antimicrobial activity of the ionic liquids triethanolamine acetate and diethanolamine chloride, and their corresponding Pd(II) complexes Journal of Molecular Liquids 170(2012):61–65
1604Etinosa O. Igbinosa, Emmanuel E. Odjadjare, Isoken H. Igbinosa, Phillips O. Orhue, May N. O. Omoigberale and Napoleon I. Amhanre 2012. Antibiotic Synergy Interaction against Multidrug-Resistant Pseudomonas aeruginosa Isolated from an Abattoir Effluent Environment The Scientific World Journal 2012:1-5
1605Vern Jou Cheng, Alaa El-Din A. Bekhit, Michelle McConnell , Sonya Mros , Jenny Zhao 2012. Effect of extraction solvent, waste fraction and grape variety on the antimicrobial and antioxidant activities of extracts from wine residue from cool climate Food Chemistry 134(2012):474–482
1606Noviany Hasan, Hasnah Osman, Suriyati Mohamad, Wong Keng Chong, Khalijah Awang and Anis Safirah Mohd Zahariluddin 2012. The Chemical Components of Sesbania grandiflora Root and Their Antituberculosis Activity Pharmaceuticals 5:882-889
1607S. Tokarzewski, G. Ziółkowska, A. Nowakiewicz 2012. Susceptibility testing of Aspergillus niger strains isolated from poultry to antifungal drugs – a comparative study of the disk diffusion, broth microdilution (M 38-A) and Etest® methods Polish Journal of Veterinary Sciences 15(1):125-133
1608MarijanaMKosani´c, Branislav R Rankovi´c and Tatjana P Stanojkovi´c 2012. Antioxidant, antimicrobial and anticancer activities of three Parmelia species Society of Chemical Industry 92:1909–1916
1609Ana P. Guedes, G. Franklin, Manuel Fernandes-Ferreira 2012. Hypericum sp.: essential oil composition and biological activities Phytochemistry Reviews 11:127–152
1610Anil K. Patel, Niraj H. Patel, Mehul A. Patel and Dinker I. Brahmbhatt 2012. Synthesis of Some 3-(4-Aryl-benzofuro[3,2-b]pyridin- 2-yl)coumarins and Their Antimicrobial Screening Journal of Heterocyclic Chemistry 49:504-510
1611 0.
1612Adam Huczyn´ ski, Jan Janczak, Joanna Stefan´ ska, Michał Antoszczak, Bogumil Brzezinski 2012. Synthesis and antimicrobial activity of amide derivatives of polyether antibiotic—salinomycin Bioorganic and Medicinal Chemistry Letters 22(2012):4697–4702
1613Bernadette Biloa Messi, Karine Ndjoko-Ioset, Barbara Hertlein-Amslinger, Alain Meli Lannang, Augustin E. Nkengfack, Jean-Luc Wolfender, Kurt Hostettmann and Gerhard Bringmann 2012. Preussianone, a New Flavanone-Chromone Biflavonoid from Garcinia preussii Engl. Molecules 17:6114-6125
1614Barry Collins, Caitriona M. Guinane, Paul D. Cotter, Colin Hill and R. Paul Ross 2012. Assessing the Contributions of the LiaS Histidine Kinase to the Innate Resistance of Listeria monocytogenes to Nisin, Cephalosporins, and Disinfectants Applied and Environmental Microbiology 78(8):2923-2929
1615Saleh A. Bahashwan, Naif O. Al-Harbi, Ahmed A. Fayed, Abd El-Galil E. Amr, Khalid A. Shadid, Ali M. Alalawia, Ibrahim M.S. Bassati 2012. Pharmacological activities of some new polycyclic triazolopyrazolopyridazine derivatives International Journal of Biological Macromolecules 51(2012):7–17
1616MM Salem-Bekhit, IMI Moussa, MM Muharram, FK Alanazy, HM Hefni 2012. Prevalence and antimicrobial resistance pattern of multidrug-resistant enterococci isolated from clinical specimens Indian Journal of Medical Microbiology 30(1):44-51
1617Olosunde O. Funmilayo, Abu-Saeed Kamaldeen, Abu-Saeed Muhammad Buhari 2012. Phytochemical Screening and Antimicrobial Properties of a Common Brand of Black Tea (Camellia sinensis) Marketed in Nigerian Environment Advanced Pharmaceutical Bulletin 2(2):259-263
1618Prajwal L.Lobo, Boja Poojary, Manjunatha K., Vasantha Kumar, Anoop Chullikana and N. SuchethaKumari 2012. Synthesis of some 7-arylidene-3-(4-(Methylthio)bezyl)-7Hthiazolo[ 2,3-c][1,2,4]triazine-4,6-diones and their anticonvulsant and antimicrobial activity Journal of Chemical and Pharmaceutical Research 4(5):2522-2531
1619Roˆmulo Rocha Regis, DDS, Maria Paula Della Vecchia, DDS, Antoˆ nio Carlos Pizzolitto, MS, Marco Antonio Compagnoni, DDS, PhD, Pedro Paulo Chaves Souza, DDS, MS, Raphael Freitas de Souza, DDS, PhD 2012. Antimicrobial Properties and Cytotoxicity of an Antimicrobial Monomer for Application in Prosthodontics Journal of Prosthodontics 21(2012):283–290
1620Cristiane F. Da Costa, Alessandra C. Pinheiro, Mauro V. De Almeida, Maria C. S. Lourenc¸o and Marcus V. N. De Souza 2012. Synthesis and Antitubercular Activity of Novel Amino Acid Derivatives Chemical Biology and Drug Design 79:216–222
1621Azza Taher Taher 2012. Synthesis and Biological Assessment of Some New Acrylonitrile Derivatives as Potential Antitumor and Antimicrobial Agents Life Science Journal 9(1):991-1005
1622Justine K. Rudkin, Andrew M. Edwards, Maria G. Bowden, Eric L. Brown, Clarissa Pozzi, Elaine M. Waters, Weng C. Chan, Paul Williams, James P. O'Gara and Ruth C. Massey 2012. Methicillin Resistance Reduces the Virulence of Healthcare-Associated Methicillin-Resistant Staphylococcus aureus by Interfering With the agr Quorum Sensing System The Journal of Infectious Diseases 205:798–806
1623Thara K. M and K. F. Zuhra 2012. Comprehensive In-vitro pharmacological activities of different extracts of Saussurea lappa European Journal of Experimental Biology 2(2):417-420
1624Meeta J. Advani, Imran Siddiqui, Pawan Sharma, Hemalatha Reddy 2012. Activity of Trifluoperazine against Replicating, Non- Replicating and Drug Resistant M. tuberculosis Plos One 7(8):1-9
1625Jie-Lun Hu, Shao-Ping Nie, Dan-Fei Huang, Chang Li, Ming-Yong Xie and Yin Wan 2012. Antimicrobial activity of saponin-rich fraction from Camellia oleifera cake and its effect on cell viability of mouse macrophage RAW 264.7 Society of Chemical Industry 92:2443–2449
1626Rabia Alghazeer, Hussein El-Saltani, Nabeel Saleh, Asma Al-Najjar, Fatma Hebail 2012. Antioxidant and antimicrobial properties of five medicinal Libyan plants extracts Natural Science 4(2012):324-335
1627Michael Stavri and Simon Gibbons 2005. The Antimycobacterial Constituents of Dill (Anethum graveolens) Phytotherapy Research 19:938–941
1628Bektas Tepe, Dimitra Daferera, Munevver Sokmen, Moschos Polissiou, Atalay Sokmen 2004. In Vitro Antimicrobial and Antioxidant Activities of the Essential Oils and Various Extracts of Thymus eigii M. Zohary et P.H. Davis Journal of Agricultural and Food Chemistry 52:1132-1137
1629Gemma ODonnell, Franz Bucar, Simon Gibbons 2006. Phytochemistry and antimycobacterial activity of Chlorophytum inornatum Phytochemistry 67(2006):178–182
1630Jang-Gi Choi, Ok-Hwa Kang, Young-Seob Lee, You-Chang Oh, Hee-Sung Chae, Hye-Jin Jang, Dong-Won Shin and Dong-Yeul Kwon 2009. Antibacterial Activity of Methyl Gallate Isolated from Galla Rhois or Carvacrol Combined with Nalidixic Acid Against Nalidixic Acid Resistant Bacteria Molecules 14:1773-1780
1631Y¨uksel KAN, U¸ckun Sait UC¸AN, Murat KARTAL, M. Levent ALTUN, Sinem ASLAN, Esin SAYAR, Timurhan CEYHAN 2006. GC-MS Analysis and Antibacterial Activity of Cultivated Satureja cuneifolia Ten. Essential Oil Turkish Journal of Chemistry 30(2006):253-259
1632Y. Zhang, W. W. Yew 2009. Mechanisms of drug resistance in Mycobacterium tuberculosis The International Journal of Tuberculosis and Lung Disease 13(11):1320-1330
1633Sri Mulyaningsih, Mahmoud Youns, Mahmoud Z. El-Readi, Mohamed L. Ashour, Endalkachew Nibret, Frank Sporer, Florian Herrmann, Jürgen Reichling and Michael Wink 2010. Biological activity of the essential oil of Kadsura longipedunculata (Schisandraceae) and its major components Journal of Pharmacy and Pharmacology 62:1037-1044
1634Maria C. Palazzo, Hilary L. Wright, Brittany R. Agius, Brenda S. Wright, Debra M. Moriarity, William A. Haber and William N. Setzer 2009. Chemical Compositions and Biological Activities of Leaf Essential Oils of Six Species of Annonaceae from Monteverde, Costa Rica Records of Natural Products 3(3):153-160
1635Simon Gibbons, Fatemeh Fallah and Colin W. Wright 2003. Cryptolepine Hydrochloride: A Potent Antimycobacterial Alkaloid Derived from Cryptolepis sanguinolenta Phytotherapy Research 17:434-436
1636Bushra Abdulkarim Moharm, Ibrahim Jantan, Jacinta Santhanam, Jamia Azdina Jamal 0. Antifungal Activity of the Bark and Leaf Oils of Cinnamomum verum J.S. Presl. Alone and in Combination against Various Fungi
1637Maryam Akhbari, Hossein Batooli and Mohammadreza Mozdianfard 2012. Comparative study of composition and biological activities of SDE prepared essential oils from flowers and fruits of two Hypericum species from central Iran Natural Product Research 26(3):193-202
1638Vivek K. Bajpai, Kwang-Hyun Baek, Sun Chul Kang 2012. Control of Salmonella in foods by using essential oils: A review Food Research International 45(2012):722-734
1639A. C. Figueiredo, J. G. Barroso, L. G. Pedro, L. Salgueiro, M. G. Miguel and M. L. Faleiro 2008. Portuguese Thymbra and Thymus Species Volatiles: Chemical Composition and Biological Activities Current Pharmaceutical Design 14(29):3120-3140
1640Jing Jin, Ji-Yu Zhang, Na Guo, Hui Sheng, Lei Li, Jun-Chao Liang, Xue-Lin Wang, Yang Li, Ming-Yuan Liu, Xiu-Ping Wu and Lu Yu 2010. Farnesol, a Potential Efflux Pump Inhibitor in Mycobacterium smegmatis Molecules 15:7750-7762
1641Amit Kumar Tyagi and AnushreeMalik 2012. Morphostructural Damage in Food-Spoiling Bacteria due to the Lemon Grass Oil and Its Vapour: SEM, TEM, and AFM Investigations Evidence-Based Complementary and Alternative Medicine 2012:1-12
1642R. A. Dickson, P. J. Houghton, P. J. Hylands and S. Gibbons 2006. Antimicrobial, Resistance-Modifying Effects, Antioxidant and Free Radical Scavenging Activities of Mezoneuron benthamianum Baill., Securinega virosa Roxb. &Wlld. and Microglossa pyrifolia Lam. Phytotherapy Research 20:41-45
1643MortenHyldgaard, TinaMygind and RikkeLouiseMeyer 2012. Essentialoilsinfoodpreservation:modeofaction,synergies,andinteractionswithfoodmatrixcomponents Frontiers in Microbiology 3:1-24
1644El-Shiekh, Y.W. A., Nour El-Din, A. Hanan Mohamed, A. A. Shaymaa and Karam EL-Din, A. Zahraa 2012. Antifungal activity of some Naturally Occurring Compounds against Economically Important Phytopathogic Fungi Nature and Science 10(6):114-123
1645S. Shin and S. Lim 2004. Antifungal effects of herbal essential oils alone and in combination with ketoconazole against Trichophyton spp. Journal of Applied Microbiology 97:1289-1296
1646Radek Sleha, Petra Mosio, Marketa Vydrzalova, Alexandra Jantovska, Vanda Bostikova, Jaroslava Mazurova 2012. In vitro antimicrobial activities of cinnamon bark oil, anethole, carvacrol, eugenol and guaiazulene against Mycoplasma hominis clinical isolates Biomedical papers 156:1-4
1647Raquel O.S. Fontenelle, Selene M. Morais, Erika H.S. Brito, Raimunda S.N. Brilhante, Rossana A. Cordeiro, Ynayara C. Lima, Nilce V.G.P.S. Brasil, André J. Monteiro, José J.C. Sidrim and Marcos F.G. Rocha 2011. Alkylphenol Activity against Candida spp. and Microsporum canis: A Focus on the Antifungal Activity of Thymol, Eugenol and O-Methyl Derivatives Molecules 16:6422-6431
1648Mastura Mohtar, Saiful Azmi Johari, Abdul Rashid Li, Mazurah Mohamed Isa, Shuhaimi Mustafa, Abdul Manaf Ali, Dayang Fredalina Basri 2009. Inhibitory and Resistance-Modifying Potential of Plant-Based Alkaloids Against Methicillin-Resistant Staphylococcus aureus (MRSA) Current Microbiology 59:181-186
1649Jong H Kim, Kathleen L Chan, Noreen Mahoney and Bruce C Campbell 2011. Antifungal activity of redox-active benzaldehydes that target cellular antioxidation Annals of Clinical Microbiology and Antimicrobials 10:23
1650H. Rostami, M. Kazemi and S. Shafiei 2012. Antibacterial Activity of Lavandula officinalis and Melissa officinalis Against Some Human Pathogenic Bacteria Asian Journal of Biochemistry 7(3):133-142
1651Yingjian Lu 2011. ANTIBACTERIAL AND ANTIVIRAL ACTIVITIES OF THYMOL AGAINST SALMONELLA AND COLIPHAGE MS2 ON GRAPE TOMATOES, BOTH ALONE AND IN COMBINATION WITH ORGANIC ACIDS AND SURFACTANTS
1652G.P.P. Kamatou, S.F. Van Vuuren, F.R. Van Heerden, T. Seaman, A.M. Viljoen 2007. Antibacterial and antimycobacterial activities of South African Salvia species and isolated compounds from S. chamelaeagnea South African Journal of Botany 73(2007):552–557
1653Sang-Eun Moon, Hye-Young Kim, Jeong-Dan Cha 2011. Synergistic effect between clove oil and its major compounds and antibiotics against oral bacteria Archives of Oral Biology 56(2011):907-916
1654R.M. Ordó˜nez, I.C. Zampini, M.I. Nieva Moreno, M.I. Isla 2011. Potential application of Northern Argentine propolis to control some phytopathogenic bacteria Microbiological Research 166(2011):578—584
1655Ph. D Thesis, David Aldred, 2009. EXPLOITATIONOF BIOACTIVE CONSTITUENTS OF OLIVE LEAVES, GRAPE POMACE,OLIVEMILLSWASTEWATER AND THEIR APPLICATIONIN PHYTOPROTECTION Titos Nikolaou Mavrakis
1656Sharif M. Al-Reza, Atiqur Rahman, Jonghwi Lee, Sun Chul Kang 2010. Potential roles of essential oil and organic extracts of Zizyphus jujuba in inhibiting food-borne pathogens Food Chemistry 119(2010):981-986
1657Vasiliki Saroglou, Petar D. Marin, Ana Rancic, Milan Veljic, Helen Skaltsa 2007. Composition and antimicrobial activity of the essential oil of six Hypericum species from Serbia Biochemical Systematics and Ecology 35(2007):146-152
1658Vasiliki Saroglou, Anastasia Karioti, Ana Rancic, Kostas Dimas, Catherine Koukoulitsa, Maria Zervou, and Helen Skaltsa 2010. Sesquiterpene Lactones from Anthemis melanolepis and Their Antibacterial and Cytotoxic Activities. Prediction of Their Pharmacokinetic Profile Journal of Natural Products 73:242–246
1659Stephen Y. Gbedema, Francis Adu, Marcel T. Bayor, Kofi Annan and Joshua S. Boateng 2010. ENHANCEMENT OF ANTIBACTERIAL ACTIVITY OF AMOXICILLIN BY SOME GHANAIAN MEDICINAL PLANT EXTRACTS International Journal of Pharmaceutical Sciences and Research 1(11):145-152
1660N. Tomprefa, M.P. McQuilken, R.A. Hill and J.M. Whipps 2009. Antimicrobial activity of Coniothyrium minitans and its macrolide antibiotic macrosphelide A Journal of Applied Microbiology 106(2009):2048–2056
1661Souren Paul, R.C. Dubey, D.K. Maheswari, Sun Chul Kang 2011. Trachyspermum ammi (L.) fruit essential oil influencing on membrane permeability and surface characteristics in inhibiting food-borne pathogens Food Control 22(2011):725-731
1662Zahra Setayesh Mehr, Nima Sanadgol and LeylaVafadar Ghasemi 2012. Effects of essential oil extracted from Citrullus colocynthis (CCT) seeds on growth of phytopathogenic bacteria African Journal of Microbiology Research 6(36):6572-6575
1663Wimonrat Tongpoothorn, Saksit Chanthai, Manop Sriuttha, Kanda Saosang, Chalerm Ruangviriyachai 2012. Bioactive properties and chemical constituents of methanolic extract and its fractions from Jatropha curcas oil Industrial Crops and Products 36(2012):437–444
1664Bijaya Pant, Yoji Kato, Takanori Kumagai, Tatsuomi Matsuoka, Masanori Sugiyama 1997. Blepharismin produced by a protozoan Blepharisma functions as an antibiotic effective against methicillin-resistant Staphylococcus aureus FEMS Microbiology Letters 155:67-71
1665S.W. Son, H.Y. Kim, G.J. Choi, H.K. Lim, K.S. Jang, S.O. Lee, S. Lee, N.D. Sung and J.-C. Kim 2007. Bikaverin and fusaric acid from Fusarium oxysporum show antioomycete activity against Phytophthora infestans Journal of Applied Microbiology 104 (2008) 692–698
1666Vincent H. Tam, Henry Cao, Kimberly R. Ledesma and Ming Hu 2011. In Vitro Potency of Various Polymyxin B Components Antimicrob. Agents Chemother